0000917520-23-000030.txt : 20230426 0000917520-23-000030.hdr.sgml : 20230426 20230426162611 ACCESSION NUMBER: 0000917520-23-000030 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 93 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230426 DATE AS OF CHANGE: 20230426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP CENTRAL INDEX KEY: 0000917520 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 510317849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-26224 FILM NUMBER: 23850131 BUSINESS ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6092750500 MAIL ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP DATE OF NAME CHANGE: 19950614 10-Q 1 iart-20230331.htm 10-Q iart-20230331
false2023Q13/31/20230000917520December 310.0135739P6Y00009175202023-01-012023-03-3100009175202023-04-25xbrli:sharesiso4217:USD00009175202022-01-012022-03-31iso4217:USDxbrli:shares00009175202023-03-3100009175202022-12-3100009175202021-12-3100009175202022-03-310000917520us-gaap:CommonStockMember2022-12-310000917520us-gaap:TreasuryStockMember2022-12-310000917520us-gaap:AdditionalPaidInCapitalMember2022-12-310000917520us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000917520us-gaap:RetainedEarningsMember2022-12-310000917520us-gaap:RetainedEarningsMember2023-01-012023-03-310000917520us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000917520us-gaap:CommonStockMember2023-01-012023-03-310000917520us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000917520us-gaap:TreasuryStockMember2023-01-012023-03-310000917520us-gaap:CommonStockMember2023-03-310000917520us-gaap:TreasuryStockMember2023-03-310000917520us-gaap:AdditionalPaidInCapitalMember2023-03-310000917520us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000917520us-gaap:RetainedEarningsMember2023-03-310000917520us-gaap:CommonStockMember2021-12-310000917520us-gaap:TreasuryStockMember2021-12-310000917520us-gaap:AdditionalPaidInCapitalMember2021-12-310000917520us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000917520us-gaap:RetainedEarningsMember2021-12-310000917520us-gaap:RetainedEarningsMember2022-01-012022-03-310000917520us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000917520us-gaap:CommonStockMember2022-01-012022-03-310000917520us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000917520us-gaap:TreasuryStockMember2022-01-012022-03-310000917520us-gaap:CommonStockMember2022-03-310000917520us-gaap:TreasuryStockMember2022-03-310000917520us-gaap:AdditionalPaidInCapitalMember2022-03-310000917520us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000917520us-gaap:RetainedEarningsMember2022-03-310000917520iart:SurgicalInnovationAssociatesIncMember2022-12-062022-12-06iart:payment0000917520iart:SurgicalInnovationAssociatesIncMemberiart:RevenueBasedPerformanceMilestonesMember2022-12-060000917520iart:FDAApprovalOfPremarketApprovalMemberiart:SurgicalInnovationAssociatesIncMember2022-12-060000917520iart:SurgicalInnovationAssociatesIncMember2022-12-06xbrli:pure0000917520iart:SurgicalInnovationAssociatesIncMember2023-03-310000917520us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberiart:TraditionalWoundCareMember2022-08-310000917520us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberiart:TraditionalWoundCareMember2022-08-312022-08-310000917520us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberiart:TraditionalWoundCareMember2022-01-012022-12-310000917520us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberiart:TraditionalWoundCareMember2023-03-3100009175202023-04-012023-03-310000917520iart:CodmanSpecialtySurgicalMemberiart:NeurosurgeryMember2023-01-012023-03-310000917520iart:CodmanSpecialtySurgicalMemberiart:NeurosurgeryMember2022-01-012022-03-310000917520iart:CodmanSpecialtySurgicalMemberiart:InstrumentsMember2023-01-012023-03-310000917520iart:CodmanSpecialtySurgicalMemberiart:InstrumentsMember2022-01-012022-03-310000917520iart:CodmanSpecialtySurgicalMember2023-01-012023-03-310000917520iart:CodmanSpecialtySurgicalMember2022-01-012022-03-310000917520iart:TissueTechnologiesMemberiart:RegenerativeSkinAndWoundMember2023-01-012023-03-310000917520iart:TissueTechnologiesMemberiart:RegenerativeSkinAndWoundMember2022-01-012022-03-310000917520iart:PrivateLabelMemberiart:TissueTechnologiesMember2023-01-012023-03-310000917520iart:PrivateLabelMemberiart:TissueTechnologiesMember2022-01-012022-03-310000917520iart:TissueTechnologiesMember2023-01-012023-03-310000917520iart:TissueTechnologiesMember2022-01-012022-03-310000917520iart:CodmanSpecialtySurgicalMember2022-12-310000917520iart:TissueTechnologiesMember2022-12-310000917520iart:CodmanSpecialtySurgicalMemberiart:SurgicalInnovationAssociatesIncMember2023-01-012023-03-310000917520iart:TissueTechnologiesMemberiart:SurgicalInnovationAssociatesIncMember2023-01-012023-03-310000917520iart:SurgicalInnovationAssociatesIncMember2023-01-012023-03-310000917520iart:CodmanSpecialtySurgicalMember2023-03-310000917520iart:TissueTechnologiesMember2023-03-310000917520iart:CompletedTechnologyMember2023-01-012023-03-310000917520iart:CompletedTechnologyMember2023-03-310000917520us-gaap:CustomerRelationshipsMember2023-01-012023-03-310000917520us-gaap:CustomerRelationshipsMember2023-03-310000917520iart:TrademarksBrandNamesMember2023-01-012023-03-310000917520iart:TrademarksBrandNamesMember2023-03-310000917520us-gaap:TradeNamesMember2023-03-310000917520iart:SupplierRelationShipsMember2023-01-012023-03-310000917520iart:SupplierRelationShipsMember2023-03-310000917520iart:AllOtherMember2023-01-012023-03-310000917520iart:AllOtherMember2023-03-310000917520iart:CompletedTechnologyMember2022-01-012022-12-310000917520iart:CompletedTechnologyMember2022-12-310000917520us-gaap:CustomerRelationshipsMember2022-01-012022-12-310000917520us-gaap:CustomerRelationshipsMember2022-12-310000917520iart:TrademarksBrandNamesMember2022-01-012022-12-310000917520iart:TrademarksBrandNamesMember2022-12-310000917520us-gaap:TradeNamesMember2022-12-310000917520iart:SupplierRelationShipsMember2022-01-012022-12-310000917520iart:SupplierRelationShipsMember2022-12-310000917520iart:AllOtherMember2022-01-012022-12-310000917520iart:AllOtherMember2022-12-310000917520iart:SeniorCreditFacilityMember2023-03-240000917520us-gaap:SecuredDebtMemberiart:TermLoanFacilityMember2023-03-240000917520us-gaap:RevolvingCreditFacilityMember2023-03-240000917520us-gaap:StandbyLettersOfCreditMember2023-03-240000917520iart:SwinglineLoanMember2023-03-240000917520iart:DebtCovenantPeriod1Memberiart:SeniorCreditFacilityMember2023-03-240000917520iart:DebtCovenantPeriod2Memberiart:SeniorCreditFacilityMember2023-03-240000917520iart:DebtCovenantPeriod3Memberiart:SeniorCreditFacilityMember2023-03-240000917520us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberiart:SeniorCreditFacilityMember2023-01-012023-03-310000917520us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembersrt:MinimumMemberiart:SeniorCreditFacilityMember2023-01-012023-03-310000917520srt:MaximumMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberiart:SeniorCreditFacilityMember2023-01-012023-03-310000917520iart:SeniorCreditFacilityMemberus-gaap:FederalFundsEffectiveSwapRateMember2023-01-012023-03-310000917520srt:MinimumMemberiart:SeniorCreditFacilityMember2023-01-012023-03-310000917520srt:MaximumMemberiart:SeniorCreditFacilityMember2023-01-012023-03-310000917520us-gaap:RevolvingCreditFacilityMember2023-03-310000917520us-gaap:RevolvingCreditFacilityMember2023-01-012023-03-310000917520us-gaap:RevolvingCreditFacilityMember2022-12-310000917520us-gaap:SecuredDebtMemberiart:TermLoanFacilityMember2022-12-310000917520us-gaap:SecuredDebtMemberiart:TermLoanFacilityMember2023-03-310000917520us-gaap:FairValueInputsLevel2Memberus-gaap:SecuredDebtMemberiart:TermLoanFacilityMember2023-03-310000917520us-gaap:StandbyLettersOfCreditMemberiart:SeniorCreditFacilityMember2022-12-310000917520us-gaap:StandbyLettersOfCreditMemberiart:SeniorCreditFacilityMember2023-03-310000917520us-gaap:ConvertibleDebtMemberiart:TwoThousandTwentyFiveSeniorConvertibleNotesMember2020-02-040000917520us-gaap:ConvertibleDebtMemberiart:TwoThousandTwentyFiveSeniorConvertibleNotesMember2020-02-042020-02-040000917520us-gaap:ConvertibleDebtMemberiart:TwoThousandTwentyFiveSeniorConvertibleNotesMember2020-12-090000917520us-gaap:CallOptionMemberus-gaap:ConvertibleDebtMemberiart:TwoThousandTwentyFiveSeniorConvertibleNotesMember2020-02-042020-02-040000917520us-gaap:ConvertibleDebtMemberiart:TwoThousandTwentyFiveSeniorConvertibleNotesMember2023-03-310000917520us-gaap:FairValueInputsLevel2Member2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMemberiart:InterestRateSwapDesignatedDecember132017Tranche2Member2023-03-310000917520iart:InterestRateSwapDesignatedDecember132017Tranche3Memberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMember2023-03-310000917520iart:InterestRateSwapDesignatedOctober102018Tranche1Memberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMember2023-03-310000917520iart:InterestRateSwapDesignatedOctober102018Tranche2Memberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMember2023-03-310000917520iart:InterestRateSwapDesignatedOctober102018Tranche3Memberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMemberiart:InterestRateSwapDesignatedDecember182018Tranche1Member2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMemberiart:InterestRateSwapDesignatedDecember182018Tranche2Member2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberiart:InterestRateSwapDesignatedDecember152020Tranche1Memberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMemberiart:InterestRateSwapDesignatedDecember152020Tranche2Member2023-03-310000917520iart:InterestRateSwapDesignatedMarch312023Memberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMemberiart:InterestRateSwapDesignatedDecember132017Tranche2Member2022-12-310000917520iart:InterestRateSwapDesignatedDecember132017Tranche3Memberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMember2022-12-310000917520iart:InterestRateSwapDesignatedOctober102018Tranche1Memberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMember2022-12-310000917520iart:InterestRateSwapDesignatedOctober102018Tranche2Memberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMember2022-12-310000917520iart:InterestRateSwapDesignatedOctober102018Tranche3Memberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMemberiart:InterestRateSwapDesignatedDecember182018Tranche1Member2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMemberiart:InterestRateSwapDesignatedDecember182018Tranche2Member2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberiart:InterestRateSwapDesignatedDecember152020Tranche1Memberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMemberiart:InterestRateSwapDesignatedDecember152020Tranche2Member2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:CashFlowHedgingMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2022-12-310000917520us-gaap:ShortMemberiart:CodmanMemberus-gaap:CrossCurrencyInterestRateContractMember2022-09-26iso4217:CHF0000917520us-gaap:ShortMemberiart:CodmanMemberus-gaap:CrossCurrencyInterestRateContractMember2023-03-310000917520us-gaap:CrossCurrencyInterestRateContractMember2020-12-210000917520us-gaap:CrossCurrencyInterestRateContractMember2023-01-012023-03-310000917520us-gaap:LongMemberiart:CrossCurrencyInterestRateContractOneMemberiart:CodmanMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2023-03-310000917520us-gaap:LongMemberiart:CrossCurrencyInterestRateContractOneMemberiart:CodmanMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2022-12-310000917520iart:CrossCurrencyInterestRateContractOneMemberiart:CodmanMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2023-03-310000917520iart:CrossCurrencyInterestRateContractOneMemberiart:CodmanMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2022-12-310000917520iart:CrossCurrencyInterestRateContractOneMemberus-gaap:ShortMemberiart:CodmanMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2023-03-310000917520iart:CrossCurrencyInterestRateContractOneMemberus-gaap:ShortMemberiart:CodmanMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2022-12-310000917520us-gaap:LongMemberiart:CrossCurrencyInterestRateContractTwoMemberiart:CodmanMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2023-03-310000917520us-gaap:LongMemberiart:CrossCurrencyInterestRateContractTwoMemberiart:CodmanMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2022-12-310000917520iart:CrossCurrencyInterestRateContractTwoMemberiart:CodmanMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2023-03-310000917520iart:CrossCurrencyInterestRateContractTwoMemberiart:CodmanMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2022-12-310000917520iart:CrossCurrencyInterestRateContractTwoMemberus-gaap:ShortMemberiart:CodmanMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2023-03-310000917520iart:CrossCurrencyInterestRateContractTwoMemberus-gaap:ShortMemberiart:CodmanMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2022-12-310000917520iart:CodmanMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMember2023-03-310000917520iart:CodmanMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMember2023-01-012023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMember2022-01-012022-03-310000917520us-gaap:CrossCurrencyInterestRateContractMember2022-01-012022-03-310000917520us-gaap:CrossCurrencyInterestRateContractMember2023-03-310000917520us-gaap:LongMemberiart:CrossCurrencyInterestRateContractOneMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2023-03-31iso4217:EUR0000917520us-gaap:LongMemberiart:CrossCurrencyInterestRateContractOneMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2022-12-310000917520iart:CrossCurrencyInterestRateContractOneMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2023-03-310000917520iart:CrossCurrencyInterestRateContractOneMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2022-12-310000917520iart:CrossCurrencyInterestRateContractOneMemberus-gaap:ShortMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2023-03-310000917520iart:CrossCurrencyInterestRateContractOneMemberus-gaap:ShortMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2022-12-310000917520us-gaap:LongMemberiart:CrossCurrencyInterestRateContractTwoMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2023-03-310000917520us-gaap:LongMemberiart:CrossCurrencyInterestRateContractTwoMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2022-12-310000917520iart:CrossCurrencyInterestRateContractTwoMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2023-03-310000917520iart:CrossCurrencyInterestRateContractTwoMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2022-12-310000917520iart:CrossCurrencyInterestRateContractTwoMemberus-gaap:ShortMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2023-03-310000917520iart:CrossCurrencyInterestRateContractTwoMemberus-gaap:ShortMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2022-12-310000917520us-gaap:LongMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberiart:CrossCurrencyInterestRateContractThreeMember2023-03-310000917520us-gaap:LongMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberiart:CrossCurrencyInterestRateContractThreeMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberiart:CrossCurrencyInterestRateContractThreeMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberiart:CrossCurrencyInterestRateContractThreeMember2022-12-310000917520us-gaap:ShortMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberiart:CrossCurrencyInterestRateContractThreeMember2023-03-310000917520us-gaap:ShortMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberiart:CrossCurrencyInterestRateContractThreeMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2023-01-012023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2022-01-012022-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2023-01-012023-03-310000917520us-gaap:InterestRateSwapMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2023-03-310000917520us-gaap:InterestRateSwapMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2022-12-310000917520us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMember2023-03-310000917520us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMember2022-12-310000917520us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2023-03-310000917520us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2022-12-310000917520us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherAssetsMember2023-03-310000917520us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherAssetsMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherAssetsMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherAssetsMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherAssetsMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherAssetsMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000917520us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberiart:AccruedExpensesAndOtherCurrentLiabilitiesMemberus-gaap:CashFlowHedgingMember2023-03-310000917520us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberiart:AccruedExpensesAndOtherCurrentLiabilitiesMemberus-gaap:CashFlowHedgingMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberiart:AccruedExpensesAndOtherCurrentLiabilitiesMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberiart:AccruedExpensesAndOtherCurrentLiabilitiesMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberiart:AccruedExpensesAndOtherCurrentLiabilitiesMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberiart:AccruedExpensesAndOtherCurrentLiabilitiesMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberiart:AccruedExpensesAndOtherCurrentLiabilitiesMemberus-gaap:CrossCurrencyInterestRateContractMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberiart:AccruedExpensesAndOtherCurrentLiabilitiesMemberus-gaap:CrossCurrencyInterestRateContractMember2022-12-310000917520us-gaap:InterestRateSwapMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2023-03-310000917520us-gaap:InterestRateSwapMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2022-12-310000917520us-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMember2023-03-310000917520us-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMember2022-12-310000917520us-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2023-03-310000917520us-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2022-12-310000917520us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2023-03-310000917520us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2022-12-310000917520us-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2022-12-310000917520us-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2023-01-012023-03-310000917520us-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherNonoperatingIncomeExpenseMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-01-012023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-03-310000917520us-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeForwardMember2023-01-012023-03-310000917520us-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2023-01-012023-03-310000917520us-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2023-03-310000917520us-gaap:InterestIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2022-12-310000917520us-gaap:InterestIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2023-01-012023-03-310000917520us-gaap:InterestIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000917520us-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2021-12-310000917520us-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2022-01-012022-03-310000917520us-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2022-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherNonoperatingIncomeExpenseMember2021-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherNonoperatingIncomeExpenseMember2022-01-012022-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherNonoperatingIncomeExpenseMember2022-03-310000917520us-gaap:InterestIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2021-12-310000917520us-gaap:InterestIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2022-01-012022-03-310000917520us-gaap:InterestIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:CrossCurrencyInterestRateContractMember2022-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000917520us-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-03-310000917520us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000917520us-gaap:CurrencySwapMemberus-gaap:NondesignatedMember2021-06-300000917520us-gaap:CurrencySwapMemberus-gaap:NondesignatedMember2021-09-300000917520us-gaap:CurrencySwapMember2023-01-012023-03-310000917520us-gaap:CurrencySwapMember2022-01-012022-03-310000917520srt:MaximumMemberus-gaap:EmployeeStockOptionMember2023-01-012023-03-310000917520srt:DirectorMemberus-gaap:EmployeeStockOptionMember2023-01-012023-03-310000917520iart:EmployeeMemberus-gaap:EmployeeStockOptionMember2023-01-012023-03-310000917520iart:DirectorsandCertainExecutiveOfficersMembersrt:MinimumMemberus-gaap:EmployeeStockOptionMember2023-01-012023-03-310000917520srt:MaximumMemberiart:DirectorsandCertainExecutiveOfficersMemberus-gaap:EmployeeStockOptionMember2023-01-012023-03-310000917520us-gaap:RestrictedStockMember2023-01-012023-03-310000917520us-gaap:EmployeeStockOptionMember2023-03-310000917520us-gaap:EmployeeStockOptionMember2023-01-012023-03-310000917520iart:PerformanceStockAndRestrictedStockAwardsMember2023-01-012023-03-310000917520us-gaap:RestrictedStockMember2023-03-310000917520us-gaap:PerformanceSharesMember2023-01-012023-03-31iart:renewal_option0000917520srt:AffiliatedEntityMember2022-01-012022-03-310000917520srt:AffiliatedEntityMember2023-01-012023-03-310000917520us-gaap:BuildingMember2023-03-310000917520us-gaap:BuildingMember2022-12-310000917520us-gaap:VehiclesMember2023-03-310000917520us-gaap:VehiclesMember2022-12-310000917520iart:RelatedPartiesMember2023-03-310000917520iart:ThirdPartiesMember2023-03-310000917520srt:AffiliatedEntityMemberiart:FiveYearOptionLeasePeriodOneMember2023-03-310000917520srt:AffiliatedEntityMemberiart:FiveYearOptionLeasePeriodOneMember2023-01-012023-03-310000917520srt:AffiliatedEntityMemberiart:FiveYearOptionLeasePeriodTwoMember2023-03-310000917520srt:AffiliatedEntityMemberiart:FiveYearOptionLeasePeriodTwoMember2023-01-012023-03-3100009175202023-03-312023-03-3100009175202022-12-312022-12-3100009175202023-01-2600009175202023-01-262023-01-2600009175202022-01-1200009175202022-01-122022-01-1200009175202022-03-2400009175202022-03-312022-03-310000917520us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310000917520us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000917520us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000917520us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-03-310000917520us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-03-310000917520us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310000917520us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-310000917520us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-310000917520us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000917520us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:OtherExpenseMember2023-01-012023-03-310000917520us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:InterestIncomeMember2023-01-012023-03-31iart:Segmentiart:product0000917520iart:CodmanSpecialtySurgicalMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000917520iart:CodmanSpecialtySurgicalMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000917520iart:TissueTechnologiesMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000917520iart:TissueTechnologiesMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000917520us-gaap:OperatingSegmentsMember2023-01-012023-03-310000917520us-gaap:OperatingSegmentsMember2022-01-012022-03-310000917520us-gaap:CorporateNonSegmentMember2023-01-012023-03-310000917520us-gaap:CorporateNonSegmentMember2022-01-012022-03-310000917520country:US2023-01-012023-03-310000917520country:US2022-01-012022-03-310000917520srt:EuropeMember2023-01-012023-03-310000917520srt:EuropeMember2022-01-012022-03-310000917520srt:AsiaPacificMember2023-01-012023-03-310000917520srt:AsiaPacificMember2022-01-012022-03-310000917520iart:RestOfWorldMember2023-01-012023-03-310000917520iart:RestOfWorldMember2022-01-012022-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherCurrentLiabilitiesMemberiart:ArkisBioSciencesInc.Member2022-12-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberiart:ArkisBioSciencesInc.Member2022-12-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberiart:DermaSciencesMember2022-12-310000917520iart:ACellMemberiart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2022-12-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherCurrentLiabilitiesMemberiart:SurgicalInnovationAssociatesIncMember2022-12-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberiart:SurgicalInnovationAssociatesIncMember2022-12-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherCurrentLiabilitiesMemberiart:ArkisBioSciencesInc.Member2023-01-012023-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberiart:ArkisBioSciencesInc.Member2023-01-012023-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberiart:DermaSciencesMember2023-01-012023-03-310000917520iart:ACellMemberiart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherCurrentLiabilitiesMemberiart:SurgicalInnovationAssociatesIncMember2023-01-012023-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberiart:SurgicalInnovationAssociatesIncMember2023-01-012023-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherCurrentLiabilitiesMemberiart:ArkisBioSciencesInc.Member2023-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberiart:ArkisBioSciencesInc.Member2023-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberiart:DermaSciencesMember2023-03-310000917520iart:ACellMemberiart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2023-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherCurrentLiabilitiesMemberiart:SurgicalInnovationAssociatesIncMember2023-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberiart:SurgicalInnovationAssociatesIncMember2023-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherCurrentLiabilitiesMemberiart:ArkisBioSciencesInc.Member2021-12-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberiart:ArkisBioSciencesInc.Member2021-12-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberiart:DermaSciencesMember2021-12-310000917520iart:ACellMemberiart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherCurrentLiabilitiesMember2021-12-310000917520iart:ACellMemberiart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherCurrentLiabilitiesMemberiart:ArkisBioSciencesInc.Member2022-01-012022-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberiart:ArkisBioSciencesInc.Member2022-01-012022-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberiart:DermaSciencesMember2022-01-012022-03-310000917520iart:ACellMemberiart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherCurrentLiabilitiesMember2022-01-012022-03-310000917520iart:ACellMemberiart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherCurrentLiabilitiesMemberiart:ArkisBioSciencesInc.Member2022-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberiart:ArkisBioSciencesInc.Member2022-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Memberiart:DermaSciencesMember2022-03-310000917520iart:ACellMemberiart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherCurrentLiabilitiesMember2022-03-310000917520iart:ACellMemberiart:ContingentConsiderationLiabilityMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2022-03-310000917520iart:ArkisBioSciencesInc.Member2019-07-290000917520iart:MilestonePaymentOneMemberiart:ArkisBioSciencesInc.Member2019-07-290000917520iart:ArkisBioSciencesInc.Memberiart:MilestonePaymentTwoMember2019-07-290000917520iart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberiart:ArkisBioSciencesInc.Member2023-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberiart:ArkisBioSciencesInc.Member2022-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberiart:AccruedExpensesAndOtherCurrentLiabilitiesMemberiart:ArkisBioSciencesInc.Member2023-03-310000917520iart:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel3Memberiart:AccruedExpensesAndOtherCurrentLiabilitiesMemberiart:ArkisBioSciencesInc.Member2022-03-310000917520iart:BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMemberiart:DermaSciencesMember2023-01-012023-03-310000917520iart:DermaSciencesMember2023-03-31iart:liability0000917520us-gaap:FairValueInputsLevel3Memberiart:DermaSciencesMember2023-03-310000917520us-gaap:FairValueInputsLevel3Memberiart:DermaSciencesMember2022-03-310000917520iart:ACellIncMember2021-01-200000917520iart:ACellIncMember2023-03-310000917520iart:ACellIncMember2022-03-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 10-Q
 
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             
COMMISSION FILE NO. 000-26224
 
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
 
Delaware 51-0317849
(STATE OR OTHER JURISDICTION OF
INCORPORATION OR ORGANIZATION)
 (I.R.S. EMPLOYER
IDENTIFICATION NO.)
1100 Campus Road 08540
Princeton,New Jersey(ZIP CODE)
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) 
Registrant's Telephone Number, Including Area Code: (609275-0500
Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report:
Securities registered pursuant to Section 12(b) of the Act:
TITLE OF EACH CLASSTRADING SYMBOLNAME OF EACH EXCHANGE ON WHICH REGISTERED
Common Stock, Par Value $.01 Per ShareIARTNasdaq Global Select Market
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and "emerging growth company" in Rule 12b-2 of the Exchange Act.





Large accelerated filerAccelerated filer
Non-accelerated filer
  
Smaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes      No  
The number of shares of the registrant’s Common Stock, $0.01 par value, outstanding as of April 25, 2023 was 81,904,442.



INTEGRA LIFESCIENCES HOLDINGS CORPORATION
INDEX

 
 Page
Number



PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME
(UNAUDITED)
(Dollars in thousands, except per share amounts)
 Three Months Ended March 31,
 20232022
Total revenue, net$380,846 $376,638 
Costs and expenses:
Cost of goods sold147,975 142,569 
Research and development26,724 24,085 
Selling, general and administrative166,657 159,926 
Intangible asset amortization3,108 3,894 
Total costs and expenses344,464 330,474 
Operating income36,382 46,164 
Interest income4,107 1,377 
Interest expense(12,100)(11,655)
Other income, net1,389 3,429 
Income before income taxes29,778 39,315 
Provision for income taxes5,552 6,414 
Net income $24,226 $32,901 
Net income per share
Basic$0.30 $0.39 
Diluted$0.29 $0.39 
Weighted average common shares outstanding (See Note 13):
Basic81,871 83,632 
Diluted82,323 84,276 
Comprehensive income (See Note 14)
21,02857,031 
The accompanying unaudited notes are an integral part of these condensed consolidated financial statements.
4

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(Dollars in thousands, except per share amounts)
March 31, 2023December 31, 2022
ASSETS
Current assets:
Cash and cash equivalents$307,367 $456,661 
Trade accounts receivable, net of allowances of $3,544 and $4,304
253,995 263,465 
Inventories, net351,275 324,583 
Prepaid expenses and other current assets116,845 116,789 
Total current assets1,029,482 1,161,498 
Property, plant and equipment, net315,175 311,302 
Right of use asset - operating leases146,514 148,284 
Intangible assets, net1,108,759 1,126,609 
Goodwill1,041,606 1,038,881 
Deferred tax assets, net44,680 45,994 
Other assets56,183 57,190 
Total assets$3,742,399 $3,889,758 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of borrowings under senior credit facility$ $38,125 
Current portion of lease liability - operating leases14,792 14,624 
Accounts payable, trade112,785 102,100 
Contract liabilities7,743 7,253 
Accrued compensation53,611 78,771 
Accrued expenses and other current liabilities93,362 80,033 
Total current liabilities282,293 320,906 
Long-term borrowings under senior credit facility769,143 733,149 
Long-term borrowings under securitization facility102,500 104,700 
Long-term convertible securities568,069 567,341 
Lease liability - operating leases156,910 157,420 
Deferred tax liabilities61,693 63,338 
Other liabilities126,853 138,501 
Total liabilities2,067,461 2,085,355 
Stockholders’ equity:
Preferred stock; no par value; 15,000 authorized shares; none outstanding
  
Common stock; $0.01 par value; 240,000 authorized shares; 90,813 and 90,477 issued at March 31, 2023 and December 31, 2022, respectively
908 905 
Additional paid-in capital1,245,297 1,276,977 
Treasury stock, at cost; 8,918 shares and 6,823 shares at March 31, 2023 and December 31, 2022, respectively
(481,678)(362,862)
Accumulated other comprehensive loss7,067 10,265 
Retained earnings903,344 879,118 
Total stockholders’ equity1,674,938 1,804,403 
Total liabilities and stockholders’ equity$3,742,399 $3,889,758 
The accompanying unaudited notes are an integral part of these condensed consolidated financial statements.
5


INTEGRA LIFESCIENCES HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(Dollars in thousands)
 Three Months Ended March 31,
 20232022
OPERATING ACTIVITIES:
Net income$24,226 $32,901 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization31,143 29,724 
Deferred income tax provision1,953 3,544 
Share-based compensation3,620 6,291 
Amortization of debt issuance costs and expenses associated with debt refinancing1,890 1,724 
Non-cash lease expense1,260 (17)
Loss (gain) on disposal of property and equipment(23)712 
Change in fair value of contingent consideration and others4,699 (765)
Changes in assets and liabilities:
Accounts receivable10,041 (3,116)
Inventories(25,423)(11,561)
Prepaid expenses and other current assets(2,164)(5,046)
Other non-current assets(6,009)2,283 
Accounts payable, accrued expenses and other current liabilities(4,984)(9,754)
Other non-current liabilities(14,073)(2,576)
Net cash provided by operating activities26,156 44,344 
INVESTING ACTIVITIES:
Purchases of property and equipment(13,704)(9,325)
Acquired in-process research and development milestone (4,742)
Net cash used in investing activities(13,704)(14,067)
FINANCING ACTIVITIES:
Proceeds from borrowings of long-term indebtedness10,200 11,250 
Payments on debt(12,400)(11,750)
Payment of debt issuance costs(7,578) 
Purchases of treasury stock(150,000)(125,000)
Proceeds from exercised stock options2,326 1,239 
Cash taxes paid in net equity settlement(5,231)(9,204)
Net cash used in financing activities(162,683)(133,465)
Effect of exchange rate changes on cash and cash equivalents937 (3,168)
Net decrease in cash and cash equivalents(149,294)(106,356)
Cash and cash equivalents at beginning of period456,661 513,448 
Cash and cash equivalents at end of period$307,367 $407,092 
The accompanying unaudited notes are an integral part of these condensed consolidated financial statements.
6

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(UNAUDITED)
(Dollars in thousands)
Three Months Ended March 31, 2023
Common StockTreasury StockAdditional Paid-In CapitalAccumulated Other Comprehensive LossRetained EarningsTotal Equity
SharesAmountSharesAmount
Balance, January 1, 202390,476 $905 (6,823)$(362,862)$1,276,977 $10,265 $879,118 $1,804,403 
Net income— — — — — — 24,226 24,226 
Other comprehensive income (loss), net of tax— — — — — (3,198)— (3,198)
Issuance of common stock through employee stock purchase plan21 — — — 1,107 — — 1,107 
Issuance of common stock for vesting of share based awards, net of shares withheld for taxes316 1 16 846 (4,858)— — (4,011)
Share-based compensation— 2 — — 3,609 — — 3,611 
Accelerated shares repurchased— $— (2,111)$(119,662)$(31,538)$— $— $(151,200)
Balance, March 31, 202390,813 $908 (8,918)$(481,678)$1,245,297 $7,067 $903,344 $1,674,938 
Three Months Ended March 31, 2022
Common StockTreasury StockAdditional Paid-In CapitalAccumulated Other Comprehensive LossRetained EarningsTotal Equity
SharesAmountSharesAmount
Balance, January 1, 202289,600 $896 (4,899)$(234,448)$1,264,943 $(45,155)$698,568 $1,684,804 
Net income— — — — — — 32,901 32,901 
Other comprehensive income (loss), net of tax— — — — — 24,130 — 24,130 
Issuance of common stock through employee stock purchase plan17 — — — 1,078 — — 1,078 
Issuance of common stock for vesting of share based awards, net of shares withheld for taxes339 4 14 714 (9,758)— — (9,040)
Share-based compensation— — — — 6,324 — — 6,324 
Accelerated shares repurchased— — (1,938)(129,152)4,152 — — (125,000)
Balance, March 31, 202289,956 $900 (6,823)$(362,886)$1,266,739 $(21,025)$731,469 $1,615,197 
The accompanying unaudited notes are an integral part of these condensed consolidated financial statements.
7

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1. BASIS OF PRESENTATION
General
The terms “we,” “our,” “us,” “Company” and “Integra” refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries unless the context suggests otherwise.
In the opinion of management, the March 31, 2023 unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the financial position, statement of changes in shareholders' equity, results of operations and cash flows of the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP") have been condensed or omitted in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements for the year ended December 31, 2022 included in the Company’s Annual Report on Form 10-K. The December 31, 2022 consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. Operating results for the three-month period ended March 31, 2023 are not necessarily indicative of the results to be expected for the entire year.
The preparation of consolidated financial statements is in conformity with GAAP, which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the condensed consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.

Recent Accounting Pronouncements
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848), and subsequent amendment to the initial guidance: ASU 2021-01, Reference Rate Reform (Topic 848): Scope (collectively, “Topic 848”). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied through December 31, 2024. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of the Secured Overnight Financing Rate ("SOFR") as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition. On March 24, 2023, the Company entered into the seventh amendment and restatement (the "March 2023 Amendment") of its Senior Credit Facility (the “Senior Credit Facility”) with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. In connection with the March 2023 Amendment the Company replaced all LIBOR-based contracts with SOFR, which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities (See Note 6). In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of interest rate swaps from LIBOR to SOFR. Integra has elected to adopt the optional expedient under ASC 848, which will allow the interest rate swap hedging relationship to continue, without de-designation, due to the change in the indexed rate from LIBOR to SOFR.
There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.
8

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
2. ACQUISITIONS AND DIVESTITURES
Surgical Innovation Associates, Inc. Acquisition

On December 6, 2022, the Company completed its acquisition of Surgical Innovation Associates, Inc. ("SIA") for an acquisition purchase price of $51.5 million (the "SIA Acquisition"). In addition to the purchase price, the acquisition includes two separate contingent considerations payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $50.0 million in additional payments), as well as 2) the approval by the FDA of the Premarket Approval (“PMA”) Application for DuraSorb for certain uses by certain timing targets (up to $40.0 million in additional payments). SIA's core technology, DuraSorb, is a fully resorbable scaffold of a globally accepted polymer, which is cleared for use in hernia repair, abdominal wall, and other soft tissue reinforcement. DuraSorb sales will be reported within Integra’s Tissue Technologies ("TT") segment as part of its Wound Reconstruction and Care franchise.

Assets Acquired and Liabilities Assumed at Fair Value

The SIA Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired, and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date.



The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:

Dollars in thousandsPreliminary ValuationWeighted Average Life
Current assets:
Cash4,438 
Trade accounts receivable, net 1,551 
Inventories, net2,900 
Prepaid expenses and other current assets1,654 
Total current assets$10,543 
Intangible assets75,000 14 years
Goodwill41,854 
Total assets acquired$127,397 
Current liabilities:
Accounts payable and accrued expenses$2,044 
Total current liabilities$2,044 
Deferred Tax Liability11,799 
Contingent consideration57,607 
Total liabilities assumed71,450 
Net assets acquired$55,947 

Developed Technology

The estimated fair value of the developed technology was determined using the multi-period excess earnings method of the income approach, which estimates value based on the present value of future economic benefits. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&D costs, selling and marketing costs, working capital, and contributory asset charges, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of the asset’s life cycle, and competitive trends impacting the asset and the cash flow stream.

The Company used a discount rate of 18% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.



9

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
Goodwill

The Company allocated goodwill related to the SIA Acquisition to the TT segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. A key factor that contributes to the recognition of goodwill, and a driver for the Company’s acquisition of SIA, is the attractive growth opportunities presented by the surgical matrix business in the breast reconstruction market. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.

Contingent Consideration

The Company determines the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resulting most likely payouts are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation will be revalued to estimated fair value and changes in fair value will be reflected as income or expense in the consolidated statement of operations. Changes in the fair value of the contingent considerations may result from changes in discount periods and rates and changes in the timing and amount of revenue estimates. Changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.

As part of the SIA Acquisition, the Company is required to pay to the shareholder of SIA up to $90.0 million for two separate payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $50.0 million in additional payments), as well as 2) the approval by the FDA of the PMA for DuraSorb for certain uses by certain timing targets (up to $40.0 million in additional payments). The Company used iterations of the Monte Carlo simulation to calculate the fair value of the contingent consideration for the revenue-based milestone that considered the possible outcomes of scenarios related to each specific milestone for the revenue based performance milestone. The Company used probabilities of achieving the conditions to calculate the fair value of the contingent consideration for the PMA approval milestone. The Company estimated the fair value of the contingent consideration for the revenue based milestone to be $32.6 million at the acquisition date and $25.0 million for the PMA approval milestone as of December 31, 2022. The company recorded a total of $48.7 million in other liabilities as of March 31, 2023 and $12.5 million in accrued expenses and other current liabilities at March 31, 2023 in the consolidated balance sheet of the company. The change in the fair value of the contingent obligation was primarily as a result of changes in the timing.

Deferred Tax Liabilities

Deferred tax liabilities result from identifiable intangible assets’ fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.

Sale of non-core traditional wound care business
On August 31, 2022, the Company completed its sale of its non-core traditional wound care ("TWC") business to Gentell, LLC ("Gentell") for $28.8 million, which consists of $27.8 million in cash plus $1.0 million in contingent consideration which may be received upon achieving certain revenue-based performance milestones two years after the closing date. The proceeds from the sale of the TWC business of $27.8 million is presented in the consolidated statement of cash flows net of cash transferred of $3.5 million and other transaction fees. The transaction included the sale of the Company's TWC products, such as sponges, gauze and conforming bandages, and certain advanced wound care dressings, such as supportive, calcium alginate, hydrogel, and foam dressings.
10

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
The divestiture did not represent a strategic shift that had a major effect on the Company's operations and financial statements. Goodwill was allocated to the assets and liabilities divested using the relative fair value method of the TWC business to the Company's TT reportable business segment. In connection with the sale, the Company recognized $0.6 million as a gain from the sale of the business in the condensed consolidated statement of operations for the year ended December 31, 2022. The transaction is subject to final working capital adjustments.
In addition to the purchase and sale agreement, the Company also entered into a contract manufacturing agreement with Gentell. Under the terms of the agreement, Gentell received inventory, equipment, and tooling to manufacture certain MediHoney® and TCC-EZ® products on behalf of the Company. On the close date of this transaction, the Company transferred all inventory associated with these products to Gentell and recognized an asset of $11.1 million, as a form of a deposit for the inventory transferred, which based on the expected timing of inventory purchases, was primarily included within prepaid expenses and other current assets in the consolidated balance sheet. This deposit will be utilized by the Company on future orders placed to Gentell for such products. As of March 31, 2023, the Company had a deposit remaining of $7.3 million which is included in prepaid assets and recognized a payable due to Gentell of $0.7 million, which is included in the condensed consolidated balance sheet within accrued expenses and other current liabilities.
3. REVENUES FROM CONTRACTS WITH CUSTOMERS
Summary of Accounting Policies on Revenue Recognition
Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services.
Performance Obligations
The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.
Significant Estimates
Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant.
The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract.
The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally 90 days.
The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.
Contract Asset and Liability
Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheets.
Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.
11

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
The following table summarized the changes in the contract asset and liability balances for the three months ended March 31, 2023:
Dollars in thousandsTotal
Contract Asset
Contract asset, January 1, 2023
$10,122 
Transferred to trade receivable from contract asset included in beginning of the year contract asset(9,765)
Contract asset, net of transferred to trade receivables on contracts during the period9,713 
Contract asset, March 31, 2023
$10,070 
Contract Liability
Contract liability, January 1, 2023
$16,127 
Recognition of revenue included in beginning of year contract liability$(2,492)
Contract liability, net of revenue recognized on contracts during the period2,921 
Foreign currency translation3 
Contract liability, March 31, 2023
$16,559 
At March 31, 2023, the short-term portion of the contract liability of $7.7 million and the long-term portion of $8.8 million is included in current liabilities and other liabilities, respectively, in the consolidated balance sheets.
As of March 31, 2023, the Company is expected to recognize revenue of approximately 47% of unsatisfied (or partially unsatisfied) performance obligations as revenue within 12 months, with the remaining balance to be recognized thereafter.
Shipping and Handling Fees
The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.
Product Warranties
Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.
Taxes Collected from Customers
The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.
12

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
Disaggregated Revenue
The following table presents revenues disaggregated by the major sources of revenues for the three months ended March 31, 2023 and 2022 (dollar amounts in thousands):
Three Months Ended March 31, 2023Three Months Ended March 31, 2022
Neurosurgery$192,870 $194,675 
Instruments55,266 52,633 
Total Codman Specialty Surgical248,136 247,308 
Wound Reconstruction and Care100,940 94,630 
Private Label31,770 34,700 
Total Tissue Technologies132,710 129,330 
Total revenue$380,846 $376,638 
See Note 15, Segment and Geographical Information, for details of revenues based on the location of the customer.
4. INVENTORIES
Inventories, net consisted of the following:
Dollars in thousandsMarch 31, 2023December 31, 2022
Finished goods$178,626 $172,088 
Work in process80,532 70,598 
Raw materials92,117 81,897 
Total inventories, net$351,275 $324,583 
5. GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill
Changes in the carrying amount of goodwill for the three-month period ended March 31, 2023 were as follows:
Dollars in thousandsCodman Specialty
Surgical
Tissue TechnologiesTotal
Goodwill at December 31, 2022$656,219 $382,662 $1,038,881 
SIA Acquisition Working Capital Adjustment 129 129 
Foreign currency translation1,639 957 2,596 
Goodwill at March 31, 2023
$657,858 $383,748 $1,041,606 
13

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
Other Intangible Assets
The components of the Company’s identifiable intangible assets were as follows:
 March 31, 2023
Dollars in thousandsWeighted
Average
Life
CostAccumulated
Amortization
Net
Completed technology18 years$1,206,748 $(389,297)$817,451 
Customer relationships12 years$193,297 $(146,098)$47,199 
Trademarks/brand names28 years$97,554 $(35,665)$61,889 
Codman tradenameIndefinite$167,529 $— $167,529 
Supplier relationships30 years$30,211 $(17,415)$12,796 
All other11 years$6,024 $(4,129)$1,895 
$1,701,363 $(592,604)$1,108,759 
 December 31, 2022
Dollars in thousandsWeighted
Average
Life
CostAccumulated
Amortization
Net
Completed technology18 years$1,204,325 $(370,968)$833,357 
Customer relationships12 years193,081 (144,040)49,041 
Trademarks/brand names28 years97,265 (34,674)62,591 
Codman tradenameIndefinite166,693 — 166,693 
Supplier relationships30 years30,211 (17,170)13,041 
All other11 years5,957 (4,071)1,886 
$1,697,532 $(570,923)$1,126,609 
Based on quarter-end exchange rates, amortization expense (including amounts reported in cost of goods sold) is expected to be approximately $61.8 million for the remainder of 2023, $81.8 million in 2024, $81.8 million in 2025, $81.6 million in 2026, $79.7 million in 2027, $78.1 million in 2028 and $474.4 million thereafter.
6. DEBT
Amendment to the Seventh Amended and Restated Senior Credit Agreement
On March 24, 2023, the Company entered into the March 2023 Amendment of the Senior Credit Facility with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The March 2023 Amendment extended the maturity date to March 24, 2028, amended the contractual repayments of Term loan A, and amended the interest rate from LIBOR to SOFR-indexed interest. The Company continues to have the aggregate principal amount of up to approximately $2.1 billion available to it through the following facilities: (i) a $775.0 million term loan facility, and (ii) a $1.3 billion revolving credit facility, which includes a $60 million sublimit for the issuance of standby letters of credit and a $60 million sublimit for swingline loans.
The Company’s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:
Fiscal QuarterMaximum Consolidated Total Leverage Ratio
March 31, 2023 through December 31, 2024
4.50 to 1.00
March 31, 2025 through June 30, 2026
4.25 to 1.00
September 30, 2026 and the last day of each fiscal quarter thereafter
4.00 to 1.00
Borrowings under the Senior Credit Facility bear interest, at the Company’s option, at a rate equal to the following:
i.term SOFR in effect from time to time plus 0.10% plus the applicable rate (ranging from 1.00% to 1.75%), or
ii.the highest of:
1.the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus 0.50%
14

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
2.the prime lending rate of Bank of America, N.A. or
3.the one-month Term SOFR plus 1.00%
The applicable rates are based on the Company’s consolidated total leverage ratio (defined as the ratio of (a) consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof to (b) consolidated EBITDA (as defined by the amended Seventh Amended and Restated Credit Agreement (the "Credit Agreement")), for the period of four consecutive fiscal quarters ending on such date).
The Company will pay an annual commitment fee (ranging from 0.15% to 0.30%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility.
The Senior Credit Facility is collateralized by substantially all of the assets of the Company’s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at March 31, 2023, the Company was in compliance with all such covenants. The Company capitalized $7.6 million in deferred financing costs in connection with the modification of the Senior Credit Facility and wrote off $0.2 million of previously capitalized financing costs during the first quarter of 2023.
At March 31, 2023 and December 31, 2022 there was no balance outstanding under the revolving portion of the Senior Credit Facility. At March 31, 2023 and December 31, 2022, there was $775.0 million outstanding under the term loan component of the Senior Credit Facility at a weighted average interest rate of 6.3% and 5.6%, respectively. As of March 31, 2023 there was no portion of the Term Loan component of the Senior Credit Facility classified as current on the condensed consolidated balance sheet. As of December 31, 2022, there was $38.1 million of the Term Loan component of the Senior Credit Facility classified as current on the consolidated balance sheets under the prior terms of the agreement.
The fair value of outstanding borrowings of the Senior Credit Facility's Term Loan component at March 31, 2023 was $750.9 million. This fair value was determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities.
Letters of credit outstanding as of March 31, 2023 and December 31, 2022 totaled $1.6 million. There were no amounts drawn as of March 31, 2023.
Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:
Quarter Ended March 31, 2023
Principal Repayment
Dollars in thousands
Remainder of 2023
$ 
2024
$14,531 
2025
$33,906 
2026
$38,750 
Thereafter687,813 
$775,000 
Future interest payments on the term loan component of the Senior Credit Facility based on current interest rates are expected to approximate $35.9 million for remainder of 2023, $38.1 million in 2024, $32.6 million in 2025, $30.0 million in 2026, and $34.5 million thereafter . Interest is calculated on the term loan portion of the Senior Credit Facility based on SOFR plus the certain amounts set forth in the Credit Agreement. As the revolving credit facility and Securitization Facility can be repaid at any time, no interest has been included in the calculation.
Any outstanding borrowings on the revolving credit component of the Senior Credit Facility is due on March 24, 2028.
Convertible Senior Notes
On February 4, 2020, the Company issued $575.0 million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of 0.5% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the 2025 Notes. In connection with this offering, the Company capitalized $13.2 million of financing fees.
15

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of 13.5739 shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $73.67 per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least 130% of the conversion price during the period; (2) if the average trading price per $1,000 principal amount of the 2025 Notes is less than or equal to 98% of the average conversion value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if specified corporate transactions occur. As of March 31, 2023, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.
On December 9, 2020, the Company entered into the First Supplemental Indenture to the original agreement dated as of February 4, 2020 between the Company and Citibank, N.A., as trustee, governing the Company’s outstanding 2025 Notes. The Company irrevocably elected (1) to eliminate the Company’s option to choose physical settlement on any conversion of the 2025 Notes that occurs on or after the date of the First Supplemental Indenture and (2) with respect to any Combination Settlement for a conversion of the 2025 Notes, the Specified Dollar Amount that will be settled in cash per $1,000 principal amount of the 2025 Notes shall be no lower than $1,000.
Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption.
In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the “hedge participants”). The cost of the call transactions was $104.2 million for the 2025 Notes. The Company received $44.5 million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $73.67, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $113.34 for the 2025 Notes, subject to customary anti-dilution adjustments.
At March 31, 2023, the carrying amount of the liability was $575.0 million. The fair value of the 2025 Notes at March 31, 2023 was $561.7 million. Factors that the Company considered when estimating the fair value of the 2025 Notes included recent quoted market prices or dealer quote. The level of the 2025 Notes is considered as Level 1.
Securitization Facility
In 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (“SPE”), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to $150.0 million. The Securitization Facility Agreement ("Securitization Agreement") governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of March 31, 2023, the Company was in compliance with the covenants and none of the termination events had occurred.
On May 28, 2021, the Company entered into an amendment (the "May 2021 Amendment") of the Securitization Facility which extended the maturity date from December 21, 2021 to May 28, 2024. The May 2021 Amendment does not increase the Company’s total indebtedness.
The Securitization Facility is currently indexed to LIBOR. At March 31, 2023 and December 31, 2022, the Company had $102.5 million and $104.7 million, respectively, of outstanding borrowings under its Securitization Facility at a weighted average interest rate of 5.8% and 5.0%, respectively. In April 2023, we amended the facility to replace LIBOR with SOFR-indexed interest. The fair value of the outstanding borrowing of the Securitization Facility at March 31, 2023 was $102.2 million. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities.
16

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
7. DERIVATIVE INSTRUMENTS
Interest Rate Hedging
The Company’s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected SOFR-indexed borrowings. In connection with the March 2023 Amendment to the Senior Credit Facility, the Company amended its interest rate from LIBOR to SOFR-indexed interest. In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of swaps from LIBOR to SOFR.
The Company held the following interest rate swaps as of March 31, 2023 and December 31, 2022 (dollar amounts in thousands):
March 31, 2023March 31, 2023
Hedged ItemNotional AmountDesignation DateEffective DateTermination DateFixed Interest RateEstimated Fair Value
Asset (Liability)
1-month Term SOFR Loan150,000 December 13, 2017July 1, 2019June 30, 20242.423 %4,022 
1-month Term SOFR Loan200,000 December 13, 2017January 1, 2018December 31, 20242.313 %6,738 
1-month Term SOFR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.220 %1,329 
1-month Term SOFR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.199 %1,539 
1-month Term SOFR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.209 %1,441 
1-month Term SOFR Loan100,000 December 18, 2018December 30, 2022December 31, 20272.885 %2,770 
1-month Term SOFR Loan100,000 December 18, 2018December 30, 2022December 31, 20272.867 %2,708 
1-month Term SOFR Loan575,000 December 15, 2020July 31, 2025December 31, 20271.415 %19,406 
1-month Term SOFR Loan125,000 December 15, 2020July 1, 2025December 31, 20271.404 %4,567 
Basis Swap (1)
March 31, 2023March 24, 2023December 31, 2027N/A(1,842)
$1,475,000 $42,678 
(1) The notional of the basis swap amortizes to match the total notional of the interest rate swap portfolio over time

17

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
December 31, 2022December 31, 2022
Hedged ItemNotional AmountDesignation DateEffective DateTermination DateFixed Interest RateEstimated Fair Value
Asset (Liability)
1-month USD LIBOR Loan150,000 December 13, 2017July 1, 2019June 30, 20242.423 %5,012 
1-month USD LIBOR Loan200,000 December 13, 2017January 1, 2018December 31, 20242.313 %8,380 
1-month USD LIBOR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.220 %1,831 
1-month USD LIBOR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.199 %1,905 
1-month USD LIBOR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.209 %1,970 
1-month USD LIBOR Loan100,000 December 18, 2018December 30, 2022December 31, 20272.885 %4,252 
1-month USD LIBOR Loan100,000 December 18, 2018December 30, 2022December 31, 20272.867 %4,153 
1-month USD LIBOR Loan575,000 December 15, 2020July 31, 2025December 31, 20271.415 %23,742 
1-month USD LIBOR Loan125,000 December 15, 2020July 1, 2025December 31, 20271.404 %5,467 
$1,475,000 $56,712 
The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive loss (“AOCL”), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCL to interest expense at that time.
Foreign Currency Hedging
From time to time, the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCL, net of tax. Those amounts are subsequently reclassified to earnings from AOCL as impacted by the hedged item when the hedged item affects earnings. If the hedged forecasted transaction does not occur or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income, net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.
The success of the Company’s hedging anticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows.
Cross-Currency Rate Swaps
On September 26, 2022, the Company amended the CHF-denominated intercompany loan to extend the termination date to September 2023 and as a result, the Company early terminated the cross-currency swap designated as cash flow hedge of an intercompany loan with aggregate notional amount of 50.0 million. Simultaneously, the Company entered into a cross-currency swap agreement to convert a notional amount of CHF 48.5 million equivalent to 49.1 million of this amended intercompany loan into U.S. dollars. The loss recorded by the Company upon the settlement of the swap was not material for the period.
On December 21, 2020, the Company entered into cross-currency swap agreements to convert a notional amount of $471.6 million equivalent to 420.1 million of a CHF-denominated intercompany loan into U.S. dollars. The CHF-denominated intercompany loan was the result of an intra-entity transfer of certain intellectual property rights to a subsidiary in Switzerland completed during the fourth quarter of 2020. The intercompany loan requires quarterly payments of CHF 5.8 million plus accrued interest. As a result, the aggregate notional amount of the related cross-currency swaps will decrease by a corresponding amount.
18

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.
The Company held the following cross-currency rate swaps as of March 31, 2023 and December 31, 2022 (dollar amounts in thousands):
March 31, 2023December 31, 2022March 31, 2023December 31, 2022
Effective DateTermination DateFixed RateAggregate Notional AmountFair Value
Asset (Liability)
Pay CHFDecember 21, 2020December 22, 20253.00%CHF373,227 397,137 (3,033)(4,241)
Receive U.S.$3.98%$418,980 445,821 
Pay CHFSeptember 28, 2022September 29, 20231.95%CHF48,533 48,532 (4,011)(3,528)
Receive U.S.$5.32%$49,142 49,142 
Total$(7,044)$(7,769)
The cross-currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCL. For the three months ended March 31, 2023, and 2022, the Company recorded a loss of $4.9 million and a gain $6.5 million, respectively, in other income, net related to change in fair value related to the foreign currency rate translation to offset the losses recognized on the intercompany loans.
For the three months ended March 31, 2023, and 2022, the Company recorded a gain of $7.5 million and $7.9 million in AOCL, respectively, related to change in fair value of the cross-currency swaps.
For the three months ended March 31, 2023, and 2022, the Company recorded a gain of $1.5 million and $1.8 million, respectively, in other income, net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.
The estimated gain that is expected to be reclassified to other income (expense), net from AOCL as of March 31, 2023 within the next twelve months is $0.1 million. As of March 31, 2023, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.
Net Investment Hedges
The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018 and December 16, 2020, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of foreign currency on foreign subsidiaries.
19

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
The Company held the following cross-currency rate swaps designated as net investment hedges as of March 31, 2023 and December 31, 2022, respectively (dollar amounts in thousands):
March 31, 2023December 31, 2022
March 31, 2023
December 31, 2022
Effective DateTermination DateFixed RateAggregate Notional AmountFair Value
Asset (Liability)
Pay EUROctober 3, 2018September 30, 2023%EUR51,760 51,760 3,989 4,713 
Receive U.S.$2.57%$60,000 60,000 
Pay EUROctober 3, 2018September 30, 2025%EUR38,820 38,820 3,932 4,307 
Receive U.S.$2.19%$45,000 45,000 
Pay CHFMay 26, 2022December 16, 2028%CHF288,210 288,210 (14,711)(14,663)
Receive U.S.$1.94%$300,000 300,000 
Total$(6,790)$(5,643)
The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were recorded as unrealized gains or losses in AOCL. For the three months ended March 31, 2023 and 2022, the Company recorded a loss of $1.1 million and a gain $1.3 million, respectively, in AOCL related to the change in fair value of the cross-currency swaps.
For the three months ended March 31, 2023, and 2022, the Company recorded gains of $2.1 million and $1.3 million, respectively, in interest income included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.
The estimated gain that is expected to be reclassified to interest income from AOCL as of March 31, 2023 within the next twelve months is $10.9 million.
Foreign Currency Forward Contract
The Company has entered into a hedge for forecasted intercompany purchases denominated in foreign currencies through the use of forward contracts designated as cash flow hedges. To the extent these forward contracts meet hedge accounting criteria, changes in their fair value are not included in accumulated comprehensive loss. These changes in fair value will be recognized into earnings as a component of cost of sales when the forecasted-transaction occurs.
During the first quarter of 2023 the Company entered into Foreign Currency Forward Contracts with a notional amount of $10.8 million to mitigate the risk of foreign currency on intercompany purchases in CHF. During the three months ended March 31, 2023 the Company recorded an immaterial loss in AOCL related to the change in fair value of the Foreign Currency Forward Contracts.
Counterparty Credit Risk
The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company’s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company’s credit ratings from any credit rating agency.
Fair Value of Derivative Instruments
The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk.
20

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
The following table summarizes the fair value for derivatives designated as hedging instruments in the condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022:
Fair Value as of
Location on Balance Sheet (1):
March 31, 2023December 31, 2022
Dollars in thousands
Derivatives designated as hedges — Assets:
Prepaid expenses and other current assets
Cash Flow Hedges
Interest rate swap(2)
$15,659 $16,682 
Cross-currency swap4,139 4,497 
Net Investment Hedges
Cross-currency swap10,942 11,653 
Other assets
Cash Flow Hedges
Interest rate swap(2)
28,861 40,030 
Cross-currency swap  
Net Investment Hedges
Cross-currency swap2,940 3,311 
Total derivatives designated as hedges — Assets$62,541 $76,173 
Derivatives designated as hedges — Liabilities:
Accrued expenses and other current liabilities
Cash Flow Hedges
Interest rate swap(2)
$762 $ 
Cross-currency swap4,011 3,528 
Foreign currency forward contracts69 
Net Investment Hedges
Cross-currency swap  
Other liabilities
Cash Flow Hedges
Interest rate swap(2)
1,080  
Cross-currency swap7,172 8,738 
Net Investment Hedges
Cross-currency swap20,672 20,608 
Total derivatives designated as hedges — Liabilities$33,766 $32,874 
(1) The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12 months.
(2) At March 31, 2023 and December 31, 2022, the total notional amounts related to the Company’s interest rate swaps were both $1.5 billion, respectively.
21

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying condensed consolidated statement of operations during the three months ended March 31, 2023 and 2022:
Dollars in thousandsBalance in AOCL
Beginning of
Quarter
Amount of
Gain (Loss)
Recognized in
AOCL
Amount of Gain (Loss)
Reclassified from
AOCL into
Earnings
Balance in AOCL
End of Quarter
Location in
Statements of
Operations
Three Months Ended March 31, 2023
Cash Flow Hedges
Interest rate swap$56,712 $(10,534)$3,500 $42,678 Interest expense
Cross-currency swap(20,271)2,191 (3,504)(14,576)Other income, net
Foreign Currency Forward Contract (69) (69)Cost of Sales
Net Investment Hedges
Cross-currency swap(6,914)950 2,096 (8,060)Interest income
$29,527 $(7,462)$2,092 $19,973 
Three Months Ended March 31, 2022
Cash Flow Hedges
Interest rate swap$(43,956)$41,675 $(5,213)$2,932 Interest expense
Cross-currency swap(9,688)316 8,331 (17,703)Other income, net
Net Investment Hedges
Cross-currency swap(2,312)1,309 1,320 (2,323)Interest income
$(55,956)$43,300 $4,438 $(17,094)
Derivative Instruments not designated hedges:
During the second quarter of 2021, the Company entered into a foreign currency swap, with a notional amount of $7.3 million to mitigate the risk from fluctuations in foreign currency exchange rates associated with an intercompany loan denominated in JPY. In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another currency at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company subsequently paid down a portion of this swap, bringing the notional amount down to $6.4 million.
The following table summarizes the gains (losses) of derivative instruments not designated as hedges on the condensed consolidated statements of income, which was included in other income:
Dollars in thousandsThree Months Ended March 31,
20232022
Foreign currency swaps55 360 
Total$55 $360 
8. STOCK-BASED COMPENSATION
As of March 31, 2023, the Company had stock options, restricted stock awards, performance stock awards, contract stock awards and restricted stock unit awards outstanding under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan (the “2003 Plan”). The 2000 and 2001 Equity Incentive Plans were terminated as of February 19, 2021, and no further awards may be issued under the plans.
Stock options issued under the 2003 Plan become exercisable over specified periods, generally within four years from the date of grant for officers and employees, within one year from date of grant for directors which generally expire eight years from the grant date for employees, and from six to ten years for directors and certain executive officers, except in certain instances that result in accelerated vesting due to death, disability, retirement age or change in-control provisions within their grant agreements. The Company values stock option grants using the binomial distribution model. Restricted stock issued under the Plans vests over specified periods, generally three years after the date of grant. The vesting of performance stock issued under the Plans is subject to service and performance conditions.
22

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
Stock Options
As of March 31, 2023, there were approximately $5.6 million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately three years. There were 151,293 stock options granted during the three months ended March 31, 2023. For the three months ended March 31, 2023, the weighted average grant date fair value for stock options granted was $21.58 per option.
Awards of Restricted Stock and Performance Stock
Performance stock and restricted stock awards generally have requisite service periods of three years, except in certain instances that result in accelerated vesting due to death, disability, retirement age provision or change in-control provisions in their grant agreements. Performance stock units are subject to graded vesting conditions based on revenue goals of the Company. The Company expenses the fair value of restricted stock awards on a straight-line basis over the requisite service period. As of March 31, 2023, there was approximately $48.6 million of total unrecognized compensation costs related to these unvested awards. The Company expects to recognize these costs over a weighted-average period of approximately two years. The Company granted 346,745 restricted stock awards and 161,218 performance stock awards during the three months ended March 31, 2023. For the three months ended March 31, 2023, the weighted average grant date fair value for restricted stock awards and performance stock units granted was $53.37 and $52.87 per award, respectively.
The Company also maintains an Employee Stock Purchase Plan (the “ESPP”), which provides eligible employees with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan based on its terms.
9. RETIREMENT PLANS
The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland.
Net periodic benefit costs for the Company’s defined benefit pension plans for the three months ended March 31, 2023 were $0.3 million. The components of the net periodic benefit costs other than the service cost component of $0.5 million for the three months ended March 31, 2023 are included in other income, net in the consolidated statements of operations.
Net periodic benefit costs for the Company’s defined benefit pension plans for the three months ended March 31, 2022 were $0.3 million. The components of the net periodic benefit costs other than the service cost component of $0.7 million for the three months ended March 31, 2022 are included in other income, net in the consolidated statements of operations.
The estimated fair values of plan assets were $36.4 million and $38.1 million as of March 31, 2023 and December 31, 2022, respectively. The net plan assets of the pension plans are invested in common trusts as of March 31, 2023 and December 31, 2022. Common trusts are classified as Level 2 in the fair value hierarchy. The fair value of common trusts is valued at the net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within an appropriate risk profile.
Deferred Compensation Plan
The Company maintains a Deferred Compensation Plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.
This deferred compensation is invested in funds offered under this plan and is valued based on Level 1 measurements in the fair value hierarchy. Assets of the Company's deferred compensation plan are included in other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets were $5.0 million and $4.7 million as of March 31, 2023 and December 31, 2022, respectively. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.
10. LEASES AND RELATED PARTY LEASES
The Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of March 31, 2023. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components.
23

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
Most facility leases include one or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the Right of Use ("ROU") assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.
As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments.
Total operating lease expense for the three months ended March 31, 2023 and March 31, 2022 was $6.0 million and $4.9 million respectively, which includes $0.1 million, in related party operating lease expense.
Supplemental balance sheet information related to operating leases were as follows:
Dollars in thousands, except lease term and discount rateMarch 31, 2023
December 31, 2022
ROU assets$146,514 $148,284 
Current lease liabilities14,792 14,624 
Non-current lease liabilities156,910 157,420 
Total lease liabilities$171,702 $172,044 
Weighted average remaining lease term (in years):
Leased facilities17.1 years16.9 years
Leased vehicles2.0 years2.0 years
Weighted average discount rate:
Leased facilities5.4 %5.4 %
Leased vehicles2.8 %2.7 %
Supplemental cash flow information related to leases for the three months ended March 31, 2023 and 2022 were as follows:
Dollars in thousandsMarch 31, 2023
March 31, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$4,319 $4,696 
ROU assets obtained in exchange for lease liabilities:
Operating leases$1,721 $507 
Future minimum lease payments under operating leases at March 31, 2023 were as follows:
Dollars in thousandsRelated PartiesThird PartiesTotal
Remainder of 2023
$222 $15,870 $16,092 
2024296 21,086 21,382 
2025296 19,753 20,049 
2026296 17,148 17,444 
2027296 16,205 16,501 
2028296 13,951 14,247 
Thereafter246 151,206 151,452 
Total minimum lease payments$1,948 $255,219 $257,167 
Less: Imputed interest85,465 
Total lease liabilities171,702 
Less: Current lease liabilities14,792 
Long-term lease liabilities156,910 
24

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
There were no future minimum lease payments under finance leases at March 31, 2023.
Related Party Leases
The Company leases its manufacturing facility in Plainsboro, New Jersey, from Plainsboro Associates, a New Jersey general partnership. Ocirne, Inc., a subsidiary of Provco Industries, owns a 50% % interest in Plainsboro Associates. Provco Industries is the corporate general partner of Tru St. Partnership LLP, a principal stockholder of the Company. The term of the current lease agreement is through October 31, 2029 at an annual rate of approximately $0.3 million per year. The current lease agreement also provides (i) a 5-year renewal option for the Company to extend the lease from November 1, 2029 through October 31, 2034 at the fair market rental rate of the premises, and (ii) another 5-year renewal option to extend the lease from November 1, 2034 through October 31, 2039 at the fair market rental rate of the premises.
11. TREASURY STOCK
As of March 31, 2023 and December 31, 2022, there were 8.9 million and 6.8 million shares of treasury stock outstanding with a cost of $481.7 million and $362.9 million, at a weighted average cost per share of $54.01 and $53.18, respectively.
On January 26, 2023, the Company entered into a $150 million accelerated share repurchase ("2023 ASR") and received 2.1 million shares of the Company common stock at inception of the 2023 ASR, which represented approximately 80% of the expected total shares under the 2023 ASR. The remaining repurchase transactions are expected to be completed in the second quarter of 2023.
On August 16, 2022, the Inflation Reduction Act of 2022 (the “Act”) was signed into law. The Act implements a new excise tax of 1% on the net share repurchases made by the company effective for share repurchases performed January 1, 2023, or after. The company accrued $1.2 million regarding the excise tax in Q-1 related to the ASR mentioned above.
On January 12, 2022, the Company entered into a $125 million accelerated share repurchase ("2022 ASR") and received 1.48 million shares of Company common stock at inception of the 2022 ASR, which represented approximately 80% of the expected total shares under the 2022 ASR. On March 24, 2022, the early exercise provision under the 2022 ASR was exercised by 2022 ASR counterparty. Upon settlement on March 24, 2022, the Company received an additional 0.46 million shares determined using the volume-weighted average price of the Company's common stock during the term of the 2022 ASR.
12. INCOME TAXES
The following table provides a summary of the Company's effective tax rate:
 Three Months Ended March 31,
 20232022
Reported tax rate18.6 %16.3 %
The Company’s effective income tax rates for the three months ended March 31, 2023 and 2022 were 18.6% and 16.3%, respectively. For the three months ended March 31, 2023, the primary driver of the higher tax rate relates to a reduction of excess tax benefits from stock compensation.
Changes to income tax laws and regulations, in any of the tax jurisdictions in which the Company operates, could impact the effective tax rate. Various governments, both U.S. and non-U.S., are increasingly focused on tax reform and revenue-raising legislation. Further, legislation in foreign jurisdictions may be enacted, in response to the base erosion and profit-sharing project begun by the Organization for Economic Cooperation and Development ("OECD"). The OECD recently finalized major reform of the international tax system with respect to a global minimum tax rate. Such changes in U.S. and non-U.S. jurisdictions could have an adverse effect on the Company’s effective tax rate.
As of March 31, 2023, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested unless there is a manner under which to remit the earnings with no material tax cost. Material taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed. The Company will repatriate foreign earnings when there is no need for reinvestment overseas and there is no material cost to bring the earnings back to the United States. Reinvestment considerations would include future acquisitions, transactions, and capital expenditure plans.
25

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
13. NET INCOME PER SHARE
Basic and diluted net income per share was as follows:
 Three Months Ended March 31,
 Dollars in thousands, except per share amounts20232022
Basic net income per share:
Net income $24,226 $32,901 
Weighted average common shares outstanding81,871 83,632 
Basic net income per common share$0.30 $0.39 
Diluted net income per share:
Net income $24,226 $32,901 
Weighted average common shares outstanding — Basic81,871 83,632 
Effect of dilutive securities:
Stock options and restricted stock452 644 
Weighted average common shares for diluted earnings per share82,323 84,276 
Diluted net income per common share$0.29 $0.39 
Common stock of approximately 0.3 million and 0.2 million shares at March 31, 2023, and 2022, respectively that are issuable through exercise of dilutive securities were not included in the computation of diluted net income per share because their effect would have been anti-dilutive.
14. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Comprehensive income for the three months ended March 31, 2023 and 2022 was as follows:
 Three Months Ended March 31,
Dollars in thousands20232022
Net income $24,226 $32,901 
Foreign currency translation adjustment4,076 (5,683)
Change in unrealized loss/(gain) on derivatives, net of tax(7,377)29,822 
Pension liability adjustment, net of tax103 (9)
Comprehensive income, net$21,028 $57,031 
Changes in accumulated other comprehensive income by component between December 31, 2022 and March 31, 2023 are presented in the table below, net of tax:
Dollars in thousandsGains and Losses on DerivativesDefined Benefit Pension ItemsForeign Currency ItemsTotal
Balance at January 1, 2023
$22,817 $9,322 $(21,874)$10,265 
Other comprehensive gain (loss)(5,754)103 4,076 (1,575)
Less: Amounts reclassified from accumulated other comprehensive income, net1,623   1,623 
Net current-period other comprehensive gain (loss)(7,377)103 4,076 (3,198)
Balance at March 31, 2023
$15,440 $9,425 $(17,798)$7,067 
For the three months ended March 31, 2023, the Company reclassified a gain of $4.3 million and a loss of $2.7 million from accumulated other comprehensive income to other income, net and interest income, respectively.
26

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
15. SEGMENT AND GEOGRAPHIC INFORMATION
The Company internally manages two global reportable segments and reports the results of its businesses to its chief operating decision maker. The two reportable segments and their activities are described below.
The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.
The TT segment includes such offerings as skin and wound repair, plastics & surgical reconstruction products, bone grafts, and nerve and tendon repair products.
The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.
The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by each reportable segment for the three months ended March 31, 2023 and 2022 are as follows:
Three Months Ended March 31,
Dollars in thousands20232022
Segment Net Sales
Codman Specialty Surgical$248,136 $247,308 
Tissue Technologies
132,710 129,330 
Total revenues$380,846 $376,638 
Segment Profit
Codman Specialty Surgical$110,933 $110,160 
Tissue Technologies
52,281 53,893 
Segment profit163,214 164,053 
Amortization(3,108)(3,894)
Corporate and other(123,724)(113,995)
Operating income$36,382 $46,164 
The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:
 Three Months Ended March 31,
Dollars in thousands20232022
United States$271,002 $263,351 
Europe41,064 43,744 
Asia Pacific50,473 47,717 
Rest of World18,307 21,826 
Total Revenues$380,846 $376,638 
16. COMMITMENTS AND CONTINGENCIES
In consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.
27

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.
The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.
Contingent Consideration
The Company determined the fair value of contingent consideration during the three month period ended March 31, 2023 and March 31, 2022 to reflect the change in estimate, additions, payments, transfers and the time value of money during the period.
A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the three months ended March 31, 2023 and March 31, 2022 is as follows (in thousands):
Three Months Ended March 31, 2023Contingent Consideration Liability Related to Acquisition of:
ArkisLocation in Financial StatementsDerma SciencesACellSurgical Innovations Associates, Inc. (FN 2)Location in Financial Statements
Short-termLong-termLong-termLong-termShort-termLong-term
Balance as of January 1, 2023
$2,845 $10,050 $230 $3,700 $ $57,607 
Transfers    12,500 (12,500)
Change in fair value of contingent consideration liabilities 1,543 1,756 Research and development (2,200) 3,600 Selling, general and administrative
Balance as of March 31, 20234,388 11,806 230 1,500 12,500 48,707 
Three Months Ended March 31, 2022Contingent Consideration Liability Related to Acquisition of:
Arkis Location in Financial StatementsDerma SciencesACell Inc.Location in Financial Statements
Short-termLong-termLong-termShort-termLong-term
Balance as of January 1, 2022
$3,691 $11,408 $230 $ $21,800 
Transfers59 (59) 4,885 (4,885)
Change in fair value of contingent consideration liabilities (1,065)Research and development  300 Selling, general and administrative
Balance as of March 31, 2022
$3,750 $10,284 $230 $4,885 $17,215 
28

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued)
Arkis BioSciences Inc.
As part of the acquisition of Arkis BioSciences Inc. ("Arkis"), the Company is required to pay the former shareholders of Arkis up to $25.5 million based on the timing of certain development milestones of $10.0 million and commercial sales milestones of $15.5 million, respectively. The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $13.1 million at the acquisition date. The estimated fair value as of March 31, 2023 and March 31, 2022 was $16.2 million and $14.0 million, respectively. The Company recorded $11.8 million and $10.3 million in other liabilities at March 31, 2023 and March 31, 2022, respectively, and $4.4 million and $3.8 million in accrued expenses and other current liabilities at March 31, 2023 and March 31, 2022, respectively, in the consolidated balance sheet of the Company.
Derma Sciences
The Company assumed contingent consideration incurred by Derma Sciences, Inc. ("Derma Sciences") related to its acquisitions of BioD and the intellectual property related to Medihoney products. The Company accounted for the contingent liabilities by recording their fair value on the date of the acquisition based on a probability weighted income approach. The Company has already paid $33.3 million related to the aforementioned contingent liabilities. One contingent milestone remains which relates to net sales of Medihoney™ products exceeding certain amounts defined in the agreement between the Company and Derma Sciences. The potential maximum undiscounted payment amounts to $3.0 million. The estimated fair value as of March 31, 2023 and March 31, 2022 was $0.2 million.

ACell Inc.
As part of the ACell Acquisition, the Company is required to make payments to the former shareholders of ACell up to $100 million based on the achievement by the Company of certain revenue-based performance milestones in 2023 and 2025. The Company used iterations of the Monte Carlo simulation to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specific milestone. The Company estimated the fair value of the contingent consideration to be $23.9 million at the acquisition date. The estimated fair value as of March 31, 2023 was $1.5 million. The Company recorded $1.5 million and $17.2 million in other liabilities at March 31, 2023 and March 31, 2022, respectively, and $4.9 million in accrued expenses and other current liabilities at March 31, 2022 in the consolidated balance sheets of the Company. The change in the fair value of the contingent obligation was primarily as a result of changes in the timing and amount of revenue estimates.

29

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of the Company's financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the related notes thereto appearing elsewhere in this report and our consolidated financial statements for the year ended December 31, 2022 included in our Annual Report on Form 10-K.

We have made statements in this report that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). All statements other than statements of historical fact contained in this Quarterly Report on Form 10-Q (this “Quarterly Report”), including statements regarding our future results of operations and financial position, business strategy and plans, objectives of management for future operations and current expectations or forecasts of future results, are forward-looking statements. These forward-looking statements are subject to a number of risks, uncertainties and assumptions about the Company and other matters that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements.

These statements involve known and unknown risks, uncertainties, and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Our forward-looking statements may include statements related to our growth and growth strategies, developments in the markets for our products and services, financial results, development launches and effectiveness, research and development strategy, regulatory approvals, competitive strengths, the potential or anticipated direct or indirect impact of the Coronavirus pandemic on our business, results of operations, and/or financial condition, restructuring and cost-saving initiatives, intellectual property rights, litigation and tax matters, governmental proceedings and investigations, mergers and acquisitions, divestitures, market acceptance of our products and services, accounting estimates, financing activities, ongoing contractual obligations, working capital adequacy, value of our investments, our effective tax rate, our expected returns to shareholders, and sales efforts.

In some cases, these forward-looking statements may be identified by forward-looking words such as “believe,” “may,” “might,” “could,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “seek,” “plan,” “expect,” “should,” “would” and similar words and expressions in this report. Forward-looking statements in this Quarterly Report include, but are not limited to, statements regarding our ability to drive long-term shareholder value, development and future launches of products and continued or future acceptance of products and services in our segments; our ability to navigate and mitigate any on-going or future impact associated with economic disruptions, including supply chain constraints and inflation; expected timing for completion of research studies relating to our products; market positioning and performance of our products; divestitures and the potential benefits thereof; the costs and benefits of integrating previous acquisitions; anticipated timing for Food and Drug Administration (“FDA”) in the U.S., as well as for non-U.S. regulatory approval of new products; increased presence in new markets, including markets outside the U.S.; changes in the market and our market share; acquisitions and investment initiatives, including the timing of regulatory approvals as well as integration of acquired companies into our operations; the resolution of tax matters; the effectiveness of our development activities in reducing patient care costs and hospital stay lengths; our approach towards cost containment; our expectations regarding healthcare costs; general economic conditions; and the potential impact of our compliance with governmental regulations and accounting guidance.

We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, results of operations, financial condition, and/or cash flows. These forward-looking statements speak only as of the date of this Quarterly Report and are subject to a number of risks, uncertainties and assumptions described in the “Risk Factors” section and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2022. As forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. One must carefully consider forward-looking statements and understand that such forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and involve a variety of risks and uncertainties, known and unknown, including, among others, those discussed in the sections entitled “Government Regulation” within “Item 1. Business” and “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable law.

30

GENERAL
Integra, headquartered in Princeton, New Jersey, is a world leader in neurosurgical solutions and regenerative tissue technologies. The Company was founded in 1989 with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Integra has developed numerous product lines from this technology for applications ranging from burn and deep tissue wounds to the repair of dura mater in the brain, as well as nerves and tendons. We have expanded our base regenerative technology business to include surgical instruments, neurosurgical products and advanced wound care through global acquisitions and product development to meet the evolving needs of its customers and enhance patient care. Integra LifeSciences Holdings Corporation common stock trades on the Nasdaq Global Select Market (“Nasdaq”) under the symbol “IART.”
We manufacture and sell medical technologies and products in two reportable business segments: Codman Specialty Surgical ("CSS") and Tissue Technologies ("TT"). The CSS segment, which represents approximately two-thirds of our total revenue, consists of market-leading technologies and instrumentation used for a wide range of specialties, such as neurosurgery, neurocritical care and otolaryngology. We are the world leader in neurosurgery and one of the top three providers in instruments used in precision, specialty, and general surgical procedures. Our TT segment generates about one-third of our overall revenue and focuses on three main areas: complex wound surgery, surgical reconstruction, and peripheral nerve repair.
We have key manufacturing and research facilities located in California, Indiana, Maryland, Massachusetts, New Jersey, Ohio, Puerto Rico, Tennessee, Utah, France, Germany, Ireland and Switzerland. We source most of our handheld surgical instruments and sealant products through specialized third-party vendors.

Integra is committed to restoring patients’ lives through transformative technologies and products in the segments in which we compete. Our mission is to innovate treatment pathways to advance patient outcomes and set new standards of care. We refocused our strategies around five pillars, specifically three core growth drivers -- innovating for outcomes, growing internationally, broadening our impact on care pathways – enabled by two key levers: driving operational and customer excellence and cultivating a high-performance culture. These five pillars drive how and where we aim to accelerate in 2023 and in the coming years.

Innovating for Outcomes. An important part of Integra’s growth strategy is introducing new products to strengthen and expand our portfolio. Additionally, we seek clinical evidence to support regulatory approval and strong reimbursement of our product portfolio around the world, including new indications for existing technologies. On December 6, 2022, we completed the acquisition of Surgical Innovation Associates, Inc. (“SIA”), which develops, markets and sells DuraSorb, a resorbable synthetic matrix for plastic and reconstructive surgery. This acquisition advances our global strategy in breast reconstruction, expanding plans to access the U.S. market where SIA is pursuing pre-market approval for use in implant-based breast reconstruction ("IBBR"). We also continued to advance the development of pioneering neurosurgical technologies with the expansion of our product offerings. In early 2023, the CUSA® Clarity Bone Tip was launched in U.S., which is used when controlled fragmentation, emulsification and aspiration of bone is necessary. This follows the CUSA® Clarity extended laparoscopic tip, launched in the U.S. in late 2022 to enhance the benefits of ultrasonic ablation to minimally invasive laparoscopic liver surgery.

Growing International. Over the years, we have been significantly expanding our global footprint through investments in our commercial organization, expansion and development of international markets and new product introductions. Several new products were introduced in 2023, including MicroMatrix® and Certas Plus® Programmable Valve which were launched in Europe, and CUSA Clarity Laparoscopic ("Lap") tip which was launched in Australia and New Zealand.

Broadening Impact on Care Pathways. Integra seeks ways to develop products and technologies that impact the lives of patients, starting with the journey that a patient takes from diagnosis and treatment planning to surgery and postoperative care. Integra is well-established in acute care in the hospital setting and plans to leverage that strong position to grow in this segment and shape treatment pathways into preoperative care and additional sites of care.

Driving Operations and Customer Excellence. Integra has been making investments to build more responsive and scalable processes, enhance the reliability of our supply chain, and drive productivity initiatives to further supply and lower costs. Additionally, we continue to invest in technologies, systems and processes to enhance the customer experience. In 2022, certain transactional back-office finance and customer service activities were outsourced to enhance customer quality, build scale for future growth, and capture cost efficiencies.

Cultivating a High-Performance Culture. Creating a culture focused on empowerment and agility and building a diverse and inclusive workplace are cornerstones of our people strategy. These efforts resulted in Integra being named in several best workplace lists globally in 2022. Most recently, Integra China was recognized as a Great Place to Work in Greater China.
31

Additionally, we have been making great strides in advancing our environmental, social and governance ("ESG") agenda to drive sustainability across the organization and recently published our first ESG report in late 2022.
Clinical and Product Development Activities
Integra continues to invest in collecting clinical evidence to support our existing products and new product launches, and to ensure that we obtain market access for broader and more cost-effective solutions
In 2022, we made progress to several enhancements to our CUSA Clarity Tissue Ablation System. The extended laparoscopic tip was launched in the U.S. to enhance laparoscopic liver procedures. In addition, a single-sided bone tip received 510(k) clearance. In early 2023, we had our commercial launch with initial surgeries successfully completed. We continue to update our CUSA Clarity platform by incorporating new ultrasonic handpiece and integrated electrosurgical capabilities.
In 2022, we continued to advance the early-stage technology platforms we acquired in 2019. Through the acquisition of Arkis Biosciences, Inc. ("Arkis") we added a platform technology, CerebroFlo® external ventricular drainage ("EVD"), catheter with Endexo® technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation. The CerebroFlo EVD Catheter has demonstrated an average of 99% less thrombus accumulation onto its surface, in vitro, compared to a market leading EVD catheter. Our work to combine our bactiseal antimicrobial technology with the Endexo anti-occlusive technology obtained through our 2019 acquisition of Arkis continues to progress for both a silicone-based hydrocephalus and EVD project.

In 2019, we also acquired Rebound Therapeutics Corporation ("Rebound Therapeutics"), a company that specialized in single-use medical device, known as Aurora Surgiscope, which is the only tubular retractor system designed for cranial surgery with an integrated access channel, camera and lighting. In the third quarter of 2021, we conducted a limited clinical launch of the Aurora Surgiscope for use in minimally invasive neurosurgery as well as initiated a registry called MIRROR to collect data on early surgical intervention using this same technology platform for the treatment of ICH. In 2022, we launched the Aurora® Evacuator with Coagulation device in the U.S., designed to be used in conjunction with our Aurora Surgiscope to safely address and evacuate blood in the brain caused by hemorrhagic stroke. 
We are focused on the development of core clinical applications in our electromechanical technologies portfolio. In June 2022, we launched the Neutus® EVD system, our first EVD in China. The Neutus EVD system is manufactured in China by Shanghai Haoju Medical Technology Co., Ltd. under an exclusive distribution arrangement. The device is used in the management of CSF and is highly complementary to our Bactiseal® catheter and advanced intercranial pressure monitoring products. In 2021, we launched our CereLink ICP Monitor System in the U.S. and Europe direct markets and continued the global rollout in the first half of 2022. CereLink provides enhanced accuracy, usability and advanced data presentation that provides clinicians with uncompromised, advanced continuous ICP monitoring that until now, has not been available when treating patients with traumatic brain injuries. Refer below to the information appearing in the "FDA Matters" section for additional information on the voluntary recall of the CereLink ICP Monitor System.
Within our TT segment, in 2022, we launched NeuraGen 3D Nerve Guide Matrix, a resorbable implant for repair of peripheral nerve discontinuities and engineered to create an optimized environment for nerve regeneration. In the third quarter of 2021, we filed the PMA application for a specific indication for SurgiMend in the use of post-mastectomy breast reconstruction, for which we hope to obtain FDA approval in 2024. On December 6, 2022, we completed the acquisition of SIA, which develops, markets and sells DuraSorb®, a resorbable synthetic matrix for plastic and reconstructive surgery. This acquisition advances our global strategy in breast reconstruction, expanding plans to access the U.S. market where SIA is pursuing pre-market approval for use in IBBR.

FDA Matters
On August 18, 2022, we, after consultation with the FDA and other regulatory authorities outside of the United States, initiated an immediate voluntary global product removal of all CereLink intracranial pressure monitors as a result of customer reports about monitors whose pressure readings were out of range. We believe that the out-of-range readings are principally caused by electrical interference from the external environment and/or interference from a component on the circuit board of the monitor. These out-of-range readings have occurred at a low incidence rate and at a limited number of sites; however, out of an abundance of caution, we removed all CereLink monitors from the field.

We are continuing our investigation into the matter in order to remedy the observed issue and plans to resume shipment of the CereLink monitors as soon as any such issues have been resolved and required regulatory reviews have been completed. Based on the outlook for returning the product to market and feedback from customers, we recorded a $1.9 million provision for product returns, as a reduction of net revenue, and a $0.8 million rework accrual in cost of goods sold in 2022. In the first quarter of 2023 we recorded an additional $0.8M in provision for product returns as a reduction of net revenue, and no additional rework costs.
32

On March 7, 2019, TEI Biosciences, Inc. ("TEI"), one of our wholly-owned subsidiaries , received a Warning Letter (the “Warning Letter”), dated March 6, 2019, from the FDA. The warning letter related to quality systems issues at TEI's manufacturing facility located in Boston, Massachusetts. The letter resulted from an inspection held at that facility in October and November 2018 and did not identify any new observations that were not already provided in the Form 483 that followed the inspection. We submitted our initial response to the FDA Warning Letter on March 28, 2019 and provide regular progress reports to the FDA as to its corrective actions and, since the conclusion of the inspection, we have undertaken significant efforts to remediate the observations and continue to do so. On October 28, 2021 the FDA initiated an inspection of the facility and at the conclusion of the inspection issued a FDA Form 483 on November 12, 2021 (the "2021 Form 483"). We provided an initial response to the inspection observations and will continue to provide responses to the FDA. On March 1, 2023, the FDA commenced an inspection of the facility, and we anticipate that the FDA will issue an FDA Form 483 at the conclusion of this inspection. The Warning Letter and the 2021 FDA Form 483 do not restrict our ability to manufacture or ship products or require the recall of any products, nor do they restrict our ability to seek FDA 510(k) clearance of products. Additionally, premarket approval applications for Class III devices to which the Quality System regulation violations are reasonably related will not be approved until the violations have been corrected. The TEI Boston facility manufactures extracellular bovine matrix products. We cannot give any assurances that the FDA will be satisfied with our response to the Warning Letter or as to the expected date of the resolution of the matters included in the letter. Until the issues cited in the letter are resolved to the FDA’s satisfaction, the FDA may initiate additional regulatory action without further notice. Any adverse regulatory action, depending on its magnitude, may restrict us from effectively manufacturing, marketing and selling our products and could have a material adverse effect on our business, financial condition and results of operations.
Revenues of products manufactured in the TEI Boston facility for the three months ended March 31, 2023 were approximately 4.4% of consolidated revenues.

OPTIMIZATION AND INTEGRATION ACTIVITIES
As a result of our ongoing acquisition strategy and significant growth in recent years, we have undertaken cost-saving initiatives to consolidate manufacturing operations, distribution facilities and transfer activities, eliminate duplicative positions, realign various sales and marketing activities, and expand and upgrade production capacity for our regenerative technology products. These efforts are expected to continue and while we expect a positive impact from ongoing restructuring, integration, and manufacturing transfer and expansion activities, such results remain uncertain. In support of our continued focus on product margins during 2022, we closed a manufacturing facility located in France and transferred production to our existing Switzerland facility. In 2022, we outsourced certain transactional back-office finance and customer service activities to enhance customer quality, build scale for future growth, and capture cost efficiencies.
RESULTS OF OPERATIONS
Executive Summary
Net income for the three months ended March 31, 2023 was $24.2 million, or $0.29 per diluted share, as compared to $32.9 million or $0.39 per diluted share for the three months ended March 31, 2022. The decrease in net income for the three months ended March 31, 2023, was primarily driven by impacts from the SIA acquisition, including additional amortization, research and development, and other costs.
33

Special Charges
Income before taxes includes the following special charges:
Three Months Ended March 31,
Dollars in thousands20232022
Acquisition, divestiture and integration-related charges$8,776 $574 
Structural optimization charges4,335 6,320 
EU medical device regulation11,404 9,513 
Total$24,515 $16,407 
The items reported above are reflected in the condensed consolidated statements of operations as follows:
Three Months Ended March 31,
Dollars in thousands20232022
Cost of goods sold $6,066 $4,530 
Research and development4,218 4,267 
Selling, general and administrative14,730 8,902 
Other income(499)(1,292)
 Total$24,515 $16,407 
We typically define special charges as items for which the amounts and/or timing of such expenses may vary significantly from period to period, depending upon our acquisition, divestiture, integration and restructuring activities, and for which the amounts are non-cash in nature, and for which the amounts are not expected to recur at the same magnitude. We believe that given our ongoing strategy of seeking acquisitions, our continuing focus on rationalizing our existing manufacturing and distribution infrastructure and our continuing review of various product lines in relation to our current business strategy, some of the special charges discussed above could recur with similar materiality in the future.
We believe that the separate identification of these special charges provides important supplemental information to investors regarding financial and business trends relating to our financial condition and results of operations. Investors may find this information useful in assessing comparability of our operating performance from period to period, against the business model objectives that management has established, and against other companies in our industry. We provide this information to investors so that they can analyze our operating results in the same way that management does and to use this information in their assessment of our core business and valuation of Integra.
Revenues and Gross Margin
The Company's revenues and gross margin on product revenues were as follows:
 Three Months Ended March 31,
Dollars in thousands20232022
Segment Net Sales
Codman Specialty Surgical$248,136$247,308
Tissue Technologies132,710129,330
Total revenues$380,846$376,638
Cost of goods sold147,975142,569
Gross margin on total revenues$232,871$234,069
Gross margin as a percentage of total revenues61.1 %62.1 %
Three Months Ended March 31, 2023 as Compared to Three Months Ended March 31, 2022
Revenues
For the three months ended March 31, 2023, total revenues increased by $4.2 million to $380.8 million from $376.6 million for the same period in 2022, inclusive of a unfavorable foreign currency impact of $7.0 million on revenues, as well as a $4.5 million decrease that impacts both domestic and international revenues related to the divestiture of the TWC business. This also includes an increase of $1.8 million related to the SIA acquisition. Excluding the impacts of these items, domestic revenues increased by $6.8 million, or 2.6% as compared to the prior year period. International revenues increased by $7.1 million or 6.5% as compared to the prior period. The increase in domestic revenues was primarily driven by strong sales in our TT segment. The increase in international revenues was primarily driven by Advanced Energy.
34



In the CSS segment, revenues were $248.1 million which was an increase of $0.8 million, or 0.3% as compared to the prior-year period, inclusive of a $6.4 million unfavorable foreign currency impact on revenue. Excluding the impact of foreign exchange, Neurosurgery portfolio grew low single digits primarily due to sales in Advanced Energy. Sales in our instruments portfolio increased mid-single digits as compared to the same period in the prior year.
In the TT segment, revenues were $132.7 million which was an increase of $3.4 million, or 2.6% from the prior-year period, inclusive of a $0.6 million unfavorable foreign currency impact on revenue, as well as a $4.5 million decrease that impacts both domestic and international revenues related to the divestiture of the TWC business. This also includes an increase of $1.8 million related to the SIA acquisition. Excluding the impact of these items, our sales increased mid single digits, driven by strong customer demand and increased burn cases.
Gross Margin
Gross margin was $232.9 million for the three months ended March 31, 2023, a decrease of $1.2 million from $234.1 million for the same period in 2022. Gross margin as a percentage of revenues was 61.1% for the three months ended March 31, 2023 and 62.1% for the same period in 2022. This decrease in gross margin is a result of unfavorable product mix and an increase in manufacturing costs.
Operating Expenses
The following is a summary of operating expenses as a percent of total revenues: 
 Three Months Ended March 31,
 20232022
Research and development7.0 %6.4 %
Selling, general and administrative43.8 %42.5 %
Intangible asset amortization0.8 %1.0 %
Total operating expenses51.6 %49.9 %
Total operating expenses, which consist of research and development, selling, general and administrative, and amortization expenses, increased by $8.6 million, or 4.6% to $196.5 million in the three months ended March 31, 2023, compared to $187.9 million in the same period in 2022. The increase in operating expenses compared to the prior year is primarily a result of the SIA acquisition combined with increases in selling costs associated with higher revenue.
Research and Development
Research and development expenses for the three months ended March 31, 2023 increased by $2.6 million as compared to the same period in the prior year. This increase in spending resulted from additional spending related to the SIA acquisition, new product development and clinical studies.
Selling, General and Administrative
Selling, general and administrative costs for the three months ended March 31, 2023 increased by $6.7 million as compared to the same period in the prior year driven primarily due to increased selling costs associated with SIA acquisition and costs associated with consulting activities.
Intangible Asset Amortization
Amortization expense (excluding amounts reported in cost of product revenues for technology-based intangible assets) for the three months ended March 31, 2023 was $3.1 million compared to $3.9 million for the same period in the prior year.
35

Non-Operating Income and Expenses
The following is a summary of non-operating income and expenses:
 Three Months Ended March 31,
Dollars in thousands20232022
Interest income$4,107 $1,377 
Interest expense(12,100)(11,655)
Other income, net1,389 3,429 
Total non-operating income and expense$(6,604)$(6,849)
Interest Income
Interest income for the three months ended March 31, 2023 increased by $2.7 million as compared to the same period in the prior year due to higher interest rates.
Interest Expense
Interest expense for the three months ended March 31, 2023 decreased by $0.4 million as compared to the same period in the prior year.
Other Income, net
Other income, net for the three months ended March 31, 2023 decreased by $2.0 million compared to the same period in the prior year. The decrease is primarily driven by lower Transition Service Agreement ("TSA") income from the sale of our Extremity orthopedics business, offset by additional TSA income from the sale of our TWC business.
Income Taxes
 Three Months Ended March 31,
Dollars in thousands20232022
Income before income taxes$29,778 $39,315 
Income tax (benefit) expense5,552 6,414 
Effective tax rate18.6 %16.3 %
Our effective income tax rates for the three months ended March 31, 2023 and 2022 were 18.6% and 16.3%, respectively.
For the three months ended March 31, 2023, the primary driver of the higher tax rate relates to a reduction of excess tax benefits from stock compensation.
The effective tax rate may vary from period to period depending on, among other factors, the geographic and business mix of taxable earnings and losses, tax planning and settlements with various taxing authorities. We consider these factors and others, including the Company's history of generating taxable earnings, in assessing our ability to realize tax assets on a quarterly basis.
Additionally, changes to income tax laws and regulations, in any of the tax jurisdictions in which we operate, could impact the effective tax rate. Various governments, both U.S. and non-U.S., are increasingly focused on tax reform and revenue-raising legislation. Further, legislation in foreign jurisdictions may be enacted, in response to the base erosion and profit-shifting project begun by the Organization for Economic Cooperation and Development ("OECD"). The OECD recently finalized major reform of the international tax system with respect to implementing a global minimum tax rate. Such changes in U.S. and non-U.S. jurisdictions could have an adverse effect on the Company’s effective tax rate.

While it is often difficult to predict the outcome or the timing of the resolution of a particular matter with the various federal, state, and foreign tax authorities, we believe that our reserves reflect the most probable outcome of known tax contingencies. Settlement of a particular issue would usually require the use of cash. A favorable resolution would be recognized as a reduction to our annual effective tax rate in the year of resolution. Our tax reserves are presented in the balance sheet within other liabilities, except for amounts relating to items that we expect to pay in the coming year, which would be classified as current income taxes payable.
36

GEOGRAPHIC PRODUCT REVENUES AND OPERATIONS
We attribute revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:
Three Months Ended March 31,
Dollars in thousands20232022
United States$271,002 $263,351 
Europe41,064 43,744 
Asia Pacific50,473 47,717 
Rest of World18,307 21,826 
Total Revenues$380,846 $376,638 
We generate significant revenues outside the U.S., a portion of which are U.S. dollar-denominated transactions conducted with customers that generate revenue in currencies other than the U.S. dollar. As a result, currency fluctuations between the U.S. dollar and the currencies in which those customers do business could have an impact on the demand for our products in foreign countries. Local economic conditions, regulatory compliance or political considerations, the effectiveness of our sales representatives and distributors, local competition and changes in local medical practice all may combine to affect our sales into markets outside the U.S.
Domestic revenues increased by $7.7 million for the three months ended March 31, 2023 compared to the same period last year. European sales decreased by $2.7 million for the three months ended March 31, 2023 compared to the same period last year. Sales to customers in Asia Pacific increased by $2.8 million for the three months ended March 31, 2023. The Rest of World for the three months ended March 31, 2023 decreased by $3.5 million compared to the same period last year. The international revenues were impacted by $7.0 million of unfavorable foreign exchange impact, with the larger impact in Europe. The increase in global revenues, inclusive of a $7.0 million unfavorable foreign exchange impact on revenue, is a result of strong sales in our TT division and our international businesses. Sales in Japan, China, Europe, Canada and our indirect markets continue to drive international growth.
LIQUIDITY AND CAPITAL RESOURCES
Working Capital
The Company's working capital as of March 31, 2023 and December 31, 2022 was $747.2 million and $840.6 million, respectively. Working capital consists of total current assets less total current liabilities as presented in the consolidated balance sheets.
Cash and Marketable Securities
The Company had cash and cash equivalents totaling approximately $307.4 million and $456.7 million at March 31, 2023 and December 31, 2022 respectively, which are valued based on Level 1 measurements in the fair value hierarchy. At March 31, 2023, our non-U.S. subsidiaries held approximately $242.2 million of cash and cash equivalents that are available for use outside the U.S. The Company asserts that it has the ability and intends to indefinitely reinvest the undistributed earnings from its foreign operations unless there is no material tax cost to remit the earnings into the U.S..
Cash Flows
 Three Months Ended March 31,
Dollars in thousands20232022
Net cash provided by operating activities$26,156 $44,344 
Net cash used in investing activities(13,704)(14,067)
Net cash used in financing activities(162,683)(133,465)
Effect of exchange rate fluctuations on cash937 (3,168)
Cash Flows Provided by Operating Activities
Operating cash flows for the three months ended March 31, 2023 decreased by $18.2 million compared to the same period in 2022. Net income after removing the non-cash adjustments decreased for the three months ended March 31, 2023 by approximately $5.3 million as compared to the same period in 2022 primarily due to higher product costs and expenses related to support for key growth initiatives in research and development, selling and marketing areas.
37

The changes in assets and liabilities in the first quarter of 2023, net of business acquisitions, decreased cash flows by $42.6 million, mainly attributable to increases in inventory to support increased sales and decreases in accrued expenses and other current liabilities due to increased payments processed in the quarter.
The changes in assets and liabilities in the first quarter of 2022, net of business acquisitions, decreased cash flows by $29.8 million, primarily due to increases in inventory to support increased sales and decreases in accounts payable, accrued expenses and other current liabilities due to increased payments processed in the quarter.
Cash Flows Used in Investing Activities
During the three months ended March 31, 2023, we paid $13.7 million for capital expenditures to support operations improvement initiatives at a number of our manufacturing facilities and other information technology investments.
During the three months ended March 31, 2022, we paid $9.3 million for capital expenditures to support operations improvement initiatives at a number of our manufacturing facilities and other information technology investments as well as the final $4.7 million payment related to the final developmental milestone for Rebound Therapeutics Corporation.
Cash Flows Used in Financing Activities
Uses of cash from financing activities in the three months ended March 31, 2023 related to the repurchase of treasury stock of $150.0 million under the 2023 accelerated share repurchase agreement, repayments of $12.4 million under our Senior Credit Facility and Securitization Facility. We also had $7.6 million in payment of debt issuance costs. In addition, the Company had $5.2 million in cash taxes paid for net equity settlements.
Sources of cash from financing activities for the three months ended March 31, 2023 were $10.2 million borrowing under our Senior Credit Facility and Securitization Facility and $2.3 million proceeds from the exercise of stock options.
Uses of cash from financing activities in the three months ended March 31, 2022 related to the repurchase of treasury stock of $125.0 million under the 2022 accelerated share repurchase agreement, repayments of $11.8 million under our Senior Credit Facility and Securitization Facility. In addition, we had $9.2 million in cash taxes paid for net equity settlements.
Sources of cash from financing activities for the three months ended March 31, 2022 were $11.3 million borrowing under our Senior Credit Facility and Securitization Facility and $1.2 million proceeds from the exercise of stock options.
Amended and Restated Senior Credit Agreement, Convertible Senior Notes, Securitization and Related Hedging Activities
See Note 6. Debt, to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for a discussion of our Amended and Restated Senior Credit Agreement, the 2025 Notes and Securitization Facility and Note 7, Derivative Instruments, to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for discussion of our hedging activities. We are forecasting that sales and earnings for the next twelve months will be sufficient to remain in compliance with our financial covenants under the terms of the March 2023 Amendment to the Senior Credit Facility.
Share Repurchase Plan
On January 26, 2023, we entered into ("the 2023 ASR") and received 2.1 million shares of our common stock at inception of the 2023 ASR, which represented approximately 80% of the expected total shares under the 2023 ASR. The remaining repurchase transactions are expected to be completed in the second quarter of 2023.
On January 12, 2022, we entered into a $125.0 million accelerated share repurchase ("2022 ASR") and received 1.48 million shares of our common stock at inception of the 2022 ASR, which represented approximately 80% of the expected total shares under the 2022 ASR. On March 24, 2022, the early exercise provision under the 2022 ASR was exercised by 2022 ASR counterparty. Upon settlement of the 2022 ASR on March 24, 2022, we received an additional 0.46 million shares determined using the volume-weighted average price of our common stock during the term of the 2022 ASR.
See Note 11. Treasury Stock, to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for further details.
Dividend Policy
We have not paid any cash dividends on our common stock since our formation. Our Senior Credit Facility limits the amount of dividends that we may pay. Any future determinations to pay cash dividends on our common stock will be at the discretion of the Board and will depend upon our financial condition, results of operations, cash flows and other factors deemed relevant by the Board.
38

Capital Resources
We believe that our cash and available borrowings under the Senior Credit Facility are sufficient to finance our operations and capital expenditures for the foreseeable future. Our future capital requirements will depend on many factors, including the growth of our business, the timing and introduction of new products and investments, strategic plans and acquisitions, among others. Additional sources of liquidity available to us include short term borrowings and the issuance of long term debt and equity securities.
Off-Balance Sheet Arrangements
We do not have any off–balance sheet financing arrangements during the three months ended March 31, 2023 that have or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our interests.
Contractual Obligations and Commitments
We will continue to have cash requirements to support seasonal working capital needs and capital expenditures, to pay interest, to service debt, and to fund acquisitions. As part of our ongoing operations, we enter into contractual arrangements that obligate us to make future cash payments.
Our primary obligations include principal and interest payments on revolving portion and Term Loan component of the Senior Credit Facility, Securitization Facility and Convertible Securities. See Note 6. Debt, to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for details. We also lease some of our manufacturing facilities and office buildings which have future minimum lease payments associated. See Note 10. Leases and Related Party Leases, to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for a schedule of our future minimum lease payments. Amounts related to our other obligations, including employment agreements and purchase obligations were not material.
The Company has contingent consideration obligation related to prior and current year acquisitions and future pension contribution obligations. See Note 9. Retirement Plans, and Note 16. Commitments and Contingencies, to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for details. The associated obligations are not fixed. We also have a liability for uncertain tax benefits including interest and penalties. We cannot make a reliable estimate of the period in which the uncertain tax benefits may be realized.

OTHER MATTERS
Critical Accounting Estimates
The critical accounting estimates included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 have not materially changed.
Recently Issued Accounting Standards
Information regarding new accounting pronouncements is included in Note 1. Basis of Presentation, to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) to the current period’s condensed consolidated financial statements.
39

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to various market risks, including changes in foreign currency exchange rates and interest rates that could adversely affect our results of operations and financial condition. To manage the volatility relating to these typical business exposures, we may enter into various derivative transactions when appropriate. We do not hold or issue derivative instruments for trading or other speculative purposes.
Foreign Currency Exchange and Other Rate Risks
We operate on a global basis and are exposed to the risk that changes in foreign currency exchange rates could adversely affect our financial condition, results of operations and cash flows. We are primarily exposed to foreign currency exchange rate risk with respect to transactions and net assets denominated in Euros, British pounds, Swiss francs, Canadian dollars, Japanese yen, Mexican pesos, Brazilian reais, Australian dollars and Chinese yuan. We manage the foreign currency exposure centrally, on a combined basis, which allows us to net exposures and to take advantage of any natural offsets. To mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, we periodically enter into derivative financial instruments in the form of foreign currency exchange forward contracts with major financial institutions. We temporarily record realized and unrealized gains and losses on these contracts that qualify as cash flow hedges in other comprehensive income, and then recognize them in other income or expense when the hedged item affects net earnings.
From time to time, we enter into foreign currency forward exchange contracts to manage currency exposures for transactions denominated in a currency other than an entity’s functional currency. As a result, the impact of foreign currency gains/losses recognized in earnings are partially offset by gains/losses on the related foreign currency forward exchange contracts in the same reporting period. Refer to Note 7. Derivative Instruments, to Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for further information.
We maintain written policies and procedures governing our risk management activities. With respect to derivatives, changes in hedged items are generally expected to be completely offset by changes in the fair value of hedge instruments. Consequently, foreign currency exchange contracts would not subject us to material risk due to exchange rate movements, because gains and losses on these contracts offset gains and losses on the assets, liabilities or transactions being hedged.
The results of operations discussed herein have not been materially affected by inflation.
Interest Rate Risk
Cash and Cash Equivalents - We are exposed to the risk of interest rate fluctuations on the interest income earned on our cash and cash equivalents. A hypothetical 100 basis points movement in interest rates applicable to our cash and cash equivalents outstanding at March 31, 2023 would impact interest income by approximately $3.1 million on an annual basis. We are subject to foreign currency exchange risk with respect to cash balances maintained in foreign currencies.
Debt - Our interest rate risk relates primarily to U.S. dollar SOFR-indexed borrowings. We use interest rate swap derivative instruments to manage our earnings and cash flow exposure to changes in interest rates. These interest rate swaps fix the interest rate on a portion of our expected SOFR-indexed floating-rate borrowings. These interest rate swaps were designated as cash flow hedges as of March 31, 2023. The total notional amounts related to the Company’s interest rate swaps were $1.5 billion with $775.0 million effective as of March 31, 2023. Based on our outstanding borrowings at March 31, 2023, a 100 basis points change in interest rates would have impacted interest expense on the unhedged portion of the debt by $1.0 million on an annualized basis. See Note 7. Derivative Instruments, to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for further information regarding interest rate swaps.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our Exchange Act report is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. Disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Management has designed our disclosure controls and procedures to provide reasonable assurance of achieving the desired control objectives.
40

As required by Exchange Act Rule 13a-15(b), we have carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2023. Based upon this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of March 31, 2023 to provide such reasonable assurance.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended March 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
In response to business integration activities, we have and will continue to further align and streamline the design and operation of the financial control environment to be responsive to the changing business model.
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Information pertaining to legal proceedings can be found in Note 16, Commitment and Contingencies, to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report).
ITEM 1A. RISK FACTORS
There have been no material changes in our risk factors included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and subsequent periodic reports filed with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange Act").
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The following table provides information about purchases by us during the quarter ended March 31, 2023 of equity securities that are registered by us pursuant to Section 12 of the Exchange Act. Subject to applicable law, share repurchases may be made from time to time in open market transactions, privately negotiated transactions including accelerated share repurchase agreements, or pursuant to instruments and plans complying with Rule 10b5-1 under the Exchange Act, among other types of transactions and arrangements.
Issuer purchases of equity securities
PeriodTotal number of shares purchased by monthAverage price paid per shareTotal number of shares purchased by month as part of publicly announced repurchase programsApproximate dollar value of shares that may yet be purchased under the plans or program
01/01/23 - 01/31/232,111,189 $56.68 2,111,189 30,000,000 
02/01/23 - 02/28/23— — — — 
03/01/23 - 03/31/23— — — — 
2,111,189 $56.68 2,111,189 30,000,000 
On January 26, 2023, the Company entered into the 2023 ASR and received 2.1 million shares of our common stock at inception of the 2023 ASR, which represented approximately 80% of the expected total shares under the 2023 ASR. The remaining repurchase transactions are expected to be completed in the second quarter of 2023.
See Note 11, Treasury Stock, to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for additional information regarding our share repurchase program and the 2023 ASR.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
Not applicable.
41

ITEM 6. EXHIBITS
Exhibits
3.1(a)
3.1(b)
3.1(c)
3.1(d)
3.2
3.3
10.1
10.2
10.3(a)
10.3(b)
10.3(c)
10.3(d)
10.3(e)
42

*10.4
*31.1 
*31.2 
*32.1 
*32.2 
*†101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
*†101.SCH XBRL Taxonomy Extension Schema Document
*†101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
*†101.DEF XBRL Definition Linkbase Document
*†101.LAB XBRL Taxonomy Extension Labels Linkbase Document
*†101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
 
*Filed herewith
#Indicates a management contract or compensatory plan or arrangement.
The financial information of Integra LifeSciences Holdings Corporation Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 filed on April 26, 2023 formatted in XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Statements of Operations and Comprehensive Income, (ii) the Condensed Consolidated Balance Sheets, (iii) Parenthetical Data to the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements, is furnished electronically herewith.
43

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
Date:April 26, 2023/s/ Jan De Witte
 Jan De Witte
 President and Chief Executive Officer
(Principal Executive Officer)
Date:April 26, 2023/s/ Jeffrey A. Mosebrook
 Jeffrey A. Mosebrook
 Senior Vice President, Finance
(Principal Financial Officer and Principal Accounting Officer)

44
EX-10.4 2 iart-20230331xexx104.htm EX-10.4 Document
Exhibit 10.4
AMENDMENT NO. 4 TO RECEIVABLES FINANCING AGREEMENT
AND
REAFFIRMATION OF PERFORMANCE GUARANTY
This AMENDMENT NO. 4 TO RECEIVABLES FINANCING AGREEMENT AND REAFFIRMATION OF PERFORMANCE GUARANTY (this “Amendment”), dated as of April 17, 2023 is entered into by and among INTEGRA RECEIVABLES LLC (“Integra”), as borrower under the Receivables Financing Agreement (as defined below) (in such capacity, together with its successors and permitted assigns in such capacity, the “Borrower”), INTEGRA LIFESCIENCES SALES LLC (“Integra Sales”), as initial servicer under the Receivables Financing Agreement (in such capacity, together with its successors and permitted assigns in such capacity, the “Servicer”), PNC BANK, NATIONAL ASSOCIATION (“PNC”), as administrative agent under the Receivables Financing Agreement (in such capacity, together with its successors and permitted assigns in such capacity, the “Administrative Agent”), as a committed lender under the Receivables Financing Agreement (in such capacity, together with its successors and permitted assigns in such capacity, a “Committed Lender”), and as group agent for the PNC Group under the Receivables Financing Agreement (in such capacity, together with its successors and permitted assigns in such capacity, a “Group Agent”), and the various other Lenders and Group Agents from time to time party to the Receivables Financing Agreement, and acknowledged and agreed to by PNC CAPITAL MARKETS LLC, as structuring agent (in such capacity, together with its successors and permitted assigns in such capacity, the “Structuring Agent”), and is reaffirmed by, with respect to Section 11 hereof, INTEGRA LIFESCIENCES HOLDINGS CORPORATION (“Integra Holdings”), as performance guarantor (in such capacity, together with its successors and permitted assigns in such capacity, the “Performance Guarantor”).
BACKGROUND
WHEREAS, the Borrower, the Servicer, the Persons from time to time party thereto as Lenders and as Group Agents, the Administrative Agent, and, solely with respect to Section 10.10 thereof, the Structuring Agent, entered into the Receivables Financing Agreement, dated as of December 21, 2018 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Original Receivables Financing Agreement”; and as amended by this Amendment and as may be further amended, restated, supplemented or otherwise modified from time to time, the “Receivables Financing Agreement”);
WHEREAS, the Performance Guarantor entered into the Performance Guaranty as of December 21, 2018 (as may be further amended, restated, supplemented or otherwise modified from time to time, the “Performance Guaranty”) in favor of, and as accepted by, the Administrative Agent; and
WHEREAS, the parties hereto wish to further amend the Original Receivables Financing Agreement pursuant to the terms and conditions set forth herein.
NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
SECTION 1.Definitions. Capitalized terms used but not defined in this Amendment shall have the meanings assigned to them in the Receivables Financing Agreement.
SECTION 2.Amendments to Original Receivables Financing Agreement. Effective as of the date hereof and subject to the satisfaction of the conditions precedent set forth in Section 4
1
123470162\V-4


hereof, the Original Receivables Financing Agreement is hereby amended to add or delete such text as may be necessary to conform the Original Receivables Purchase Agreement to the agreement attached as Exhibit A.
SECTION 3.Representations, Warranties and Enforceability. Each of the Borrower and the Servicer hereby represents and warrants to the Administrative Agent, the Group Agents and the Lenders, as applicable, as of the date hereof with respect to itself, as follows:
(a)the representations and warranties of it contained in Section 6.01 and Section 6.02, as applicable, of the Receivables Financing Agreement are true and correct in all material respects (unless such representations and warranties contain a materiality qualification, in which case, such representations and warranties shall be true and correct as made) on and as of the date hereof as though made on and as of such date unless such representations and warranties by their terms refer to an earlier date, in which case they shall be true and correct in all material respects (unless such representations and warranties contain a materiality qualification, in which case such representations and warranties shall be true and correct as made) on and as of such earlier date; and
(b)(i) the execution and delivery by it of this Amendment, and the performance of its obligations under this Amendment and the Receivables Financing Agreement are within its organizational powers and have been duly authorized by all necessary action on its part and (ii) this Amendment and the Receivables Financing Agreement are its valid and legally binding obligations, enforceable in accordance with their respective terms.
SECTION 4.Conditions Precedent. The effectiveness of this Amendment is subject to the satisfaction of all of the following conditions precedent:
(a)The Administrative Agent shall have received a fully executed counterpart of this Amendment.
(b)(i) PNC, as the Administrative Agent, as a Committed Lender and as the Group Agent for the PNC Group under the Receivables Financing Agreement, as applicable, shall have received all fees and other amounts due and payable to it under the Transaction Documents and in connection with this Amendment on or prior to the date hereof, including, to the extent invoiced, payment or reimbursement of all fees and expenses (including reasonable and documented out-of-pocket fees, charges and disbursements of counsel) required to be paid or reimbursed on or prior to the date hereof and (ii) PNC Capital Markets LLC, as Structuring Agent under the Receivables Financing Agreement, shall have received a one-time fee (the “Amendment Fee”) in an amount equal to Fifty Thousand Dollars ($50,000), which Amendment Fee shall accrue and be due and payable on the date hereof . To the extent such fees and other amounts have not yet been invoiced, the Borrower agrees to remit payment to the applicable party promptly upon receipt of such invoice.

(c)No Event of Default or Unmatured Event of Default, as set forth in Section 9.01 of the Receivables Financing Agreement, shall have occurred and be continuing.
SECTION 5.Amendment. The Borrower, the Servicer, the Administrative Agent, the Group Agents, the Lenders, and, with respect to Section 11 hereof, the Performance Guarantor, hereby agree that the provisions and effectiveness of this Amendment shall apply to the Receivables Financing Agreement as of the date hereof. Except as amended by this Amendment, the Original Receivables Financing Agreement remains unchanged and in full force and effect. This Amendment is a Transaction Document.
2
123470162\V-4


SECTION 6.Counterparts. This Amendment may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement. Delivery of an executed counterpart hereof by facsimile or other electronic means shall be equally effective as delivery of an originally executed counterpart.
SECTION 7.Captions. The headings of the Sections of this Amendment are provided solely for convenience of reference and shall not modify, define, expand or limit any of the terms or provisions of this Amendment.
SECTION 8.Successors and permitted assigns. The terms of this Amendment shall be binding upon, and shall inure to the benefit of, the Borrower, the Servicer, the Administrative Agent, the Group Agents, the Lenders, and, with respect to Section 11 hereof, the Performance Guarantor and their respective successors and permitted assigns.
SECTION 9.Severability. Any provision of this Amendment which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.
SECTION 10.Governing Law and Jurisdiction. The provisions of the Receivables Financing Agreement with respect to governing law, jurisdiction, and agent for service of process are incorporated in this Amendment by reference as if such provisions were set forth herein.
SECTION 11.Ratification of Performance Guarantee. After giving effect to this Amendment, all of the provisions of the Performance Guaranty shall remain in full force and effect and the Performance Guarantor hereby ratifies and affirms the Performance Guaranty and acknowledges that the Performance Guaranty has continued and shall continue in full force and effect in accordance with its terms.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

3
123470162\V-4


IN WITNESS WHEREOF, the parties hereto have executed this Amendment by their duly authorized officers as of the date first above written.
INTEGRA RECEIVABLES LLC,
as the Borrower
By:     /s/ Matthieu Aussermeier        
Name: Matthieu Aussermeier        
Title:     Treasurer                
INTEGRA LIFESCIENCES SALES LLC,
as the Servicer
By: Integra LifeSciences Corporation, its sole member
By:     /s/ Matthieu Aussermeier        
Name: Matthieu Aussermeier        
Title:     Treasurer                

Amendment No. 4 to RFA (Integra)
S-1


Acknowledged and reaffirmed by, with respect to Section 11 hereof, as of the date first written above:                
INTEGRA LIFESCIENCES HOLDINGS CORPORATION,
as the Performance Guarantor
By:     /s/ Matthieu Aussermeier            
Name: Matthieu Aussermeier            
Title:      Treasurer                    

Amendment No. 4 to RFA (Integra)
S-2


PNC BANK, NATIONAL ASSOCIATION,
as the Administrative Agent
By: /s/ Eric Bruno                
Name: Eric Bruno                
Title:     Senior Vice President            
PNC BANK, NATIONAL ASSOCIATION,
as the Group Agent for the PNC Group
By: /s/ Eric Bruno                
Name: Eric Bruno                
Title:     Senior Vice President            
PNC BANK, NATIONAL ASSOCIATION,
as a Committed Lender
By: /s/ Eric Bruno                
Name: Eric Bruno                
Title:     Senior Vice President            

Amendment No. 4 to RFA (Integra)
S-3


Acknowledged and agreed to by, as of the date first written above:    
PNC CAPITAL MARKETS LLC,
as the Structuring Agent
By: /s/ Eric Bruno                
Name: Eric Bruno                
Title:     Managing Director            



Amendment No. 4 to RFA (Integra)
S-4


Exhibit A to Amendment No. 4 to RFA
CONFORMED RECEIVABLES FINANCING AGREEMENT
Exhibit A
123470162\V-4

Exhibit A to Amendment No. 4
RECEIVABLES FINANCING AGREEMENT
Dated as of December 21, 2018
by and among
INTEGRA RECEIVABLES LLC,
as Borrower,
THE PERSONS FROM TIME TO TIME PARTY HERETO,
as Lenders and as Group Agents,
PNC BANK, NATIONAL ASSOCIATION,
as Administrative Agent,
INTEGRA LIFESCIENCES SALES LLC,
as initial Servicer,
and
PNC CAPITAL MARKETS LLC,
as Structuring Agent
Error! Unknown document property name.

TABLE OF CONTENTS
Page
-i-
Error! Unknown document property name.

TABLE OF CONTENTS
(continued)
Page
-ii-
Error! Unknown document property name.

TABLE OF CONTENTS
(continued)
Page
-iii-
Error! Unknown document property name.

TABLE OF CONTENTS
(continued)
Page
-iv-
Error! Unknown document property name.

TABLE OF CONTENTS
(continued)
Page



-v-
Error! Unknown document property name.

TABLE OF CONTENTS
(continued)
Page
EXHIBITS
EXHIBIT A        –    Form of Loan Request
EXHIBIT B        –    Form of Reduction Notice
EXHIBIT C            Form of Assignment and Acceptance Agreement
EXHIBIT D        –    Form of Assumption Agreement
EXHIBIT E        –    Credit and Collection Procedures
EXHIBIT F        –    Form of Information Package
EXHIBIT G        –    Form of Compliance Certificate
EXHIBIT H        –    Closing Memorandum
EXHIBIT I            Form of Interim Report
SCHEDULES
SCHEDULE I        –    Commitments
SCHEDULE II    –    Lock-Boxes, Collection Accounts and Collection Account Banks
SCHEDULE III    –    Notice Addresses
SCHEDULE IV    –    Excluded Obligors and Originators

-vi-
Error! Unknown document property name.



This RECEIVABLES FINANCING AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”) is entered into as of December 21, 2018 by and among the following parties:
(i)    INTEGRA RECEIVABLES LLC, a Delaware limited liability company, as Borrower (together with its successors and assigns, the “Borrower”);
(ii)    the Persons from time to time party hereto as Lenders and as Group Agents;
(iii)    PNC BANK, NATIONAL ASSOCIATION (“PNC”), as Administrative Agent;
(iv)    INTEGRA LIFESCIENCES SALES LLC, a Delaware limited liability company, in its individual capacity (“Integra Sales”) and as initial servicer (in such capacity, together with its successors and assigns in such capacity, the “Servicer”); and
(v)    PNC CAPITAL MARKETS LLC, a Pennsylvania limited liability company, as Structuring Agent.
PRELIMINARY STATEMENTS
The Borrower has acquired, and will acquire from time to time, Receivables from the Originator(s) pursuant to the Purchase and Sale Agreement. The Borrower has requested that the Lenders make Loans from time to time to the Borrower, on the terms, and subject to the conditions set forth herein, secured by, among other things, the Receivables.
In consideration of the mutual agreements, provisions and covenants contained herein, the sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
ARTICLE 1

DEFINITIONS
SECTION 1.0a.Certain Defined Terms. As used in this Agreement, the following terms shall have the following meanings (such meanings to be equally applicable to both the singular and plural forms of the terms defined):
Account Control Agreement” means each agreement, in form and substance satisfactory to the Administrative Agent, among the Borrower, the Servicer (if applicable), the Administrative Agent and a Collection Account Bank, governing the terms of the related Collection Accounts that (i) provides the Administrative Agent with control within the meaning of the UCC over the deposit accounts subject to such agreement and (ii) by its terms, may not be terminated or canceled by the related Collection Account Bank without the written consent of the Administrative Agent or upon no less than sixty (60) calendar days’ prior written notice to the Administrative Agent, as the same may be amended, restated, supplemented or otherwise modified from time to time.
Adjusted Net Receivables Pool Balance” means an amount equal to (a) the Net Receivables Pool Balance minus (b) the greater of (i) the Specifically Reserved Dilution Amount and (ii) zero.
Error! Unknown document property name.



Administrative Agent” means PNC, in its capacity as contractual representative for the Credit Parties, and any successor thereto in such capacity appointed pursuant to Article X or Section 13.03(g).
Adverse Claim” means any ownership interest or claim, mortgage, deed of trust, pledge, lien, security interest, hypothecation, charge or other encumbrance or security arrangement of any nature whatsoever, whether voluntarily or involuntarily given, including, but not limited to, any conditional sale or title retention arrangement, and any assignment, deposit arrangement or lease intended as, or having the effect of, security and any filed financing statement or other notice of any of the foregoing (whether or not a lien or other encumbrance is created or exists at the time of the filing); it being understood that any of the foregoing in favor of, or assigned to, the Administrative Agent (for the benefit of the Secured Parties) shall not constitute an Adverse Claim.
Advisors” has the meaning set forth in Section 13.06(c).
Affected Person” means each Credit Party, each Program Support Provider, each Liquidity Agent and each of their respective Affiliates.
Affiliate” means, as to any Person: (a) any Person that, directly or indirectly, is in control of, is controlled by or is under common control with such Person or (b) who is a director or officer: (i) of such Person or (ii) of any Person described in clause (a), except that, in the case of each Conduit Lender, Affiliate shall mean the holder(s) of its Capital Stock or membership interests, as the case may be. For purposes of this definition, control of a Person shall mean the power, direct or indirect, whether or not exercised: (x) to vote 25% or more of the securities having ordinary voting power for the election of directors or managers of such Person or (y) to direct or cause the direction of the management and policies of such Person, in either case whether by ownership of securities, contract, proxy or otherwise.
Aggregate Capital” means, at any time of determination, the aggregate outstanding Capital of all Lenders at such time.
Aggregate Interest” means, at any time of determination, the aggregate accrued and unpaid Interest on the Loans of all Lenders at such time.
Agreement” has the meaning set forth in the preamble to this Agreement.
Alternative Currency” means each of Euro and GBP.
Anti-Terrorism Laws” means any Applicable Law relating to terrorism financing, trade sanctions programs and embargoes, import/export licensing, money laundering or bribery, and any regulation, order, or directive promulgated, issued or enforced pursuant to such Applicable Laws, all as amended, supplemented or replaced from time to time.
Applicable Law” means, with respect to any Person, (x) all provisions of law, statute, treaty, constitution, ordinance, rule, regulation, ordinance, requirement, restriction, permit, executive order, certificate, decision, directive or order of any Governmental Authority applicable to such Person or any of its property and (y) all judgments, injunctions, orders, writs, decrees and awards of all courts and arbitrators in proceedings or actions in which such Person is a party or by which any of its property is bound. For the avoidance of doubt, FATCA shall constitute an “Applicable Law” for all purposes of this Agreement.
Assignment and Acceptance Agreement” means an assignment and acceptance agreement entered into by a Committed Lender, an Eligible Assignee, such Committed Lender’s
2
Error! Unknown document property name.



Group Agent and the Administrative Agent, and, if required, the Borrower, pursuant to which such Eligible Assignee may become a party to this Agreement, in substantially the form of Exhibit C hereto.
Assumption Agreement” has the meaning set forth in Section 13.03(i).
Attorney Costs” means and includes all fees, costs, expenses and disbursements of any law firm or other external counsel and all disbursements of internal counsel.
Available Tenor” means, as of any date of determination and with respect to the then-current Benchmark, as applicable, if such Benchmark (a) is Term SOFR or Daily 1M SOFR, one (1) month, and (b) is a term rate, any tenor for such Benchmark (or component thereof) that is or may be used for determining the length of an interest period pursuant to this Agreement as of such date and not including, for the avoidance of doubt, any tenor of such Benchmark that is then-removed from the definition of “Interest Period” pursuant to Section 4.06(d)(iv).
Bankruptcy Code” means the United States Bankruptcy Reform Act of 1978 (11 U.S.C. § 101, et seq.), as amended from time to time.
Base Rate” means, for any day and any Lender, a fluctuating interest rate per annum as shall be in effect from time to time, which rate shall be at all times equal to the greater of:
(1)the rate of interest in effect for such day as publicly announced from time to time by the applicable Group Agent or its Affiliate as its “reference rate” or “prime rate”, as applicable. Such “reference rate” or “prime rate” is set by the applicable Group Agent or its Affiliate based upon various factors, including such Person’s costs and desired return, general economic conditions and other factors, and is used as a reference point for pricing some loans, which may be priced at, above or below such announced rate, and is not necessarily the lowest rate charged to any customer; and
(2)a half percent (0.50%) per annum above the latest Overnight Bank Funding Rate.
Base Rate Loan” means a Loan bearing interest at the Base Rate.
Benchmark” means, initially, the Term SOFR Rate or the Daily SOFR Rate, as applicable; provided, that if a Benchmark Transition Event has occurred with respect to the then-current Benchmark, then “Benchmark” means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate pursuant to Section 4.06.
Benchmark Replacement” means, with respect to any Benchmark Transition Event, the first alternative set forth in the order below that can be determined by the Administrative Agent for the applicable Benchmark Replacement Date:
(1)    the sum of: (A) Daily Simple SOFR, and (B) the SOFR Adjustment;
(2)    the sum of (A) the alternate benchmark rate that has been selected by the Administrative Agent and the Borrower, giving due consideration to (x) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body or (y) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement to the then-current Benchmark for U.S. dollar-denominated syndicated credit facilities at such time and (B) the related Benchmark Replacement Adjustment;
3
Error! Unknown document property name.



provided, that if the Benchmark Replacement as determined pursuant to clause (2) above would be less than the Floor, the Benchmark Replacement will be deemed to be the Floor for the purposes of this Agreement and the other Transaction Documents.
Benchmark Replacement Adjustment” means, with respect to any replacement of the then-current Benchmark with an Unadjusted Benchmark Replacement, the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) that has been selected by the Administrative Agent and the Borrower, giving due consideration to (A) any selection or recommendation of a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement by the Relevant Governmental Body or (B) any evolving or then-prevailing market convention for determining a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement for U.S. dollar-denominated syndicated credit facilities at such time.
Benchmark Replacement Date” means a date and time determined by the Administrative Agent, which date shall be no later than the earliest to occur of the following events with respect to the then-current Benchmark:
(1) in the case of clause (1) or (2) of the definition of “Benchmark Transition Event,” the later of (A) the date of the public statement or publication of information referenced therein and (B) the date on which the administrator of such Benchmark (or the published component used in the calculation thereof) permanently or indefinitely ceases to provide such Benchmark (or such component thereof) or, if such Benchmark is a term rate or is based on a term rate, all Available Tenors of such Benchmark (or such component thereof); or
(2) in the case of clause (3) of the definition of “Benchmark Transition Event,” the date determined by the Administrative Agent, which date shall promptly follow the date of the public statement or publication of information referenced therein;
For the avoidance of doubt, if such Benchmark is a term rate or is based on a term rate, the “Benchmark Replacement Date” will be deemed to have occurred in the case of clause (1) or (2) with respect to any Benchmark upon the occurrence of the applicable event or events set forth therein with respect to all then-current Available Tenors of such Benchmark (or the published component used in the calculation thereof).
Benchmark Transition Event” means, the occurrence of one or more of the following events, with respect to the then-current Benchmark:
(1)    a public statement or publication of information by or on behalf of the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that such administrator has ceased or will cease to provide such Benchmark (or such component thereof) or, if such Benchmark is a term rate or is based on a term rate, all Available Tenors of such Benchmark (or such component thereof), permanently or indefinitely; provided, that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof);
(2)    a public statement or publication of information by a Governmental Authority having jurisdiction over the Administrative Agent, the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof), the Federal Reserve Board, the Federal Reserve Bank of New York, an insolvency official with jurisdiction over the administrator for such Benchmark (or such component), a resolution authority with jurisdiction over the administrator for such Benchmark (or such component) or a court or an
4
Error! Unknown document property name.



entity with similar insolvency or resolution authority over the administrator for such Benchmark (or such component), which states that the administrator of such Benchmark (or such component) has ceased or will cease to provide such Benchmark (or such component thereof) or, if such Benchmark is a term rate or is based on a term rate, all Available Tenors of such Benchmark (or such component thereof) permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide such Benchmark (or such component thereof) or, if such Benchmark is a term rate or is based on a term rate, any Available Tenor of such Benchmark (or such component thereof); or
(3)    a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof) or a Governmental Authority having jurisdiction over the Administrative Agent announcing that such Benchmark (or such component thereof) or, if such Benchmark is a term rate or is based on a term rate, all Available Tenors of such Benchmark (or such component thereof) are not, or as of a specified future date will not be, representative.
For the avoidance of doubt, if such Benchmark is a term rate or is based on a term rate, a “Benchmark Transition Event” will be deemed to have occurred with respect to any Benchmark if a public statement or publication of information set forth above has occurred with respect to each then-current Available Tenor of such Benchmark (or the published component used in the calculation thereof).
Benchmark Unavailability Period” means the period (if any) (x) beginning at the time that a Benchmark Replacement Date has occurred if, at such time, no Benchmark Replacement has replaced the then-current Benchmark for all purposes hereunder and under any Transaction Document in accordance with Section 4.06(d) and (y) ending at the time that a Benchmark Replacement has replaced the then-current Benchmark for all purposes hereunder and under any Transaction Document in accordance with Section 4.06(d).
Borrower” has the meaning specified in the preamble to this Agreement.
Borrower Indemnified Amounts” has the meaning set forth in Section 12.01(a).
Borrower Indemnified Party” has the meaning set forth in Section 12.01(a).
Borrower Obligations” means all present and future indebtedness, reimbursement obligations, and other liabilities and obligations (howsoever created, arising or evidenced, whether direct or indirect, absolute or contingent, or due or to become due) of the Borrower to any Credit Party, Borrower Indemnified Party and/or any Affected Person, arising under or in connection with this Agreement or any other Transaction Document or the transactions contemplated hereby or thereby, and shall include, without limitation, all Capital and Interest on the Loans, all Fees and all other amounts due or to become due under the Transaction Documents (whether in respect of fees, costs, expenses, indemnifications or otherwise), including, without limitation, interest, fees and other obligations that accrue after the commencement of any Insolvency Proceeding with respect to the Borrower (in each case whether or not allowed as a claim in such proceeding).
Borrower’s Net Worth” means, at any time of determination, an amount equal to (i) the Outstanding Balance of all Pool Receivables at such time, minus (ii) the sum of (A) the Aggregate Capital at such time, plus (B) the Aggregate Interest at such time, plus (C) the aggregate accrued and unpaid Fees at such time, plus (D) the aggregate outstanding principal balance of all Subordinated Notes at such time, plus (E) the aggregate accrued and unpaid interest on all Subordinated Notes at such time, plus (F) without duplication, the aggregate accrued and unpaid other Borrower Obligations at such time.
5
Error! Unknown document property name.



Borrowing Base” means, at any time of determination, the amount equal to the lesser of (a) the Facility Limit and (b) an amount equal to (i) the Adjusted Net Receivables Pool Balance at such time, minus (ii) the Total Reserves at such time.
Borrowing Base Deficit” means, at any time of determination, the amount, if any, by which (a) the Aggregate Capital at such time, exceeds (b) the Borrowing Base at such time, or, in each case, if such day is not a Business Day, then the immediately preceding Business Day.
Breakage Fee” means (i) for any Interest Period for which Interest is computed by reference to the CP Rate, the Term SOFR Rate or the Daily SOFR Rate, as applicable, and a reduction of Capital is made for any reason on any day other than a Settlement Date or (ii) to the extent that the Borrower shall for any reason, fail to borrow on the date specified by the Borrower in connection with any request for funding pursuant to Article II of this Agreement, the amount, if any, by which (A) the additional Interest (calculated without taking into account any Breakage Fee or any shortened duration of such Interest Period pursuant to the definition thereof) which would have accrued during such Interest Period (or, in the case of clause (i) above, until the maturity of the underlying Note) on the reductions of Capital relating to such Interest Period had such reductions not been made (or, in the case of clause (ii) above, the amounts so failed to be borrowed or accepted in connection with any such request for funding by the Borrower), exceeds (B) the income, if any, received by the applicable Lender from the investment of the proceeds of such reductions of Capital (or such amounts failed to be borrowed by the Borrower). A certificate as to the amount of any Breakage Fee (including the computation of such amount) shall be submitted by the affected Lender (or applicable Group Agent on its behalf) to the Borrower and shall be conclusive and binding for all purposes, absent manifest error.
“Business Day” means any day other than a Saturday or Sunday or a legal holiday on which commercial banks are authorized or required to be closed, or are in fact closed, for business in Pittsburgh, Pennsylvania or New York, New York (or, if otherwise, any day other than a Saturday or Sunday or a legal holiday on which the lending office of the Administrative Agent is authorized or required to be closed, or is in fact closed, for business); provided, that, when used in connection with an amount that bears interest at a rate based on SOFR or any direct or indirect calculation or determination of SOFR, the term “Business Day” means any such day that is also a U.S. Government Securities Business Day.
Capital” means, with respect to any Lender, without duplication, the aggregate amounts paid to, or on behalf of, the Borrower in connection with all Loans made by such Lender pursuant to Article II, as reduced from time to time by Collections distributed and applied on account of such Capital pursuant to Section 3.01; provided, that if such Capital shall have been reduced by any distribution and thereafter all or a portion of such distribution is rescinded or must otherwise be returned for any reason, such Capital shall be increased by the amount of such rescinded or returned distribution as though it had not been made.
Capital Stock” means, with respect to any Person, any and all common shares, preferred shares, interests, participations, rights in or other equivalents (however designated) of such Person’s capital stock, partnership interests, limited liability company interests, membership interests or other equivalent interests and any rights (other than debt securities convertible into or exchangeable for capital stock), warrants or options exchangeable for or convertible into such capital stock or other equity interests.
Change in Control” means the occurrence of any of the following:
(1)Integra LifeSciences Corporation ceases to own, directly, 100% of the issued and outstanding Capital Stock and all other equity interests of the Borrower free and clear of all Adverse Claims;
6
Error! Unknown document property name.



(2)the Parent ceases to own, directly or indirectly, 100% of the issued and outstanding Capital Stock, membership interests or other equity interests of any Originator free and clear of all Adverse Claims;
(3)any Subordinated Note shall at any time cease to be owned by an Originator, free and clear of all Adverse Claims; or
(4)with respect to the Parent:
(a)any Person (or two or more Persons acting in concert) shall have acquired by contract or otherwise, or shall have entered into a contract or arrangement that, upon consummation thereof, will result in its or their acquisition of control over Voting Securities of the Borrower on a fully-diluted basis assuming the conversion and/or exercise of all outstanding Equity Interests of the Parent owned by such Person or Persons representing thirty percent (30%) or more of the combined voting power of all Voting Securities of the Parent; or
(b)during any period of twenty four (24) consecutive months, a majority of the members of the board of directors or other equivalent governing body of the Parent cease to be composed of individuals (i) who were members of that board or equivalent governing body on the first day of such period, (ii) whose election or nomination to that board or equivalent governing body was approved by individuals referred to in clause (i) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body or (iii) whose election or nomination to that board or equivalent governing body was approved by individuals referred to in clauses (i) and (ii) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body.
Change in Law” means the occurrence, after the Closing Date (or with respect to any Lender, if later, the date on which such Lender becomes a Lender), of any of the following: (a) the adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation, implementation or application thereof by any Governmental Authority or (c) the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) by any Governmental Authority; provided that notwithstanding anything herein to the contrary, (w) the final rule titled Risk-Based Capital Guidelines; Capital Adequacy Guidelines; Capital Maintenance: Regulatory Capital; Impact of Modifications to Generally Accepted Accounting Principles; Consolidation of Asset-Backed Commercial Paper Programs; and Other Related Issues, adopted by the United States bank regulatory agencies on December 15, 2009, (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (y) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to the agreements reached by the Basel Committee on Banking Supervision in “Basel III: A Global Regulatory Framework for More Resilient Banks and Banking Systems” (as amended, supplemented or otherwise modified or replaced from time to time), shall in each case be deemed to be a “Change in Law”, regardless of the date enacted, adopted or issued.
Closing Date” means December 21, 2018.
Code” means the Internal Revenue Code of 1986, as amended, reformed or otherwise modified from time to time.
7
Error! Unknown document property name.



Collateral” has the meaning set forth in Section 4.05(a).
Collection Account” means each account listed on Schedule II to this Agreement (as such schedule may be modified from time to time in connection with the closing or opening of any Collection Account in accordance with the terms hereof), in each case, in the name of the Borrower and maintained at a bank or other financial institution acting as a Collection Account Bank pursuant to an Account Control Agreement for the purpose of receiving Collections.
Collection Account Bank” means any of the banks or other financial institutions holding one or more Collection Accounts.
Collections” means, with respect to any Pool Receivable: (a) all funds that are received by any Integra Party or any other Person on their behalf in payment of any amounts owed in respect of such Pool Receivable (including purchase price, finance charges, interest and all other charges), or applied to amounts owed in respect of such Pool Receivable (including insurance payments and net proceeds of the sale or other disposition of repossessed goods or other collateral or property of the related Obligor or any other Person directly or indirectly liable for the payment of such Pool Receivable and available to be applied thereon), (b) all Deemed Collections, (c) all proceeds of all Related Security with respect to such Pool Receivable and (d) all other proceeds of such Pool Receivable.
Commitment” means, with respect to any Committed Lender (including a Related Committed Lender), the maximum aggregate amount which such Person is obligated to lend or pay hereunder on account of all Loans, on a combined basis, as set forth on Schedule I or in the Assumption Agreement or other agreement pursuant to which it became a Lender, as such amount may be modified in connection with any subsequent assignment pursuant to Section 13.03 or in connection with a reduction in the Facility Limit pursuant to Section 2.02(e). If the context so requires, “Commitment” also refers to a Committed Lender’s obligation to make Loans hereunder in accordance with this Agreement.
Committed Lenders” means PNC and each other Person that is or becomes a party to this Agreement in the capacity of a “Committed Lender”.
Concentration Percentage” means (a) for any Group A Obligor, twenty percent (20.00%), (b) for any Group B Obligor, fifteen percent (15.00%), (c) for any Group C Obligor, ten percent (10.00%), (d) for the largest Group D Obligor, five percent (5.00%) and (e) for any Group D Obligor (excluding the largest Group D Obligor), three percent (3.00%).
Concentration Reserve Percentage” means, at any time of determination, the largest of: (a) the sum of the four (4) largest Obligor Percentages of the Group D Obligors, (b) the sum of the two (2) largest Obligor Percentages of the Group C Obligors, (c) the largest Obligor Percentage of the Group B Obligors and (d) twelve percent (12.00%).
Conduit Lender” means each commercial paper conduit that is or becomes a party to this Agreement in the capacity of a “Conduit Lender”.
Conforming Changes” means, with respect to Term SOFR or Daily 1M SOFR, as applicable, or any Benchmark Replacement in relation thereto, any technical, administrative or operational changes (including changes to the definition of “Base Rate,” the definition of “Business Day,” the definition of “Interest Period,” the definition of “U.S. Government Securities Business Day,” timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, the applicability and length of lookback periods, the applicability of breakage provisions, and other technical, administrative or operational matters) that the Administrative Agent decides may be
8
Error! Unknown document property name.



appropriate to reflect the adoption and implementation of any such rate and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent determines that no market practice for the administration of any such rate exists, in such other manner of administration as the Administrative Agent decides is reasonably necessary in connection with the administration of this Agreement and the other Transaction Documents).
Connection Income Taxes” means Other Connection Taxes that are imposed on or measured by net income (however denominated) or that are franchise Taxes or branch profits Taxes.
Consolidated Total Leverage Ratio” shall have the same meaning attributed to such term in the Credit Agreement.
Contract” means, with respect to any Receivable, any and all contracts, instruments, agreements, leases, invoices, notes or other writings pursuant to which such Receivable arises or that evidence such Receivable or under which an Obligor becomes or is obligated to make payment in respect of such Receivable.
Controlled Group” means all members of a controlled group of corporations or other business entities and all trades or businesses (whether or not incorporated) under common control which, together with Parent or any of its Subsidiaries, are treated as a single employer under Section 414 of the Code.
Covered Entity” means (a) each Integra Party, the Parent and each of Parent’s Subsidiaries and (b) each Person that, directly or indirectly, is in control of a Person described in clause (a) above. For purposes of this definition, control of a Person shall mean the direct or indirect (x) ownership of, or power to vote, 25% or more of the issued and outstanding equity interests having ordinary voting power for the election of directors of such Person or other Persons performing similar functions for such Person, or (y) power to direct or cause the direction of the management and policies of such Person whether by ownership of equity interests, contract or otherwise.
CP Rate” means, for any Conduit Lender and for any Interest Period for any Portion of Capital (a) the per annum rate equivalent to the weighted average cost (as determined by the applicable Group Agent and which shall include commissions of placement agents and dealers, incremental carrying costs incurred with respect to Notes of such Person maturing on dates other than those on which corresponding funds are received by such Conduit Lender, other borrowings by such Conduit Lender (other than under any Program Support Agreement) and any other costs associated with the issuance of Notes) of or related to the issuance of Notes that are allocated, in whole or in part, by the applicable Conduit Lender to fund or maintain such Portion of Capital (and which may be also allocated in part to the funding of other assets of such Conduit Lender); provided, however, that if any component of such rate is a discount rate, in calculating the “CP Rate” for such Portion of Capital for such Interest Period, the applicable Group Agent shall for such component use the rate resulting from converting such discount rate to an interest bearing equivalent rate per annum; provided, further, that notwithstanding anything in this Agreement or the other Transaction Documents to the contrary, the Borrower agrees that any amounts payable to Conduit Lenders in respect of Interest for any Interest Period with respect to any Portion of Capital funded by such Conduit Lenders at the CP Rate shall include an amount equal to the portion of the face amount of the outstanding Notes issued to fund or maintain such Portion of Capital that corresponds to the portion of the proceeds of such Notes that was used to pay the interest component of maturing Notes issued to fund or maintain such Portion of Capital, to the extent that such Conduit Lenders had not received payments of interest in respect of such interest
9
Error! Unknown document property name.



component prior to the maturity date of such maturing Notes (for purposes of the foregoing, the “interest component” of Notes equals the excess of the face amount thereof over the net proceeds received by such Conduit Lender from the issuance of Notes, except that if such Notes are issued on an interest-bearing basis its “interest component” will equal the amount of interest accruing on such Notes through maturity) or (b) any other rate designated as the “CP Rate” for such Conduit Lender in the Assumption Agreement or other document pursuant to which such Person becomes a party as a Conduit Lender to this Agreement, or any other writing or agreement provided by such Conduit Lender to the Borrower, the Servicer and the applicable Agent from time to time. The “CP Rate” for any Conduit Lender for any day while an Event of Default has occurred and is continuing shall be an interest rate equal to the greater of (i) 2.50% per annum above the Base Rate and (ii) 2.50% per annum above the “CP Rate” calculated without giving effect to such Event of Default.
Credit Agreement” means that certain Sixth Amended and Restated Credit Agreement, dated as of February 3, 2020, by and among the Parent, as the borrower thereunder, each lender and issuing bank from time to time party thereto, Bank of America, N.A., as administrative agent, swing line lender and an L/C issuer thereunder, Citibank N.A., Morgan Stanley MUFG Loan Partners, LLC and Wells Fargo Bank, N.A., as co-syndication agents thereunder, and the various other co-documentation agents, joint lead arrangers and joint book managers party thereto, and so long as PNC and Mizuho Bank, Ltd. are each a lender under the Credit Agreement as amended, restated, supplemented or otherwise modified from time to time.
Credit and Collection Procedures” means, as the context may require, those receivables credit and collection policies and historical practices of the Originators and/or Servicer in effect on the Closing Date and described in Exhibit E, as modified in compliance with this Agreement.
Credit Extension” means the making of any Loan.
Credit Party” means each Lender, the Administrative Agent and each Group Agent.
Currency Reserve Amount” means, at any time of determination, the sum of (a) the Euro Volatility Reserve, plus (b) the GBP Volatility Reserve, plus (c) the excess (if any) of (i) the U.S. Dollar Equivalent of the aggregate Outstanding Balance of all Pool Receivables denominated in an Alternative Currency, over (ii) the product of (x) two and a half percent (2.5%), multiplied by (y) the U.S. Dollar Equivalent of the aggregate Outstanding Balance of all Pool Receivables.
Daily 1M SOFR” means, for any day, the rate per annum determined by the Administrative Agent (rounded upwards, at the Administrative Agent’s discretion, to the nearest 1/100th of 1%) equal to the Term SOFR Reference Rate for such day for a one (1) month period, as published by the Term SOFR Administrator; provided, that if Daily 1M SOFR, determined as provided above, would be less than the Floor, then Daily 1M SOFR shall be deemed to be the Floor. The rate of interest will be adjusted automatically as of each Business Day based on changes in Daily 1M SOFR without notice to the Borrower.
Daily Simple SOFR” means, for any day (a “SOFR Rate Day”), the interest rate per annum determined by the Administrative Agent (rounded upwards, at the Administrative Agent’s discretion, to the nearest 1/100th of 1%) equal to SOFR for the day (the “SOFR Determination Date”) that is two (2) Business Days prior to (i) such SOFR Rate Day if such SOFR Rate Day is a Business Day or (ii) the Business Day immediately preceding such SOFR Rate Day if such SOFR Rate Day is not a Business Day, in each case, as such SOFR is published by the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate) on the website of the Federal Reserve Bank of New York, currently at http://www.newyorkfed.org, or any successor source identified by the Federal Reserve Bank of New York or its successor administrator for the secured overnight financing rate from time to time. If
10
Error! Unknown document property name.



Daily Simple SOFR as determined above would be less than the Floor, then Daily Simple SOFR shall be deemed to be the Floor. If SOFR for any SOFR Determination Date has not been so published or replaced with a Benchmark Replacement by 5:00 p.m. (Pittsburgh, Pennsylvania time) on the second Business Day immediately following such SOFR Determination Date, then SOFR for such SOFR Determination Date will be SOFR for the first Business Day preceding such SOFR Determination Date for which SOFR was published as described above; provided, that SOFR determined pursuant to this sentence shall be used for purposes of calculating Daily Simple SOFR for no more than three (3) consecutive SOFR Rate Days. If and when Daily Simple SOFR as determined above changes, any applicable rate of interest based on Daily Simple SOFR will change automatically without notice to the Borrower, effective on the date of any such change.
Daily SOFR Option” means the option of the Borrower to have Loans bearing interest at the rate and under the terms specified in Section 2.05(a)(iii).
Daily SOFR Rate” means with respect to Loans to which the Daily SOFR Option applies, a fluctuating interest rate per annum as shall be in effect from time to time equal to (a) Daily 1M SOFR, plus (b) the SOFR Adjustment.
Daily SOFR Rate Loan” means a Loan that bears interest based on the Daily SOFR Rate.
Days’ Sales Outstanding” means, for any Fiscal Month, an amount computed as of the last day of such Fiscal Month equal to: (a) the average of the Outstanding Balance of all Pool Receivables as of the last day of each of the three (3) most recent Fiscal Months ended on the last day of such Fiscal Month, divided by (b) (i) the aggregate initial Outstanding Balance of all Pool Receivables generated by the Originators during the three (3) most recent Fiscal Months ended on the last day of such Fiscal Month, divided by (ii) ninety (90).
Debt” means, as to any Person at any time of determination, any and all indebtedness, obligations or liabilities (whether matured or unmatured, liquidated or unliquidated, direct or indirect, absolute or contingent, or joint or several) of such Person for or in respect of: (i) borrowed money, (ii) amounts raised under or liabilities in respect of any bonds, debentures, notes, note purchase, acceptance or credit facility, or other similar instruments or facilities, (iii) reimbursement obligations (contingent or otherwise) under any letter of credit, (iv) any other transaction (including production payments (excluding royalties), installment purchase agreements, forward sale or purchase agreements, capitalized leases and conditional sales agreements) having the commercial effect of a borrowing of money entered into by such Person to finance its operations or capital requirements (but not including accounts payable incurred in the ordinary course of such Person’s business payable on terms customary in the trade), (v) all net obligations of such Person in respect of interest rate on currency hedges or (vi) any Guaranty of any such Debt.
Deemed Collections” has the meaning set forth in Section 3.01(d).
Defaulting Lender” means any Lender that (a) has failed, within one (1) Business Day of the date required to be funded or paid, to (i) fund any portion of its Loans or (ii) pay over to any Credit Party any other amount required to be paid by it hereunder, unless, in the case of clause (i) above, such Lender notifies the Administrative Agent in writing that such failure is the result of such Lender’s good faith determination that a condition precedent to funding (specifically identified and including the particular default, if any) has not been satisfied, (b) has notified the Borrower or any Credit Party in writing, or has made a public statement to the effect, that it does not intend or expect to comply with any of its funding obligations under this Agreement (unless such writing or public statement indicates that such position is based on such Lender’s good faith
11
Error! Unknown document property name.



determination that a condition precedent (specifically identified and including the particular default, if any) to funding a Loan under this Agreement cannot be satisfied) or generally under other agreements in which it commits to extend credit, (c) has failed, within three (3) Business Days after request by a Credit Party, acting in good faith, to provide a certification in writing from an authorized officer of such Lender that it will comply with its obligations (and is financially able to meet such obligations) to fund prospective Loans under this Agreement, provided that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon such Credit Party’s receipt of such certification in form and substance satisfactory to it and the Administrative Agent, or (d) has become the subject of an Insolvency Proceeding.
Default Ratio” means the ratio (expressed as a percentage and rounded to the nearest 1/100 of 1%, with 5/1000th of 1% rounded upward) computed as of the last day of each Fiscal Month by dividing: (a) the aggregate Outstanding Balance of all Pool Receivables that became Defaulted Receivables during such Fiscal Month, by (b) the aggregate initial Outstanding Balance of all Pool Receivables generated by the Originators during the month that is six (6) Fiscal Months before such Fiscal Month.
Defaulted Receivable” means a Receivable:
(1)as to which any payment, or part thereof, remains unpaid for one hundred fifty one (151) calendar days or more from the original due date for such payment;
(2)without duplication, as to which any payment, or part thereof, remains unpaid for less than or equal to one hundred fifty one (151) calendar days from the original due date for such payment and, consistent with the Credit and Collection Procedures, is or should be written off the applicable Originator’s or the Borrower’s books as uncollectible; or
(3)without duplication, as to which an Insolvency Proceeding shall have occurred with respect to the Obligor thereof or any other Person obligated thereon or owning any Related Security with respect thereto;
provided, however, that in each case above such amount shall be calculated without giving effect to any netting of credits that have not been matched to a particular Receivable for the purposes of aged trial balance reporting.
Delinquency Ratio” means the ratio (expressed as a percentage and rounded to the nearest 1/100 of 1%, with 5/1000th of 1% rounded upward) computed as of the last day of each Fiscal Month by dividing: (a) the sum of (I) the aggregate Outstanding Balance of all Pool Receivables that were Delinquent Receivables on such day, plus (II) the aggregate amount of Deemed Collections as of such date with respect to such Delinquent Receivables, by (b) the aggregate Outstanding Balance of all Pool Receivables on such day.
Delinquent Receivable” means a Receivable as to which any payment, or part thereof, remains unpaid for ninety one (91) calendar days or more from the original due date for such payment; provided, however, that such amount shall be calculated without giving effect to any netting of credits that have not been matched to a particular Receivable for the purposes of aged trial balance reporting.
Dilution Horizon Ratio” means, for any Fiscal Month, the ratio (expressed as a percentage and rounded to the nearest 1/100th of 1%, with 5/1000th of 1% rounded upward) computed as of the last day of such Fiscal Month by dividing: (a) the sum of (i) the aggregate initial Outstanding Balance of all Pool Receivables (other than Unbilled Receivables) generated by the Originators during such Fiscal Month, plus (ii) fifty percent (50%) of the aggregate initial
12
Error! Unknown document property name.



Outstanding Balance of all Pool Receivables generated by the Originators during the preceding Fiscal Month, by (b) the Net Receivables Pool Balance as of the last day of such Fiscal Month. Within thirty (30) calendar days of the completion and the receipt by the Administrative Agent of the results of any annual audit or field exam of the Receivables and the servicing and origination practices of the Servicer and the Originators, the numerator of the Dilution Horizon Ratio may be adjusted by the Administrative Agent upon not less than five (5) Business Days’ notice to the Borrower to reflect such number of Fiscal Months as the Administrative Agent and the Borrower agree best reflects the business practices of the Servicer and the Originators and the actual amount of dilution and Deemed Collections that occur with respect to Pool Receivables based on the weighted average dilution lag calculation completed as part of such audit or field exam.
Dilution Ratio” means the ratio (expressed as a percentage and rounded to the nearest 1/100th of 1%, with 5/1000th of 1% rounded upward), computed as of the last day of each Fiscal Month by dividing: (a) the aggregate amount of Deemed Collections during such Fiscal Month (other than amounts related to the Specifically Reserved Dilution Amount), by (b) the aggregate initial Outstanding Balance of all Pool Receivables generated by the Originators during the prior Fiscal Month.
Dilution Reserve Percentage” means, on any day, the product of (a) the Dilution Horizon Ratio multiplied by (b) the sum of (i) 2.00 times the average of the Dilution Ratios for the twelve (12) most recent Fiscal Months and (ii) the Dilution Volatility Component.
Dilution Volatility Component” means, for any Fiscal Month, the product (expressed as a percentage and rounded to the nearest 1/100 of 1%, with 5/1000th of 1% rounded upward) of (a) the positive difference, if any, between: (i) the highest Dilution Ratio for any Fiscal Month during the twelve (12) most recent Fiscal Months and (ii) the arithmetic average of the Dilution Ratios for such twelve (12) Fiscal Months times (b) the quotient of (i) the highest Dilution Ratio for any Fiscal Month during the twelve (12) most recent consecutive Fiscal Months divided by (ii) the arithmetic average of the Dilution Ratios for such twelve (12) consecutive Fiscal Months.
Dollars” and “$” each mean the lawful currency of the United States of America.
Earned Milestone Receivable” means a Receivable earned, notwithstanding the fact that the Originator thereof has not recognized the related revenue on its financial books and records under GAAP, paid in accordance with the milestones set forth in the Contract giving rise to such Receivable, and is not subject to the performance of additional services by the Originator thereof.
Eligible Assignee” means (a) any Committed Lender or any of its Affiliates, (b) any Person managed by a Committed Lender or any of its Affiliates and (c) any other financial or other institution.
Eligible Foreign Currency Receivable” means, at any time, any Foreign Currency Receivable that is denominated and payable in an Alternative Currency.
Eligible Foreign Obligor” an Obligor that is a corporation or other business organization that is organized in or that has a head office (domicile), registered office, and chief executive office located in a country other than (a) the United States or (b) a Sanctioned Country.
Eligible In-Transit Receivable” means, at any time, any In-Transit Receivable if (a) the related goods have been shipped not more than thirty (30) calendar days prior to such date, (b) the related Originator has not pledged inventory as collateral for any Debt and (c) no inventory of such Originator is encumbered in any way.
Eligible Receivable” means, at any time of determination, a Pool Receivable:
13
Error! Unknown document property name.



(1)the Obligor of which: (i) is either a U.S. Obligor or an Eligible Foreign Obligor; (ii) is not a Sanctioned Person; (iii) is not subject to any Insolvency Proceeding; (iv) is not an Affiliate of an Integra Party or the Parent; (v) does not have an aggregate Outstanding Balance of Pool Receivables as to which any payment, or part thereof, remains unpaid for one hundred twenty one (121) calendar days or more from the original due date for such payment that exceeds fifty percent (50%) of the aggregate Outstanding Balance of all of such Obligor’s Pool Receivables; (vi) is not a natural person; (vii) is not a material supplier to any Originator or an Affiliate of a material supplier; and (viii) is not a Temporarily Ineligible Obligor;
(2)for which an Insolvency Proceeding shall not have occurred with respect to the Obligor thereof or any other Person obligated thereon or owning any Related Security with respect thereto;
(3)that is denominated and payable only in Dollars in the United States of America or an Alternative Currency payable in the United States of America, and the Obligor with respect to which has been instructed to remit Collections in respect thereof directly to a Lock-Box or Collection Account in the United States of America;
(4)that does not have a due date which is more than one hundred eighty (180) calendar days after the original invoice date of such Receivable;
(5)that arises under a Contract for the sale of goods or services on an arm’s-length basis in the ordinary course of the applicable Originator’s business;
(6)that arises under a duly authorized Contract that is in full force and effect and that is a legal, valid and binding obligation of the related Obligor, enforceable against such Obligor in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization or other similar laws affecting the enforcement of creditors’ rights generally and by general principles of equity regardless of whether enforceability is considered in a proceeding in equity or at law;
(7)that has been transferred by an Originator to the Borrower pursuant to the Purchase and Sale Agreement with respect to which transfer all conditions precedent under the Purchase and Sale Agreement have been met;
(8)that, together with the Contract related thereto, conforms in all material respects with all Applicable Laws (including any Applicable Laws relating to usury, truth in lending, fair credit billing, fair credit reporting, equal credit opportunity, fair debt collection practices and privacy);
(9)with respect to which all consents, licenses, approvals or authorizations of, or registrations or declarations with or notices to, any Governmental Authority or other Person required to be obtained, effected or given by an Originator in connection with the creation of such Receivable, the execution, delivery and performance by such Originator of the related Contract or the assignment thereof under the Purchase and Sale Agreement have been duly obtained, effected or given and are in full force and effect;
(10)that is not subject to any existing dispute, litigation, right of rescission, set-off (including, customer deposits, advance payments (including payments related to unearned revenues, but at any time prior to the occurrence of a Specific Reporting Event not including Earned Milestone Receivables), etc.), counterclaim, hold back defense, any other defense against the applicable Originator (or any assignee of such Originator) or Adverse Claim, and the Obligor of which holds no right as against the applicable
14
Error! Unknown document property name.



Originator to cause such Originator to repurchase the goods or merchandise, the sale of which shall have given rise to such Receivable;
(11)that satisfies all applicable requirements of the Credit and Collection Procedures;
(12)that, together with the Contract related thereto, has not been modified, waived or restructured since its creation, except as permitted pursuant to Section 8.02(a) of this Agreement;
(13)in which the Borrower owns good and marketable title, free and clear of any Adverse Claims, and that is freely assignable (including without any consent of the related Obligor or any Governmental Authority);
(14)for which the Administrative Agent (on behalf of the Secured Parties) shall have a valid and enforceable first priority perfected security interest therein and in the Related Security and Collections with respect thereto, in each case free and clear of any Adverse Claim;
(15)that (i) constitutes an “account” or “payment intangible” (as defined in the UCC), (ii) is not evidenced by instruments or chattel paper and (iii) does not constitute, or arise from the sale of, as extracted collateral (as defined in the UCC);
(16)that is neither a Defaulted Receivable nor a Delinquent Receivable;
(17)for which no Integra Party has established any offset or netting arrangements with the related Obligor in connection with the ordinary course of payment of such Receivable;
(18)that, other than for Eligible In-Transit Receivables, represents amounts earned and payable by the Obligor that are not subject to the performance of additional services by the Originator thereof or by the Borrower and the related goods or merchandise shall have been shipped and/or services performed; provided, that if such Receivable is subject to the performance of additional services, only the portion of such Receivables attributable to such additional services shall be excluded;
(19)which (i) does not arise from a sale of accounts made as part of a sale of a business or constitute an assignment for the purpose of collection only, (ii) is not a transfer of a single account made in whole or partial satisfaction of a preexisting indebtedness or an assignment of a right to payment under a contract to an assignee that is also obligated to perform under the contract and (iii) is not a transfer of an interest in or an assignment of a claim under a policy of insurance;
(20)which does not relate to the sale of any consigned goods or finished goods which have incorporated any consigned goods into such finished goods;
(21)that represents amounts earned by the Originator thereof and payable by the related Obligor in accordance with the Contract related thereto that are not subject to the performance of any additional services by the Originator thereof or by the Borrower, other than, (i) the billing or invoicing of such Receivable in the case of an Eligible Unbilled Receivable and (ii) the obligation of the applicable Originator with respect to standard warranties and indemnities related to the goods or services sold that gave rise to such Receivable; provided, that if such Receivable is subject to the performance of
15
Error! Unknown document property name.



additional services, only the portion of such Receivable attributable to such additional services shall be ineligible;
(22)that, if such Receivable is an In-Transit Receivable, is an Eligible In-Transit Receivable; and
(23)that, if such Receivable is a Foreign Currency Receivable, is an Eligible Foreign Currency Receivable.
Eligible Unbilled Receivable” means, at any time, any Unbilled Receivable if (a) the related Originator has recognized the related revenue on its financial books and records under GAAP, and (b) not more than thirty (30) calendar days have expired since the date such Unbilled Receivable arose.
Equity Interests” means, with respect to any Person, all of the shares of capital stock of (or other ownership or profit interests in) such Person, all of the warrants, options or other rights for the purchase or acquisition from such Person of shares of capital stock of (or other ownership or profit interest in) such Person, all of the securities convertible into or exchangeable for shares of capital stock of (or other ownership or profit interests in) such Person or warrants, rights or options for the purchase or acquisition from such Person of such shares (or such other interests), and all of the other ownership or profit interests in such Person (including partnership, member or trust interests therein), whether voting or nonvoting, and whether or not such shares, warrants, options, rights or other interests are outstanding on any date of determination, not including debt securities convertible into or exchangeable for capital stock.
ERISA” means the Employee Retirement Income Security Act of 1974, as amended from time to time, and any rule or regulation issued thereunder.
ERISA Affiliate” means, with respect to any Person, any corporation, trade or business which together with the Person is a member of a controlled group of corporations or a controlled group of trades or businesses and would be deemed a “single employer” within the meaning of Sections 414(b), (c), (m) of the Code or Section 4001(b) of ERISA.
Erroneous Payment” has the meaning set forth in Section 10.11(a).
Erroneous Payment Notice” has the meaning set forth in Section 10.11(b).
Euro” and “” each mean the single currency of participating member states of the European Monetary Union.
Euro VaR Percentage” means six percent (6.00%), or such other percentage designated as such by the Administrative Agent from time to time upon ten (10) Business Days’ written notice to the Borrower.
Euro Volatility Reserve” means, at any time of determination, the product of (a) the U.S. Dollar Equivalent of the aggregate Outstanding Balance of all Pool Receivables denominated in Euro at such time, times (b) the Euro VaR Percentage at such time.
Event of Default” has the meaning specified in Section 9.01. For the avoidance of doubt, any Event of Default that occurs shall be deemed to be continuing at all times thereafter unless and until waived in accordance with Section 13.01.
Excess Concentration” means the sum of the following amounts, without duplication:
16
Error! Unknown document property name.



(1)the sum of the amounts calculated for each of the Obligors equal to the excess (if any) of (i) the aggregate Outstanding Balance of the Eligible Receivables of such Obligor, over (ii) the product of (x) such Obligor’s Concentration Percentage, multiplied by (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool; plus
(2)the excess (if any) of (i) the aggregate Outstanding Balance of all Eligible Receivables, the Obligors of which are Eligible Foreign Obligors, over (ii) the product of (x) thirty percent (30.00%), multiplied by (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool; provided, however, that the aggregate Outstanding Balance of all Eligible Receivables, the Obligors of which are Eligible Foreign Obligors (A) organized in, and whose principal place of business is in, a country that has a long-term sovereign foreign-currency rating from and including “A” to and including “BBB-” by S&P or from and including “A2” to and including “Baa3” by Moody’s, shall not exceed twenty percent (20.00%) of the aggregate Outstanding Balance of all Eligible Receivables, (B) organized in, and whose principal place of business is in, a country that has a long-term sovereign foreign-currency rating equal to or less than “BB+” by S&P or “Ba1” by Moody’s, shall not exceed five percent (5.00%) of the aggregate Outstanding Balance of all Eligible Receivables, (C) organized in, and whose principal place of business is in, the People’s Republic of China, shall not exceed seven and one half percent (7.50%) of the aggregate Outstanding Balance of all Eligible Receivables and (D) organized in, and whose principal place of business is in, a country other than the People’s Republic of China, shall not exceed five percent (5.00%) of the aggregate Outstanding Balance of all Eligible Receivables; plus
(3)the excess (if any) of (i) the aggregate Outstanding Balance of all Eligible Receivables as to which any payment, or part thereof, remain unpaid for sixty one (61) to ninety (90) calendar days from the original due date for such payment, over (ii) the product of (x) five percent (5.00%), multiplied by (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool; plus
(4)the excess (if any) of (i) the aggregate Outstanding Balance of all Eligible Receivables that have a due date which is between ninety one (91) to one hundred twenty (120) calendar days after the original invoice date of such Receivable, over (ii) the product of (x) ten percent (10.00%), multiplied by (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool; plus
(5)the excess (if any) of (i) the aggregate Outstanding Balance of all Eligible Receivables that have a due date which is between one hundred twenty one (121) to one hundred eighty (180) calendar days after the original invoice date of such Receivable, over (ii) the product of (x) five percent (5.00%), multiplied by (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool; plus
(6)the excess (if any) of (i) the aggregate Outstanding Balance of all Eligible In-Transit Receivables, over (ii) the product of (x) two and a half percent (2.50%), multiplied by (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool; plus
(7)the excess (if any) of (i) the aggregate Outstanding Balance of all Eligible Receivables, the Obligors of which are the federal government of the United States of America or any political subdivision, department, affiliate, agency or other entity thereof (which, for the avoidance of doubt, does not include any state or local government body or any political subdivision, department, affiliate, agency or other entity thereof), over (ii)
17
Error! Unknown document property name.



the product of (x) one percent (1.00%), multiplied by (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool; plus
(8)the excess (if any) of (i) the aggregate Outstanding Balance of all Eligible Receivables owing from the four (4) Group D Obligors with the four (4) largest Obligor Percentages of all Group D Obligors, over (ii) the product of (x) twelve percent (12.00%), multiplied by (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool.
Exchange Act” means the Securities Exchange Act of 1934, as amended or otherwise modified from time to time.
Excluded Obligor” means each Obligor listed on Schedule IV, which schedule may be amended, modified, restated, supplemented or replaced from time to time with the consent of the Administrative Agent, the Majority Group Agents and the Borrower.
Excluded Originator” means each Originator (or sub-division or business unit or other similar entity thereof) listed on Schedule IV, which schedule may be amended, modified, restated, supplemented or replaced from time to time with the consent of the Administrative Agent, the Majority Group Agents and the Borrower.
Excluded Receivable” means any Receivable, (a) the Obligor of which is an Excluded Obligor or (b) the Originator of which is an Excluded Originator.
Excluded Taxes” means any of the following Taxes imposed on or with respect to an Affected Person or required to be withheld or deducted from a payment to an Affected Person: (a) Taxes imposed on or measured by net income (however denominated), franchise Taxes and branch profits Taxes, in each case, (i) imposed as a result of such Affected Person being organized under the laws of, or having its principal office or, in the case of any Lender, its applicable lending office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii) that are Other Connection Taxes, (b) in the case of a Lender, U.S. federal withholding Taxes imposed on amounts payable to or for the account of such Lender with respect to an applicable interest in the Loans or Commitment pursuant to a law in effect on the date on which (i) such Lender makes a Loan or its Commitment or (ii) such Lender changes its lending office, except in each case to the extent that, pursuant to Section 4.03, amounts with respect to such Taxes were payable either to such Lender’s assignor immediately before such Lender became a party hereto or to such Lender immediately before it changed its lending office, (c) Taxes attributable to such Affected Person’s failure to comply with Section 4.03(f) and Section 4.03(g) and (d) any withholding Taxes imposed pursuant to FATCA.
Facility Limit” means one hundred fifty million dollars ($150,000,000) as reduced or increased from time to time pursuant to Section 2.02(e). References to the unused portion of the Facility Limit shall mean, at any time of determination, an amount equal to (x) the Facility Limit at such time, minus (y) the Aggregate Capital.
FATCA” means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with) and any current or future regulations or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Code and any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities entered into in connection with the implementation of the foregoing.
18
Error! Unknown document property name.



Federal Reserve Board” means the Board of Governors of the Federal Reserve System, or any entity succeeding to any of its principal functions.
Fee Letter” has the meaning specified in Section 2.03(a).
Fees” has the meaning specified in Section 2.03(a).
Final Maturity Date” means the date that (i) is thirty (30) calendar days following the Scheduled Termination Date or (ii) such earlier date on which the Loans become due and payable pursuant to Section 9.01.
Final Payout Date” means the date on or after the Termination Date when (i) the Aggregate Capital and Aggregate Interest have been paid in full, (ii) all Borrower Obligations shall have been paid in full, (iii) all other amounts owing to the Credit Parties and any other Borrower Indemnified Party or Affected Person hereunder and under the other Transaction Documents have been paid in full and (iv) all accrued Servicing Fees have been paid in full.
Financial Officer” of any Person means, the chief executive officer, the chief financial officer, the chief accounting officer, the principal accounting officer, the controller, the treasurer or the assistant treasurer of such Person.
Fiscal Month” means each calendar month.
Fitch” means Fitch, Inc. and any successor thereto that is a nationally recognized statistical rating organization.
Floor” means the benchmark rate floor, if any, provided in this Agreement initially (as of the execution of this Agreement, the modification, amendment or renewal of this Agreement or otherwise) with respect to Term SOFR, Daily 1M SOFR or Daily Simple SOFR, as applicable, or, if no floor is specified, zero.
Foreign Currency Receivable” means, at any time, any Receivable that is denominated and payable in a lawful currency of a country other than the United States of America.
GAAP” means generally accepted accounting principles in the United States of America, consistently applied.
GBP”, “Pounds Sterling” and “£” each mean the lawful currency of the United Kingdom.
GBP VaR Percentage” means seven percent (7.00%), or such other percentage designated as such by the Administrative Agent from time to time upon ten (10) Business Days’ written notice to the Borrower.
GBP Volatility Reserve” means, at any time of determination, the product of (a) the U.S. Dollar Equivalent of the aggregate Outstanding Balance of all Pool Receivables denominated in GBP at such time, times (b) the GBP VaR Percentage at such time.
Governmental Authority” means the government of the United States of America or any other nation, or any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supra-national bodies such as the European Union or the European Central Bank) and any group or body charged with setting financial accounting or
19
Error! Unknown document property name.



regulatory capital rules or standards (including the Financial Accounting Standards Board, the Bank for International Settlements or the Basel Committee on Banking Supervision or any successor or similar authority to any of the foregoing).
Group” means, (i) for any Conduit Lender, such Conduit Lender, together with such Conduit Lender’s Related Committed Lenders and related Group Agent, (ii) for PNC, PNC as a Committed Lender and as a Group Agent, (iii) for any other Lender that does not have a Related Conduit Lender, such Lender, together with such Lender’s related Group Agent and each other Lender for which such Group Agent acts as a Group Agent hereunder.
Group A Obligor” means any Obligor (or its parent or majority owner, as applicable, if such Obligor is not rated) with a short-term rating of at least: (a) “A-1” by S&P, or if such Obligor does not have a short-term rating from S&P, a rating of “A+” or better by S&P on such Obligor’s, its parent’s, or its majority owner’s (as applicable) long-term senior unsecured and uncredit-enhanced debt securities, or (b) “P 1” by Moody’s, or if such Obligor does not have a short-term rating from Moody’s, “Al” or better by Moody’s on such Obligor’s, its parent’s or its majority owner’s (as applicable) long-term senior unsecured and uncredit-enhanced debt securities; provided, that if an Obligor (or its parent or majority owner, as applicable, if such Obligor is not rated) receives a split rating from S&P and Moody’s, then such Obligor (or its parent or majority owner, as applicable) shall be deemed to have the higher rating, and such deemed rating shall be used for the purposes of whether such rating satisfies clauses (a) or (b) above. Notwithstanding the foregoing, any Obligor that is a Subsidiary of an Obligor that satisfies the definition of “Group A Obligor” shall be deemed to be a Group A Obligor and shall be aggregated with the Obligor that satisfies such definition for the purposes of determining the “Concentration Reserve Percentage”, the “Concentration Reserve” and clause (i) of the definition of “Excess Concentration” for such Obligors, unless such deemed Obligor separately satisfies the definition of “Group A Obligor”, “Group B Obligor”, or “Group C Obligor”, in which case such Obligor shall be separately treated as a Group A Obligor, a Group B Obligor or a Group C Obligor, as the case may be, and shall be aggregated and combined for such purposes with any of its Subsidiaries that are Obligors.
Group Agent” means each Person acting as agent on behalf of a Group and designated as the Group Agent for such Group on the signature pages to this Agreement or any other Person who becomes a party to this Agreement as a Group Agent for any Group pursuant to an Assumption Agreement, an Assignment and Acceptance Agreement or otherwise in accordance with this Agreement.
Group Agent’s Account” means, with respect to any Group, the account(s) from time to time designated in writing by the applicable Group Agent to the Borrower and the Servicer for purposes of receiving payments to or for the account of the members of such Group hereunder.
Group B Obligor” means an Obligor (or its parent or majority owner, as applicable, if such Obligor is not rated) that is not a Group A Obligor, with a short-term rating of at least: (a) “A-2” by S&P, or if such Obligor does not have a short-term rating from S&P, a rating of “BBB+” to “A” by S&P on such Obligor’s, its parent’s or its majority owner’s (as applicable) long-term senior unsecured and uncredit-enhanced debt securities, or (b) “P 2” by Moody’s, or if such Obligor does not have a short-term rating from Moody’s, “Baal” to “A2” by Moody’s on such Obligor’s, its parent’s or its majority owner’s (as applicable) long-term senior unsecured and uncredit-enhanced debt securities; provided, that if an Obligor (or its parent or majority owner, as applicable, if such Obligor is not rated) receives a split rating from S&P and Moody’s, then such Obligor (or its parent or majority owner, as applicable) shall be deemed to have the higher rating, and such deemed rating shall be used for the purposes of whether such rating satisfies clauses (a) or (b) above. Notwithstanding the foregoing, any Obligor that is a Subsidiary of an Obligor that satisfies the definition of “Group B Obligor” shall be deemed to be
20
Error! Unknown document property name.



a Group B Obligor and shall be aggregated with the Obligor that satisfies such definition for the purposes of determining the “Concentration Reserve Percentage”, the “Concentration Reserve” and clause (i) of the definition of “Excess Concentration” for such Obligors, unless such deemed Obligor separately satisfies the definition of “Group A Obligor”, “Group B Obligor”, or “Group C Obligor”, in which case such Obligor shall be separately treated as a Group A Obligor, a Group B Obligor or a Group C Obligor, as the case may be, and shall be aggregated and combined for such purposes with any of its Subsidiaries that are Obligors.
Group C Obligor” means an Obligor (or its parent or majority owner, as applicable, if such Obligor is not rated) that is not a Group A Obligor or a Group B Obligor, with a short-term rating of at least: (a) “A-3” by S&P, or if such Obligor does not have a short-term rating from S&P, a rating of “BBB-” to “BBB” by S&P on such Obligor’s, its parent’s or its majority owner’s (as applicable) long-term senior unsecured and uncredit-enhanced debt securities, or (b) “P 3” by Moody’s, or if such Obligor does not have a short-term rating from Moody’s, “Baa3” to “Baa2” by Moody’s on such Obligor’s, its parent’s or its majority owner’s (as applicable) long-term senior unsecured and uncredit-enhanced debt securities; provided, that if an Obligor (or its parent or majority owner, as applicable, if such Obligor is not rated) receives a split rating from S&P and Moody’s, then such Obligor (or its parent or majority owner, as applicable) shall be deemed to have the higher rating, and such deemed rating shall be used for the purposes of whether such rating satisfies clauses (a) or (b) above. Notwithstanding the foregoing, any Obligor that is a Subsidiary of an Obligor that satisfies the definition of “Group C Obligor” shall be deemed to be a Group C Obligor and shall be aggregated with the Obligor that satisfies such definition for the purposes of determining the “Concentration Reserve Percentage”, the “Concentration Reserve” and clause (i) of the definition of “Excess Concentration” for such Obligors, unless such deemed Obligor separately satisfies the definition of “Group A Obligor”, “Group B Obligor”, or “Group C Obligor”, in which case such Obligor shall be separately treated as a Group A Obligor, a Group B Obligor or a Group C Obligor, as the case may be, and shall be aggregated and combined for such purposes with any of its Subsidiaries that are Obligors.
Group Commitment” means, with respect to any Group, at any time of determination, the aggregate Commitments of all Committed Lenders within such Group.
Group D Obligor” means any Obligor that is not a Group A Obligor, Group B Obligor or Group C Obligor; provided, that any Obligor (or its parent or majority owner, as applicable, if such Obligor is unrated) that is not rated by both Moody’s and S&P shall be a Group D Obligor.
Guaranty” of any Person means any obligation of such Person guarantying or in effect guarantying any Debt, liability or obligation of any other Person in any manner, whether directly or indirectly, including any such liability arising by virtue of partnership agreements, including any agreement to indemnify or hold harmless any other Person, any performance bond or other surety ship arrangement and any other form of assurance against loss, except endorsement of negotiable or other instruments for deposit or collection in the ordinary course of business.
Indemnified Taxes” means (a) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of the Borrower or any of its Affiliates under any Transaction Document and (b) to the extent not otherwise described in clause (a) above, Other Taxes.
Independent Director” has the meaning set forth in Section 7.03(c).
Information Package” means a report, in substantially the form of Exhibit F.
Insolvency Proceeding” means (a) any case, action or proceeding before any court or other Governmental Authority relating to bankruptcy, reorganization, insolvency, liquidation,
21
Error! Unknown document property name.



receivership, dissolution, winding-up or relief of debtors or (b) any general assignment for the benefit of creditors of a Person, composition, marshaling of assets for creditors of a Person, or other, similar arrangement in respect of its creditors generally or any substantial portion of its creditors, in each of clauses (a) and (b) undertaken under U.S. Federal, state or foreign law, including the Bankruptcy Code.
Integra Party” means, the Borrower, the Servicer, each Originator and the Performance Guarantor, either individually or collectively as the context may require.
Integra Sales” has the meaning set forth in the preamble to this Agreement.
Intended Tax Treatment” has the meaning set forth in Section 13.14.
Interest” means, for each Loan for any day during any Interest Period (or portion thereof), the amount of interest accrued on the Capital of such Loan during such Interest Period (or portion thereof) in accordance with Section 2.03(b).
Interest Period” means, with respect to each Loan, (a) before the Termination Date: (i) initially, the period commencing on the date such Loan is made pursuant to Section 2.01 (or in the case of any fees payable hereunder, commencing on the Closing Date) and ending on (but not including) the next Monthly Settlement Date and (ii) thereafter, each period commencing on such Monthly Settlement Date and ending on (but not including) the next Monthly Settlement Date and (b) on and after the Termination Date, such period (including a period of one day) as shall be selected from time to time by the Administrative Agent (with the consent or at the direction of the Majority Group Agents) or, in the absence of any such selection, each period of thirty (30) calendar days from the last day of the preceding Interest Period.
Interest Rate” means, for any day in any Interest Period for any Loan (or any portion of Capital thereof):
(1)if such Loan (or such portion of Capital thereof) is being funded by a Conduit Lender on such day through the issuance of Notes, the applicable CP Rate; or
(2)if such Loan (or such portion of Capital thereof) is being funded by any Lender on such day other than through the issuance of Notes (including, without limitation, if a Conduit Lender is then funding such Loan (or such portion of Capital thereof) under a Program Support Agreement, or if a Committed Lender is then funding such Loan (or such portion of Capital thereof)), then the Base Rate, the Term SOFR Rate or the Daily SOFR Rate as determined pursuant to Section 2.05; provided, however, that the Interest Rate applicable to any Loan that is not advanced on a Monthly Settlement Date shall be the Daily SOFR Rate for each day during the initial Interest Period applicable to such Loan from the date such Loan is made pursuant to Section 2.01 until the next occurring Monthly Settlement Date.
provided, however, that the “Interest Rate” for each Loan and any day while an Event of Default has occurred and is continuing shall be an interest rate per annum equal the sum of two and a half percent (2.50)% per annum plus the greater of (i) the interest rate per annum determined for such Loan and such day pursuant to clause (a) or (b) above, as applicable, and (ii) the Base Rate in effect on such day; provided, further, that no provision of this Agreement shall require the payment or permit the collection of Interest in excess of the maximum permitted by Applicable Law; provided, further, however, that Interest for any Loan shall not be considered paid by any distribution to the extent that at any time all or a portion of such distribution is rescinded or must otherwise be returned for any reason.
22
Error! Unknown document property name.



Interim Report” means a report, in substantially the form of Exhibit I.
In-Transit Receivable” means, at any time, any Receivable arising in connection with the sale of any goods or merchandise that as of such time, have been shipped but not delivered to the related Obligor.
Investment Company Act” means the Investment Company Act of 1940, as amended or otherwise modified from time to time.
Lenders” means the Conduit Lenders and the Committed Lenders.
Linked Account” means any deposit account which is or could be linked to a Collection Account by a controlled balance arrangement.
Liquidity Amount” means, on any date of determination, the sum of (a) the amount of borrowing availability under the Credit Agreement, plus (b) unrestricted cash balances and liquid investments held by the Parent and its Affiliates.
Liquidity Agent” means any bank or other financial institution acting as agent for the various Liquidity Providers under each Liquidity Agreement.
Liquidity Agreement” means any agreement entered into in connection with this Agreement pursuant to which a Liquidity Provider agrees to make purchases or advances to, or purchase assets from, any Conduit Lender in order to provide liquidity for such Conduit Lender’s Loans.
Liquidity Provider” means each bank or other financial institution that provides liquidity support to any Conduit Lender pursuant to the terms of a Liquidity Agreement.
Loan” means any loan made by a Lender pursuant to Section 2.01.
Loan Request” means a letter in substantially the form of Exhibit A hereto executed and delivered by the Borrower to the Administrative Agent and the Group Agents pursuant to Section 2.02(a).
Lock-Box” means each locked postal box with respect to which a Collection Account Bank has executed an Account Control Agreement pursuant to which it has been granted exclusive access for the purpose of retrieving and processing payments made on the Receivables and which is listed on Schedule II (as such schedule may be modified from time to time in connection with the addition or removal of any Lock-Box in accordance with the terms hereof).
Loss Horizon Ratio” means, for any Fiscal Month, the ratio (expressed as a percentage and rounded to the nearest 1/100 of 1%, with 5/1000th of 1% rounded upward) computed, as of the last day of such Fiscal Month, by dividing: (a) the sum of (i) the aggregate initial Outstanding Balance of all Pool Receivables (other than Unbilled Receivables) generated by the Originators during the five (5) most recent Fiscal Months, plus (ii) the product of (x) the sum of the Loss Horizon Terms Component, plus five percent (5.00%), and (y) the aggregate initial Outstanding Balance of all Pool Receivables originated by the Originators during the sixth (6th) most recent Fiscal Month; by (b) the Net Receivables Pool Balance as of such date.
Loss Horizon Terms Component” means (a) the Weighted Average Remaining Credit Terms of the most recent Fiscal Month minus thirty (30) divided by (b) thirty (30).
23
Error! Unknown document property name.



Loss Reserve Percentage” means, at any time of determination, the product of (a) 2.00, times (b) the highest average of the Default Ratios for any three consecutive Fiscal Months during the twelve (12) most recent Fiscal Months, times (c) the Loss Horizon Ratio.
Majority Group Agents” means one or more Group Agents which in its Group, or their combined Groups, as the case may be, have Committed Lenders representing more than fifty percent (50%) of the aggregate Commitments of all Committed Lenders in all Groups (or, if the Commitments have been terminated, have Lenders representing more than fifty percent (50%) of the aggregate outstanding Capital held by all the Lenders in all Groups); provided, however, that in no event shall the Majority Group Agents include fewer than two (2) Group Agents at any time when there are two (2) or more Groups.
Material Adverse Effect” means relative to any Person (provided that if no particular Person is specified, “Material Adverse Effect” shall be deemed to be relative to the Borrower, the Servicer, the Performance Guarantor and the Originators, individually and in the aggregate) with respect to any event or circumstance, a material adverse effect on any of the following:
(1)the assets, operations, business or financial condition of such Person;
(2)the ability of such Person to perform its obligations under this Agreement or any other Transaction Document to which it is a party;
(3)the validity or enforceability of this Agreement or any other Transaction Document, or the validity, enforceability, value or collectibility of any material portion of the Pool Receivables;
(4)the status, perfection, enforceability or priority of the Administrative Agent’s security interest in the Collateral; or
(5)the rights and remedies of any Credit Party under the Transaction Documents or associated with its respective interest in the Collateral.
Minimum Dilution Reserve Percentage” means, on any day, the product (expressed as a percentage and rounded to the nearest 1/100 of 1%, with 5/1000th of 1% rounded upward) of (a) the average of the Dilution Ratios for the twelve (12) most recent Fiscal Months, multiplied by (b) the Dilution Horizon Ratio.
Minimum Funding Threshold” means an amount equal to the lesser of (a) seventy five percent (75%) of the Facility Limit and (b) the Borrowing Base.
Minimum Liquidity Amount” means a Liquidity Amount that is equal to or greater than three hundred million dollars ($300,000,000).
Monthly Settlement Date” means the twenty-fifth (25th) calendar day of each calendar month (or if such day is not a Business Day, the next occurring Business Day).
Moody’s” means Moody’s Investors Service, Inc. and any successor thereto that is a nationally recognized statistical rating organization.
Multiemployer Plan” means a multiemployer plan as defined in Section 4001(a)(3) of ERISA to which the Borrower, the Servicer, any Originator, the Parent or any of their respective ERISA Affiliates (other than one considered an ERISA Affiliate only pursuant to subsection (m) or (o) of Section 414 of the Code) is making or accruing an obligation to make contributions, or
24
Error! Unknown document property name.



has within any of the preceding five plan years made or accrued an obligation to make contributions.
Net Receivables Pool Balance” means, at any time of determination: (a) the aggregate Outstanding Balance of Eligible Receivables then in the Receivables Pool, minus (b) the Excess Concentration.
Notes” means short-term promissory notes issued, or to be issued, by any Conduit Lender to fund its investments in accounts receivable or other financial assets.
Obligor” means, with respect to any Receivable, the Person obligated to make payments pursuant to the Contract relating to such Receivable.
Obligor Percentage” means, at any time of determination, for each Obligor, a fraction, expressed as a percentage, (a) the numerator of which is the aggregate Outstanding Balance of the Eligible Receivables of such Obligor less the amount (if any) then included in the calculation of the Excess Concentration with respect to such Obligor and (b) the denominator of which is the aggregate Outstanding Balance of all Eligible Receivables at such time.
OFAC” means the U.S. Department of Treasury’s Office of Foreign Assets Control.
Originator” and “Originators” have the meaning set forth in the Purchase and Sale Agreement, as the same may be modified from time to time by adding new Originators or removing Originators, in each case with the prior written consent of the Administrative Agent.
Other Connection Taxes” means, with respect to any Affected Person, Taxes imposed as a result of a present or former connection between such Affected Person and the jurisdiction imposing such Tax (other than connections arising from such Affected Person having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Transaction Document, or sold or assigned an interest in any Loan or Transaction Document).
Other Taxes” means any and all present or future stamp or documentary Taxes or any other excise or property Taxes, charges or similar levies or fees arising from any payment made hereunder or from the execution, delivery, filing, recording or enforcement of, or otherwise in respect of, this Agreement, the other Transaction Documents and the other documents or agreements to be delivered hereunder or thereunder, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment.
Outstanding Balance” means, at any time of determination, with respect to any Receivable, the then outstanding principal balance thereof.
Overnight Bank Funding Rate” means for any day, the rate comprised of both overnight federal funds and overnight eurocurrency borrowings by U.S.-managed banking offices of depository institutions, as such composite rate shall be determined by the Federal Reserve Bank of New York, as set forth on its public website from time to time, and as published on the next succeeding Business Day as the overnight bank funding rate by the Federal Reserve Bank of New York (or by such other recognized electronic source (such as Bloomberg) selected by the Administrative Agent for the purpose of displaying such rate); provided, that if such day is not a Business Day, the Overnight Bank Funding Rate for such day shall be such rate on the immediately preceding Business Day; provided, further, that if such rate shall at any time, for any reason, no longer exist, a comparable replacement rate determined by the Administrative Agent at such time (which determination shall be conclusive absent manifest error). If the
25
Error! Unknown document property name.



Overnight Bank Funding Rate determined as above would be less than zero, then such rate shall be deemed to be zero. The rate of interest charged shall be adjusted as of each Business Day based on changes in the Overnight Bank Funding Rate without notice to the Borrower.
Parent” means Integra LifeSciences Holdings Corporation, a Delaware corporation.
Parent Group” has the meaning set forth in Section 7.03(c).
Participant” has the meaning set forth in Section 13.03(e).
Participant Register” has the meaning set forth in Section 13.03(f).
PATRIOT Act” has the meaning set forth in Section 13.15.
PBGC” means the Pension Benefit Guaranty Corporation, or any successor thereto.
Pension Plan” means a pension plan (other than a Multiemployer Plan) as defined in Section 3(2) of ERISA that is subject to Title IV of ERISA which any Originator, the Borrower or any other member of the Controlled Group has an obligation to contribute to or maintain or has made contributions within the preceding five (5) years.
Percentage” means, at any time of determination, with respect to any Committed Lender, a fraction (expressed as a percentage), (a) the numerator of which is (i) prior to the termination of all Commitments hereunder, its Commitment at such time or (ii) if all Commitments hereunder have been terminated, the aggregate outstanding Capital of all Loans being funded by the Lenders in such Committed Lender’s Group at such time and (b) the denominator of which is (i) prior to the termination of all Commitments hereunder, the aggregate Commitments of all Committed Lenders at such time or (ii) if all Commitments hereunder have been terminated, the aggregate outstanding Capital of all Loans at such time.
Performance Guarantor” means Integra LifeSciences Holdings Corporation, a Delaware corporation.
Performance Guaranty” means the Performance Guaranty, dated as of the Closing Date, by the Performance Guarantor in favor of the Administrative Agent for the benefit of the Secured Parties, as such agreement may be amended, restated, supplemented or otherwise modified from time to time.
Person” means an individual, partnership, corporation (including a business trust), joint stock company, trust, unincorporated association, joint venture, limited liability company or other entity, or a government or any political subdivision or agency thereof.
PNC” has the meaning set forth in the preamble to this Agreement.
Pool Receivable” means a Receivable in the Receivables Pool.
Portion of Capital” means, with respect to any Lender and its related Capital, the portion of such Capital being funded or maintained by such Lender by reference to a particular interest rate basis.
Program Support Agreement” means and includes any Liquidity Agreement and any other agreement entered into by any Program Support Provider providing for: (a) the issuance of one or more letters of credit for the account of any Conduit Lender, (b) the issuance of one or more surety bonds for which any Conduit Lender is obligated to reimburse the applicable
26
Error! Unknown document property name.



Program Support Provider for any drawings thereunder, (c) the sale by any Conduit Lender to any Program Support Provider of any Loan (or portions thereof or participation interest therein) maintained by such Conduit Lender and/or (d) the making of loans and/or other extensions of credit to any Conduit Lender in connection with such Conduit Lender’s receivables-securitization program contemplated in this Agreement, together with any letter of credit, surety bond or other instrument issued thereunder.
Program Support Provider” means and includes, with respect to any Conduit Lender, any Liquidity Provider and any other Person (other than any customer of such Conduit Lender) now or hereafter extending credit or having a commitment to extend credit to or for the account of, or to make purchases from, such Conduit Lender pursuant to any Program Support Agreement.
Purchase and Sale Agreement” means the Purchase and Sale Agreement, dated as of the Closing Date, among the Servicer, the Originators and the Borrower, as such agreement may be amended, supplemented or otherwise modified from time to time.
Purchase and Sale Termination Event” has the meaning set forth in the Purchase and Sale Agreement.
Rating Agency” mean each of S&P, Fitch and Moody’s (and/or each other rating agency then rating the Notes of any Conduit Lender).
Receivable” means any right to payment of a monetary obligation, whether or not earned by performance, owed to any Originator or the Borrower (as assignee of an Originator), whether constituting an account, chattel paper, payment intangible, instrument or general intangible, in each instance arising in connection with the sale of goods that have been or are to be sold or for services rendered or to be rendered, and includes, without limitation, the obligation to pay any finance charges, fees and other charges with respect thereto. Any such right to payment arising from any one transaction, including, without limitation, any such right to payment represented by an individual invoice or agreement, shall constitute a Receivable separate from a Receivable consisting of any such right to payment arising from any other transaction. Notwithstanding the foregoing, “Receivable” shall not include any Excluded Receivables.
Receivables Pool” means, at any time of determination, all of the then outstanding Receivables transferred (or purported to be transferred) to the Borrower pursuant to the Purchase and Sale Agreement prior to the Termination Date.
Register” has the meaning set forth in Section 13.03(c).
Related Committed Lender” means with respect to any Conduit Lender, each Committed Lender listed as such for each Conduit Lender as set forth on the signature pages of this Agreement or in any Assumption Agreement.
Related Conduit Lender” means, with respect to any Committed Lender, each Conduit Lender which is, or pursuant to any Assignment and Acceptance Agreement or Assumption Agreement or otherwise pursuant to this Agreement becomes, included as a Conduit Lender in such Committed Lender’s Group, as designated on its signature page hereto or in such Assignment and Acceptance Agreement, Assumption Agreement or other agreement executed by such Committed Lender, as the case may be.
Related Rights” has the meaning set forth in Section 1.1 of the Purchase and Sale Agreement.
27
Error! Unknown document property name.



Related Security” means, with respect to any Receivable:
(1)all of the Borrower’s and each Originator’s interest in any goods (including returned goods), and documentation of title evidencing the shipment or storage of any goods (including returned goods), the sale of which gave rise to such Receivable;
(2)all instruments and chattel paper that may evidence such Receivable;
(3)all other security interests or liens and property subject thereto from time to time purporting to secure payment of such Receivable, whether pursuant to the Contract related to such Receivable or otherwise, together with all UCC financing statements or similar filings relating thereto;
(4)all of the Borrower’s and each Originator’s rights, interests and claims under the related Contracts and all guaranties, indemnities, insurance and other agreements (including the related Contract) or arrangements of whatever character from time to time supporting or securing payment of such Receivable or otherwise relating to such Receivable, whether pursuant to the Contract related to such Receivable or otherwise; and
(5)all of the Borrower’s rights, interests and claims under the Purchase and Sale Agreement and the other Transaction Documents.
Release” has the meaning set forth in Section 3.01(a).
Relevant Governmental Body” means the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or any successor thereto.
Relief Period” means the Fiscal Months beginning and including March 2023 through and including December 2023.
Reportable Compliance Event” means that any Covered Entity becomes a Sanctioned Person, or is charged by indictment, criminal complaint or similar charging instrument, arraigned, or custodially detained in connection with any Anti-Terrorism Law or any predicate crime to any Anti-Terrorism Law, or has knowledge of facts or circumstances to the effect that it is reasonably likely that any aspect of its operations is in actual or probable violation of any Anti-Terrorism Law.
Reportable Event” means any reportable event as defined in Section 4043(c) of ERISA for which the notice provision has not been waived under the applicable regulations issued thereunder with respect to a Pension Plan (other than a Pension Plan maintained by an ERISA Affiliate which is considered an ERISA Affiliate only pursuant to subsection (m) or (o) of Section 414 of the Code).
Representatives” has the meaning set forth in Section 13.06(c).
Required Capital Amount” means, as of any date of determination, an amount equal to the product of (a) the Loss Reserve Percentage at such time times, multiplied by (b) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool.
Restricted Payments” has the meaning set forth in Section 7.01(v).
28
Error! Unknown document property name.



S&P” means Standard & Poor’s Rating Services, a Standard & Poor’s Financial Services LLC business, and any successor thereto that is a nationally recognized statistical rating organization.
Sanctioned Country” means a country or territory that is the subject or target of a sanctions program maintained under any Anti-Terrorism Law, including any such country identified on the list maintained by OFAC and available at: http://www.treasury.gov/resource-center/sanctions/Programs/Pages/Programs.aspx, or as otherwise published from time to time.
Sanctioned Person” means (a) a person named on the list of “Specially Designated Nationals” or “Blocked Persons” maintained by OFAC available at: https://www.treasury.gov/resource-center/sanctions/SDN-List/Pages/default.aspx, or as otherwise published from time to time, (b) (i) an agency of the government of a Sanctioned Country, (ii) an organization controlled by a Sanctioned Country or (iii) a person resident in a Sanctioned Country, to the extent subject to a sanctions program administered by OFAC, or (c) any individual person, group, regime, entity or thing listed or otherwise recognized as a specially designated, prohibited, sanctioned or debarred person, group, regime, entity or thing, or subject to any limitations or prohibitions (including but not limited to the blocking of property or rejection of transactions), under any Anti-Terrorism Law.
Scheduled Termination Date” means May 28, 2024.
SEC” means the U.S. Securities and Exchange Commission or any governmental agencies substituted therefor.
Secured Parties” means each Credit Party, each Borrower Indemnified Party and each Affected Person.
Securities Act” means the Securities Act of 1933, as amended or otherwise modified from time to time.
Servicer” has the meaning set forth in the preamble to this Agreement.
Servicer Indemnified Amounts” has the meaning set forth in Section 12.02(a).
Servicer Indemnified Party” has the meaning set forth in Section 12.02(a).
Servicing Fee” means the fee referred to in Section 8.06(a) of this Agreement.
Servicing Fee Rate” means the rate referred to in Section 8.06(a) of this Agreement.
Settlement Date” means with respect to any Portion of Capital for any Interest Period or any Interest or Fees, (i) so long as no Event of Default has occurred and is continuing and the Termination Date has not occurred, the Monthly Settlement Date and (ii) on and after the Termination Date or if an Event of Default has occurred and is continuing, each day selected from time to time by the Administrative Agent (with the consent or at the direction of the Majority Group Agents) (it being understood that the Administrative Agent (with the consent or at the direction of the Majority Group Agents) may select such Settlement Date to occur as frequently as daily), or, in the absence of such selection, the Monthly Settlement Date.
SOFR” means, for any day, a rate equal to the secured overnight financing rate as administered by the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate).
29
Error! Unknown document property name.



SOFR Adjustment” means ten (10) basis points (0.10%) per annum.
SOFR Determination Date” shall have the meaning set forth in the definition of “Daily Simple SOFR”.
SOFR Rate Day” shall have the meaning set forth in the definition of “Daily Simple SOFR”.
Solvent” means, with respect to any Person and as of any particular date, (i) the present fair market value (or present fair saleable value) of the assets of such Person is not less than the total amount required to pay the probable liabilities of such Person on its total existing debts and liabilities (including contingent liabilities) as they become absolute and matured, (ii) such Person is able to realize upon its assets and pay its debts and other liabilities, contingent obligations and commitments as they mature and become due in the normal course of business, (iii) such Person is not incurring debts or liabilities beyond its ability to pay such debts and liabilities as they mature and (iv) such Person is not engaged in any business or transaction, and is not about to engage in any business or transaction, for which its property would constitute unreasonably small capital after giving due consideration to the prevailing practice in the industry in which such Person is engaged.
Specifically Reserved Dilution Amount” means for any Fiscal Month, an amount computed on the last day of such Fiscal Month, equal to the greater of:
(1)the product of (i) the U.S. Dollar Equivalent of the aggregate amount of dilution or similar adjustments arising out of volume rebates, terms discounts, indirect rebates, direct rebates (net of any direct rebate recovery), key promotional programs or similar arrangements which are customary for the Originators and specified in the related Contract or applicable marketing program related to the applicable Receivable and Obligor thereof that are expected by the Servicer to be made or otherwise incurred with respect to the then outstanding Pool Receivables as such expected dilution and similar adjustments are reflected on the books and records of the Originators and their Affiliates and reserved for by the Originator and their Affiliates (GL Account # 231230), as determined in consultation with the external accountants of the Originators and in accordance with the customary procedures established by the Originators and such accountants and (ii) one hundred percent (100.00%) (or such lesser percentage specified by the Administrative Agent upon not less than five (5) Business Days’ notice to the Borrower to reflect such percentage as the Administrative Agent reasonably believes best reflects the reserve coverage relative to Pool Receivables based on the observed historical information and/or the results of any audit or field exam of the Originators; and
(2)the product of (i) the aggregate credit sales made by each Originator, as applicable, during the most recent Fiscal Month and (ii) three percent (3.00%) (or such other percentage specified by the Administrative Agent upon not less than five (5) Business Days’ notice to the Borrower to reflect such percentage as the Administrative Agent reasonably believes best reflects the dilution activity described in section (a) herein based on the observed historical information and/or the results of any audit or field exam of the Originators.
Specific Reporting Event” shall occur when the Minimum Liquidity Amount has not been maintained for a period of five (5) consecutive Business Days; provided, that such Specific Reporting Event shall cease to occur once the Minimum Liquidity Amount has been maintained for a period of thirty (30) consecutive calendar days.
30
Error! Unknown document property name.



Spot Rate” means, on any day, (a) for the purpose of exchanging U.S. Dollars to Alternative Currency or Alternative Currency to U.S. Dollars in connection with applying funds to pay amounts owing hereunder or under the Transaction Documents in accordance with this Agreement, the actual rate used by the Administrative Agent’s principal foreign exchange trading office for the purchase by the Administrative Agent of the applicable currency with the other currency through its principal foreign exchange trading office, and (b) for the purpose of making any calculation hereunder that does not require the actual exchange of U.S. Dollars for Alternative Currency or Alternative Currency for U.S. Dollars to make a payment of amounts owing hereunder or under the Transaction Documents, (i) with respect to the determination of the U.S. Dollar Equivalent of any amount denominated in Alternative Currency, the exchange rate at which such Alternative Currency may be exchanged into U.S. Dollars as set forth at approximately 11:00 a.m. New York City time, on such day as published on the Bloomberg Key Cross-Currency Rates Page for such Alternative Currency or (ii) with respect to the determination of the Alternative Currency equivalent of any amount denominated in U.S. Dollars, the exchange rate at which U.S. Dollars may be exchanged into Alternative Currency as set forth at approximately 11:00 a.m. New York City time, on such day as published on the Bloomberg Key Cross-Currency Rates Page for U.S. Dollars. In the event that such rate does not appear on any Bloomberg Key Cross Currency Rates Page, the Spot Rate shall be determined by reference to such other publicly available service for displaying exchange rates as may be selected by the Administrative Agent and is reasonably satisfactory to the Servicer, or, in the absence of such an agreement, such Spot Rate shall instead be the arithmetic average of the spot rates of exchange of the Administrative Agent in the market where its foreign currency exchange operations in respect of such currency are then being conducted, at or about 11:00 a.m. New York time, on such date for the purchase of U.S. Dollars with the applicable Alternative Currency for delivery two (2) Business Days later; provided that if at the time of any such determination, for any reason, no such spot rate is being quoted, the Administrative Agent may use any reasonable method it deems appropriate to determine such rate, and such determination shall be conclusive absent manifest error.
Structuring Agent” means PNC Capital Markets LLC, a Pennsylvania limited liability company.
Subordinated Note” has the meaning set forth in the Purchase and Sale Agreement.
Sub-Servicer” has the meaning set forth in Section 8.01(d).
Subsidiary” means, as to any Person, a corporation, partnership, limited liability company or other entity of which shares of stock of each class or other interests having ordinary voting power (other than stock or other interests having such power only by reason of the happening of a contingency) to elect a majority of the Board of Directors or other managers of such entity are at the time owned, or management of which is otherwise controlled: (a) by such Person, (b) by one or more Subsidiaries of such Person or (c) by such Person and one or more Subsidiaries of such Person.
Taxes” means any and all present or future taxes, levies, imposts, duties, deductions, charges or withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority and all interest, penalties, additions to tax and any similar liabilities with respect thereto.
Temporarily Ineligible Obligor” means Promedon Do Brazil or any other Obligor requested by the Borrower and consented to in writing by the Majority Group Agents in their sole discretion until such time that the Majority Group Agents and the Borrower mutually agree that such Obligor is no longer deemed ineligible (including, for the avoidance of doubt, Promedon Do Brazil).
31
Error! Unknown document property name.



Temporarily Ineligible Receivable” means any Receivable the Obligor of which is a Temporarily Ineligible Obligor.
Term SOFR” shall mean, with respect to any Loan (or portion thereof) to which the Term SOFR Option applies, for any Interest Period, the interest rate per annum determined by the Administrative Agent (rounded upwards, at the Administrative Agent’s discretion, to the nearest 1/100th of 1%) equal to the Term SOFR Reference Rate for a tenor comparable to such Interest Period, as such rate is published by the Term SOFR Administrator on the day (the “Term SOFR Determination Date”) that is two (2) Business Days prior to the first day of such Interest Period. If the Term SOFR Reference Rate for the applicable tenor has not been published or replaced with a Benchmark Replacement by 5:00 p.m. (Pittsburgh, Pennsylvania time) on the Term SOFR Determination Date, then the Term SOFR Reference Rate shall be the Term SOFR Reference Rate for such tenor on the first Business Day preceding such Term SOFR Determination Date for which such Term SOFR Reference Rate for such tenor was published by the Term SOFR Administrator in accordance herewith, so long as such first preceding Business Day is not more than three (3) Business Days prior to such Term SOFR Determination Date. If Term SOFR, determined as provided above, would be less than the Floor, then Term SOFR shall be deemed to be the Floor. Term SOFR shall be adjusted automatically without notice to the Borrower on and as of the first day of each Interest Period.
Term SOFR Administrator” means CME Group Benchmark Administration Limited (CBA) (or a successor administrator of the Term SOFR Reference Rate selected by the Administrative Agent in its reasonable discretion).
Term SOFR Determination Date” shall have the meaning set forth in the definition of “Term SOFR”.
Term SOFR Option” means the option of the Borrower to have Loans bearing interest at the rate and under the terms specified in Section 2.05(a)(ii).
Term SOFR Rate” means with respect to Loans to which the Term SOFR Option applies, a fluctuating interest rate per annum as shall be in effect from time to time equal to (a) Term SOFR, plus (b) the SOFR Adjustment.
Term SOFR Rate Loan” means a Loan that bears interest based on the Term SOFR Rate.
Term SOFR Reference Rate” shall mean the forward-looking term rate based on SOFR.
Termination Date” means the earliest to occur of (a) the Scheduled Termination Date, (b) the date on which the “Termination Date” is declared or deemed to have occurred under Section 9.01 (c) the date selected by the Borrower on which all Commitments have been reduced to zero pursuant to Section 2.02(e) and (d) the date as determined pursuant to Section 7.01(z)(i).
Total Reserves” means, at any time of determination, an amount equal to the sum of (a) the product of (i) the sum of: (A) the Yield Reserve Percentage, plus (B) the greatest of (I) the sum of the Concentration Reserve Percentage plus the Minimum Dilution Reserve Percentage and (II) the sum of the Loss Reserve Percentage plus the Dilution Reserve Percentage, multiplied by (ii) the Adjusted Net Receivables Pool Balance at such time, plus (b) the Currency Reserve Amount; provided, that Temporarily Ineligible Receivables shall be excluded from each component of the calculations used to determine Total Reserves.
Transaction Documents” means this Agreement, the Purchase and Sale Agreement, the Account Control Agreement(s), the Fee Letter, each Subordinated Note, the Performance
32
Error! Unknown document property name.



Guaranty and all other certificates, instruments, UCC financing statements, reports, notices, agreements and documents executed or delivered under or in connection with this Agreement, in each case as the same may be amended, supplemented or otherwise modified from time to time in accordance with this Agreement.
Transaction Information” means any information provided to any Rating Agency, in each case, to the extent related to such Rating Agency providing or proposing to provide a rating of any Notes or monitoring such rating including, without limitation, information in connection with the Borrower, the Originator, the Servicer or the Receivables.
UCC” means the Uniform Commercial Code as from time to time in effect in the applicable jurisdiction.
Unadjusted Benchmark Replacement” means the applicable Benchmark Replacement excluding the related Benchmark Replacement Adjustment.
Unbilled Receivable” means, at any time, any Receivable as to which the invoice or bill with respect thereto has not yet been sent to the Obligor thereof.
Unmatured Event of Default” means an event that but for notice or lapse of time or both would constitute an Event of Default.
Unmatured Purchase and Sale Termination Event” has the meaning set forth in the Purchase and Sale Agreement.
U.S. Dollar Equivalent” means, on any date on which a determination thereof is to be made, with respect to (a) any amount denominated in U.S. Dollars, such amount and (b) any amount denominated in an Alternative Currency, the U.S. Dollar equivalent of such amount of such Alternative Currency determined by reference to the Spot Rate determined as of such determination date.
U.S. Government Securities Business Day” means any day except for (a) a Saturday or Sunday or (b) a day on which the Securities Industry and Financial Markets Association recommends that the fixed income departments of its members be closed for the entire day for purposes of trading in United States government securities.
U.S. Obligor” means an Obligor that is (a) a corporation or other business organization and is organized under the laws of the United States of America (or of a United States of America territory, district, state, commonwealth, or possession, including, without limitation, Puerto Rico and the U.S. Virgin Islands) or any political subdivision thereof, (b) the federal government of the United States of America or any political subdivision, department, affiliate, agency or other entity thereof, and (c) any state or local government body in the United States of America or any political subdivision, department, affiliate, agency or other entity thereof.
U.S. Tax Compliance Certificate” has the meaning set forth in Section 4.03(f)(ii)(B)(3).
Volcker Rule” means Section 13 of the U.S. Bank Holding Company Act of 1956, as amended, and the applicable rules and regulations thereunder.
Voting Securities” means, with respect to any Person, securities or other ownership interests having by the terms thereof ordinary voting power to elect the board of directors or other persons performing similar functions of such Person (irrespective of whether or not at such time securities or other ownership interests of any other class or classes of such Person shall have or might have voting power by reason of the happening of any contingency).
33
Error! Unknown document property name.



Weighted Average Remaining Credit Terms” means, for any Fiscal Month, the weighted average (weighted based on the Outstanding Balance of all Pool Receivables) remaining payment period (computed in days and calculated based on the difference between the date of determination and the stated due date for payment) of invoices for all Pool Receivables (for which the related stated due date for payment has not occurred as of such date of determination) as of the last day of such Fiscal Month.
Withdrawal Liability” means liability to a Multiemployer Plan as a result of a complete or partial withdrawal from such Multiemployer Plan, as such terms are defined in Part I of Subtitle E of Title IV of ERISA.
Yield Reserve Percentage” means at any time of determination:
1.50 x DSO x (BR + SFR)
        360
where:
BR    =    the Base Rate;
DSO    =    the Days’ Sales Outstanding for the most recently ended Fiscal Month; and
SFR    =    the Servicing Fee Rate.
SECTION 1.0b.Other Interpretative Matters. All accounting terms not specifically defined herein shall be construed in accordance with GAAP. All terms used in Article 9 of the UCC in the State of New York and not specifically defined herein, are used herein as defined in such Article 9. Unless otherwise expressly indicated, all references herein to “Article,” “Section,” “Schedule”, “Exhibit” or “Annex” shall mean articles and sections of, and schedules, exhibits and annexes to, this Agreement. For purposes of this Agreement, the other Transaction Documents and all such certificates and other documents, unless the context otherwise requires: (a) references to any amount as on deposit or outstanding on any particular date means such amount at the close of business on such day; (b) the words “hereof,” “herein” and “hereunder” and words of similar import refer to such agreement (or the certificate or other document in which they are used) as a whole and not to any particular provision of such agreement (or such certificate or document); (c) references to any Section, Schedule or Exhibit are references to Sections, Schedules and Exhibits in or to such agreement (or the certificate or other document in which the reference is made), and references to any paragraph, subsection, clause or other subdivision within any Section or definition refer to such paragraph, subsection, clause or other subdivision of such Section or definition; (d) the term “including” means “including without limitation”; (e) references to any Applicable Law refer to that Applicable Law as amended from time to time and include any successor Applicable Law; (f) references to any agreement refer to that agreement as from time to time amended, restated or supplemented or as the terms of such agreement are waived or modified in accordance with its terms; (g) references to any Person include that Person’s permitted successors and assigns; (h) headings are for purposes of reference only and shall not otherwise affect the meaning or interpretation of any provision hereof; (i) unless otherwise provided, in the calculation of time from a specified date to a later specified date, the term “from” means “from and including”, and the terms “to” and “until” each means “to but excluding”; (j) terms in one gender include the parallel terms in the neuter and opposite gender; (k) references to any amount as on deposit or outstanding on any particular date means such amount at the close of business on such day and (l) the term “or” is not exclusive.
34
Error! Unknown document property name.



ARTICLE 2

TERMS OF THE LOANS
SECTION 1.0a.Loan Facility. Upon a request by the Borrower pursuant to Section 2.02, and on the terms and subject to the conditions hereinafter set forth, the Conduit Lenders, ratably, in accordance with the aggregate of the Commitments of the Related Committed Lenders with respect to each such Conduit Lender, severally and not jointly, may, in their sole discretion, make Loans to the Borrower on a revolving basis, and if and to the extent any Conduit Lender does not make any such requested Loan or if any Group does not include a Conduit Lender, the Related Committed Lender(s) for such Conduit Lender or the Committed Lender for such Group, as the case may be, shall, ratably in accordance with their respective Commitments, severally and not jointly, make such Loans to the Borrower, in either case, from time to time during the period from the Closing Date to the Termination Date. Under no circumstances shall any Lender be obligated to make any such Loan if, after giving effect to such Loan:
i.the Aggregate Capital would exceed the Facility Limit at such time;
ii.the sum of (A) the Capital of such Lender, plus (B) the aggregate outstanding Capital of each other Lender in its Group, would exceed the Group Commitment of such Lender’s Group;
iii.if such Lender is a Committed Lender, the aggregate outstanding Capital of such Committed Lender would exceed its Commitment; or
iv.the Aggregate Capital would exceed the Borrowing Base at such time.
SECTION 1.0b.Making Loans; Repayment of Loans.
i.Each Loan hereunder shall be made on at least one (1) Business Day’s prior written request from the Borrower to the Administrative Agent and each Group Agent in the form of a Loan Request attached hereto as Exhibit A. Each such request for a Loan shall be made no later than 1:00 p.m. (New York City time) on a Business Day (it being understood that any such request made after such time shall be deemed to have been made on the following Business Day) and shall specify (i) the amount of the Loan(s) requested (which shall not be less than one million dollars ($1,000,000) and shall be an integral multiple of one hundred thousand dollars ($100,000)), (ii) the allocation of such amount among the Groups (which shall be ratable based on the Group Commitments), (iii) the account to which the proceeds of such Loan shall be distributed and (iv) the date such requested Loan is to be made (which shall be a Business Day).
ii.On the date of each Loan specified in the applicable Loan Request, the Lenders shall, upon satisfaction of the applicable conditions set forth in Article V and pursuant to the other conditions set forth in this Article II, make available to the Borrower in same day funds an aggregate amount equal to the amount of such Loans requested, at the account set forth in the related Loan Request.
iii.Each Committed Lender’s obligation shall be several, such that the failure of any Committed Lender to make available to the Borrower any funds in connection with any Loan shall not relieve any other Committed Lender of its obligation, if any, hereunder to make funds available on the date such Loans are requested (it being understood, that no Committed Lender shall be responsible for the failure of any other Committed Lender (other than a Committed Lender in its Group) to make funds available to the Borrower in connection with any Loan hereunder).
35
Error! Unknown document property name.



iv.The Borrower shall repay in full the outstanding Capital of each Lender on the Final Maturity Date. Prior thereto, the Borrower shall, on each Settlement Date, make a prepayment of the outstanding Capital of the Lenders to the extent required under Section 3.01 and otherwise in accordance therewith. Notwithstanding the foregoing, the Borrower, in its discretion, shall have the right to make a prepayment, in whole or in part, of the outstanding Capital of the Lenders on any Business Day upon at least (x) with respect to any Base Rate Loan, one (1) Business Day’s prior written notice thereof to the Administrative Agent and each Group Agent, and (y) with respect to any Term SOFR Rate Loan or Daily SOFR Rate Loan, three (3) Business Days prior written notice thereof to the Administrative Agent and each Group Agent, in any case in the form of a Reduction Notice attached hereto as Exhibit B; provided, however, that (i) each such prepayment shall be in a minimum aggregate amount of one hundred thousand dollars ($100,000) and shall be an integral multiple of one hundred thousand dollars ($100,000); provided, however, that notwithstanding the foregoing, a prepayment may be in an amount necessary to reduce any Borrowing Base Deficit existing at such time or the outstanding Capital of the Lenders to zero ($0), and (ii) any accrued Interest and Fees in respect of such prepaid Capital shall be paid on the immediately following Settlement Date; provided, further, that the Borrower shall not provide any Reduction Notice, and no such Reduction Notice shall be effective, if after giving effect thereto, the Aggregate Capital at such time would be less than the Minimum Funding Threshold.
v.All prepayments required pursuant to this Section 2.02 shall be applied first to Base Rate Loans, then to Daily SOFR Rate Loans, then to Term SOFR Rate Loans. In accordance with Section 12.01, the Borrower shall indemnify the Lenders for any loss or expense, including loss of margin, incurred with respect to any such prepayments applied against Loans subject to a Term SOFR Option or Daily SOFR Option on any day other than the last day of the applicable Interest Period.
vi.Decreases or Increases in Commitments.
1.The Borrower may, at any time upon at least thirty (30) calendar days’ prior written notice to the Administrative Agent and each Group Agent, terminate the Facility Limit in whole or ratably reduce the Facility Limit in part. Each partial reduction in the Facility Limit shall be in a minimum aggregate amount of five million dollars ($5,000,000) or integral multiples of one million dollars ($1,000,000) in excess thereof, and no such partial reduction shall reduce the Facility Limit to an amount less than one hundred million dollars ($100,000,000). In connection with any partial reduction in the Facility Limit, the Commitment of each Committed Lender shall be ratably reduced.
2.So long as no Event of Default or Unmatured Event of Default has occurred and is continuing, the Borrower may, with the prior written consent of the Majority Group Agents (in their sole discretion), upon thirty (30) calendar days’ prior written notice to the Administrative Agent and the Majority Group Agents, from time to time, request an increase in the Commitment with respect to one or more Lenders (and a related increase in the Facility Limit) or cause additional Persons to become parties to this Agreement, as lenders, at any time following the Closing Date and prior to the Termination Date; it being understood and agreed that the Administrative Agent, any Majority Group Agent or any Lender increasing its Commitment pursuant to this Section 2.02(e)(ii) may request any of (A) resolutions of the Board of Managers of the Borrower approving or consenting to such Commitment increase and authorizing the execution, delivery and performance of any amendment to this Agreement, (B) a corporate and enforceability opinion of counsel of the Borrower and (C) such other documents, agreements and opinions reasonably requested by the Administrative Agent, such Majority Group Agent or such Lender. For the avoidance of doubt, Any such Person not
36
Error! Unknown document property name.



responding within such time period shall be deemed to have declined to consent to an increase in such Lender’s Commitment.
vii.In connection with any reduction of the Commitments, the Borrower shall remit to the Administrative Agent (i) instructions regarding such reduction and (ii) for payment to the Lenders, cash in an amount sufficient to pay (A) Capital of Lenders in each Group in excess of the Group Commitment of such Group and (B) all other outstanding Borrower Obligations with respect to such reduction (determined based on the ratio of the reduction of the Commitments being effected to the amount of the Commitments prior to such reduction or, if the Administrative Agent reasonably determines that any portion of the outstanding Borrower Obligations is allocable solely to that portion of the Commitments being reduced or has arisen solely as a result of such reduction, all of such portion) including, without duplication, any associated Breakage Fees. Upon receipt of any such amounts, the Administrative Agent shall apply such amounts first to the reduction of the outstanding Capital, and second to the payment of the remaining outstanding Borrower Obligations with respect to such reduction, including any Breakage Fees, by paying such amounts to the Lenders.
viii.The Borrower hereby covenants and agrees from time to time to request Loans pursuant to Section 2.02(a) in amounts and at such times such that the Aggregate Capital at all times is no less than the Minimum Funding Threshold at such time; it being understood and agreed that each Credit Extension pursuant to this Agreement is subject to the applicable conditions set forth in Article V and the other conditions set forth in this Article II.
SECTION 1.0c.Interest and Fees.
i.On each Settlement Date, the Borrower shall, in accordance with the terms and priorities for payment set forth in Section 3.01, pay to each Group Agent, each Lender, the Administrative Agent and the Structuring Agent certain fees (collectively, the “Fees”) in the amounts set forth in the fee letter agreements from time to time entered into, among the Borrower, the members of the applicable Group (or their Group Agent on their behalf) and/or the Administrative Agent (each such fee letter agreement, as amended, restated, supplemented or otherwise modified from time to time, collectively being referred to herein as the “Fee Letter”). Undrawn Fees (as defined in the Fee Letter) shall cease to accrue on the unfunded portion of the Commitment of such Defaulting Lender as provided in Section 2.06.
ii.Each Loan of each Lender and the Capital thereof shall accrue interest on each day when such Capital remains outstanding at the then applicable Interest Rate for such Loan. The Borrower shall pay all Interest (including, for the avoidance of doubt, all Interest accrued on Loans during an Interest Period regardless of whether the applicable Interest Period has ended), Fees and Breakage Fees accrued during each Interest Period on each Settlement Date in accordance with the terms and priorities for payment set forth in Section 3.01.
SECTION 1.0d.Records of Loans. Each Group Agent shall record in its records, the date and amount of each Loan made by the Lenders in its Group hereunder, the interest rate with respect thereto, the Interest accrued thereon and each repayment and payment thereof. Subject to Section 13.03(c), such records shall be conclusive and binding absent manifest error. The failure to so record any such information or any error in so recording any such information shall not, however, limit or otherwise affect the obligations of the Borrower hereunder or under the other Transaction Documents to repay the Capital of each Lender, together with all Interest accruing thereon and all other Borrower Obligations.
SECTION 1.0e.Selection of Interest Rates.
37
Error! Unknown document property name.



i.The Borrower shall have the right to select from the following types of Interest Rate applicable to a Loan:
1.Base Rate Option: the Base Rate (computed on the basis of a year of 365 or 366 days, as the case may be, and actual days elapsed), subject to change automatically from time to time effective as of the effective date of each change in the Base Rate;
2.Term SOFR Option: the Term SOFR Rate (computed on the basis of a year of 360 days and actual days elapsed) as determined for each applicable Interest Period; or
3.Daily SOFR Option: the Daily SOFR Rate (computed on the basis of a year of 360 days and actual days elapsed) as determined for each applicable Interest Period.
ii.So long as no Event of Default has occurred and is continuing, the Borrower may from time to time elect to change or continue the type of Interest Rate borne by each Loan or, subject to the minimum amount requirement for each outstanding Loan set forth in Section 2.02, a portion thereof by notice to the Administrative Agent not later than 11:00 a.m. (New York City time), one (1) Business Day prior to the expiration of the applicable Interest Period, as applicable; provided, that there shall not be more than three (3) Loans accruing interest at any Interest Rate and outstanding hereunder at any one time; provided, further, that for the avoidance of doubt, any change to the Interest Rate applicable to a Loan shall not be effective until the Monthly Settlement Date occurring after the date of such request. Any such notices requesting the continuation or conversion of a Loan to the Administrative Agent may be given by telephone, telecopy, or other telecommunication device acceptable to the Administrative Agent (which notice shall be irrevocable once given and, if by telephone, shall be promptly confirmed in writing in a manner acceptable to the Administrative Agent).
iii.If, by the time required in Section 2.05(a), the Borrower fails to select an Interest Rate for any Loan, such Loan shall automatically accrue Interest at the Daily SOFR Rate for the next occurring Interest Period.
SECTION 1.0f.Defaulting Lenders. Notwithstanding any provision of this Agreement to the contrary, if any Lender becomes a Defaulting Lender, then the following provisions shall apply for so long as such Lender is a Defaulting Lender:
i.Undrawn Fees (as defined in the Fee Letter) shall cease to accrue on the unfunded portion of the Commitment of such Defaulting Lender.
ii.The Commitment and Capital of such Defaulting Lender shall not be included in determining whether the Majority Group Agents have taken or may take any action hereunder (including any consent to any amendment, waiver or other modification pursuant to Section 13.01); provided, that, except as otherwise provided in Section 13.01, this clause (b) shall not apply to the vote of a Defaulting Lender in the case of an amendment, waiver or other modification requiring the consent of such Lender or each Lender directly affected thereby (if such Lender is directly affected thereby).
iii.In the event that the Administrative Agent, the Borrower and the Servicer each agrees in writing that a Defaulting Lender has adequately remedied all matters that caused such Lender to be a Defaulting Lender, then on such date such Lender shall purchase at par such of the Loans of the other Lenders as the Administrative Agent shall determine may be necessary in order for such Lender to hold such Loans in accordance with its Pro Rata Percentage; provided, that no adjustments shall be made retroactively with respect to fees accrued or payments made by
38
Error! Unknown document property name.



or on behalf of the Borrower while such Lender was a Defaulting Lender, and provided, further, that except to the extent otherwise agreed by the affected parties, no change hereunder from Defaulting Lender to Lender that is not a Defaulting Lender will constitute a waiver or release of any claim of any party hereunder arising from that Lender having been a Defaulting Lender.
ARTICLE 3

SETTLEMENT PROCEDURES AND PAYMENT PROVISIONS
SECTION 1.0a.Settlement Procedures.
i.The Servicer shall set aside and hold in trust for the benefit of the Secured Parties (or, upon the occurrence and during the continuation of a Specific Reporting Event or at any time Days’ Sales Outstanding exceeds fifty-five (55) calendar days, if so requested by the Administrative Agent, promptly upon (but in no event later than one (1) Business Day after) receipt of such request, segregate in a separate account approved by the Administrative Agent, which shall be an account maintained and controlled by the Administrative Agent unless the Administrative Agent otherwise instructs in its sole discretion, for application in accordance with the priority of payments set forth below, all Collections on Pool Receivables that are received by the Servicer or the Borrower or received in any Lock-Box or Collection Account; provided, however, that so long as each of the conditions precedent set forth in Section 5.03 are satisfied on such date, the Servicer may release to the Borrower from such Collections the amount (if any) necessary to pay (i) the purchase price for Receivables purchased by the Borrower on such date in accordance with the terms of the Purchase and Sale Agreement or (ii) amounts owing by the Borrower to the Originators under the Subordinated Notes (each such release, a “Release”). On each Settlement Date, the Servicer (or, following its assumption of control of the Collection Accounts, the Administrative Agent) shall, distribute such Collections in the following order of priority:
1.first, to the Servicer for the payment of the accrued Servicing Fees payable for the immediately preceding Interest Period (plus, if applicable, the amount of Servicing Fees payable for any prior Interest Period to the extent such amount has not been distributed to the Servicer);
2.second, to each Lender and other Credit Party (ratably, based on the amount then due and owing), all accrued and unpaid Interest, Fees and Breakage Fees due to such Lender and other Credit Party for the immediately preceding Interest Period (including any additional amounts or indemnified amounts payable under Sections 4.03 and 12.01 in respect of such payments), plus, if applicable, the amount of any such Interest, Fees and Breakage Fees (including any additional amounts or indemnified amounts payable under Sections 4.03 and 12.01 in respect of such payments) payable for any prior Interest Period to the extent such amount has not been distributed to such Lender or Credit Party;
3.third, as set forth in clause (A), (B) or (C) below, as applicable:
a.prior to the occurrence of the Termination Date, to the extent that a Borrowing Base Deficit exists on such date or the Aggregate Capital on such date exceeds the Facility Limit, to the Lenders (ratably, based on the aggregate outstanding Capital of each Lender at such time) for the payment of a portion of the outstanding Aggregate Capital at such time, in an aggregate amount equal to the amount necessary to reduce the Borrowing Base Deficit to zero ($0) or the amount necessary to reduce the
39
Error! Unknown document property name.



Aggregate Capital to an amount equal to or less than the Facility Limit, as applicable;
b.on and after the occurrence of the Termination Date, to each Lender (ratably, based on the aggregate outstanding Capital of each Lender at such time) for the payment in full of the aggregate outstanding Capital of such Lender at such time; or
c.prior to the occurrence of the Termination Date, at the election of the Borrower from time to time and in accordance with Section 2.02(d), to the payment of all or any portion of the outstanding Capital of the Lenders at such time (ratably, based on the aggregate outstanding Capital of each Lender at such time);
4.fourth, to the Credit Parties, the Affected Persons and the Borrower Indemnified Parties (ratably, based on the amount due and owing at such time), for the payment of all other Borrower Obligations then due and owing by the Borrower to the Credit Parties, the Affected Persons and the Borrower Indemnified Parties; and
5.fifth, the balance, if any, to be paid to the Borrower for its own account.
ii.All payments or distributions to be made by the Servicer, the Borrower and any other Person to the Lenders (or their respective related Affected Persons and the Borrower Indemnified Parties) shall be paid or distributed to the related Group Agent at its Group Agent’s Account. Each Group Agent, upon its receipt in the applicable Group Agent’s Account of any such payments or distributions, shall distribute such amounts to the applicable Lenders, Affected Persons and the Borrower Indemnified Parties within its Group ratably; provided that if such Group Agent shall have received insufficient funds to pay all of the above amounts in full on any such date, such Group Agent shall pay such amounts to the applicable Lenders, Affected Persons and the Borrower Indemnified Parties within its Group in accordance with the priority of payments set forth above, and with respect to any such category above for which there are insufficient funds to pay all amounts owing on such date, ratably (based on the amounts in such categories owing to each such Person in such Group) among all such Persons in such Group entitled to payment thereof.
iii.If and to the extent the Administrative Agent, any Credit Party, any Affected Person or any Borrower Indemnified Party shall be required, for any reason relating to any act or omission of any Integra Party or any Insolvency Event relating to any Integra Party, to pay over to any Person any amount received on its behalf hereunder, such amount shall be deemed not to have been so received but rather to have been retained by the Borrower and, accordingly, the Administrative Agent, such Credit Party, such Affected Person or such Borrower Indemnified Party, as the case may be, shall have a claim against the Borrower for such amount.
iv.For the purposes of this Section 3.01:
1.If, on any day, the Outstanding Balance of any Pool Receivable is reduced or adjusted as a result of any defective, rejected, returned, repossessed or foreclosed goods or services, or any revision, cancellation, allowance, rebate, credit memo, discount or other adjustment made by the Borrower, any Originator, the Servicer or any Affiliate of the Servicer, or any setoff, counterclaim or dispute between the Borrower or any Affiliate of the Borrower, an Originator or any Affiliate of an Originator, or the Servicer or any Affiliate of the Servicer, and an Obligor, the Borrower shall be deemed to have received on such day a Collection of such Pool Receivable in the
40
Error! Unknown document property name.



amount of such reduction or adjustment and shall immediately pay any and all such amounts in respect thereof to a Collection Account (or as otherwise directed by the Administrative Agent at such time) for the benefit of the Credit Parties for application pursuant to Section 3.01(a);
2.if on any day any of the representations or warranties in Section 6.01(o) or Section 6.01(w) is not true with respect to any Pool Receivable, the Borrower shall be deemed to have received on such day a Collection of such Pool Receivable in full and shall immediately pay the amount of such deemed Collection to a Collection Account (or as otherwise directed by the Administrative Agent at such time) for the benefit of the Credit Parties for application pursuant to Section 3.01(a) (Collections deemed to have been received pursuant this Section 3.01(d) are hereinafter sometimes referred to as “Deemed Collections”);
3.except as provided in clauses (i) or (ii) above or otherwise required by Applicable Law or the relevant Contract, all Collections received from an Obligor of any Receivable shall be applied to the Receivables of such Obligor in the order of the age of such Receivables, starting with the oldest such Receivable, unless such Obligor designates in writing its payment for application to specific Receivables; and
4.if and to the extent the Administrative Agent, any Credit Party, any Affected Person or any Borrower Indemnified Party shall be required for any reason to pay over to an Obligor (or any trustee, receiver, custodian or similar official in any Insolvency Proceeding) any amount received by it hereunder, such amount shall be deemed not to have been so received by such Person but rather to have been retained by the Borrower and, accordingly, such Person shall have a claim against the Borrower for such amount, payable when and to the extent that any distribution from or on behalf of such Obligor is made in respect thereof.
SECTION 1.0b.Payments and Computations, Etc.
i.All amounts to be paid by the Borrower or the Servicer to the Administrative Agent, any Credit Party, any Affected Person or any Borrower Indemnified Party hereunder shall be paid no later than noon (12:00 p.m.) (New York City time) on the day when due in same day funds to the applicable Group Agent’s Account.
ii.Each of the Borrower and the Servicer shall, to the extent permitted by Applicable Law, pay interest on any amount not paid or deposited by it when due hereunder, at an interest rate per annum equal to 2.50% per annum above the Base Rate, payable on demand.
iii.All computations of interest under subsection (b) above and all computations of Interest, Fees and other amounts hereunder shall be made on the basis of a year of 360 days (or, in the case of amounts determined by reference to the Base Rate, 365 or 366 days, as applicable) for the actual number of days (including the first but excluding the last day) elapsed. Whenever any payment or deposit to be made hereunder shall be due on a day other than a Business Day, such payment or deposit shall be made on the next succeeding Business Day and such extension of time shall be included in the computation of such payment or deposit.
ARTICLE 4

INCREASED COSTS; FUNDING LOSSES; TAXES; ILLEGALITY AND SECURITY INTEREST
SECTION 1.0a.Increased Costs.
41
Error! Unknown document property name.



i.Increased Costs Generally. If any Change in Law shall:
1.impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement against assets of, deposits with or for the account of, or credit extended or participated in by, any Affected Person;
2.subject any Affected Person to any Taxes (other than (A) Indemnified Taxes, (B) Taxes described in clauses (b) through (d) of the definition of Excluded Taxes and (C) Connection Income Taxes) on its loans, loan principal, commitments or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto; or
3.impose on any Affected Person any other condition, cost or expense (other than Taxes) (A) affecting the Collateral, this Agreement, any other Transaction Document, any Program Support Agreement, any Loan or (B) affecting its obligations or rights to make Loans;
and the result of any of the foregoing shall be to increase the cost to such Affected Person of making, converting to, continuing or maintaining any Loan or of maintaining its obligation to make any such Loan, or to increase the cost to such Affected Person of participating in, converting to, continuing or maintaining any Loan, or to reduce the amount of any sum received or receivable by such Affected Person hereunder (whether of principal, interest or any other amount) then, upon request of such Affected Person, the Borrower will pay to such Affected Person, as the case may be, such additional amount or amounts as will compensate such Affected Person, as the case may be, for such additional costs incurred or reduction suffered; provided, that upon the occurrence of any Change in Law imposing a reserve percentage on any interest rate based on SOFR, the Administrative Agent, in its reasonable discretion, may modify the calculation of each such SOFR-based interest rate to add (or otherwise account for) such reserve percentage.
ii.Capital and Liquidity Requirements. If any Affected Person determines that any Change in Law affecting such Affected Person or any lending office of such Affected Person or such Affected Person’s holding company, if any, regarding capital or liquidity requirements, has or would have the effect of (x) increasing the amount of capital required to be maintained by such Affected Person or Affected Person’s holding company, if any, (y) reducing the rate of return on such Affected Person’s capital or on the capital of such Affected Person’s holding company, if any, or (z) causing an internal capital or liquidity charge or other imputed cost to be assessed upon such Affected Person or Affected Person’s holding company, if any, in each case, as a consequence of (A) this Agreement or any other Transaction Document, (B) the commitments of such Affected Person hereunder or under any other Transaction Document or related Program Support Agreement, (C) the Loans made by such Affected Person or (D) any Capital (or portion thereof), to a level below that which such Affected Person or such Affected Person’s holding company could have achieved but for such Change in Law (taking into consideration such Affected Person’s policies and the policies of such Affected Person’s holding company with respect to capital adequacy and liquidity), then from time to time, upon request of such Affected Person (or its Group Agent), the Borrower will pay to such Affected Person such additional amount or amounts as will compensate such Affected Person or such Affected Person’s holding company for any such increase, reduction or charge.
iii.Adoption of Changes in Law. The Borrower acknowledges that any Affected Person may institute measures in anticipation of a Change in Law (including, without limitation, the imposition of internal charges on such Affected Person’s interests or obligations under any Transaction Document or Program Support Agreement), and may commence allocating charges to or seeking compensation from the Borrower under this Section 4.01 in connection with such
42
Error! Unknown document property name.



measures, in advance of the effective date of such Change in Law, and the Borrower agrees to pay such charges or compensation to such Affected Person, following demand therefor in accordance with the terms of this Section 4.01, without regard to whether such effective date has occurred.
iv.Certificates for Reimbursement. A certificate of an Affected Person (or its Group Agent on its behalf) setting forth the amount or amounts necessary to compensate such Affected Person or its holding company, as the case may be, as specified in clause (a), (b) or (c) of this Section 4.01 and delivered to the Borrower, shall be conclusive absent manifest error. The Borrower shall, subject to the priorities of payment set forth in Section 3.01, pay such Affected Person the amount shown as due on any such certificate on the first Settlement Date occurring after the Borrower’s receipt of such certificate.
v.Delay in Requests. Failure or delay on the part of any Affected Person to demand compensation pursuant to this Section 4.01 shall not constitute a waiver of such Affected Person’s right to demand such compensation.
vi.Replacement of Lenders. If any Lender requests compensation under this Section 4.01, or if the Borrower is required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 4.03, the Borrower may replace such Lender in accordance with Section 13.03(j).
SECTION 1.0b.Funding Losses.
i.The Borrower will pay each Lender its ratable portion of Breakage Fees in accordance herewith.
ii.A certificate of a Lender (or its Group Agent on its behalf) setting forth the amount or amounts necessary to compensate such Lender, as specified in clause (a) above and delivered to the Borrower, shall be conclusive absent manifest error. The Borrower shall, subject to the priorities of payment set forth in Section 3.01, pay such Lender the amount shown as due on any such certificate on the first Settlement Date occurring after the Borrower’s receipt of such certificate.
SECTION 1.0c.Taxes.
i.Payments Free of Taxes. Any and all payments by or on account of any obligation of the Borrower under any Transaction Document shall be made without deduction or withholding for any Taxes, except as required by Applicable Law. If any Applicable Law (as determined in the good faith discretion of the applicable Credit Party, Affected Person or Borrower Indemnified Party) requires the deduction or withholding of any Tax from any such payment by a Credit Party, Affected Person or Borrower Indemnified Party, then the applicable Credit Party, Affected Person or Borrower Indemnified Party shall be entitled to make such deduction or withholding and shall timely pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with Applicable Law, and, if such Tax is an Indemnified Tax, then the sum payable by the Borrower shall be increased as necessary so that after such deduction or withholding has been made (including such deductions and withholdings applicable to additional sums payable under this Section), the applicable Credit Party, Affected Person or Borrower Indemnified Party receives an amount equal to the sum it would have received had no such deduction or withholding been made.
ii.Payment of Other Taxes by the Borrower. The Borrower shall timely pay to the relevant Governmental Authority in accordance with Applicable Law, or, at the option of the Administrative Agent, timely reimburse it for the payment of, any Other Taxes.
43
Error! Unknown document property name.



iii.Indemnification by the Borrower. The Borrower shall indemnify each Affected Person, within ten (10) calendar days after demand therefor, for the full amount of any Indemnified Taxes (including Indemnified Taxes imposed or asserted on or attributable to amounts payable under this Section) payable or paid by such Affected Person or required to be withheld or deducted from a payment to such Affected Person and any penalties, interest and reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority and a certificate as to the amount of such payment or liability, as well as the payee and other information necessary for the Borrower to make such payment, delivered to the Borrower by an Affected Person (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of an Affected Person, shall be conclusive absent manifest error.
iv.Indemnification by the Lenders. Each Lender (other than the Conduit Lenders) shall severally indemnify the Administrative Agent, within ten (10) calendar days after demand therefor, for (i) any Indemnified Taxes attributable to such Lender, its Related Conduit Lender or any of their respective Affiliates that are Affected Persons (but only to the extent that the Borrower and its Affiliates have not already indemnified the Administrative Agent for such Indemnified Taxes and without limiting any obligation of the Borrower, the Servicer or their Affiliates to do so), (ii) any Taxes attributable to the failure of such Lender, its Related Conduit Lender or any of their respective Affiliates that are Affected Persons to comply with Section 13.03(f) relating to the maintenance of a Participant Register and (iii) any Excluded Taxes attributable to such Lender, its Related Conduit Lender or any of their respective Affiliates that are Affected Persons, in each case, that are payable or paid by the Administrative Agent in connection with any Transaction Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to any Lender (or its Group Agent) by the Administrative Agent shall be conclusive absent manifest error. Each Lender (other than the Conduit Lenders) hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender, its Related Conduit Lender or any of their respective Affiliates that are Affected Persons under any Transaction Document or otherwise payable by the Administrative Agent to such Lender, its Related Conduit Lender or any of their respective Affiliates that are Affected Persons from any other source against any amount due to the Administrative Agent under this clause (d).
v.Evidence of Payments. As soon as practicable after any payment of Taxes by the Borrower to a Governmental Authority pursuant to this Section 4.03, the Borrower shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.
vi.Status of Affected Persons.
1.Any Affected Person that is entitled to an exemption from or reduction of withholding Tax with respect to payments made under any Transaction Document shall deliver to the Borrower and the Administrative Agent, at the time or times reasonably requested by the Borrower or the Administrative Agent, such properly completed and executed documentation reasonably requested by the Borrower or the Administrative Agent as will permit such payments to be made without withholding or at a reduced rate of withholding. In addition, any Affected Person, if reasonably requested by the Borrower or the Administrative Agent, shall deliver such other documentation prescribed by Applicable Law or reasonably requested by the Borrower or the Administrative Agent as will enable the Borrower or the Administrative Agent to determine whether or not such Affected Person is subject to backup withholding or information reporting requirements. Notwithstanding anything to the contrary in the
44
Error! Unknown document property name.



preceding two sentences, the completion, execution and submission of such documentation (other than such documentation set forth in Sections 4.03(f)(ii)(A), 4.03(f)(ii)(B) and 4.03(g)) shall not be required if, in the Affected Person’s reasonable judgment, such completion, execution or submission would subject such Affected Person to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Affected Person
2.Without limiting the generality of the foregoing:
a.an Affected Person that is a U.S. Person shall deliver to the Borrower and the Administrative Agent on or prior to the date on which such Affected Person becomes a party to this Agreement and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent, executed originals of Internal Revenue Service Form W-9 certifying that such Affected Person is exempt from U.S. federal backup withholding tax;
b.any Affected Person that is not a U.S. Person shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Affected Person becomes a party to this Agreement and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent, whichever of the following is applicable:
i.in the case of such an Affected Person claiming the benefits of an income tax treaty to which the United States is a party, (x) with respect to payments of interest under any Transaction Document, executed originals of Internal Revenue Service Form W-8BEN establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the “interest” article of such tax treaty and (y) with respect to any other applicable payments under any Transaction Document, Internal Revenue Service Form W-8BEN establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the “business profits” or “other income” article of such tax treaty;
ii.executed originals of Internal Revenue Service Form W-8ECI;
iii.in the case of such an Affected Person claiming the benefits of the exemption for portfolio interest under Section 881(c) of the Code, (x) a certificate to the effect that such Affected Person is not a “bank” within the meaning of Section 881(c)(3)(A) of the Code, a “10 percent shareholder” of the Borrower within the meaning of Section 881(c)(3)(B) of the Code, or a “controlled foreign corporation” described in Section 881(c)(3)(C) of the Code (a “U.S. Tax Compliance Certificate”) and (y) executed originals of Internal Revenue Service Form W-8BEN; or
iv.to the extent such Affected Person is not the beneficial owner, executed originals of Internal Revenue Service Form W-8IMY, accompanied by Internal Revenue Service Form W-8ECI, Internal Revenue Service Form W-8BEN, a U.S. Tax
45
Error! Unknown document property name.



Compliance Certificate, Internal Revenue Service Form W-9, and/or other certification documents from each beneficial owner, as applicable; provided that, if such Affected Person is a partnership and one or more direct or indirect partners of such Affected Person are claiming the portfolio interest exemption, such Affected Person may provide a U.S. Tax Compliance Certificate on behalf of each such direct and indirect partner; and
c.any Affected Person that is not a U.S. Person shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Affected Person becomes a party to this Agreement and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent, executed originals of any other form prescribed by Applicable Law as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by Applicable Law to permit the Borrower or the Administrative Agent to determine the withholding or deduction required to be made.
vii.Documentation Required by FATCA. If a payment made to an Affected Person under any Transaction Document would be subject to U.S. federal withholding Tax imposed by FATCA if such Affected Person were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), such Affected Person shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by Applicable Law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation prescribed by Applicable Law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that such Affected Person has complied with such Affected Person’s obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this clause (g), “FATCA” shall include any amendments made to FATCA after the date of this Agreement and any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement entered into in connection with FATCA.
viii.Survival. Each party’s obligations under this Section 4.03 shall survive the resignation or replacement of the Administrative Agent or any assignment of rights by, or the replacement of, a Credit Party or any other Affected person, the termination of the Commitments and the repayment, satisfaction or discharge of all the Borrower Obligations and the Servicer’s obligations hereunder.
ix.Updates. Each Affected Person agrees that if any form or certification it previously delivered pursuant to this Section 4.03 expires or becomes obsolete or inaccurate in any respect, it shall update such form or certification or promptly notify the Borrower and the Administrative Agent in writing of its legal inability to do so.
x.If any party determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to which it has been indemnified pursuant to this Section 4.03 (including by the payment of additional amounts pursuant to this Section 4.03), it shall pay to the indemnifying party an amount equal to such refund (but only to the extent of indemnity payments made under this Section 4.03 with respect to the Taxes giving rise to such refund), net
46
Error! Unknown document property name.



of all out-of-pocket expenses (including Taxes) of such indemnified party and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund). Such indemnifying party, upon the request of such indemnified party, shall repay to such indemnified party the amount paid over pursuant to this clause (j) (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) in the event that such indemnified party is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary in this clause (j), in no event will the indemnified party be required to pay any amount to an indemnifying party pursuant to this clause (j) the payment of which would place the indemnified party in a less favorable net after-Tax position than the indemnified party would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such Tax had never been paid. This paragraph shall not be construed to require any indemnified party to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to the indemnifying party or any other Person.
SECTION 1.0d.Conforming Changes Relating to Term SOFR or Daily 1M SOFR. With respect to Term SOFR or Daily 1M SOFR, the Administrative Agent will have the right to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Transaction Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party to this Agreement or any other Transaction Document; provided, that, the Administrative Agent shall provide notice to the Borrower and the Lenders of each such amendment implementing such Conforming Changes reasonably promptly after such amendment becomes effective.
SECTION 1.0e.Security Interest.
i.As security for the performance by the Borrower of all the terms, covenants and agreements on the part of the Borrower to be performed under this Agreement or any other Transaction Document, including the punctual payment when due of the Aggregate Capital and all Interest in respect of the Loans and all other Borrower Obligations, the Borrower hereby grants to the Administrative Agent for its benefit and the ratable benefit of the Secured Parties, a valid, continuing and perfected first priority security interest in, all of the Borrower’s right, title and interest in, to and under all of the following, whether now or hereafter owned, existing or arising (collectively, the “Collateral”): (i) all Pool Receivables, (ii) all Related Security with respect to such Pool Receivables, (iii) all Collections with respect to such Pool Receivables, (iv) the Lock-Boxes and Collection Accounts and all amounts on deposit therein, and all certificates and instruments, if any, from time to time evidencing such Lock-Boxes and Collection Accounts and amounts on deposit therein, (v) all rights (but none of the obligations) of the Borrower under the Purchase and Sale Agreement, (vi) all other personal and fixture property or assets of the Borrower of every kind and nature including, without limitation, all goods (including inventory, equipment and any accessions thereto), instruments (including promissory notes), documents, accounts, chattel paper (whether tangible or electronic), deposit accounts, securities accounts, securities entitlements, letter of credit rights, commercial tort claims, securities and all other investment property, supporting obligations, money, any other contract rights or rights to the payment of money, insurance claims and proceeds, and all general intangibles (including all payment intangibles) (each as defined in the UCC) and (vii) all proceeds of, and all amounts received or receivable under any or all of, the foregoing.
ii.The Administrative Agent (for the benefit of the Secured Parties) shall have, with respect to all the Collateral, and in addition to all the other rights and remedies available to the Administrative Agent (for the benefit of the Secured Parties), all the rights and remedies of a secured party under any applicable UCC. The Borrower hereby authorizes the Administrative Agent to file financing statements describing as the collateral covered thereby as “all of the
47
Error! Unknown document property name.



debtor’s personal property or assets” or words to that effect, notwithstanding that such wording may be broader in scope than the collateral described in this Agreement.
iii.Immediately upon the occurrence of the Final Payout Date, the Collateral shall be automatically released from the lien created hereby, and this Agreement and all obligations (other than those expressly stated to survive such termination) of the Administrative Agent, the Lenders and the other Credit Parties hereunder shall terminate, all without delivery of any instrument or performance of any act by any party, and all rights to the Collateral shall revert to the Borrower; provided, however, that promptly following written request therefor by the Borrower delivered to the Administrative Agent following any such termination, and at the expense of the Borrower, the Administrative Agent shall execute (if applicable) and deliver to the Borrower UCC-3 termination statements and such other documents as the Borrower shall reasonably request to evidence such termination.
SECTION 1.0f.Rate Unascertainable; Illegality; Benchmark Replacement Setting.
i.Rate Unascertainable. If at any time:
1.the Administrative Agent shall have determined (which determination shall be conclusive and binding absent manifest error) that the Term SOFR Rate or the Daily SOFR Rate, as applicable, cannot be determined pursuant to the definition thereof; or
2.the Majority Group Agents determine that for any reason in connection with any request for a Term SOFR Rate Loan or a Daily SOFR Rate Loan or conversion thereto or continuation thereof that the Term SOFR Rate does not adequately and fairly reflect the cost to the Lenders of funding, establishing or maintaining such Term SOFR Rate Loan during the applicable Interest Period, or the Daily SOFR Rate does not adequately and fairly reflect the cost to the Lenders of funding, establishing or maintaining such Daily SOFR Rate Loan, as applicable, and the Majority Group Agents have provided notice of such determination to the Administrative Agent,
then the Administrative Agent shall have the rights specified in Section 4.06(c).
ii.Illegality. If at any time any Lender shall have determined, or any Governmental Authority shall have asserted, that the making, maintenance or funding of any Term SOFR Rate Loan or Daily SOFR Rate Loan, or the determination or charging of interest rates based on the Term SOFR Rate or the Daily SOFR Rate, has been made impracticable or unlawful by compliance by such Lender in good faith with any Applicable Law or any interpretation or application thereof by any Governmental Authority or with any request or directive of any such Governmental Authority (whether or not having the force of Applicable Law), then the Administrative Agent shall have the rights specified in Section 4.06(c).
iii.Administrative Agent’s and Lender’s Rights. In the case of any event specified in Section 4.06(a) above, the Administrative Agent shall promptly notify the Group Agents and the Borrower thereof, and in the case of an event specified in Section 4.06(b) above, the Majority Group Agents shall promptly so notify the Administrative Agent and endorse a certificate to such notice as to the specific circumstances of such notice, and the Administrative Agent shall promptly send copies of such notice and certificate to the other Group Agents and the Borrower. Upon such date as shall be specified in such notice (which shall not be earlier than the date such notice is given), the obligation of (i) the Lenders, in the case of such notice given by the Administrative Agent, or (ii) the relevant Group Agents, in the case of such notice given by the Majority Group Agents, to allow the Borrower to select, convert to, renew or continue a Term SOFR Rate Loan or a Daily SOFR Rate Loan, as applicable, shall be suspended (to the extent of
48
Error! Unknown document property name.



the affected Term SOFR Rate Loan, Daily SOFR Rate Loan or Interest Periods) until the Administrative Agent shall have later notified the Borrower, or the Majority Group Agents shall have later notified the Administrative Agent, of the Administrative Agent’s or the Majority Group Agents’, as the case may be, determination that the circumstances giving rise to such previous determination no longer exist. Upon a determination by Administrative Agent under Section 4.06(a), (i) if the Borrower has previously notified the Administrative Agent of its selection of, conversion to or renewal of a Term SOFR Rate Loan or a Daily SOFR Rate Loan and the Term SOFR Option or the Daily SOFR Option, as applicable, has not yet gone into effect, such notification shall be deemed to provide for selection of, conversion to or renewal of a Base Rate Loan, (ii) any outstanding affected Daily SOFR Rate Loans will be deemed to have been converted into Base Rate Loans immediately, and (iii) any outstanding affected Term SOFR Rate Loans will be deemed to have been converted into Base Rate Loans at the end of the applicable Interest Period. If the Majority Group Agents notify the Administrative Agent of a determination under Section 4.06(b), the Borrower shall, subject to the Borrower’s indemnification obligations under Section 12.01, as to any Loan of a Lender to which a Term SOFR Option or a Daily SOFR Option applies, on the date specified in such notice either convert such Loan to a Base Rate Loan otherwise available with respect to such Loan or prepay such Loan in accordance with Section 2.02. Absent due notice from the Borrower of conversion or prepayment, such Loan shall automatically be converted to a Base Rate Loan upon such specified date.
iv.Benchmark Replacement Setting.
1.Benchmark Replacement. Notwithstanding anything to the contrary herein or in any other Transaction Document, if a Benchmark Transition Event and its related Benchmark Replacement Date have occurred prior to any setting of the then-current Benchmark, then (A) if a Benchmark Replacement is determined in accordance with clause (1) of the definition of “Benchmark Replacement” for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Transaction Document in respect of such Benchmark setting and subsequent Benchmark settings without any amendment to, or further action or consent of any other party to, this Agreement or any other Transaction Document and (B) if a Benchmark Replacement is determined in accordance with clause (2) of the definition of “Benchmark Replacement” for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Transaction Document in respect of any Benchmark setting at or after 5:00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Benchmark Replacement is provided to the Group Agents without any amendment to, or further action or consent of any other party to, this Agreement or any other Transaction Document so long as the Administrative Agent has not received, by such time, written notice of objection to such Benchmark Replacement from the Majority Group Agents.
2.Benchmark Replacement Conforming Changes. In connection with the use, administration, adoption or implementation of a Benchmark Replacement, the Administrative Agent will have the right to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Transaction Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party to this Agreement or any other Transaction Document.
3.Notices; Standards for Decisions and Determinations. The Administrative Agent will promptly notify the Borrower and the Group Agents of (A) the implementation of any Benchmark Replacement, and (B) the effectiveness of any Conforming Changes in connection with the use, administration, adoption or
49
Error! Unknown document property name.



implementation of a Benchmark Replacement. The Administrative Agent will notify the Borrower of (x) the removal or reinstatement of any tenor of a Benchmark pursuant to clause (iv) below and (y) the commencement of any Benchmark Unavailability Period. Any determination, decision or election that may be made by the Administrative Agent or, if applicable, any Lender (or group of Lenders) pursuant to this Section 4.06, including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action or any selection, will be conclusive and binding absent manifest error and may be made in its or their sole discretion and without consent from any other party to this Agreement or any other Transaction Document except, in each case, as expressly required pursuant to this Section 4.06.
4.Unavailability of Tenor of Benchmark. Notwithstanding anything to the contrary herein or in any other Transaction Document, at any time (including in connection with the implementation of a Benchmark Replacement), (A) if the then-current Benchmark is a term rate or based on a term rate and either (I) any tenor for such Benchmark is not displayed on a screen or other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion or (II) the regulatory supervisor for the administrator of such Benchmark has provided a public statement or publication of information announcing that any tenor for such Benchmark is not or will not be representative, then the Administrative Agent may modify the definition of “Interest Period” (or any similar or analogous definition) for any Benchmark settings at or after such time to remove such unavailable or non-representative tenor; and (B) if a tenor that was removed pursuant to clause (A) above either (I) is subsequently displayed on a screen or information service for a Benchmark (including a Benchmark Replacement) or (II) is not, or is no longer, subject to an announcement that it is not or will not be representative for a Benchmark (including a Benchmark Replacement), then the Administrative Agent may modify the definition of “Interest Period” (or any similar or analogous definition) for all Benchmark settings at or after such time to reinstate such previously removed tenor.
5.Benchmark Unavailability Period. Upon the Borrower’s receipt of notice of the commencement of a Benchmark Unavailability Period with respect to the Term SOFR Rate or the Daily SOFR Rate, as applicable, the Borrower may revoke any pending request for a Loan bearing interest based on such rate or conversion to or continuation of Loans bearing interest based on such rate to be made, converted or continued during any Benchmark Unavailability Period and, failing that, the Borrower will be deemed to have converted any such request into a request for a Base Rate Loan or conversion to a Base Rate Loan. During a Benchmark Unavailability Period or at any time that a tenor for the then-current Benchmark is not an Available Tenor, the component of the Base Rate based upon the then-current Benchmark or such tenor for such Benchmark, as applicable, will not be used in any determination of the Base Rate.
SECTION 1.0g.Benchmark Replacement Notification. Section 4.06(d) of this Agreement provides a mechanism for determining an alternative rate of interest in the event that the Term SOFR Rate or the Daily SOFR Rate, as applicable, is no longer available or in certain other circumstances. The Administrative Agent does not warrant or accept any responsibility for and shall not have any liability with respect to, the administration, submission or any other matter related to the Term SOFR Rate or the Daily SOFR Rate, as applicable, or with respect to any alternative or successor rate thereto, or replacement rate therefor.
50
Error! Unknown document property name.



ARTICLE 5

CONDITIONS TO EFFECTIVENESS AND CREDIT EXTENSIONS
SECTION 1.0a.Conditions Precedent to Effectiveness and the Initial Credit Extension. This Agreement shall become effective as of the Closing Date when (a) the Administrative Agent shall have received each of the documents, agreements (in fully executed form), opinions of counsel, lien search results, UCC filings, certificates and other deliverables listed on the closing memorandum attached as Exhibit H hereto, in each case, in form and substance acceptable to the Administrative Agent and (b) all fees and expenses payable by the Borrower on the Closing Date to the Credit Parties have been paid in full in accordance with the terms of the Transaction Documents.
SECTION 1.0b.Conditions Precedent to All Credit Extensions. Each Credit Extension hereunder on or after the Closing Date shall be subject to the conditions precedent that:
i.in the case of a Loan, the Borrower shall have delivered to the Administrative Agent and each Group Agent a Loan Request for such Loan, in accordance with Section 2.02(a);
ii.the Servicer shall have delivered to the Administrative Agent and each Group Agent all Information Packages required to be delivered hereunder;
iii.the conditions precedent to such Credit Extension specified in Section 2.01(a) through (d) shall be satisfied;
iv.on the date of such Credit Extension the following statements shall be true and correct (and upon the occurrence of such Credit Extension, the Borrower and the Servicer shall be deemed to have represented and warranted that such statements are then true and correct):
1.the representations and warranties of the Borrower and the Servicer contained in Sections 6.01 and 6.02 are true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of the date of such Credit Extension as though made on and as of such date unless such representations and warranties by their terms refer to an earlier date, in which case they shall be true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of such earlier date;
2.no Event of Default or Unmatured Event of Default has occurred and is continuing, and no Event of Default or Unmatured Event of Default would result from such Credit Extension;
3.no Borrowing Base Deficit exists or would exist after giving effect to such Credit Extension;
4.the Aggregate Capital would not equal an amount less than the Minimum Funding Threshold after giving effect to such Credit Extension; and
5.the Termination Date has not occurred.
SECTION 1.0c.Conditions Precedent to All Releases. Each Release hereunder on or after the Closing Date shall be subject to the conditions precedent that:
51
Error! Unknown document property name.



i.after giving effect to such Release, the Servicer shall be holding in trust for the benefit of the Secured Parties an amount of Collections sufficient to pay the sum of (x) all accrued and unpaid Servicing Fees, Interest, Fees and Breakage Fees, in each case, through the date of such Release, (y) the amount of any Borrowing Base Deficit and (z) the amount of all other accrued and unpaid Borrower Obligations through the date of such Release;
ii.the Borrower shall use the proceeds of such Release solely to pay (x) the purchase price for Receivables purchased by the Borrower in accordance with the terms of the Purchase and Sale Agreement and (y) any amounts owing by the Borrower to the Originators under the Subordinated Notes; and
iii.on the date of such Release the following statements shall be true and correct (and upon the occurrence of such Release, the Borrower and the Servicer shall be deemed to have represented and warranted that such statements are then true and correct):
1.the representations and warranties of the Borrower and the Servicer contained in Sections 6.01 and 6.02 are true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of the date of such Release as though made on and as of such date unless such representations and warranties by their terms refer to an earlier date, in which case they shall be true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of such earlier date;
2.no Event of Default has occurred and is continuing, and no Event of Default would result from such Release;
3.no Borrowing Base Deficit exists or would exist after giving effect to such Release; and
4.the Termination Date has not occurred.
ARTICLE 6

REPRESENTATIONS AND WARRANTIES
SECTION 1.0a.Representations and Warranties of the Borrower. The Borrower represents and warrants to each Credit Party as of the Closing Date, on each Settlement Date and on each day on which a Credit Extension shall have occurred:
i.Formation and Good Standing. The Borrower is a duly formed and validly existing limited liability company in good standing under the laws of the State of Delaware and has full power and authority under its organizational documents and under the laws of the State of Delaware to own its properties and to conduct its business as such properties are currently owned and such business is presently conducted.
ii.Due Qualification. The Borrower is duly qualified to do business, is in good standing as a foreign entity and has obtained all necessary licenses and approvals in all jurisdictions in which the conduct of its business requires such qualification, licenses or approvals, except where the failure to do so could not reasonably be expected to have a Material Adverse Effect.
52
Error! Unknown document property name.



iii.Power and Authority; Due Authorization. The Borrower (i) has all necessary power and authority to (A) execute and deliver this Agreement and the other Transaction Documents to which it is a party, (B) perform its obligations under this Agreement and the other Transaction Documents to which it is a party and (C) grant a security interest in the Collateral to the Administrative Agent on the terms and subject to the conditions herein provided and (ii) has duly authorized by all necessary action such grant and the execution, delivery and performance of, and the consummation of the transactions provided for in, this Agreement and the other Transaction Documents to which it is a party.
iv.Binding Obligations. This Agreement and each of the other Transaction Documents to which the Borrower is a party constitutes legal, valid and binding obligations of the Borrower, enforceable against the Borrower in accordance with their respective terms, except (i) as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and (ii) as such enforceability may be limited by general principles of equity, regardless of whether such enforceability is considered in a proceeding in equity or at law.
v.No Conflict or Violation. The execution, delivery and performance of, and the consummation of the transactions contemplated by, this Agreement and the other Transaction Documents to which the Borrower is a party, and the fulfillment of the terms hereof and thereof, will not (i) conflict with, result in any breach of any of the terms or provisions of, or constitute (with or without notice or lapse of time or both) a default under its organizational documents or any indenture, sale agreement, credit agreement, loan agreement, security agreement, mortgage, deed of trust or other agreement or instrument to which the Borrower is a party or by which it or any of its properties is bound, (ii) result in the creation or imposition of any Adverse Claim upon any of the Collateral or any of its properties pursuant to the terms of any such indenture, credit agreement, loan agreement, security agreement, mortgage, deed of trust or other agreement or instrument, other than this Agreement and the other Transaction Documents or (iii) conflict with or violate any Applicable Law, except to the extent that any such conflict, breach, default, Adverse Claim or violation could not reasonably be expected to have a Material Adverse Effect.
vi.Litigation and Other Proceedings. (i) There is no action, suit, proceeding or investigation pending or, to the best knowledge of the Borrower, threatened, against the Borrower before any Governmental Authority and (ii) the Borrower is not subject to any order, judgment, decree, injunction, stipulation or consent order of or with any Governmental Authority that, in the case of either of the foregoing clauses (i) and (ii), (A) asserts the invalidity of this Agreement or any other Transaction Document, (B) seeks to prevent the grant of a security interest in any Collateral by the Borrower to the Administrative Agent, the ownership or acquisition by the Borrower of any Pool Receivables or other Collateral or the consummation of any of the transactions contemplated by this Agreement or any other Transaction Document, (C) seeks any determination or ruling that could materially and adversely affect the performance by the Borrower of its obligations under, or the validity or enforceability of, this Agreement or any other Transaction Document or (D) individually or in the aggregate for all such actions, suits, proceedings and investigations could reasonably be expected to have a Material Adverse Effect.
vii.No Consents. The Borrower is not required to obtain the consent of any other party or any consent, order, license, approval, registration, authorization, action or declaration of or with any Governmental Authority in connection with the grant of a security interest in the Collateral by the Borrower to the Administrative Agent hereunder or the due execution, delivery, or performance by the Borrower of this Agreement or any other Transaction Document to which it is a party or the consummation by the Borrower of the transactions contemplated by this Agreement or any other Transaction Documents to which it is a party that has not already been obtained and are in full force and effect or the failure of which to obtain could not reasonably be expected to have a Material Adverse Effect.
53
Error! Unknown document property name.



viii.Offices; Legal Name. The Borrower’s sole jurisdiction of organization is the State of Delaware and such jurisdiction has not changed within four (4) months prior to the date of this Agreement. The office of the Borrower is located at 311 Enterprise Drive, Plainsboro, New Jersey 08536. The legal name of the Borrower is Integra Receivables LLC.
ix.Investment Company Act; Volcker Rule. The Borrower (i) is not, and is not controlled by, an “investment company” registered or required to be registered under the Investment Company Act and (ii) is not a “covered fund” under the Volcker Rule. In determining that the Borrower is not a “covered fund” under the Volcker Rule, the Borrower relies on, and is entitled to rely on, the exemption from the definition of “investment company” set forth in Section 3(c)(5) of the Investment Company Act.
x.No Material Adverse Effect. Since the date of formation of the Borrower there has been no Material Adverse Effect with respect to the Borrower.
xi.Accuracy of Information. All Information Packages, Interim Reports, Loan Requests, certificates, reports, statements, documents and other information, other than financial projections, furnished to the Administrative Agent or any other Credit Party by or on behalf of the Borrower pursuant to any provision of this Agreement or any other Transaction Document, or in connection with or pursuant to any amendment or modification of, or waiver under, this Agreement or any other Transaction Document, are, at the time the same are so furnished, complete and correct in all material respects on the date the same are furnished to the Administrative Agent or such other Credit Party, and do not contain any material misstatement of fact or omit to state a material fact or any fact necessary to make the statements contained therein not misleading.
xii.Anti-Money Laundering/International Trade Law Compliance. No Covered Entity is a Sanctioned Person. No Covered Entity, either in its own right or through any third party, (i) has any of its assets in a Sanctioned Country or in the possession, custody or control of a Sanctioned Person in violation of any Anti-Terrorism Law; (ii) does business in or with, or derives any of its income from investments in or transactions with, any Sanctioned Country or Sanctioned Person in violation of any Anti-Terrorism Law; or (iii) engages in any dealings or transactions prohibited by any Anti-Terrorism Law.
xiii.Transaction Information. None of the Borrower, any Affiliate of the Borrower or any third party with which the Borrower or any Affiliate thereof has contracted, has delivered, in writing or orally, to any Rating Agency, any Transaction Information without providing such Transaction Information to the applicable Group Agent prior to delivery to such Rating Agency and has not participated in any oral communications with respect to Transaction Information with any Rating Agency without the participation of such Group Agent.
xiv.Compliance with Law. The Borrower has complied in all respects with all Applicable Laws to which it may be subject, except to the extent that any such noncompliance could not reasonably be expected to have a Material Adverse Effect.
xv.Eligible Receivables. Each Receivable included as an Eligible Receivable in the calculation of the Net Receivables Pool Balance as of any date is an Eligible Receivable as of such date.
xvi.Bulk Sales Act. No transaction contemplated by this Agreement requires compliance by it with any bulk sales act or similar law.
xvii.Taxes. The Borrower has (i) timely filed all tax returns (federal, state and local) required to be filed by it and (ii) paid, or caused to be paid, all taxes, assessments and other
54
Error! Unknown document property name.



governmental charges, if any, other than taxes, assessments and other governmental charges being contested in good faith by appropriate proceedings and as to which adequate reserves have been provided in accordance with GAAP, except to the extent that any such non-filing or non-payment could not reasonably be expected to have a Material Adverse Effect.
xviii.Opinions. The facts regarding the Borrower, the Receivables, the Related Security and the related matters set forth or assumed in each of the opinions of counsel delivered in connection with this Agreement and the Transaction Documents are true and correct in all material respects.
xix.Other Transaction Documents. Each representation and warranty made by the Borrower under each other Transaction Document to which it is a party is true and correct in all material respects (unless such representation and warranty contains a materiality qualifier, in which case such representation and warranty shall be true and correct as made) as of the date when made, except for any such representation and warranty that applies as to an earlier date (in which case, such representation and warranty shall be true and correct in all material respects (unless such representation and warranty contains a materiality qualifier, in which case such representation and warranty shall be true and correct as made) as of such earlier date).
xx.No Linked Accounts. There are no Linked Accounts with respect to any Collection Account.
xxi.Margin Regulations. The Borrower is not engaged, principally or as one of its important activities, in the business of extending credit for the purpose of purchasing or carrying margin stock (within the meanings of Regulations T, U and X of the Board of Governors of the Federal Reserve System).
xxii.Solvency. After giving effect to the transactions contemplated by this Agreement and the other Transaction Documents, the Borrower is Solvent.
xxiii.Perfection Representations.
1.This Agreement creates a valid and continuing security interest (as defined in the applicable UCC) in the Borrower’s right, title and interest in, to and under the Collateral which (A) security interest has been perfected and is enforceable against creditors of and purchasers from the Borrower and (B) will be free of all Adverse Claims in such Collateral.
2.The Receivables constitute “accounts” or “payment intangibles” within the meaning of Section 9-102 of the UCC.
3.The Borrower owns and has good and marketable title to the Collateral free and clear of any Adverse Claim of any Person.
4.All appropriate financing statements, financing statement amendments and continuation statements have been filed in the proper filing office in the appropriate jurisdictions under Applicable Law in order to perfect (and continue the perfection of) the sale or contribution of the Receivables and Related Security from each Originator to the Borrower pursuant to the Purchase and Sale Agreement and the grant by the Borrower of a security interest in the Collateral to the Administrative Agent pursuant to this Agreement.
5.Other than the security interest granted to the Administrative Agent pursuant to this Agreement, the Borrower has not pledged, assigned, sold, granted
55
Error! Unknown document property name.



a security interest in, or otherwise conveyed any of the Collateral except as permitted by this Agreement and the other Transaction Documents. The Borrower has not authorized the filing of and is not aware of any financing statements filed against the Borrower that include a description of collateral covering the Collateral other than any financing statement (i) in favor of the Administrative Agent or (ii) that has been terminated or amended to reflect the release of any security interest in the Collateral. The Borrower is not aware of any judgment lien, ERISA lien or tax lien filings against the Borrower.
6.Notwithstanding any other provision of this Agreement or any other Transaction Document, the representations contained in this Section 6.01(w) shall be continuing and remain in full force and effect until the Final Payout Date.
xxiv.The Lock-Boxes and Collection Accounts.
1.Nature of Collection Accounts. Each Collection Account constitutes a “deposit account” within the meaning of the applicable UCC.
2.Ownership. Each Lock-Box and Collection Account is in the name of the Borrower, and the Borrower owns and has good and marketable title to the Collection Accounts free and clear of any Adverse Claim.
3.Perfection. The Borrower has delivered to the Administrative Agent a fully executed Account Control Agreement relating to each Lock-Box and Collection Account, pursuant to which each applicable Collection Account Bank has agreed to comply with the instructions originated by the Administrative Agent directing the disposition of funds in such Lock-Box and Collection Account without further consent by the Borrower, the Servicer or any other Person. The Administrative Agent has “control” (as defined in Section 9-104 of the UCC) over each Collection Account.
4.Instructions. Neither the Lock-Boxes nor the Collection Accounts are in the name of any Person other than the Borrower. Neither the Borrower nor the Servicer has consented to the applicable Collection Account Bank complying with instructions of any Person other than the Administrative Agent.
xxv.Ordinary Course of Business. Each remittance of Collections by or on behalf of the Borrower to the Credit Parties under this Agreement will have been (i) in payment of a debt incurred by the Borrower in the ordinary course of business or financial affairs of the Borrower and (ii) made in the ordinary course of business or financial affairs of the Borrower.
xxvi.Tax Status. The Borrower (i) is, and shall at all relevant times continue to be, a “disregarded entity” within the meaning of U.S. Treasury Regulation § 301.7701-3 for U.S. federal income tax purposes and (ii) is not and will not at any relevant time become an association (or publicly traded partnership) taxable as an association for U.S. federal income tax purposes.
xxvii.Liquidity Coverage Ratio. The Borrower has not, does not and will not during this Agreement (x) issue any obligations that (A) constitute asset-backed commercial paper, or (B) are securities required to be registered under the Securities Act or that may be offered for sale under Rule 144A or a similar exemption from registration under the Securities Act or the rules promulgated thereunder, or (y) issue any other debt obligations or equity interest other than debt obligations substantially similar to the obligations of the Borrower under this Agreement that are (A) issued to other banks or asset-backed commercial paper conduits in privately negotiated transactions, and (B) subject to transfer restrictions substantially similar to the transfer restrictions set forth in this Agreement. The Borrower further represents and warrants that its
56
Error! Unknown document property name.



assets and liabilities are consolidated with the assets and liabilities of Parent for purposes of generally accepted accounting principles.
xxviii.Reaffirmation of Representations and Warranties. On the date of each Credit Extension, on the date of each Release, on each Settlement Date and on the date each Information Package, Interim Report or other report is delivered to the Administrative Agent or any Group Agent hereunder, the Borrower shall be deemed to have certified that (i) all representations and warranties of the Borrower hereunder are true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of such day as though made on and as of such day, except for representations and warranties which apply as to an earlier date (in which case such representations and warranties shall be true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) as of such date) and (ii) no Event of Default or an Unmatured Event of Default has occurred and is continuing or will result from such Credit Extension or Release.
Notwithstanding any other provision of this Agreement or any other Transaction Document, the representations and warranties contained in this Section 6.01 shall be continuing, and remain in full force and effect until the Final Payout Date.
SECTION 1.0b.Representations and Warranties of the Servicer. The Servicer represents and warrants to each Credit Party as of the Closing Date, on each Settlement Date and on each day on which a Credit Extension shall have occurred:
i.Organization and Good Standing. The Servicer is a duly organized and validly existing limited liability company in good standing under the laws of the State of Delaware and has full power and authority under its organizational documents and under the laws of the State of Delaware to own its properties and to conduct its business as such properties are currently owned and such business is presently conducted.
ii.Due Qualification. The Servicer is duly qualified to do business, is in good standing as a foreign entity and has obtained all necessary licenses and approvals in all jurisdictions in which the conduct of its business or the servicing of the Pool Receivables as required by this Agreement requires such qualification, licenses or approvals, except where the failure to do so could not reasonably be expected to have a Material Adverse Effect.
iii.Power and Authority; Due Authorization. The Servicer (i) has all necessary power and authority to (A) execute and deliver this Agreement and the other Transaction Documents to which it is a party and (B) perform its obligations under this Agreement and the other Transaction Documents to which it is a party and (ii) has duly authorized by all necessary action the execution, delivery and performance of, and the consummation of the transactions provided for in, this Agreement and the other Transaction Documents to which it is a party.
iv.Binding Obligations. This Agreement and each of the other Transaction Documents to which the Servicer is a party constitutes legal, valid and binding obligations of the Servicer, enforceable against the Servicer in accordance with their respective terms, except (i) as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and (ii) as such enforceability may be limited by general principles of equity, regardless of whether such enforceability is considered in a proceeding in equity or at law.
v.No Conflict or Violation. The execution, delivery and performance of, and the consummation of the transactions contemplated by, this Agreement and the other Transaction
57
Error! Unknown document property name.



Documents to which the Servicer is a party, and the fulfillment of the terms hereof and thereof, will not (i) conflict with, result in any breach of any of the terms or provisions of, or constitute (with or without notice or lapse of time or both) a default under its organizational documents or any indenture, sale agreement, credit agreement, loan agreement, security agreement, mortgage, deed of trust or other agreement or instrument to which the Servicer is a party or by which it or any of its properties is bound, (ii) result in the creation or imposition of any Adverse Claim upon any of its properties pursuant to the terms of any such indenture, credit agreement, loan agreement, security agreement, mortgage, deed of trust or other agreement or instrument, other than this Agreement and the other Transaction Documents or (iii) conflict with or violate any Applicable Law, except to the extent that any such conflict, breach, default, Adverse Claim or violation could not reasonably be expected to have a Material Adverse Effect.
vi.Litigation and Other Proceedings. (i) There is no action, suit, proceeding or investigation pending or, to the best knowledge of the Servicer, threatened, against the Borrower before any Governmental Authority and (ii) the Servicer is not subject to any order, judgment, decree, injunction, stipulation or consent order of or with any Governmental Authority that, in the case of either of the foregoing clauses (i) and (ii), (A) asserts the invalidity of this Agreement or any other Transaction Document, (B) seeks to prevent the consummation of any of the transactions contemplated by this Agreement or any other Transaction Document, (C) seeks any determination or ruling that could materially and adversely affect the performance by the Servicer of its obligations under, or the validity or enforceability of, this Agreement or any other Transaction Document or (D) individually or in the aggregate for all such actions, suits, proceedings and investigations could reasonably be expected to have a Material Adverse Effect.
vii.No Consents. The Servicer is not required to obtain the consent of any other party or any consent, order, license, approval, registration, authorization, action or declaration of or with any Governmental Authority in connection with the due execution, delivery, or performance by the Servicer of this Agreement or any other Transaction Documents to which it is a party or the consummation by the Servicer of the transactions contemplated by this Agreement or any other Transaction Document to which it is a party that has not already been obtained and are in full force and effect or the failure of which to obtain could not reasonably be expected to have a Material Adverse Effect.
viii.Location of Records. The offices where the initial Servicer keeps all of its records relating to the servicing of the Pool Receivables are located at 311 Enterprise Drive, Plainsboro, New Jersey 08536.
ix.Investment Company Act. The Servicer is not, and is not controlled by, an “investment company” registered or required to be registered under the Investment Company Act.
x.No Material Adverse Effect. Since September 30, 2018, there has been no Material Adverse Effect with respect to the Servicer.
xi.Accuracy of Information. All Information Packages, Interim Reports, Loan Requests, certificates, reports, statements, documents and other information, other than financial projections, furnished to the Administrative Agent or any other Credit Party by or on behalf of the Servicer pursuant to any provision of this Agreement or any other Transaction Document, or in connection with or pursuant to any amendment or modification of, or waiver under, this Agreement or any other Transaction Document, are, at the time the same are so furnished, complete and correct in all material respects on the date the same are furnished to the Administrative Agent or such other Credit Party, and do not contain any material misstatement of fact or omit to state a material fact or any fact necessary to make the statements contained therein not misleading.
58
Error! Unknown document property name.



xii.Anti-Money Laundering/International Trade Law Compliance. No Covered Entity is a Sanctioned Person. No Covered Entity, either in its own right or through any third party, (i) has any of its assets in a Sanctioned Country or in the possession, custody or control of a Sanctioned Person in violation of any Anti-Terrorism Law; (ii) does business in or with, or derives any of its income from investments in or transactions with, any Sanctioned Country or Sanctioned Person in violation of any Anti-Terrorism Law; or (iii) engages in any dealings or transactions prohibited by any Anti-Terrorism Law.
xiii.Transaction Information. None of the Servicer, any Affiliate of the Servicer or any third party with which the Servicer or any Affiliate thereof has contracted, has delivered, in writing or orally, to any Rating Agency, or monitoring a rating of, any Notes, any Transaction Information without providing such Transaction Information to the applicable Group Agent prior to delivery to such Rating Agency and has not participated in any oral communications with respect to Transaction Information with any Rating Agency without the participation of such Group Agent.
xiv.Compliance with Law. The Servicer (i) has duly satisfied all obligations on its part to be fulfilled under or in connection with the Pool Receivables and the related Contracts, (ii) has maintained in effect all qualifications required under Applicable Law in order to properly service the Pool Receivables and (iii) has complied in all respects with all Applicable Laws in connection with servicing the Pool Receivables, except to the extent that any such non-satisfaction, non-maintenance or noncompliance could not reasonably be expected to have a Material Adverse Effect.
xv.Eligible Receivables. Each Receivable included as an Eligible Receivable in the calculation of the Net Receivables Pool Balance as of any date is an Eligible Receivable as of such date.
xvi.Taxes. The Servicer has (i) timely filed all tax returns (federal, state and local) required to be filed by it and (ii) paid, or caused to be paid, all taxes, assessments and other governmental charges, if any, other than taxes, assessments and other governmental charges being contested in good faith by appropriate proceedings and as to which adequate reserves have been provided in accordance with GAAP, except to the extent that any such non-filing or non-payment could not reasonably be expected to have a Material Adverse Effect.
xvii.Opinions. The facts regarding the Servicer, the Receivables, the Related Security and the related matters set forth or assumed in each of the opinions of counsel delivered in connection with this Agreement and the Transaction Documents are true and correct in all material respects.
xviii.Other Transaction Documents. Each representation and warranty made by the Servicer under each other Transaction Document to which it is a party (including, without limitation, the Purchase and Sale Agreement) is true and correct in all material respects (unless such representation and warranty contains a materiality qualifier, in which case such representation and warranty shall be true and correct as made) as of the date when made, except for any such representation and warranty that applies as to an earlier date (in which case, such representation and warranty shall be true and correct in all material respects (unless such representation and warranty contains a materiality qualifier, in which case such representation and warranty shall be true and correct as made) as of such earlier date).
xix.No Linked Accounts. There are no Linked Accounts with respect to any Collection Account.
59
Error! Unknown document property name.



xx.Credit and Collection Procedures. The Servicer has complied in all material respects with the Credit and Collection Procedures (or, prior to the existence thereof in documented form, the substance thereof) with regard to each Pool Receivable and the related Contracts.
xxi.Servicing Programs. No license or approval is required for the Administrative Agent’s use of any software or other computer program used by the Servicer, any Originator or any Sub-Servicer in the servicing of the Pool Receivables, other than those which have been obtained and are in full force and effect.
xxii.Servicing of Pool Receivables. Since the Closing Date, there has been no material adverse change in the ability of the Servicer or any Sub-Servicer to service and collect the Pool Receivables and the Related Security.
xxiii.Financial Condition. The consolidated balance sheets of the Servicer and its consolidated Subsidiaries as of September 30, 2018 and the related statements of income and shareholders’ equity of the Servicer and its consolidated Subsidiaries for the fiscal quarter then ended, copies of which have been furnished to the Administrative Agent and the Group Agents, present fairly in all material respects the consolidated financial position of the Servicer and its consolidated Subsidiaries for the period ended on such date, all in accordance with GAAP.
xxiv.Reaffirmation of Representations and Warranties. On the date of each Credit Extension, on the date of each Release, on each Settlement Date and on the date each Information Package, Interim Report or other report is delivered to the Administrative Agent or any Group Agent hereunder, the Servicer shall be deemed to have certified that (i) all representations and warranties of the Servicer hereunder are true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of such day as though made on and as of such day, except for representations and warranties which apply as to an earlier date (in which case such representations and warranties shall be true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) as of such date) and (ii) no Event of Default or an Unmatured Event of Default has occurred and is continuing or will result from such Credit Extension or Release.
Notwithstanding any other provision of this Agreement or any other Transaction Document, the representations and warranties contained in this Section 6.02 shall be continuing, and remain in full force and effect until the Final Payout Date.
ARTICLE 7

COVENANTS
SECTION 1.0a.Covenants of the Borrower. At all times from the Closing Date until the Final Payout Date:
i.Payment of Principal and Interest. The Borrower shall duly and punctually pay Capital, Interest, Fees and all other amounts payable by the Borrower hereunder in accordance with the terms of this Agreement.
ii.Existence. The Borrower shall keep in full force and effect its existence and rights as a limited liability company under the laws of the State of Delaware, and shall obtain and preserve its qualification to do business in each jurisdiction in which such qualification is or shall
60
Error! Unknown document property name.



be necessary to protect the validity and enforceability of this Agreement, the other Transaction Documents and the Collateral.
iii.Financial Reporting. The Borrower will maintain a system of accounting established and administered in accordance with GAAP, and the Borrower (or the Servicer on its behalf) shall furnish to the Administrative Agent and each Group Agent:
1.Annual Financial Statements of the Borrower. Promptly upon completion and in no event later than ninety (90) calendar days after the close of each fiscal year of the Borrower (or, if applicable, the date on which the financial statements describe in Section 7.01(c)(v) are delivered), annual unaudited financial statements of the Borrower certified by a Financial Officer of the Borrower that they fairly present in all material respects, in accordance with GAAP, the financial condition of the Borrower as of the date indicated and the results of its operations for the periods indicated.
2.Information Packages and Interim Reports. As soon as available and in any event not later than two (2) Business Days prior to each Settlement Date, an Information Package as of the most recently completed Fiscal Month; provided, that, upon the occurrence of a Specific Reporting Event and ten (10) Business Days’ prior written notice from the Administrative Agent, the Borrower shall furnish or cause to be furnished to the Administrative Agent and each Group Agent a weekly (or on a more frequent basis as indicated in the written notice from the Administrative Agent) Interim Report with respect to the Pool Receivables with data as of the close of business on the Business Day preceding the date on which such Interim Report is delivered; provided, further, that, at any time after the occurrence and during the continuance of an Event of Default, the Administrative Agent may specify in such notice that such Interim Report be furnished to the Administrative Agent and each Group Agent on a more frequent basis until the Administrative Agent gives notices otherwise.
3.Other Information. Such other information relating to the Borrower or the Pool Receivables (including non-financial information) as the Administrative Agent or any Group Agent may from time to time reasonably request.
4.Quarterly Financial Statements of Parent. As soon as available and in no event later than forty five (45) calendar days following the end of each of the first three fiscal quarters in each of Parent’s fiscal years (or, if applicable, the date on which such financial statements are required to be filed with the SEC), (i) the unaudited consolidated balance sheet and statements of income of Parent and its consolidated Subsidiaries as at the end of such fiscal quarter and the related unaudited consolidated statements of earnings and cash flows for such fiscal quarter and for the elapsed portion of the fiscal year ended with the last day of such fiscal quarter, in each case setting forth comparative figures for the corresponding fiscal quarter in the prior fiscal year, all of which shall be certified by a Financial Officer of Parent that they fairly present in all material respects, in accordance with GAAP, the financial condition of Parent and its consolidated Subsidiaries as of the dates indicated and the results of their operations for the periods indicated, subject to normal year-end audit adjustments and the absence of footnotes and (ii) management’s discussion and analysis of the important operational and financial developments during such fiscal quarter.
5.Annual Financial Statements of Parent. Within ninety (90) calendar days after the close of each of Parent’s fiscal years (or, if applicable, the date on which such financial statements are required to be filed with the SEC), the consolidated balance sheet of Parent and its consolidated Subsidiaries as at the end of such fiscal year and the related consolidated statements of earnings and cash flows for such fiscal year
61
Error! Unknown document property name.



setting forth comparative figures for the preceding fiscal year, all reported on by independent certified public accountants of recognized national standing (without a “going concern” or like qualification or exception) to the effect that such consolidated financial statements present fairly in all material respects, in accordance with GAAP, the financial condition of Parent and its consolidated Subsidiaries as of the dates indicated and the results of their operations for the periods indicated.
6.Other Reports and Filings. Promptly (but in any event within ten (10) calendar days) after the filing or delivery thereof, copies of all financial information, proxy materials and reports not otherwise delivered pursuant to Sections 7.01(c)(i) through (v) above, if any, which Parent or any of its consolidated Subsidiaries shall publicly file with the SEC or deliver to holders (or any trustee, agent or other representative therefor) of any of its material Debt pursuant to the terms of the documentation governing the same.
7.Notwithstanding anything herein to the contrary, any financial information, proxy statements or other material required to be delivered pursuant to this Section 7.01(c) shall be deemed to have been furnished to each of the Administrative Agent and each Group Agent on the date that such report, proxy statement or other material is posted on the SEC’s website at www.sec.gov.
iv.Notices. The Borrower (or the Servicer on its behalf) will notify the Administrative Agent and each Group Agent in writing of any of the following events promptly upon (but in no event later than five (5) Business Days after) a Financial Officer or other officer learning of the occurrence thereof, with such notice describing the same, and if applicable, the steps being taken by the Person(s) affected with respect thereto:
1.Notice of Events of Default or Unmatured Events of Default. A statement of a Financial Officer of the Borrower setting forth details of any Event of Default or Unmatured Event of Default that has occurred and is continuing and the action which the Borrower proposes to take with respect thereto.
2.Representations and Warranties. The failure of any representation or warranty made or deemed to be made by the Borrower under this Agreement or any other Transaction Document to be true and correct in any material respect when made.
3.Litigation. The institution of any litigation, arbitration proceeding or governmental proceeding on any Integra Party, which with respect to any Person other than the Borrower, could reasonably be expected to have a Material Adverse Effect.
4.Adverse Claim. (A) Any Person shall obtain an Adverse Claim upon the Collateral or any portion thereof, (B) any Person other than the Borrower, the Servicer or the Administrative Agent shall obtain any rights or direct any action with respect to any Collection Account (or related Lock-Box) or (C) any Obligor shall receive any change in payment instructions with respect to Pool Receivable(s) from a Person other than the Servicer or the Administrative Agent.
5.Name Changes. At least ten (10) Business Days before any change in any Originator’s or the Borrower’s name, jurisdiction of organization or any other change requiring the amendment of UCC financing statements, a notice setting forth such changes and the effective date thereof.
6.Change in Accountants or Accounting Policy. Any change in (i) the external accountants of any Integra Party, (ii) any accounting policy of the Borrower
62
Error! Unknown document property name.



or (iii) any material accounting policy of any Originator that is relevant to the transactions contemplated by this Agreement or any other Transaction Document (it being understood that any change to the manner in which any Originator accounts for the Pool Receivables shall be deemed “material” for such purpose).
7.Notice of Purchase and Sale Termination Event or Unmatured Purchase and Sale Termination Event. The occurrence of a Purchase and Sale Termination Event or an Unmatured Purchase and Sale Termination Event under the Purchase and Sale Agreement.
8.Material Adverse Change. Promptly after the occurrence thereof, notice of any material adverse change in the business, operations, property or financial or other condition of any Integra Party (including, without limitation, a change to the Credit and Collection Procedures).
v.Conduct of Business. The Borrower will carry on and conduct its business in substantially the same manner and in substantially the same fields of enterprise as it is presently conducted, and will do all things necessary to remain duly organized, validly existing and in good standing as a domestic organization in its jurisdiction of organization and maintain all requisite authority to conduct its business in each jurisdiction in which its business is conducted.
vi.Compliance with Laws. The Borrower will comply with all Applicable Laws to which it may be subject if the failure to comply could reasonably be expected to have a Material Adverse Effect.
vii.Furnishing of Information and Inspection of Receivables. The Borrower will furnish or cause to be furnished to the Administrative Agent and each Group Agent from time to time such information with respect to the Pool Receivables and the other Collateral as the Administrative Agent or any Group Agent may reasonably request. The Borrower will, (i) at the Borrower’s expense, during regular business hours with prior written notice, permit the Administrative Agent and each Group Agent or their respective agents or representatives to (A) examine and make copies of and abstracts from all books and records relating to the Pool Receivables or other Collateral, (B) visit the offices and properties of the Borrower for the purpose of examining such books and records and (C) discuss matters relating to the Pool Receivables, the other Collateral or the Borrower’s performance hereunder or under the other Transaction Documents to which it is a party with any of the officers, directors, employees or independent public accountants of the Borrower having knowledge of such matters and (ii) without limiting the provisions of clause (i) above, during regular business hours, at the Borrower’s expense, upon prior written notice from the Administrative Agent, permit certified public accountants or other auditors acceptable to the Administrative Agent to conduct a review of its books and records with respect to the Pool Receivables and other Collateral; provided, that the Borrower shall be required to reimburse the Administrative Agent for only one (1) such review pursuant to clause (ii) above in any twelve-month period, unless an Event of Default has occurred and is continuing.
viii.Payments on Receivables, Collection Accounts. The Borrower (or the Servicer on its behalf) will, and will cause each Originator to, at all times, instruct all Obligors to deliver payments on the Pool Receivables to a Collection Account or a Lock-Box. The Borrower (or the Servicer on its behalf) will, and will cause each Originator to, at all times, maintain such books and records as are necessary to identify Collections received from time to time on Pool Receivables and to segregate such Collections from other property of the Servicer and the Originators. If any payments on the Pool Receivables or other Collections are received by the Borrower, the Servicer or an Originator, it shall hold such payments in trust for the benefit of the Administrative Agent, the Group Agents and the other Secured Parties and promptly (but in any
63
Error! Unknown document property name.



event within two (2) Business Days after receipt) remit such funds into a Collection Account. The Borrower (or the Servicer on its behalf) will cause each Collection Account Bank to comply with the terms of each applicable Account Control Agreement. The Borrower shall not permit funds other than Collections on Pool Receivables and other Collateral to be deposited into any Collection Account. If such funds are nevertheless deposited into any Collection Account, the Borrower (or the Servicer on its behalf) shall, within two (2) Business Days, (x) identify and transfer such funds to the appropriate Person entitled to such funds and (y) instruct such Person to no longer deposit any such funds into any such Collection Account. The Borrower will not, and will not permit the Servicer, any Originator or any other Person to commingle Collections or other funds to which the Administrative Agent, any Group Agent or any other Secured Party is entitled, with any other funds. The Borrower shall only add a Collection Account (or a related Lock-Box) or a Collection Account Bank to those listed on Schedule II to this Agreement, if the Administrative Agent has received notice of such addition and an executed and acknowledged copy of an Account Control Agreement (or an amendment thereto) in form and substance acceptable to the Administrative Agent from the applicable Collection Account Bank. The Borrower shall only terminate a Collection Account Bank or close a Collection Account (or a related Lock-Box) with the prior written consent of the Administrative Agent.
ix.Sales, Liens, etc. Except as otherwise provided herein, the Borrower will not sell, assign (by operation of law or otherwise) or otherwise dispose of, or create or suffer to exist any Adverse Claim upon (including, without limitation, the filing of any financing statement) or with respect to, any Pool Receivable or other Collateral, or assign any right to receive income in respect thereof.
x.Extension or Amendment of Pool Receivables. Except as otherwise permitted in Section 8.02, the Borrower will not, and will not permit the Servicer to, alter the delinquency status or adjust the Outstanding Balance or otherwise modify the terms of any Pool Receivable in any respect, or amend, modify or waive, in any respect, any term or condition of any related Contract that could have a Material Adverse Effect. The Borrower shall at its expense, timely and fully perform and comply in all material respects with all provisions, covenants and other promises required to be observed by it under the Contracts related to the Pool Receivables, and timely and fully comply with the Credit and Collection Procedures with regard to each Pool Receivable and the related Contract.
xi.Change in Credit and Collection Procedures. The Borrower will not make any change that could be reasonably expected to have a Material Adverse Effect in the Credit and Collection Procedures without the prior written consent of the Administrative Agent and the Majority Group Agents. Promptly following any change in the Credit and Collection Procedures, the Borrower will deliver a copy of the updated Credit and Collection Procedures to the Administrative Agent and each Lender.
xii.Books and Records. The Borrower shall maintain and implement (or cause the Servicer to maintain and implement) administrative and operating procedures (including an ability to recreate records evidencing Pool Receivables and related Contracts in the event of the destruction of the originals thereof), and keep and maintain (or cause the Servicer to keep and maintain) all documents, books, records, computer tapes and disks and other information reasonably necessary or advisable for the collection of all Pool Receivables (including records adequate to permit the daily identification of each Pool Receivable and all Collections of and adjustments to each existing Pool Receivable).
xiii.Identifying of Records. The Borrower shall: (i) identify (or cause the Servicer to identify) its master data processing records relating to Pool Receivables and related Contracts with a legend that indicates that the Pool Receivables have been pledged in accordance with this
64
Error! Unknown document property name.



Agreement and (ii) cause each Originator so to identify its master data processing records with such a legend.
xiv.Change in Payment Instructions to Obligors. The Borrower shall not (and shall not permit the Servicer or any Sub-Servicer to) add, replace or terminate any Collection Account (or any related Lock-Box) or make any change in its (or their) instructions to the Obligors regarding payments to be made to the Collection Accounts (or any related Lock-Box), other than any instruction to remit payments to a different Collection Account (or any related Lock-Box), unless the Administrative Agent shall have received (i) prior written notice of such addition, termination or change and (ii) a signed and acknowledged Account Control Agreement (or an amendment thereto) with respect to such new Collection Accounts (or any related Lock-Box), and the Administrative Agent shall have consented to such change in writing.
xv.Security Interest, Etc. The Borrower shall (and shall cause the Servicer to), at its expense, take all action necessary or reasonably desirable to establish and maintain a valid and enforceable first priority perfected security interest in the Collateral, in each case free and clear of any Adverse Claim, in favor of the Administrative Agent (on behalf of the Secured Parties), including taking such action to perfect, protect or more fully evidence the security interest of the Administrative Agent (on behalf of the Secured Parties) as the Administrative Agent or any Secured Party may reasonably request. In order to evidence the security interests of the Administrative Agent under this Agreement, the Borrower shall, from time to time take such action, or execute and deliver such instruments as may be necessary (including, without limitation, such actions as are reasonably requested by the Administrative Agent) to maintain and perfect, as a first-priority interest, the Administrative Agent’s security interest in the Receivables, Related Security and Collections. The Borrower shall, from time to time and within the time limits established by law, prepare and present to the Administrative Agent for the Administrative Agent’s authorization and approval, all financing statements, amendments, continuations or initial financing statements in lieu of a continuation statement, or other filings necessary to continue, maintain and perfect the Administrative Agent’s security interest as a first-priority interest. The Administrative Agent’s approval of such filings shall authorize the Borrower to file such financing statements under the UCC without the signature of the Borrower, any Originator or the Administrative Agent where allowed by Applicable Law. Notwithstanding anything else in the Transaction Documents to the contrary, the Borrower shall not have any authority to file a termination, partial termination, release, partial release, or any amendment that deletes the name of a debtor or excludes collateral of any such financing statements filed in connection with the Transaction Documents, without the prior written consent of the Administrative Agent.
xvi.Further Assurances; Change in Name or Jurisdiction of Origination, etc.
1.The Borrower hereby authorizes and hereby agrees from time to time, at its own expense, promptly to execute (if necessary) and deliver all further instruments and documents, and to take all further actions, that may be necessary or desirable, or that the Administrative Agent may reasonably request, to perfect, protect or more fully evidence the security interest granted pursuant to this Agreement or any other Transaction Document, or to enable the Administrative Agent (on behalf of the Secured Parties) to exercise and enforce the Secured Parties’ rights and remedies under this Agreement or any other Transaction Document. Without limiting the foregoing, the Borrower hereby authorizes, and will, upon the request of the Administrative Agent, at the Borrower’s own expense, execute (if necessary) and file such financing statements or continuation statements, or amendments thereto, and such other instruments and documents, that may be necessary or desirable, or that the Administrative Agent may reasonably request, to perfect, protect or evidence any of the foregoing.
65
Error! Unknown document property name.



2.The Borrower authorizes the Administrative Agent to file financing statements, continuation statements and amendments thereto and assignments thereof, relating to the Receivables, the Related Security, the related Contracts, Collections with respect thereto and the other Collateral without the signature of the Borrower. A photocopy or other reproduction of this Agreement shall be sufficient as a financing statement where permitted by law.
3.The Borrower shall at all times be organized under the laws of the State of Delaware and shall not take any action to change its jurisdiction of organization.
4.The Borrower will not change its name, location, identity or corporate structure unless (x) the Borrower, at its own expense, shall have taken all action necessary or appropriate to perfect or maintain the perfection of the security interest under this Agreement (including, without limitation, the filing of all financing statements and the taking of such other action as the Administrative Agent may request in connection with such change or relocation) and (y) if requested by the Administrative Agent, the Borrower shall cause to be delivered to the Administrative Agent, an opinion, in form and substance satisfactory to the Administrative Agent as to such UCC perfection and priority matters as the Administrative Agent may request at such time.
xvii.Transaction Information. None of the Borrower, any Affiliate of the Borrower or any third party with which the Borrower or any Affiliate thereof has contracted, shall deliver, in writing or orally, to any Rating Agency, any Transaction Information without providing such Transaction Information to the applicable Group Agent prior to delivery to such Rating Agency and will not participate in any oral communications with respect to Transaction Information with any Rating Agency without the participation of such Group Agent.
xviii.Anti-Money Laundering/International Trade Law Compliance. The Borrower will not become a Sanctioned Person. No Covered Entity, either in its own right or through any third party, will (a) have any of its assets in a Sanctioned Country or in the possession, custody or control of a Sanctioned Person in violation of any Anti-Terrorism Law; (b) do business in or with, or derive any of its income from investments in or transactions with, any Sanctioned Country or Sanctioned Person in violation of any Anti-Terrorism Law; (c) engage in any dealings or transactions prohibited by any Anti-Terrorism Law or (d) use the proceeds of any Credit Extension to fund any operations in, finance any investments or activities in, or, make any payments to, a Sanctioned Country or Sanctioned Person in violation of any Anti-Terrorism Law. The funds used to repay each Credit Extension will not be derived from any unlawful activity. The Borrower shall comply with all Anti-Terrorism Laws. The Borrower shall promptly notify the Administrative Agent and each Lender in writing upon the occurrence of a Reportable Compliance Event. The Borrower has not used and will not use the proceeds of any Credit Extension to fund any operations in, finance any investments or activities in or make any payments to, a Sanctioned Person or a Sanctioned Country.
xix.Borrower’s Tax Status. The Borrower will remain a wholly-owned subsidiary of a United States person (within the meaning of Section 7701(a)(30) of the Code) and not be subject to withholding under Section 1446 of the Code. The Borrower shall not take or cause any action to be taken that could result in the Borrower (i) being treated other than as a “disregarded entity” within the meaning of U.S. Treasury Regulation § 301.7701-3 for U.S. federal income tax purposes or (ii) becoming an association taxable as a corporation or a publicly traded partnership taxable as a corporation for U.S. federal income tax purposes.
xx.Fundamental Changes. The Borrower shall not, without the prior written consent of the Administrative Agent and the Majority Group Agents, permit (i) itself to merge, divide or consolidate with or into, or convey, transfer, lease or otherwise dispose of (whether in one
66
Error! Unknown document property name.



transaction or in a series of transactions) all or substantially all of its assets (whether now owned or hereafter acquired) to, any Person or (ii) itself to be directly owned by any Person other than an Originator or (iii) any of its issued and outstanding Capital Stock or any of its other equity interests to become subject to any Adverse Claims. The Borrower shall provide the Administrative Agent with at least ten (10) Business Days’ prior written notice before making any change in the Borrower’s name or location or making any other change in the Borrower’s identity or corporate structure that could impair or otherwise render any UCC financing statement filed in connection with this Agreement or any other Transaction Document “seriously misleading” as such term (or similar term) is used in the applicable UCC; each notice to the Administrative Agent and the Group Agents pursuant to this sentence shall set forth the applicable change and the proposed effective date thereof.
xxi.Certain Agreements. Without the prior written consent of the Administrative Agent and the Majority Group Agents, the Borrower will not (and will not permit any Originator or the Servicer to) amend, modify, waive, revoke or terminate any Transaction Document to which it is a party or any provision of the Borrower’s organizational documents which requires the consent of the “Independent Director” (as such term is used in the Borrower’s Certificate of Formation and Limited Liability Company Agreement).
xxii.Restricted Payments.
1.Except pursuant to clause (ii) below, the Borrower will not: (A) purchase or redeem any of its membership interests, (B) declare or pay any dividend or set aside any funds for any such purpose, (C) prepay, purchase or redeem any Debt, (D) lend or advance any funds or (E) repay any loans or advances to, for or from any of its Affiliates (the amounts described in clauses (A) through (E) being referred to as “Restricted Payments”).
2.Subject to the limitations set forth in clause (iii) below, the Borrower may make Restricted Payments so long as such Restricted Payments are made only in one or more of the following ways: (A) the Borrower may make cash payments (including prepayments) on the Subordinated Notes in accordance with their respective terms and (B) the Borrower may declare and pay dividends if, in both cases, both immediately before and immediately after giving effect thereto, the Borrower’s Net Worth is not less than the Required Capital Amount.
3.The Borrower may make Restricted Payments only out of the funds, if any, it receives pursuant to Sections 3.01 of this Agreement; provided that the Borrower shall not pay, make or declare any Restricted Payment (including any dividend) if, after giving effect thereto, any Event of Default or Unmatured Event of Default shall have occurred and be continuing.
xxiii.Other Business. The Borrower will not: (i) engage in any business other than the transactions contemplated by the Transaction Documents, (ii) create, incur or permit to exist any Debt of any kind (or cause or permit to be issued for its account any letters of credit) or bankers’ acceptances, in the aggregate in excess of fifteen thousand dollars ($15,000), other than pursuant to this Agreement or the Subordinated Notes or (iii) form any Subsidiary or make any investments in any other Person.
xxiv.Use of Collections Available to the Borrower. The Borrower shall apply the Collections available to the Borrower to make payments in the following order of priority: (i) the payment of its obligations under this Agreement and each of the other Transaction Documents (other than the Subordinated Notes), (ii) the payment of accrued and unpaid interest on the Subordinated Notes and (iii) other legal and valid purposes.
67
Error! Unknown document property name.



xxv.Borrower’s Net Worth. The Borrower shall not permit the Borrower’s Net Worth to be less than the Required Capital Amount.
xxvi.Post-Closing Actions.
1.At any time on or after the Closing Date and within five (5) Business Days after receipt of the initial field examination report from CBIZ, Inc. by the Administrative Agent, the Administrative Agent may propose one or more amendments to this Agreement in order to (A) amend or otherwise modify, or change (directly or indirectly) the definitions of Defaulted Receivable, Delinquent Receivable, Eligible Receivable, Excess Concentration, Net Receivables Pool Balance, Adjusted Net Receivables Pool Balance, or Total Reserves, or any other term referenced in such definitions but not expressly listed hereunder; (B) increase the then existing Concentration Percentage for any Obligor; or (C) change the calculation of the Borrowing Base, in each case to reflect the findings of the initial field examination (the “Proposed Amendments”). The parties shall use commercially reasonable efforts to agree on the form and substance of any such Proposed Amendments, and to enter into a written amendment to this Agreement giving effect to the Proposed Amendments, not later than ten (10) Business Days following the Administrative Agent’s proposal. The Borrower shall not be entitled to submit any new Loan Requests until the Proposed Amendments, if requested, are entered into. If the parties are unable to agree on all or any part of the Proposed Amendments, then a Termination Date shall automatically occur on the earlier of (A) the eleventh (11th) Business Day following the Administrative Agent’s proposal or (B) the date the Borrower notifies the Administrative Agent in writing that it will not agree to the Proposed Amendments.
2.On or prior to January 31, 2019 (the “Post Closing Due Date”), the Borrower shall (A) enter into and deliver an executed copy of the applicable Account Control Agreement with respect to each Collection Account Bank and (B) take all further actions, that may be necessary or desirable, or that the Administrative Agent may reasonably request in connection with the immediately preceding clause (A) (including, but not limited to the delivery of executed copies of the opinions of counsel that would have been required had any such Account Control Agreement been executed and delivered on the Closing Date), in each case, in form and substance satisfactory to the Administrative Agent and the Majority Group Agents; provided, that the Post-Closing Due Date may be extended upon the written consent of the Administrative Agent (which may be via e-mail).
SECTION 1.0b.Covenants of the Servicer. At all times from the Closing Date until the Final Payout Date:
i.Existence. The Servicer shall keep in full force and effect its existence and rights as a limited liability company under the laws of the State of Delaware, and shall obtain and preserve its qualification to do business in each jurisdiction in which such qualification is or shall be necessary for the conduct of its business or the servicing of the Pool Receivables as required by this Agreement.
ii.Financial Reporting. The Servicer will maintain a system of accounting established and administered in accordance with GAAP, and the Servicer shall furnish to the Administrative Agent and each Group Agent:
1.Compliance Certificates. (A) A compliance certificate promptly upon completion of the annual report of the Parent and in no event later than ninety (90) calendar days after the close of each fiscal year of the Parent, in form and substance
68
Error! Unknown document property name.



substantially similar to Exhibit G signed by a Financial Officer of the Servicer stating that no Event of Default or Unmatured Event of Default has occurred and is continuing, or if any Event of Default or Unmatured Event of Default has occurred and is continuing, stating the nature and status thereof and setting forth the current Consolidated Total Leverage Ratio and (B) within thirty (30) calendar days after the close of each fiscal quarter of the Servicer, a compliance certificate in form and substance substantially similar to Exhibit G signed by a Financial Officer of the Servicer stating that no Event of Default or Unmatured Event of Default has occurred and is continuing, or if any Event of Default or Unmatured Event of Default has occurred and is continuing, stating the nature and status thereof and setting forth the current Consolidated Total Leverage Ratio.
2.Information Packages and Interim Reports. As soon as available and in any event not later than two (2) Business Days prior to each Settlement Date, an Information Package as of the most recently completed Fiscal Month; provided, that, upon the occurrence of a Specific Reporting Event and ten (10) Business Days’ prior written notice from the Administrative Agent, the Servicer shall furnish or cause to be furnished to the Administrative Agent and each Group Agent a weekly (or on a more frequent basis as indicated in the written notice from the Administrative Agent) Interim Report with respect to the Pool Receivables with data as of the close of business on the Business Day preceding the date on which such Interim Report is delivered; provided, further, that, at any time after the occurrence and during the continuance of an Event of Default, the Administrative Agent may specify in such notice that such Interim Report be furnished to the Administrative Agent and each Group Agent on a more frequent basis until the Administrative Agent gives notices otherwise.
3.Other Information. Such other information (including non-financial information) as the Administrative Agent or any Group Agent may from time to time reasonably request relating to any of the Servicer, the Borrower, any Originator, any Obligor or the Pool Receivables.
4.Notwithstanding anything herein to the contrary, any financial information, proxy statements or other material required to be delivered pursuant to this Section 7.02(b) shall be deemed to have been furnished to each of the Administrative Agent and each Group Agent on the date that such report, proxy statement or other material is posted on the SEC’s website at www.sec.gov.
iii.Notices. The Servicer will notify the Administrative Agent and each Group Agent in writing of any of the following events promptly upon (but in no event later than three (3) Business Days after) a Financial Officer or other officer learning of the occurrence thereof, with such notice describing the same, and if applicable, the steps being taken by the Person(s) affected with respect thereto:
1.Notice of Events of Default or Unmatured Events of Default. A statement of a Financial Officer of the Servicer setting forth details of any Event of Default or Unmatured Event of Default that has occurred and is continuing and the action which the Servicer proposes to take with respect thereto.
2.Representations and Warranties. The failure of any representation or warranty made or deemed to be made by the Servicer under this Agreement or any other Transaction Document to be true and correct in any material respect when made.
3.Litigation. The institution of any litigation, arbitration proceeding or governmental proceeding which could reasonably be expected to have a Material Adverse Effect.
69
Error! Unknown document property name.



4.Adverse Claim. (A) Any Person shall obtain an Adverse Claim upon the Collateral or any portion thereof, (B) any Person other than the Borrower, the Servicer or the Administrative Agent shall obtain any rights or direct any action with respect to any Collection Account (or related Lock-Box) or (C) any Obligor shall receive any change in payment instructions with respect to Pool Receivable(s) from a Person other than the Servicer or the Administrative Agent.
5.Name Changes. At least ten (10) Business Days before any change in any Originator’s or the Borrower’s name, jurisdiction of organization or any other change requiring the amendment of UCC financing statements, a notice setting forth such changes and the effective date thereof.
6.Change in Accountants or Accounting Policy. Any change in (i) the external accountants of any Integra Party, (ii) any accounting policy of the Borrower or (iii) any material accounting policy of any Originator that is relevant to the transactions contemplated by this Agreement or any other Transaction Document (it being understood that any change to the manner in which any Originator accounts for the Pool Receivables shall be deemed “material” for such purpose).
7.Notice of Purchase and Sale Termination Event or Unmatured Purchase and Sale Termination Event. The occurrence of a Purchase and Sale Termination Event or an Unmatured Purchase and Sale Termination Event under the Purchase and Sale Agreement.
8.Material Adverse Change. Promptly after the occurrence thereof, notice of any material adverse change in the business, operations, property or financial or other condition of any Integra Party (including, without limitation, a change to the Credit and Collection Procedures).
iv.Conduct of Business. The Servicer will do all things necessary to remain duly organized, validly existing and in good standing as a domestic limited liability company in its jurisdiction of organization and maintain all requisite authority to conduct its business in each jurisdiction in which its business is conducted if the failure to have such authority could reasonably be expected to have a Material Adverse Effect.
v.Compliance with Laws. The Servicer will comply with all Applicable Laws to which it may be subject if the failure to comply could reasonably be expected to have a Material Adverse Effect.
vi.Furnishing of Information and Inspection of Receivables. The Servicer will furnish or cause to be furnished to the Administrative Agent and each Group Agent from time to time such information with respect to the Pool Receivables and the other Collateral as the Administrative Agent or any Group Agent may reasonably request. The Servicer will, (i) at the Servicer’s expense, during regular business hours with prior written notice, permit the Administrative Agent and each Group Agent or their respective agents or representatives to (A) examine and make copies of and abstracts from all books and records relating to the Pool Receivables or other Collateral, (B) visit the offices and properties of the Servicer for the purpose of examining such books and records and (C) discuss matters relating to the Pool Receivables, the other Collateral or the Servicer’s performance hereunder or under the other Transaction Documents to which it is a party with any of the officers, directors, employees or independent public accountants of the Servicer (provided that representatives of the Servicer are present during such discussions) having knowledge of such matters and (ii) without limiting the provisions of clause (i) above, during regular business hours, at the Servicer’s expense, upon prior written notice from the Administrative Agent, permit certified public accountants or other
70
Error! Unknown document property name.



auditors acceptable to the Administrative Agent to conduct a review of its books and records with respect to the Pool Receivables and other Collateral; provided, that the Servicer shall be required to reimburse the Administrative Agent for only one (1) such review pursuant to clause (ii) above in any twelve-month period unless an Event of Default has occurred and is continuing.
vii.Payments on Receivables, Collection Accounts. The Servicer will at all times, instruct all Obligors to deliver payments on the Pool Receivables to a Collection Account or a Lock-Box. The Servicer will, at all times, maintain such books and records as are necessary to identify Collections received from time to time on Pool Receivables and to segregate such Collections from other property of the Servicer and the Originators. If any payments on the Pool Receivables or other Collections are received by the Borrower, the Servicer or an Originator, it shall hold such payments in trust for the benefit of the Administrative Agent, the Group Agents and the other Secured Parties and promptly (but in any event within two (2) Business Days after receipt) remit such funds into a Collection Account. The Servicer shall not permit funds other than Collections on Pool Receivables and other Collateral to be deposited into any Collection Account. If such funds are nevertheless deposited into any Collection Account, the Servicer shall, within two (2) Business Days, (x) identify and transfer such funds to the appropriate Person entitled to such funds and (y) instruct such Person to no longer deposit any such funds into any such Collection Account. The Servicer will not, and will not permit the Borrower, any Originator or any other Person to commingle Collections or other funds to which the Administrative Agent, any Group Agent or any other Secured Party is entitled, with any other funds. The Servicer shall only add a Collection Account (or a related Lock-Box) or a Collection Account Bank to those listed on Schedule II to this Agreement, if the Administrative Agent has received notice of such addition and an executed and acknowledged copy of an Account Control Agreement (or an amendment thereto) in form and substance acceptable to the Administrative Agent from the applicable Collection Account Bank. The Servicer shall only terminate a Collection Account Bank or close a Collection Account (or a related Lock-Box) with the prior written consent of the Administrative Agent.
viii.Extension or Amendment of Pool Receivables. Except as otherwise permitted in Section 8.02, the Servicer will not alter the delinquency status or adjust the Outstanding Balance or otherwise modify the terms of any Pool Receivable in any respect that could have a Material Adverse Effect, or amend, modify or waive, in any material respect, any term or condition of any related Contract. The Servicer shall at its expense, timely and fully perform and comply in all material respects with all provisions, covenants and other promises required to be observed by it under the Contracts related to the Pool Receivables, and timely and fully comply with the Credit and Collection Procedures with regard to each Pool Receivable and the related Contract.
ix.Change in Credit and Collection Procedures. The Servicer will comply in all respects with the Credit and Collection Procedures with regard to each Pool Receivable and the related Contracts, except where such noncompliance could reasonably expected to have a Material Adverse Effect. The Servicer will not make any material change in the Credit and Collection Procedures without the prior written consent of the Administrative Agent and the Majority Group Agents. Promptly following any change in the Credit and Collection Procedures, the Servicer will deliver a copy of the updated Credit and Collection Procedures to the Administrative Agent and each Lender.
x.Books and Records. The Servicer will maintain and implement administrative and operating procedures (including an ability to recreate records evidencing Pool Receivables and related Contracts in the event of the destruction of the originals thereof), and keep and maintain all documents, books, records, computer tapes and disks and other information reasonably necessary or advisable for the collection of all Pool Receivables (including records adequate to permit the daily identification of each Pool Receivable and all Collections of and adjustments to each existing Pool Receivable).
71
Error! Unknown document property name.



xi.Identifying of Records. The Servicer shall identify its master data processing records relating to Pool Receivables and related Contracts with a legend that indicates that the Pool Receivables have been pledged in accordance with this Agreement.
xii.Change in Payment Instructions to Obligors. The Servicer shall not (and shall not permit any Sub-Servicer to) add, replace or terminate any Collection Account (or any related Lock-Box) or make any change in its instructions to the Obligors regarding payments to be made to the Collection Accounts (or any related Lock-Box), other than any instruction to remit payments to a different Collection Account (or any related Lock-Box), unless the Administrative Agent shall have received (i) prior written notice of such addition, termination or change and (ii) a signed and acknowledged Account Control Agreement (or an amendment thereto) with respect to such new Collection Accounts (or any related Lock-Box) and the Administrative Agent shall have consented to such change in writing.
xiii.Security Interest, Etc. The Servicer shall, at its expense, take all action necessary or reasonably desirable to establish and maintain a valid and enforceable first priority perfected security interest in the Collateral, in each case free and clear of any Adverse Claim in favor of the Administrative Agent (on behalf of the Secured Parties), including taking such action to perfect, protect or more fully evidence the security interest of the Administrative Agent (on behalf of the Secured Parties) as the Administrative Agent or any Secured Party may reasonably request. In order to evidence the security interests of the Administrative Agent under this Agreement, the Servicer shall, from time to time take such action, or execute and deliver such instruments as may be necessary (including, without limitation, such actions as are reasonably requested by the Administrative Agent) to maintain and perfect, as a first-priority interest, the Administrative Agent’s security interest in the Receivables, Related Security and Collections. The Servicer shall, from time to time and within the time limits established by law, prepare and present to the Administrative Agent for the Administrative Agent’s authorization and approval, all financing statements, amendments, continuations or initial financing statements in lieu of a continuation statement, or other filings necessary to continue, maintain and perfect the Administrative Agent’s security interest as a first-priority interest. The Administrative Agent’s approval of such filings shall authorize the Servicer to file such financing statements under the UCC without the signature of the Borrower, any Originator or the Administrative Agent where allowed by Applicable Law. Notwithstanding anything else in the Transaction Documents to the contrary, the Servicer shall not have any authority to file a termination, partial termination, release, partial release, or any amendment that deletes the name of a debtor or excludes collateral of any such financing statements filed in connection with the Transaction Documents, without the prior written consent of the Administrative Agent.
xiv.Further Assurances; Change in Name or Jurisdiction of Origination, etc. The Servicer hereby authorizes and hereby agrees from time to time, at its own expense, promptly to execute (if necessary) and deliver all further instruments and documents, and to take all further actions, that may be necessary or desirable, or that the Administrative Agent may reasonably request, to perfect, protect or more fully evidence the security interest granted pursuant to this Agreement or any other Transaction Document, or to enable the Administrative Agent (on behalf of the Secured Parties) to exercise and enforce the Secured Parties’ rights and remedies under this Agreement or any other Transaction Document. Without limiting the foregoing, the Servicer hereby authorizes, and will, upon the request of the Administrative Agent, at the Servicer’s own expense, execute (if necessary) and file such financing statements or continuation statements, or amendments thereto, and such other instruments and documents, that may be necessary or desirable, or that the Administrative Agent may reasonably request, to perfect, protect or evidence any of the foregoing.
xv.Transaction Information. None of the Servicer, any Affiliate of the Servicer or any third party with which the Servicer or any Affiliate thereof has contracted, shall deliver, in
72
Error! Unknown document property name.



writing or orally, to any Rating Agency, any Transaction Information without providing such Transaction Information to the applicable Group Agent prior to delivery to such Rating Agency, and will not participate in any oral communications with respect to Transaction Information with any Rating Agency without the participation of such Group Agent.
xvi.Anti-Money Laundering/International Trade Law Compliance. The Servicer will not become a Sanctioned Person. No Covered Entity, either in its own right or through any third party, will (a) have any of its assets in a Sanctioned Country or in the possession, custody or control of a Sanctioned Person in violation of any Anti-Terrorism Law; (b) do business in or with, or derive any of its income from investments in or transactions with, any Sanctioned Country or Sanctioned Person in violation of any Anti-Terrorism Law; (c) engage in any dealings or transactions prohibited by any Anti-Terrorism Law or (d) use the proceeds of any Credit Extension to fund any operations in, finance any investments or activities in, or, make any payments to, a Sanctioned Country or Sanctioned Person in violation of any Anti-Terrorism Law. The funds used to repay each Credit Extension will not be derived from any unlawful activity. The Servicer shall comply with all Anti-Terrorism Laws. The Servicer shall promptly notify the Administrative Agent and each Lender in writing upon the occurrence of a Reportable Compliance Event.
xvii.Borrower’s Tax Status. The Servicer shall not take or cause any action to be taken that could result in the Borrower (i) being treated other than as a “disregarded entity” within the meaning of U.S. Treasury Regulation § 301.7701-3 for U.S. federal income tax purposes or (ii) becoming an association taxable as a corporation or a publicly traded partnership taxable as a corporation for U.S. federal income tax purposes.
SECTION 1.0c.Separate Existence of the Borrower. Each of the Borrower and the Servicer hereby acknowledges that the Secured Parties, the Group Agents and the Administrative Agent are entering into the transactions contemplated by this Agreement and the other Transaction Documents in reliance upon the Borrower’s identity as a legal entity separate from any Originator, the Servicer, the Performance Guarantor and their Affiliates. Therefore, each of the Borrower and Servicer shall take all steps specifically required by this Agreement or reasonably required by the Administrative Agent or any Group Agent to continue the Borrower’s identity as a separate legal entity and to make it apparent to third Persons that the Borrower is an entity with assets and liabilities distinct from those of the Performance Guarantor, the Originators, the Servicer and any other Person, and is not a division of the Performance Guarantor, the Originators, the Servicer, its Affiliates or any other Person. Without limiting the generality of the foregoing and in addition to and consistent with the other covenants set forth herein, each of the Borrower and the Servicer shall take such actions as shall be required in order that:
i.Special Purpose Entity. The Borrower will be a special purpose company whose primary activities are restricted in its Certificate of Formation or Limited Liability Company Agreement to: (i) purchasing or otherwise acquiring from the Originators, owning, holding, collecting, granting security interests or selling interests in, the Collateral, (ii) entering into agreements for the selling, servicing and financing of the Receivables Pool (including the Transaction Documents) and (iii) conducting such other activities as it deems necessary or appropriate to carry out its primary activities.
ii.No Other Business or Debt. The Borrower shall not engage in any business or activity except as set forth in this Agreement nor, incur any indebtedness or liability other than as expressly permitted by the Transaction Documents.
iii.Independent Director. Not fewer than one member of the Borrower’s board of directors (the “Independent Director”) shall be a natural person who (i) has never been, and shall
73
Error! Unknown document property name.



at no time be, an equityholder, director, officer, manager, member, partner, officer, employee or associate, or any relative of the foregoing, of any member of the Parent Group (as hereinafter defined) (other than his or her service as an Independent Director of the Borrower or an independent director of any other bankruptcy-remote special purpose entity formed for the sole purpose of securitizing, or facilitating the securitization of, financial assets of any member or members of the Parent Group), (ii) is not a customer or supplier of any member of the Parent Group (other than his or her service as an Independent Director of the Borrower or an independent director of any other bankruptcy-remote special purpose entity formed for the sole purpose of securitizing, or facilitating the securitization of, financial assets of any member or members of the Parent Group), (iii) is not any member of the immediate family of a person described in (i) or (ii) above, and (iv) has (x) prior experience as an independent director for a corporation or limited liability company whose organizational or charter documents required the unanimous consent of all independent directors thereof before such corporation or limited liability company could consent to the institution of bankruptcy or insolvency proceedings against it or could file a petition seeking relief under any applicable federal or state law relating to bankruptcy and (y) at least three years of employment experience with one or more entities that provide, in the ordinary course of their respective businesses, advisory, management or placement services to issuers of securitization or structured finance instruments, agreements or securities. For purposes of this clause (c), “Parent Group” shall mean (i) the Parent, the Servicer, the Performance Guarantor and each Originator, (ii) each person that directly or indirectly, owns or controls, whether beneficially, or as a trustee, guardian or other fiduciary, five percent (5%) or more of the membership interests in the Parent, (iii) each person that controls, is controlled by or is under common control with the Parent and (iv) each of such person’s officers, directors, managers, joint venturers and partners. For the purposes of this definition, “control” of a person means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a person or entity, whether through the ownership of voting securities, by contract or otherwise. A person shall be deemed to be an “associate” of (A) a corporation or organization of which such person is an officer, director, partner or manager or is, directly or indirectly, the beneficial owner of ten percent (10%) or more of any class of equity securities, (B) any trust or other estate in which such person serves as trustee or in a similar capacity and (C) any relative or spouse of a person described in clause (A) or (B) of this sentence, or any relative of such spouse.
The Borrower shall (A) give written notice to the Administrative Agent of the election or appointment, or proposed election or appointment, of a new Independent Director of the Borrower, which notice shall be given not later than five (5) Business Days prior to the date such appointment or election would be effective (except when such election or appointment is necessary to fill a vacancy caused by the death, disability, or incapacity of the existing Independent Director, or the failure of such Independent Director to satisfy the criteria for an Independent Director set forth in this clause (c), in which case the Borrower shall provide written notice of such election or appointment within one (1) Business Day) and (B) with any such written notice, certify to the Administrative Agent that the Independent Director satisfies the criteria for an Independent Director set forth in this clause (c).
The Borrower’s Limited Liability Company Agreement shall provide that: (A) the Borrower’s board of directors shall not approve, or take any other action to cause the filing of, a voluntary bankruptcy petition with respect to the Borrower unless the Independent Director shall approve the taking of such action in writing before the taking of such action and (B) such provision and each other provision requiring an Independent Director cannot be amended without the prior written consent of the Independent Director.
The Independent Director shall not at any time serve as a trustee in bankruptcy for any Integra Party or any of their Affiliates.
74
Error! Unknown document property name.



iv.Organizational Documents. The Borrower shall maintain its organizational documents in conformity with this Agreement, such that it does not amend, restate, supplement or otherwise modify its ability to comply with the terms and provisions of any of the Transaction Documents, including, without limitation, Section 7.01(o).
v.Conduct of Business. The Borrower shall conduct its affairs strictly in accordance with its organizational documents and observe all necessary, appropriate and customary company formalities, including, but not limited to, holding all regular and special members’ and board of directors’ meetings appropriate to authorize all company action, keeping separate and accurate minutes of its meetings, passing all resolutions or consents necessary to authorize actions taken or to be taken, and maintaining accurate and separate books, records and accounts, including, but not limited to, payroll and intercompany transaction accounts.
vi.Compensation. Any employee, consultant or agent of the Borrower will be compensated from the Borrower’s funds for services provided to the Borrower, and to the extent that Borrower shares the same officers or other employees as the Servicer (or any other Affiliate thereof), the salaries and expenses relating to providing benefits to such officers and other employees shall be fairly allocated among such entities, and each such entity shall bear its fair share of the salary and benefit costs associated with such common officers and employees. The Borrower will not engage any agents other than its attorneys, auditors and other professionals, and a servicer and any other agent contemplated by the Transaction Documents for the Receivables Pool, which servicer will be fully compensated for its services by payment of the Servicing Fee.
vii.Servicing and Costs. The Borrower will contract with the Servicer to perform for the Borrower all operations required on a daily basis to service the Receivables Pool. The Borrower will not incur any indirect or overhead expenses for items shared with the Servicer (or any other Affiliate thereof) that are not reflected in the Servicing Fee. To the extent, if any, that the Borrower (or any Affiliate thereof) shares items of expenses not reflected in the Servicing Fee, such as legal, auditing and other professional services, such expenses will be allocated to the extent practical on the basis of actual use or the value of services rendered, and otherwise on a basis reasonably related to the actual use or the value of services rendered.
viii.Operating Expenses. The Borrower’s operating expenses will not be paid by any Integra Party or any Affiliate thereof.
ix.Stationery. The Borrower will have its own separate stationery.
x.Books and Records. The Borrower’s books and records will be maintained separately from those of the Parent, each other Integra Party and any of their Affiliates and in a manner such that it will not be difficult or costly to segregate, ascertain or otherwise identify the assets and liabilities of the Borrower.
xi.Disclosure of Transactions. All financial statements of the Parent, each other Integra Party or any Affiliate thereof that are consolidated to include the Borrower will disclose that (i) the Borrower’s sole business consists of the purchase or acceptance through capital contributions of the Receivables and Related Rights from the Originators and the subsequent retransfer of or granting of a security interest in such Receivables and Related Rights to the Administrative Agent pursuant to this Agreement, (ii) the Borrower is a separate legal entity with its own separate creditors who will be entitled, upon its liquidation, to be satisfied out of the Borrower’s assets prior to any assets or value in the Borrower becoming available to the Borrower’s equity holders and (iii) the assets of the Borrower are not available to pay creditors of the Parent, each other Integra Party or any Affiliate thereof.
75
Error! Unknown document property name.



xii.Segregation of Assets. The Borrower’s assets will be maintained in a manner that facilitates their identification and segregation from those of the Parent, each other Integra Party or any Affiliates thereof.
xiii.Corporate Formalities. The Borrower will strictly observe limited liability company formalities in its dealings with the Parent, each other Integra Party or any Affiliates thereof, and funds or other assets of the Borrower will not be commingled with those of the Parent, each other Integra Party or any Affiliates thereof except as permitted by this Agreement in connection with servicing the Pool Receivables. The Borrower shall not maintain joint bank accounts or other depository accounts to which the Parent, each other Integra Party or any Affiliate thereof (other than the Servicer solely in its capacity as such) has independent access. The Borrower is not named, and has not entered into any agreement to be named, directly or indirectly, as a direct or contingent beneficiary or loss payee on any insurance policy with respect to any loss relating to the property of the Parent, each other Integra Party or any Subsidiaries or other Affiliates thereof. The Borrower will pay to the appropriate Affiliate the marginal increase or, in the absence of such increase, the market amount of its portion of the premium payable with respect to any insurance policy that covers the Borrower and such Affiliate.
xiv.Arm’s-Length Relationships. The Borrower will maintain arm’s-length relationships with the Parent, each other Integra Party and any Affiliates thereof. Any Person that renders or otherwise furnishes services to the Borrower will be compensated by the Borrower at market rates for such services it renders or otherwise furnishes to the Borrower. Neither the Borrower on the one hand, nor the Parent, each other Integra Party or any Affiliate thereof, on the other hand, will be or will hold itself out to be responsible for the debts of the other or the decisions or actions respecting the daily business and affairs of the other. The Parent, each Integra Party and their respective Affiliates will immediately correct any known misrepresentation with respect to the foregoing, and they will not operate or purport to operate as an integrated single economic unit with respect to each other or in their dealing with any other entity.
xv.Allocation of Overhead. To the extent that Borrower, on the one hand, and the Parent, each other Integra Party or any Affiliate thereof, on the other hand, have offices in the same location, there shall be a fair and appropriate allocation of overhead costs between them, and the Borrower shall bear its fair share of such expenses, which may be paid through the Servicing Fee or otherwise.
SECTION 1.0d.Financial Covenant. The Borrower shall not, directly or indirectly, nor shall it permit any Integra Party or the Parent to, directly or indirectly, permit the Consolidated Total Leverage Ratio of the Parent and its consolidated Subsidiaries as of the last day of any consecutive four fiscal quarter period ending on the dates identified below to be greater than the ratio set forth below opposite such date (and so long as PNC and Mizuho Bank, Ltd. are each a lender under the Credit Agreement, or such other ratio for such related period as specified in the Credit Agreement from time to time):

76
Error! Unknown document property name.



Four Fiscal Quarters EndingMaximum Consolidated Total Leverage Ratio
First fiscal quarter ending after the Effective Date through June 30, 2022
5.00 to 1.00
September 30, 2022 through June 30, 20234.50 to 1.00
September 30, 2023 and the last day of each fiscal quarter thereafter4.00 to 1.00
Notwithstanding the foregoing, at the election of the Parent, up to two times during the term of this Agreement, the maximum Consolidated Total Leverage Ratio set forth in this grid above may be increased to accommodate a Permitted Acquisition (as defined in the Credit Agreement), as determined by the Parent and as designated in the Compliance Certificate (as defined in the Credit Agreement, a copy of which shall be promptly provided to the Administrative Agent hereunder) or earlier notice given by the Parent in connection with such Permitted Acquisition (as defined in the Credit Agreement) (including for determining any ratios, baskets, representations and warranties or test any Event of Default (as defined in the Credit Agreement,) or Default (as defined in the Credit Agreement) blocker pursuant to Section 1.08 of the Credit Agreement); provided, however, such increase will not otherwise go into effect until the closing of such Permitted Acquisition (as defined in the Credit Agreement); provided, further, that (a) such increase shall only apply for a period of twelve months from and after such Permitted Acquisition and immediately upon the expiration of such twelve month period, the required maximum Consolidated Total Leverage Ratio shall revert to the level set forth above for the measurement period in which such step down occurs; (b) in no event shall the maximum Consolidated Total Leverage Ratio after giving effect to any such step-up exceed 5.00 to 1.00; and (c) the maximum amount that any Consolidated Total Leverage Ratio covenant level may step-up during any Consolidated Total Leverage Ratio measurement period is 0.50.
ARTICLE 8

ADMINISTRATION AND COLLECTION
OF RECEIVABLES
SECTION 1.0a.Appointment of the Servicer.
i.The servicing, administering and collection of the Pool Receivables shall be conducted by the Person so designated from time to time as the Servicer in accordance with this Section 8.01. Until the Administrative Agent gives notice to the Servicer (in accordance with this Section 8.01) of the designation of a new Servicer following an Event of Default, Integra Sales is hereby designated as, and hereby agrees to perform the duties and obligations of, the Servicer pursuant to the terms hereof. Upon the occurrence of an Event of Default, the Administrative Agent may (with the consent of the Majority Group Agents) and shall (at the direction of the Majority Group Agents) designate as Servicer any Person (including itself) to succeed Integra Sales or any successor Servicer, on the condition in each case that any such Person so designated shall agree to perform the duties and obligations of the Servicer pursuant to the terms hereof.
ii.Upon the designation of a successor Servicer as set forth in clause (a) above, Integra Sales agrees that it will terminate its activities as Servicer hereunder in a manner that the
77
Error! Unknown document property name.



Administrative Agent reasonably determines will facilitate the transition of the performance of such activities to the new Servicer, and Integra Sales shall cooperate with and assist such new Servicer. Such cooperation shall include access to and transfer of records (including all Contracts) related to Pool Receivables and use by the new Servicer of all licenses (or the obtaining of new licenses), hardware or software necessary or reasonably desirable to collect the Pool Receivables and the Related Security.
iii.Integra Sales acknowledges that, in making its decision to execute and deliver this Agreement, the Administrative Agent and each member in each Group have relied on Integra Sales’s agreement to act as Servicer hereunder. Accordingly, Integra Sales agrees that it will not voluntarily resign as Servicer without the prior written consent of the Administrative Agent and the Majority Group Agents, except if such activity is no longer permitted by Applicable Law, as confirmed by an opinion of counsel reasonably satisfactory to the Administrative Agent.
iv.The Servicer may delegate its duties and obligations hereunder to any subservicer (each a “Sub-Servicer”); provided, that, in each such delegation: (i) such Sub-Servicer shall agree in writing to perform the delegated duties and obligations of the Servicer pursuant to the terms hereof, (ii) the Servicer shall remain liable for the performance of the duties and obligations so delegated, (iii) the Borrower, the Administrative Agent, each Lender and each Group Agent shall have the right to look solely to the Servicer for performance, (iv) the terms of any agreement with any Sub-Servicer shall provide that the Administrative Agent may terminate such agreement upon the termination of the Servicer hereunder by giving notice of its desire to terminate such agreement to the Servicer (and the Servicer shall provide appropriate notice to each such Sub-Servicer) and (v) if such Sub-Servicer is not an Affiliate of the Parent, the Administrative Agent and the Majority Group Agents shall have consented in writing in advance to such delegation.
v.For so long as an Integra Party or an Affiliate of an Integra Party is the Servicer, the Servicer may assign its duties hereunder to any Affiliate without the consent of the Administrative Agent or any Lender.
SECTION 1.0b.Duties of the Servicer.
i.The Servicer shall take or cause to be taken all such action as may be necessary or reasonably advisable to service, administer and collect each Pool Receivable from time to time, all in accordance with this Agreement and all Applicable Laws, with reasonable care and diligence, and in accordance with the Credit and Collection Procedures and consistent with the past practices of the Originators. The Servicer shall set aside, for the accounts of each Group, the amount of Collections to which each such Group is entitled in accordance with Article III hereof. The Servicer may, in accordance with the Credit and Collection Procedures and consistent with past practices of the Originators, take such action, including modifications, waivers or restructurings of Pool Receivables and related Contracts, as the Servicer may reasonably determine to be appropriate to maximize Collections thereof or reflect adjustments expressly permitted under the Credit and Collection Procedures or as expressly required under Applicable Laws or the applicable Contract; provided, that for purposes of this Agreement: (i) such action shall not, and shall not be deemed to, change the number of days such Pool Receivable has remained unpaid from the date of the original due date related to such Pool Receivable, (ii) such action shall not alter the status of such Pool Receivable as a Delinquent Receivable or a Defaulted Receivable or limit the rights of any Secured Party under this Agreement or any other Transaction Document and (iii) if an Event of Default has occurred and is continuing, the Servicer may take such action only upon the prior written consent of the Administrative Agent. The Borrower shall deliver to the Servicer and the Servicer shall hold for the benefit of the Administrative Agent (individually and for the benefit of each Group), in accordance with their respective interests, all records and documents (including computer tapes
78
Error! Unknown document property name.



or disks) with respect to each Pool Receivable. Notwithstanding anything to the contrary contained herein, if an Event of Default has occurred and is continuing, the Administrative Agent may direct the Servicer to commence or settle any legal action to enforce collection of any Pool Receivable that is a Defaulted Receivable or to foreclose upon or repossess any Related Security with respect to any such Defaulted Receivable.
ii.The Servicer shall, as soon as practicable following actual receipt of collected funds, turn over to the Borrower the collections of any indebtedness that is not a Pool Receivable, less, if Integra Sales or an Affiliate thereof is not the Servicer, all reasonable and appropriate out-of-pocket costs and expenses of such Servicer of servicing, collecting and administering such collections. The Servicer, if other than Integra Sales or an Affiliate thereof, shall, as soon as practicable upon demand, deliver to the Borrower all records in its possession that evidence or relate to any indebtedness that is not a Pool Receivable, and copies of records in its possession that evidence or relate to any indebtedness that is a Pool Receivable.
iii.The Servicer’s obligations hereunder shall terminate on the Final Payout Date. Promptly following the Final Payout Date, the Servicer shall deliver to the Borrower all books, records and related materials that the Borrower previously provided to the Servicer, or that have been obtained by the Servicer, in connection with this Agreement.
SECTION 1.0c.Collection Account Arrangements. On or prior to the date set forth in Section 7.01(z)(ii), the Borrower shall have entered into Account Control Agreements with all of the Collection Account Banks and delivered executed counterparts of each to the Administrative Agent. Upon the occurrence and during the continuance of an Event of Default, the Administrative Agent may (with the consent of the Majority Group Agents) and shall (upon the direction of the Majority Group Agents) at any time thereafter give notice to each Collection Account Bank that the Administrative Agent is exercising its rights under the Account Control Agreements to do any or all of the following: (a) to have the exclusive ownership and control of the Collection Accounts transferred to the Administrative Agent (for the benefit of the Secured Parties) and to exercise exclusive dominion and control over the funds deposited therein, (b) to have the proceeds that are sent to the respective Collection Accounts redirected pursuant to the Administrative Agent’s instructions rather than deposited in the applicable Collection Account and (c) to take any or all other actions permitted under the applicable Account Control Agreement. The Borrower hereby agrees that if the Administrative Agent at any time takes any action set forth in the preceding sentence, the Administrative Agent shall have exclusive control (for the benefit of the Secured Parties) of the proceeds (including Collections) of all Pool Receivables and the Borrower hereby further agrees to take any other action that the Administrative Agent may reasonably request to transfer such control. Any proceeds of Pool Receivables received by the Borrower or the Servicer thereafter shall be sent immediately to, or as otherwise instructed by, the Administrative Agent.
SECTION 1.0d.Enforcement Rights.
i.At any time following the occurrence and during the continuation of an Event of Default:
1.the Administrative Agent (at the Borrower’s expense) may direct the Obligors that payment of all amounts payable under any Pool Receivable is to be made directly to the Administrative Agent or its designee;
2.the Administrative Agent may instruct the Borrower or the Servicer to give notice of the Secured Parties’ interest in Pool Receivables to each Obligor, which notice shall direct that payments be made directly to the Administrative Agent or its designee (on behalf of the Secured Parties), and the Borrower or the Servicer,
79
Error! Unknown document property name.



as the case may be, shall give such notice at the expense of the Borrower or the Servicer, as the case may be; provided, that if the Borrower or the Servicer, as the case may be, fails to so notify each Obligor within two (2) Business Days following instruction by the Administrative Agent, the Administrative Agent (at the Borrower’s or the Servicer’s, as the case may be, expense) may so notify the Obligors;
3.the Administrative Agent may request the Servicer to, and upon such request the Servicer shall: (A) assemble all of the records necessary or desirable to collect the Pool Receivables and the Related Security, and transfer or license to a successor Servicer the use of all software necessary or desirable to collect the Pool Receivables and the Related Security, and make the same available to the Administrative Agent or its designee (for the benefit of the Secured Parties) at a place selected by the Administrative Agent and (B) segregate all cash, checks and other instruments received by it from time to time constituting Collections in a manner reasonably acceptable to the Administrative Agent and, promptly upon receipt, remit all such cash, checks and instruments, duly endorsed or with duly executed instruments of transfer, to the Administrative Agent or its designee;
4.the Administrative Agent may notify the Collection Account Banks that the Borrower and the Servicer will no longer have any access to the Collection Accounts;
5.the Administrative Agent may (or, at the direction of the Majority Group Agents shall) replace the Person then acting as Servicer; and
6.the Administrative Agent may collect any amounts due from an Originator under the Purchase and Sale Agreement or the Performance Guarantor under the Performance Guaranty.
ii.The Borrower hereby authorizes the Administrative Agent (on behalf of the Secured Parties), and irrevocably appoints the Administrative Agent as its attorney-in-fact with full power of substitution and with full authority in the place and stead of the Borrower, which appointment is coupled with an interest, to take any and all steps in the name of the Borrower and on behalf of the Borrower necessary or desirable, in the reasonable determination of the Administrative Agent, after the occurrence and during the continuation of an Event of Default, to collect any and all amounts or portions thereof due under any and all Collateral, including endorsing the name of the Borrower on checks and other instruments representing Collections and enforcing such Collateral. Notwithstanding anything to the contrary contained in this subsection, none of the powers conferred upon such attorney-in-fact pursuant to the preceding sentence shall subject such attorney-in-fact to any liability if any action taken by it shall prove to be inadequate or invalid, nor shall they confer any obligations upon such attorney-in-fact in any manner whatsoever.
iii.The Servicer hereby authorizes the Administrative Agent (on behalf of the Secured Parties), and irrevocably appoints the Administrative Agent as its attorney-in-fact with full power of substitution and with full authority in the place and stead of the Servicer, which appointment is coupled with an interest, to take any and all steps in the name of the Servicer and on behalf of the Servicer necessary or desirable, in the reasonable determination of the Administrative Agent, after the occurrence and during the continuation of an Event of Default, to collect any and all amounts or portions thereof due under any and all Collateral, including endorsing the name of the Servicer on checks and other instruments representing Collections and enforcing such Collateral. Notwithstanding anything to the contrary contained in this subsection, none of the powers conferred upon such attorney-in-fact pursuant to the preceding sentence shall subject such attorney-in-fact to any liability if any action taken by it shall prove to be inadequate
80
Error! Unknown document property name.



or invalid, nor shall they confer any obligations upon such attorney-in-fact in any manner whatsoever.
SECTION 1.0e.Responsibilities of the Borrower.
i.Anything herein to the contrary notwithstanding, the Borrower shall: (i) perform all of its obligations, if any, under the Contracts related to the Pool Receivables to the same extent as if interests in such Pool Receivables had not been transferred hereunder, and the exercise by the Administrative Agent, or any other Credit Party of their respective rights hereunder shall not relieve the Borrower from such obligations and (ii) pay when due any taxes, including any sales taxes payable in connection with the Pool Receivables and their creation and satisfaction. None of the Credit Parties shall have any obligation or liability with respect to any Collateral, nor shall any of them be obligated to perform any of the obligations of the Borrower, the Servicer or any Originator thereunder.
ii.Integra Sales hereby irrevocably agrees that if at any time it shall cease to be the Servicer hereunder, it shall act (if the then-current Servicer so requests) as the data-processing agent of the Servicer and, in such capacity, Integra Sales shall conduct the data-processing functions (including but not limited to compiling and inputting data regarding the Receivables and Collections thereon and producing reports based on such data) of the administration of the Receivables and the Collections thereon in substantially the same way that Integra Sales conducted such data-processing functions while it acted as the Servicer. In connection with any such processing functions, the Borrower shall pay to Integra Sales its reasonable out-of-pocket costs and expenses from the Borrower’s own funds (subject to the priority of payments set forth in Section 3.01).
SECTION 1.0f.Servicing Fee.
i.Subject to clause (b) below, the Borrower shall pay the Servicer a fee (the “Servicing Fee”) equal to 1.00% per annum (the “Servicing Fee Rate”) of the daily average aggregate Outstanding Balance of the Pool Receivables. Accrued Servicing Fees shall be payable from Collections to the extent of available funds in accordance with Section 3.01.
ii.If the Servicer ceases to be Integra Sales or an Affiliate thereof, the Servicing Fee shall be the greater of: (i) the amount calculated pursuant to clause (a) above and (ii) an alternative amount specified by the successor Servicer not to exceed 110% of the aggregate reasonable costs and expenses incurred by such successor Servicer in connection with the performance of its obligations as Servicer hereunder.
ARTICLE 9

EVENTS OF DEFAULT
SECTION 1.0a.Events of Default. If any of the following events (each an “Event of Default”) shall occur:
i.(i) any Integra Party shall fail to perform or observe any term, covenant or agreement under this Agreement or any other Transaction Document (other than any such failure which would constitute an Event of Default under clause (ii) or (iii) of this Section 9.01(a)), and such failure, solely to the extent capable of cure, shall continue unremedied for thirty (30) calendar days solely to the extent (A) such failure is capable of being cured (as determined by the Administrative Agent) and (B) an Integra Party provides written notice to the Administrative Agent detailing the action which it is taking in order to cure such failure, (ii) any Integra Party shall fail to make when due any payment or deposit to be made by it under this Agreement or any
81
Error! Unknown document property name.



other Transaction Document and such failure shall continue unremedied for two (2) Business Days (unless such failure is related to an Event of Default set forth in Section 9.01(h)), (iii) Integra Sales shall resign as Servicer, and no successor Servicer reasonably satisfactory to the Administrative Agent shall have been appointed or (iv) immediately upon the breach of any covenant set forth in Section 7.04 of this Agreement;
ii.any representation or warranty made or deemed made by an Integra Party (or any of their respective officers) under or in connection with this Agreement or any other Transaction Document or any information or report delivered by an Integra Party pursuant to this Agreement or any other Transaction Document, shall prove to have been incorrect or untrue in any material respect when made or deemed made or delivered, and, solely to the extent such breach is capable of being cured (as determined by the Administrative Agent), such breach shall continue unremedied for fifteen (15) calendar days following the earlier of (A) any Integra Party’s actual knowledge of such breach and (B) the Administrative Agent’s written notice to any Integra Party of such breach;
iii.the Borrower or the Servicer shall fail to deliver an Information Package or Interim Report pursuant to this Agreement, and such failure shall remain unremedied for two (2) Business Days with respect to an Information Package or two (2) Business Days with respect to an Interim Report;
iv.this Agreement or any security interest granted pursuant to this Agreement or any other Transaction Document shall for any reason cease to create, or for any reason cease to be, a valid and enforceable first priority perfected security interest in favor of the Administrative Agent with respect to the Collateral, free and clear of any Adverse Claim;
v.any Integra Party shall generally not pay its debts as such debts become due, or shall admit in writing its inability to pay its debts generally, or shall make a general assignment for the benefit of creditors; or any Insolvency Proceeding shall be instituted by or against any Integra Party and, in the case of any such proceeding instituted against such Person (but not instituted by such Person), either such proceeding shall remain undismissed or unstayed for a period of sixty (60) consecutive calendar days, or any of the actions sought in such proceeding (including the entry of an order for relief against, or the appointment of a receiver, trustee, custodian or other similar official for, it or for any substantial part of its property) shall occur; or any Integra Party shall take any corporate or organizational action to authorize any of the actions set forth above in this Section 9.01(e);
vi.(i) the average for three (3) consecutive Fiscal Months of: (A) the Default Ratio shall exceed four percent (4.00%), (B) the Delinquency Ratio shall exceed (x) during the Relief Period, eighteen percent (18.00%), and (y) at all other times, twelve percent (12.00%) or (C) the Dilution Ratio shall exceed six percent (6.00%) or (ii) the Days’ Sales Outstanding shall exceed sixty five (65) calendar days; provided, that solely for purposes of this clause (f), Temporarily Ineligible Receivables shall be excluded from each component of the calculations used to determine compliance with the tests relating to the Default Ratio, the Delinquency Ratio, the Dilution Ratio and Days’ Sales Outstanding set forth in this clause (f);
vii.a Change in Control shall occur;
viii.a Borrowing Base Deficit shall occur, and shall not have been cured within two (2) Business Days;
ix.(i) the Borrower shall fail to pay any principal of or premium or interest on any of its Debt when the same becomes due and payable (whether by scheduled maturity, required prepayment, acceleration, demand or otherwise), and such failure shall continue after the
82
Error! Unknown document property name.



applicable grace period (not to exceed thirty (30) calendar days), if any, specified in the agreement, mortgage, indenture or instrument relating to such Debt (whether or not such failure shall have been waived under the related agreement); (ii) any other Integra Party or any of their respective Subsidiaries, individually or in the aggregate, shall fail to pay any principal of or premium or interest on any of its Debt that is outstanding in a principal amount of at least fifty million dollars ($50,000,000) in the aggregate when the same becomes due and payable (whether by scheduled maturity, required prepayment, acceleration, demand or otherwise), and such failure shall continue after the applicable grace period (not to exceed thirty (30) calendar days), if any, specified in the agreement, mortgage, indenture or instrument relating to such Debt (whether or not such failure shall have been waived under the related agreement); (iii) any other event shall occur or condition shall exist under any agreement, mortgage, indenture or instrument relating to any such Debt (as referred to in clause (i) or (ii) of this Section 9.01(i)) and shall continue after the applicable grace period (not to exceed thirty (30) calendar days), if any, specified in such agreement, mortgage, indenture or instrument (whether or not such failure shall have been waived under the related agreement), if the effect of such event or condition is to give the applicable debtholders the right (whether acted upon or not) to accelerate or permit the acceleration of the maturity of such Debt (as referred to in clause (i) or (ii) of this Section 9.01(i)) or to terminate the commitment of any lender thereunder, or (iv) any such Debt (as referred to in clause (i) or (ii) of this Section 9.01(i)) shall be declared to be due and payable, or required to be prepaid (other than by a regularly scheduled required prepayment), redeemed, purchased or defeased, or an offer to repay, redeem, purchase or defease such Debt shall be required to be made or the commitment of any lender thereunder terminated, in each case before the stated maturity thereof;
x.the Performance Guarantor shall fail to perform any of its obligations under the Performance Guaranty;
xi.the Borrower shall fail (x) at any time (other than for ten (10) Business Days following notice of the death or resignation of any Independent Director) to have an Independent Director who satisfies each requirement and qualification specified in Section 7.03(c) of this Agreement for Independent Directors, on the Borrower’s board of directors or (y) to timely notify the Administrative Agent of any replacement or appointment of any director that is to serve as an Independent Director on the Borrower’s board of directors as required pursuant to Section 7.03(c) of this Agreement;
xii.there shall have occurred any event which materially adversely impairs, the collectibility of the Pool Receivables generally or any material portion thereof;
xiii.either (i) the Internal Revenue Service shall file notice of a lien pursuant to Section 6323 of the Code with regard to any assets of the Borrower, any Originator or the Parent or (ii) the PBGC shall, or shall indicate its intention to, file notice of a lien pursuant to Section 4068 of ERISA with regard to any of the assets of the Borrower, the Servicer, any Originator or the Parent, and in either case with respect to any Originator or Parent, such lien shall not have been released within thirty (30) calendar days;
xiv.(i) the occurrence of a Reportable Event with respect to a Pension Plan; (ii) the adoption of an amendment to a Pension Plan that would require the provision of security pursuant to Section 401(a)(29) of the Code; (iii) the existence with respect to any Multiemployer Plan of an “accumulated funding deficiency” (as defined in Section 431 of the Code or Section 304 of ERISA), whether or not waived; (iv) the failure to satisfy the minimum funding standard under Section 412 of the Code with respect to any Pension Plan (v) the incurrence of any liability under Title IV of ERISA with respect to the termination of any Pension Plan or the withdrawal or partial withdrawal of any of the Borrower, any Originator, the Servicer, the Parent or any of their respective ERISA Affiliates from any Multiemployer Plan; (vi) the receipt by any of the
83
Error! Unknown document property name.



Borrower, any Originator, the Servicer, the Parent or any of their respective ERISA Affiliates from the PBGC or any plan administrator of any notice relating to the intention to terminate any Pension Plan or Multiemployer Plan or to appoint a trustee to administer any Pension Plan or Multiemployer Plan; (vii) with respect to the Borrower, any Originator, the Servicer, the Parent or any of their respective ERISA Affiliates, the imposition of Withdrawal Liability or a determination that a Multiemployer Plan is insolvent or in reorganization, within the meaning of Title IV of ERISA; or (viii) the occurrence of a prohibited transaction with respect to any of the Borrower, any Originator, the Servicer, the Parent or any of their respective ERISA Affiliates (pursuant to Section 4975 of the Code); provided that, the occurrence or existence of any event or condition described in each of clause (i) through (viii) will only constitute an Event of Default if either individually or in the aggregate, it could reasonably be expected to result in a Material Adverse Effect;
xv.a Purchase and Sale Termination Event shall occur under the Purchase and Sale Agreement;
xvi.the Borrower shall be required to register as an “investment company” within the meaning of the Investment Company Act;
xvii.any material provision of this Agreement or any other Transaction Document shall cease to be in full force and effect or any Integra Party (or any of their respective Affiliates) shall so state in writing; or
xviii.one or more judgments or decrees shall be entered against any Integra Party or any Affiliate of any of the foregoing involving in the aggregate a liability (not paid or to the extent not covered by a reputable and solvent insurance company) and such judgments and decrees either shall be final and non-appealable or shall not be vacated, discharged or stayed or bonded pending appeal for any period of thirty (30) consecutive calendar days, and the aggregate amount of all such judgments equals or exceeds fifty million dollars ($50,000,000) (or solely with respect to the Borrower, fifteen thousand dollars ($15,000));
then, and in any such event, the Administrative Agent may (or, at the direction of the Majority Group Agents shall) by notice to the Borrower (x) declare the Termination Date to have occurred (in which case the Termination Date shall be deemed to have occurred), (y) declare the Final Maturity Date to have occurred (in which case the Final Maturity Date shall be deemed to have occurred) and (z) declare the Aggregate Capital and all other Borrower Obligations to be immediately due and payable (in which case the Aggregate Capital and all other Borrower Obligations shall be immediately due and payable); provided that, automatically upon the occurrence of any event (without any requirement for the giving of notice) described in subsection (e) of this Section 9.01, the Termination Date shall occur and the Aggregate Capital and all other Borrower Obligations shall be immediately due and payable. Upon any such declaration or designation or upon such automatic termination, the Administrative Agent and the other Secured Parties shall have, in addition to the rights and remedies which they may have under this Agreement and the other Transaction Documents, all other rights and remedies provided after default under the UCC and under other Applicable Law, which rights and remedies shall be cumulative. Any proceeds from liquidation of the Collateral shall be applied in the order of priority set forth in Section 3.01.
ARTICLE 10

THE ADMINISTRATIVE AGENT
SECTION 1.0a.Authorization and Action. Each Credit Party hereby appoints and authorizes the Administrative Agent to take such action as agent on its behalf and to exercise
84
Error! Unknown document property name.



such powers under this Agreement as are delegated to the Administrative Agent by the terms hereof, together with such powers as are reasonably incidental thereto. The Administrative Agent shall not have any duties other than those expressly set forth in the Transaction Documents, and no implied obligations or liabilities shall be read into any Transaction Document, or otherwise exist, against the Administrative Agent. The Administrative Agent does not assume, nor shall it be deemed to have assumed, any obligation to, or relationship of trust or agency with, the Borrower or any Affiliate thereof or any Credit Party except for any obligations expressly set forth herein. Notwithstanding any provision of this Agreement or any other Transaction Document, in no event shall the Administrative Agent ever be required to take any action which exposes the Administrative Agent to personal liability or which is contrary to any provision of any Transaction Document or Applicable Law.
SECTION 1.0b.Administrative Agent’s Reliance, Etc. Neither the Administrative Agent nor any of its directors, officers, agents or employees shall be liable for any action taken or omitted to be taken by it or them as Administrative Agent under or in connection with this Agreement (including, without limitation, the Administrative Agent’s servicing, administering or collecting Pool Receivables in the event it replaces the Servicer in such capacity pursuant to Section 8.01), in the absence of its or their own gross negligence or willful misconduct. Without limiting the generality of the foregoing, the Administrative Agent: (a) may consult with legal counsel (including counsel for any Credit Party or the Servicer), independent certified public accountants and other experts selected by it and shall not be liable for any action taken or omitted to be taken in good faith by it in accordance with the advice of such counsel, accountants or experts; (b) makes no warranty or representation to any Credit Party (whether written or oral) and shall not be responsible to any Credit Party for any statements, warranties or representations (whether written or oral) made by any other party in or in connection with this Agreement; (c) shall not have any duty to ascertain or to inquire as to the performance or observance of any of the terms, covenants or conditions of this Agreement on the part of any Credit Party or to inspect the property (including the books and records) of any Credit Party; (d) shall not be responsible to any Credit Party for the due execution, legality, validity, enforceability, genuineness, sufficiency or value of this Agreement or any other instrument or document furnished pursuant hereto; and (e) shall be entitled to rely, and shall be fully protected in so relying, upon any notice (including notice by telephone), consent, certificate or other instrument or writing (which may be by facsimile) believed by it to be genuine and signed or sent by the proper party or parties.
SECTION 1.0c.Administrative Agent and Affiliates. With respect to any Credit Extension or interests therein owned by any Credit Party that is also the Administrative Agent, such Credit Party shall have the same rights and powers under this Agreement as any other Credit Party and may exercise the same as though it were not the Administrative Agent. The Administrative Agent and any of its Affiliates may generally engage in any kind of business with the Borrower or any Affiliate thereof and any Person who may do business with or own securities of the Borrower or any Affiliate thereof, all as if the Administrative Agent were not the Administrative Agent hereunder and without any duty to account therefor to any other Secured Party.
SECTION 1.0d.Indemnification of Administrative Agent. Each Committed Lender agrees to indemnify the Administrative Agent (to the extent not reimbursed by the Borrower or any Affiliate thereof), ratably according to the respective Percentage of such Committed Lender, from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever which may be imposed on, incurred by, or asserted against the Administrative Agent in any way relating to or arising out of this Agreement or any other Transaction Document or any action taken or omitted by the Administrative Agent under this Agreement or any other Transaction Document; provided that no Committed Lender shall be liable for any portion of such liabilities, obligations,
85
Error! Unknown document property name.



losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements resulting from the Administrative Agent’s gross negligence or willful misconduct.
SECTION 1.0e.Delegation of Duties. The Administrative Agent may execute any of its duties through agents or attorneys-in-fact and shall be entitled to advice of counsel concerning all matters pertaining to such duties. The Administrative Agent shall not be responsible for the negligence or misconduct of any agents or attorneys-in-fact selected by it with reasonable care.
SECTION 1.0f.Action or Inaction by Administrative Agent. The Administrative Agent shall in all cases be fully justified in failing or refusing to take action under any Transaction Document unless it shall first receive such advice or concurrence of the Group Agents or the Majority Group Agents, as the case may be, and assurance of its indemnification by the Committed Lenders, as it deems appropriate. The Administrative Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Agreement or any other Transaction Document in accordance with a request or at the direction of the Group Agents or the Majority Group Agents, as the case may be, and such request or direction and any action taken or failure to act pursuant thereto shall be binding upon all Credit Parties. The Credit Parties and the Administrative Agent agree that unless any action to be taken by the Administrative Agent under a Transaction Document (i) specifically requires the advice or concurrence of all Group Agents or (ii) may be taken by the Administrative Agent alone or without any advice or concurrence of any Group Agent, then the Administrative Agent may take action based upon the advice or concurrence of the Majority Group Agents.
SECTION 1.0g.Notice of Events of Default; Action by Administrative Agent. The Administrative Agent shall not be deemed to have knowledge or notice of the occurrence of any Unmatured Event of Default or Event of Default unless the Administrative Agent has received notice from any Credit Party or the Borrower stating that an Unmatured Event of Default or Event of Default has occurred hereunder and describing such Unmatured Event of Default or Event of Default. If the Administrative Agent receives such a notice, it shall promptly give notice thereof to each Group Agent, whereupon each Group Agent shall promptly give notice thereof to its respective Conduit Lender(s) and Related Committed Lender(s). The Administrative Agent may (but shall not be obligated to) take such action, or refrain from taking such action, concerning an Unmatured Event of Default or Event of Default or any other matter hereunder as the Administrative Agent deems advisable and in the best interests of the Secured Parties.
SECTION 1.0h.Non-Reliance on Administrative Agent and Other Parties. Each Credit Party expressly acknowledges that neither the Administrative Agent nor any of its directors, officers, agents or employees has made any representations or warranties to it and that no act by the Administrative Agent hereafter taken, including any review of the affairs of the Borrower or any Affiliate thereof, shall be deemed to constitute any representation or warranty by the Administrative Agent. Each Credit Party represents and warrants to the Administrative Agent that, independently and without reliance upon the Administrative Agent or any other Credit Party and based on such documents and information as it has deemed appropriate, it has made and will continue to make its own appraisal of, and investigation into, the business, operations, property, prospects, financial and other conditions and creditworthiness of each Integra Party and the Pool Receivables and its own decision to enter into this Agreement and to take, or omit, action under any Transaction Document. Except for items expressly required to be delivered under any Transaction Document by the Administrative Agent to any Credit Party, the Administrative Agent shall not have any duty or responsibility to provide any Credit Party with any information concerning any Integra Party that comes into the possession of the Administrative Agent or any of its directors, officers, agents, employees, attorneys-in-fact or Affiliates.
86
Error! Unknown document property name.



SECTION 1.0i.Successor Administrative Agent.
i.The Administrative Agent may, upon at least thirty (30) calendar days’ notice to the Borrower, the Servicer and each Group Agent, resign as Administrative Agent. Except as provided below, such resignation shall not become effective until a successor Administrative Agent is appointed by the Majority Group Agents as a successor Administrative Agent and has accepted such appointment. If no successor Administrative Agent shall have been so appointed by the Majority Group Agents, within thirty (30) calendar days after the departing Administrative Agent’s giving of notice of resignation, the departing Administrative Agent may, on behalf of the Secured Parties, appoint a successor Administrative Agent as successor Administrative Agent. If no successor Administrative Agent shall have been so appointed by the Majority Group Agents within sixty (60) calendar days after the departing Administrative Agent’s giving of notice of resignation, the departing Administrative Agent may, on behalf of the Secured Parties, petition a court of competent jurisdiction to appoint a successor Administrative Agent.
ii.Upon such acceptance of its appointment as Administrative Agent hereunder by a successor Administrative Agent, such successor Administrative Agent shall succeed to and become vested with all the rights and duties of the resigning Administrative Agent, and the resigning Administrative Agent shall be discharged from its duties and obligations under the Transaction Documents. After any resigning Administrative Agent’s resignation hereunder, the provisions of this Article X and Article XII shall inure to its benefit as to any actions taken or omitted to be taken by it while it was the Administrative Agent.
SECTION 1.j.Structuring Agent. Each of the parties hereto hereby acknowledges and agrees that the Structuring Agent shall not have any right, power, obligation, liability, responsibility or duty under this Agreement, other than the Structuring Agent’s right to receive fees pursuant to Section 2.03 and expenses (if any) pursuant to Section 13.04. Each Credit Party acknowledges that it has not relied, and will not rely, on the Structuring Agent in deciding to enter into this Agreement and to take, or omit to take, any action under any Transaction Document.
SECTION 1.k.Erroneous Payment.
i.Each Lender hereby agrees that (i) if the Administrative Agent notifies such Lender that the Administrative Agent has determined in its sole discretion that any funds received by such Lender from the Administrative Agent or any of its Affiliates were erroneously transmitted to, or otherwise erroneously or mistakenly received by, such Lender (whether or not known to such Lender (whether as a payment, prepayment or repayment of principal, interest, fees or otherwise), individually and collectively, an “Erroneous Payment”) and demands the return of such Erroneous Payment (or a portion thereof), such Lender shall promptly, but in no event later than one Business Day thereafter, return to the Administrative Agent the amount of any such Erroneous Payment (or portion thereof) as to which such a demand was made, in same day funds (in the currency so received), together with interest thereon in respect of each day from and including the date such Erroneous Payment (or portion thereof) was received by such Lender to the date such amount is repaid to the Administrative Agent in same day funds at the greater of the Overnight Bank Funding Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation from time to time in effect, and (ii) such Lender shall not assert any right or claim to the Erroneous Payment, and hereby waives any claim, counterclaim, defense or right of set-off or recoupment with respect to any demand, claim or counterclaim by the Administrative Agent for the return of any Erroneous Payments received, including without limitation waiver of any defense based on “discharge for value” or any similar
87
Error! Unknown document property name.



doctrine. A notice of the Administrative Agent to any Lender under this clause (a) shall be conclusive, absent manifest error.
ii.Without limiting immediately preceding clause (a), each Lender hereby further agrees that if it receives an Erroneous Payment from the Administrative Agent (or any of its Affiliates) (i) that is in an amount different than (other than a de minimis difference), or on a different date from, that specified in a notice of payment sent by the Administrative Agent (or any of its Affiliates) with respect to such Erroneous Payment (an “Erroneous Payment Notice”), or (ii) that was not preceded or accompanied by an Erroneous Payment Notice, it shall be on notice that, in each such case, an error has been made with respect to such Erroneous Payment. Each Lender further agrees that, in each such case, or if it otherwise becomes aware an Erroneous Payment (or portion thereof) may have been sent in error, such Lender shall promptly notify the Administrative Agent of such occurrence and, upon demand from the Administrative Agent, it shall promptly, but in no event later than one (1) Business Day thereafter, return to the Administrative Agent the amount of any such Erroneous Payment (or portion thereof) that was received by such Lender to the date such amount is repaid to the Administrative Agent in same day funds at the greater of the Overnight Bank Funding Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation from time to time in effect.
iii.The Borrower and the Servicer hereby agree that (i) in the event an Erroneous Payment (or portion thereof) is not recovered from any Lender that has received such Erroneous Payment (or portion thereof) for any reason, the Administrative Agent shall be subrogated to all the rights of such Lender with respect to such amount and (ii) an Erroneous Payment shall not pay, prepay, repay, discharge or otherwise satisfy any Obligations owed by the Borrower or the Servicer.
iv.Each party’s obligations under this Section 10.11 shall survive the resignation or replacement of the Administrative Agent or any transfer of rights or obligations by, or the replacement of, a Lender, the termination of the Commitments or the repayment, satisfaction or discharge of all Borrower Obligations (or any portion thereof) and the Servicer’s obligations (or any portion thereof) under any Transaction Document.
ARTICLE 11

THE GROUP AGENTS
SECTION 1.0a.Authorization and Action. Each Credit Party that belongs to a Group hereby appoints and authorizes the Group Agent for such Group to take such action as agent on its behalf and to exercise such powers under this Agreement as are delegated to such Group Agent by the terms hereof, together with such powers as are reasonably incidental thereto. No Group Agent shall have any duties other than those expressly set forth in the Transaction Documents, and no implied obligations or liabilities shall be read into any Transaction Document, or otherwise exist, against any Group Agent. No Group Agent assumes, nor shall it be deemed to have assumed, any obligation to, or relationship of trust or agency with the Borrower or any Affiliate thereof, any Lender except for any obligations expressly set forth herein. Notwithstanding any provision of this Agreement or any other Transaction Document, in no event shall any Group Agent ever be required to take any action which exposes such Group Agent to personal liability or which is contrary to any provision of any Transaction Document or Applicable Law.
SECTION 1.0b.Group Agent’s Reliance, Etc. No Group Agent nor any of its directors, officers, agents or employees shall be liable for any action taken or omitted to be taken by it or them as a Group Agent under or in connection with this Agreement or any other
88
Error! Unknown document property name.



Transaction Documents in the absence of its or their own gross negligence or willful misconduct. Without limiting the generality of the foregoing, a Group Agent: (a) may consult with legal counsel (including counsel for the Administrative Agent, the Borrower or the Servicer), independent certified public accountants and other experts selected by it and shall not be liable for any action taken or omitted to be taken in good faith by it in accordance with the advice of such counsel, accountants or experts; (b) makes no warranty or representation to any Credit Party (whether written or oral) and shall not be responsible to any Credit Party for any statements, warranties or representations (whether written or oral) made by any other party in or in connection with this Agreement or any other Transaction Document; (c) shall not have any duty to ascertain or to inquire as to the performance or observance of any of the terms, covenants or conditions of this Agreement or any other Transaction Document on the part of the Borrower or any Affiliate thereof or any other Person or to inspect the property (including the books and records) of the Borrower or any Affiliate thereof; (d) shall not be responsible to any Credit Party for the due execution, legality, validity, enforceability, genuineness, sufficiency or value of this Agreement, any other Transaction Documents or any other instrument or document furnished pursuant hereto; and (e) shall be entitled to rely, and shall be fully protected in so relying, upon any notice (including notice by telephone), consent, certificate or other instrument or writing (which may be by facsimile) believed by it to be genuine and signed or sent by the proper party or parties.
SECTION 1.0c.Group Agent and Affiliates. With respect to any Credit Extension or interests therein owned by any Credit Party that is also a Group Agent, such Credit Party shall have the same rights and powers under this Agreement as any other Lender and may exercise the same as though it were not a Group Agent. A Group Agent and any of its Affiliates may generally engage in any kind of business with the Borrower or any Affiliate thereof and any Person who may do business with or own securities of the Borrower or any Affiliate thereof or any of their respective Affiliates, all as if such Group Agent were not a Group Agent hereunder and without any duty to account therefor to any other Secured Party.
SECTION 1.0d.Indemnification of Group Agents. Each Committed Lender in any Group agrees to indemnify the Group Agent for such Group (to the extent not reimbursed by the Borrower or any Affiliate thereof), ratably according to the proportion of the Percentage of such Committed Lender to the aggregate Percentages of all Committed Lenders in such Group, from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever which may be imposed on, incurred by, or asserted against such Group Agent in any way relating to or arising out of this Agreement or any other Transaction Document or any action taken or omitted by such Group Agent under this Agreement or any other Transaction Document; provided that no Committed Lender shall be liable for any portion of such liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements resulting from such Group Agent’s gross negligence or willful misconduct.
SECTION 1.0e.Delegation of Duties. Each Group Agent may execute any of its duties through agents or attorneys-in-fact and shall be entitled to advice of counsel concerning all matters pertaining to such duties. No Group Agent shall be responsible for the negligence or misconduct of any agents or attorneys-in-fact selected by it with reasonable care.
SECTION 1.0f.Notice of Events of Default. No Group Agent shall be deemed to have knowledge or notice of the occurrence of any Unmatured Event of Default or Event of Default unless such Group Agent has received notice from the Administrative Agent, any other Group Agent, any other Credit Party, the Servicer or the Borrower stating that an Unmatured Event of Default or Event of Default has occurred hereunder and describing such Unmatured Event of Default or Event of Default. If a Group Agent receives such a notice, it shall promptly give notice thereof to the Credit Parties in its Group and to the Administrative Agent (but only if
89
Error! Unknown document property name.



such notice received by such Group Agent was not sent by the Administrative Agent). A Group Agent may take such action concerning an Unmatured Event of Default or Event of Default as may be directed by Committed Lenders in its Group representing a majority of the Commitments in such Group (subject to the other provisions of this Article XI), but until such Group Agent receives such directions, such Group Agent may (but shall not be obligated to) take such action, or refrain from taking such action, as such Group Agent deems advisable and in the best interests of the Conduit Lenders and Committed Lenders in its Group.
SECTION 1.0g.Non-Reliance on Group Agent and Other Parties. Each Credit Party expressly acknowledges that neither the Group Agent for its Group nor any of such Group Agent’s directors, officers, agents or employees has made any representations or warranties to it and that no act by such Group Agent hereafter taken, including any review of the affairs of the Borrower or any Affiliate thereof, shall be deemed to constitute any representation or warranty by such Group Agent. Each Credit Party represents and warrants to the Group Agent for its Group that, independently and without reliance upon such Group Agent, any other Group Agent, the Administrative Agent or any other Credit Party and based on such documents and information as it has deemed appropriate, it has made and will continue to make its own appraisal of, and investigation into, the business, operations, property, prospects, financial and other conditions and creditworthiness of the Borrower or any Affiliate thereof and the Receivables and its own decision to enter into this Agreement and to take, or omit, action under any Transaction Document. Except for items expressly required to be delivered under any Transaction Document by a Group Agent to any Credit Party in its Group, no Group Agent shall have any duty or responsibility to provide any Credit Party in its Group with any information concerning the Borrower or any Affiliate thereof that comes into the possession of such Group Agent or any of its directors, officers, agents, employees, attorneys-in-fact or Affiliates.
SECTION 1.0h.Successor Group Agent. Any Group Agent may, upon at least thirty (30) days’ notice to the Administrative Agent, the Borrower, the Servicer and the Credit Parties in its Group, resign as Group Agent for its Group. Such resignation shall not become effective until a successor Group Agent is appointed by the Lender(s) in such Group. Upon such acceptance of its appointment as Group Agent for such Group hereunder by a successor Group Agent, such successor Group Agent shall succeed to and become vested with all the rights and duties of the resigning Group Agent, and the resigning Group Agent shall be discharged from its duties and obligations under the Transaction Documents. After any resigning Group Agent’s resignation hereunder, the provisions of this Article XI and Article XII shall inure to its benefit as to any actions taken or omitted to be taken by it while it was a Group Agent.
SECTION 1.0i.Reliance on Group Agent. Unless otherwise advised in writing by a Group Agent or by any Credit Party in such Group Agent’s Group, each party to this Agreement may assume that (i) such Group Agent is acting for the benefit and on behalf of each of the Credit Parties in its Group, as well as for the benefit of each assignee or other transferee from any such Person and (ii) each action taken by such Group Agent has been duly authorized and approved by all necessary action on the part of the Credit Parties in its Group.
ARTICLE 12

INDEMNIFICATION
SECTION 1.0a.Indemnities by the Borrower.
i.Without limiting any other rights that the Administrative Agent, the Credit Parties, the Affected Persons and their respective assigns, officers, directors, agents and employees (each, a “Borrower Indemnified Party”) may have hereunder or under Applicable Law, the Borrower hereby agrees to indemnify each Borrower Indemnified Party from and
90
Error! Unknown document property name.



against any and all claims, expenses, damages, losses and liabilities suffered or sustained (including Attorney Costs) (all of the foregoing being collectively referred to as “Borrower Indemnified Amounts”) arising out of, relating to or in connection this Agreement or any other Transaction Document or the use of proceeds of the Credit Extensions or the security interest in respect of any Pool Receivable or any other Collateral; excluding, however, (x) Borrower Indemnified Amounts to the extent a final non-appealable judgment of a court of competent jurisdiction holds that such Borrower Indemnified Amounts resulted solely from the gross negligence, bad faith, willful misconduct by the Borrower Indemnified Party seeking indemnification, (y) Borrower Indemnified Amounts to the extent a final non-appealable judgment of a court of competent jurisdiction holds that such Borrower Indemnified Amounts resulted solely from a material breach of a Transaction Document by the Borrower Indemnified Party seeking indemnification and (z) Taxes that are covered by Section 4.03. Without limiting or being limited by the foregoing, the Borrower shall pay on demand (it being understood that if any portion of such payment obligation is made from Collections, such payment will be made at the time and in the order of priority set forth in Section 3.01), to each Borrower Indemnified Party any and all amounts necessary to indemnify such Borrower Indemnified Party from and against any and all Borrower Indemnified Amounts relating to or resulting from any of the following (but excluding Borrower Indemnified Amounts and Taxes described in clauses (x), (y) and (z) above):
1.any Pool Receivable which the Borrower or the Servicer includes as an Eligible Receivable as part of the Net Receivables Pool Balance but which is not an Eligible Receivable at such time;
2.any representation, warranty or statement made or deemed made by the Borrower (or any of its respective officers) under or in connection with this Agreement, any of the other Transaction Documents, any Information Package, Interim Report or any other information or report delivered by or on behalf of the Borrower pursuant hereto which shall have been untrue or incorrect when made or deemed made;
3.the failure by the Borrower to comply with any Applicable Law with respect to any Pool Receivable or the related Contract; or the failure of any Pool Receivable or the related Contract to conform to any such Applicable Law;
4.the failure to vest in the Administrative Agent a first priority perfected security interest in all or any portion of the Collateral, in each case free and clear of any Adverse Claim;
5.the failure to have filed, or any delay in filing, financing statements, financing statement amendments, continuation statements or other similar instruments or documents under the UCC of any applicable jurisdiction or other Applicable Laws with respect to any Pool Receivable and the other Collateral and Collections in respect thereof, whether at the time of any Credit Extension or at any subsequent time;
6.any dispute, claim or defense (other than discharge in bankruptcy), of an Obligor to the payment of any Pool Receivable (including, without limitation, a defense based on such Pool Receivable or the related Contract not being a legal, valid and binding obligation of such Obligor enforceable against it in accordance with its terms), or any other claim resulting from or relating to collection activities with respect to such Pool Receivable;
7.any failure of the Borrower to perform any of its duties or obligations in accordance with the provisions hereof and of each other Transaction
91
Error! Unknown document property name.



Document related to Pool Receivables or to timely and fully comply with the Credit and Collection Procedures in regard to each Pool Receivable;
8.any products liability, environmental or other claim arising out of or in connection with any Pool Receivable or other merchandise, goods or services which are the subject of or related to any Pool Receivable;
9.the commingling of Collections of Pool Receivables at any time with other funds;
10.any investigation, litigation or proceeding (actual or threatened) related to this Agreement or any other Transaction Document or the use of proceeds of any Credit Extensions or in respect of any Pool Receivable or other Collateral or any related Contract;
11.any failure of the Borrower to comply with its covenants, obligations and agreements contained in this Agreement or any other Transaction Document;
12.any offset, setoff, adjustment, or other non-cash reduction of any Pool Receivable (including Deemed Collections) not arising from the bankruptcy or insolvency, lack of creditworthiness or other financial default or inability to pay of the related Obligor any undisputed indebtedness;
13.any claim brought by any Person other than a Borrower Indemnified Party arising from any activity by the Borrower or any Affiliate of the Borrower in servicing, administering or collecting any Pool Receivable;
14.the failure by the Borrower to pay when due any taxes, including, without limitation, sales, excise or personal property taxes;
15.any failure of a Collection Account Bank to comply with the terms of the applicable Account Control Agreement, the termination by a Collection Account Bank prior to the appointment of a successor collection account bank or any amounts payable by the Administrative Agent to a Collection Account Bank under any Account Control Agreement;
16.any dispute, claim, offset or defense (other than discharge in bankruptcy of the Obligor) of the Obligor to the payment of any Pool Receivable (including, without limitation, a defense based on such Pool Receivable or the related Contract not being a legal, valid and binding obligation of such Obligor enforceable against it in accordance with its terms), or any other claim resulting from the sale of goods or the rendering of services related to such Pool Receivable or the furnishing or failure to furnish any such goods or services or other similar claim or defense not arising from the financial inability of any Obligor to pay undisputed indebtedness;
17.any action taken by the Administrative Agent as attorney-in-fact for the Borrower, any Originator or the Servicer pursuant to this Agreement or any other Transaction Document;
18.the use of proceeds of any Credit Extension;
92
Error! Unknown document property name.



19.any reduction in Capital as a result of the distribution of Collections if all or a portion of such distributions shall thereafter be rescinded or otherwise must be returned for any reason;
20.any failure by any Originator to provide an Obligor with an invoice evidencing indebtedness related to a Pool Receivable;
21.payment, prepayment, conversion or renewal of any Loan to which a Term SOFR Option or Daily SOFR Option applies on a day other than the last day of the corresponding Interest Period (whether or not any such payment or prepayment is mandatory, voluntary or automatic and whether or not any such payment or prepayment is then due); or
22.any assignment of a Loan under the Term SOFR Option or the Daily SOFR Rate Option on a day other than the last day of the Interest Period therefor as a result of a request by the Borrower pursuant to Section 4.01(f).
ii.Notwithstanding anything to the contrary in this Agreement, solely for purposes of the Borrower’s indemnification obligations in clauses (ii), (iii), (vii) and (xi) of this Article XII, any representation, warranty or covenant qualified by the occurrence or non-occurrence of a material adverse effect or similar concepts of materiality shall be deemed to be not so qualified.
iii.If for any reason the foregoing indemnification is unavailable to any Borrower Indemnified Party or insufficient to hold it harmless, then the Borrower shall contribute to such Borrower Indemnified Party the amount paid or payable by such Borrower Indemnified Party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect the relative economic interests of the Borrower and its Affiliates on the one hand and such Borrower Indemnified Party on the other hand in the matters contemplated by this Agreement as well as the relative fault of the Borrower and its Affiliates and such Borrower Indemnified Party with respect to such loss, claim, damage or liability and any other relevant equitable considerations. The reimbursement, indemnity and contribution obligations of the Borrower under this Section 12.01 shall be in addition to any liability which the Borrower may otherwise have, shall extend upon the same terms and conditions to each Borrower Indemnified Party, and shall be binding upon and inure to the benefit of any successors, assigns, heirs and personal representatives of the Borrower and the Borrower Indemnified Parties.
iv.Any indemnification or contribution under this Section 12.01 shall survive the termination of this Agreement.
SECTION 1.0b.Indemnification by the Servicer.
i.The Servicer hereby agrees to indemnify and hold harmless the Borrower, the Administrative Agent, the Credit Parties, the Affected Persons and their respective assigns, officers, directors, agents and employees (each, a “Servicer Indemnified Party”), from and against any and all claims, expenses, damages, losses and liabilities suffered or sustained by reason of any acts, omissions or alleged acts or omissions arising out of activities of the Servicer pursuant to this Agreement or any other Transaction Document, including any judgment, award, settlement, Attorney Costs and other costs or expenses incurred in connection with the defense of any actual or threatened action, proceeding or claim (all of the foregoing being collectively referred to as, “Servicer Indemnified Amounts”); excluding (w) Servicer Indemnified Amounts to the extent a final non-appealable judgment of a court of competent jurisdiction holds that such Servicer Indemnified Amounts resulted solely from the gross negligence, bad faith or willful misconduct by the Servicer Indemnified Party seeking indemnification, (x) Servicer Indemnified Amounts to the extent a final non-appealable judgment of a court of competent jurisdiction holds
93
Error! Unknown document property name.



that such Servicer Indemnified Amounts resulted solely from a material breach of a Transaction Document by the Servicer Indemnified Party seeking indemnification, (y) Taxes that are covered by Section 4.03 and (z) Servicer Indemnified Amounts to the extent the same includes losses in respect of Pool Receivables that are uncollectible solely on account of the insolvency, bankruptcy, lack of creditworthiness or other financial inability to pay of the related Obligor. Without limiting or being limited by the foregoing, the Servicer shall pay on demand, to each Servicer Indemnified Party any and all amounts necessary to indemnify such Servicer Indemnified Party from and against any and all Servicer Indemnified Amounts relating to or resulting from any of the following (but excluding Servicer Indemnified Amounts described in clauses (z), (y) and (z) above):
1.any representation, warranty or statement made or deemed made by the Servicer (or any of its respective officers) under or in connection with this Agreement, any of the other Transaction Documents, any Information Package, Interim Report or any other information or report delivered by or on behalf of the Servicer pursuant hereto which shall have been untrue or incorrect when made or deemed made;
2.the failure by the Servicer to comply with any Applicable Law with respect to any Pool Receivable or the related Contract; or the failure of any Pool Receivable or the related Contract to conform to any such Applicable Law;
3.the commingling of Collections of Pool Receivables at any time with other funds; or
4.any failure of the Servicer to comply with its covenants, obligations and agreements contained in this Agreement or any other Transaction Document (including, without limitation, the failure or delay by the Servicer to provide, or cause the applicable Originator to provide, any Obligor with an invoice or other evidence of Indebtedness related to a Pool Receivable).
ii.If for any reason the foregoing indemnification is unavailable to any Servicer Indemnified Party or insufficient to hold it harmless, then the Servicer shall contribute to the amount paid or payable by such Servicer Indemnified Party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect the relative economic interests of the Servicer and its Affiliates on the one hand and such Servicer Indemnified Party on the other hand in the matters contemplated by this Agreement as well as the relative fault of the Servicer and its Affiliates and such Servicer Indemnified Party with respect to such loss, claim, damage or liability and any other relevant equitable considerations. The reimbursement, indemnity and contribution obligations of the Servicer under this Section 12.02 shall be in addition to any liability which the Servicer may otherwise have, shall extend upon the same terms and conditions to Servicer Indemnified Party, and shall be binding upon and inure to the benefit of any successors, assigns, heirs and personal representatives of the Servicer and the Servicer Indemnified Parties.
iii.Any indemnification or contribution under this Section 12.02 shall survive the termination of this Agreement.
ARTICLE 13

MISCELLANEOUS
SECTION 1.0a.Amendments, Etc.
94
Error! Unknown document property name.



No failure on the part of any Credit Party to exercise, and no delay in exercising, any right hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right hereunder preclude any other or further exercise thereof or the exercise of any other right. No amendment or waiver of any provision of this Agreement or consent to any departure by any of the Borrower or any Affiliate thereof shall be effective unless in a writing signed by the Administrative Agent and the Majority Group Agents (and, in the case of any amendment, also signed by the Borrower), and then such amendment, waiver or consent shall be effective only in the specific instance and for the specific purpose for which given; provided, however, that (A) no amendment, waiver or consent shall, unless in writing and signed by the Servicer, affect the rights or duties of the Servicer under this Agreement; (B) no amendment, waiver or consent shall, unless in writing and signed by the Administrative Agent and each Group Agent:
i.change (directly or indirectly) the definitions of, Borrowing Base Deficit, Defaulted Receivable, Delinquent Receivable, Eligible Receivable, Facility Limit, Final Maturity Date, Net Receivables Pool Balance, Adjusted Net Receivables Pool Balance or Total Reserves contained in this Agreement, or increase the then existing Concentration Percentage for any Obligor or change the calculation of the Borrowing Base;
ii.reduce the amount of Capital or Interest or any Fee that is payable on account of any Loan or with respect to any other Credit Extension or delay any scheduled date for payment thereof;
iii.change any Event of Default;
iv.release all or a material portion of the Collateral from the Administrative Agent’s security interest created hereunder;
v.release the Performance Guarantor from any of its obligations under the Performance Guaranty or terminate the Performance Guaranty;
vi.change any of the provisions of this Section 13.01 or the definition of “Majority Group Agents”; or
vii.change the order of priority in which Collections are applied pursuant to Section 3.01.
Notwithstanding the foregoing, (i) no amendment, waiver or consent shall increase any Committed Lender’s Commitment hereunder without the consent of such Committed Lender and (ii) no amendment, waiver or consent shall reduce any Fees payable by the Borrower to any member of any Group or delay the dates on which any such Fees are payable, in either case, without the consent of the Group Agent for such Group and (iii) no consent with respect to any amendment, waiver or other modification of this Agreement shall be required of any Defaulting Lender, except with respect to any amendment, waiver or other modification referred to in clauses (i) through (vii) above and then only in the event such Defaulting Lender shall be directly affected by such amendment, waiver or other modification.
SECTION 1.0b.Notices, Etc. All notices and other communications hereunder shall, unless otherwise stated herein, be in writing (which shall include facsimile communication) and faxed or delivered, to each party hereto, at its address set forth under its name on Schedule III hereto or at such other address as shall be designated by such party in a written notice to the other parties hereto. Notices and communications by facsimile shall be effective when sent (and shall be followed by hard copy sent by regular mail), and notices and communications sent by other means shall be effective when received.
95
Error! Unknown document property name.



SECTION 1.0c.Assignability; Addition of Lenders; Removal of Lenders.
i.Assignment by Conduit Lenders. This Agreement and the rights of each Conduit Lender hereunder (including each Loan made by it hereunder) shall be assignable by such Conduit Lender and its successors and permitted assigns (i) to any Program Support Provider of such Conduit Lender without prior notice to or consent from the Borrower or any other party, or any other condition or restriction of any kind, (ii) to any other Lender with prior notice to the Borrower but without consent from the Borrower or (iii) with the prior written consent of the Borrower (such consent not to be unreasonably withheld, conditioned or delayed; provided, however, that such consent shall not be required if an Event of Default or Unmatured Event of Default has occurred and is continuing), to any other Eligible Assignee. Each assignor of a Loan or any interest therein may, in connection with the assignment or participation, disclose to the assignee or Participant any information relating to the Borrower and its Affiliates, including the Receivables, furnished to such assignor by or on behalf of the Borrower and its Affiliates or by the Administrative Agent; provided that, prior to any such disclosure, the assignee or Participant agrees to preserve the confidentiality of any confidential information relating to the Borrower and its Affiliates received by it from any of the foregoing entities in a manner consistent with Section 13.06(b).
ii.Assignment by Committed Lenders. Each Committed Lender may assign to any Eligible Assignee or to any other Committed Lender all or a portion of its rights and obligations under this Agreement (including, without limitation, all or a portion of its Commitment and any Loan or interests therein owned by it); provided, however that
1.except for an assignment by a Committed Lender to either an Affiliate of such Committed Lender or any other Committed Lender, each such assignment shall require the prior written consent of the Borrower (such consent not to be unreasonably withheld, conditioned or delayed; provided, however, that such consent shall not be required if an Event of Default or an Unmatured Event of Default has occurred and is continuing);
2.each such assignment shall be of a constant, and not a varying, percentage of all rights and obligations under this Agreement;
3.the amount being assigned pursuant to each such assignment (determined as of the date of the Assignment and Acceptance Agreement with respect to such assignment) shall in no event be less than the lesser of (x) five million dollars ($5,000,000) and (y) all of the assigning Committed Lender’s Commitment; and
4.the parties to each such assignment shall execute and deliver to the Administrative Agent, for its acceptance and recording in the Register, an Assignment and Acceptance Agreement.
Upon such execution, delivery, acceptance and recording from and after the effective date specified in such Assignment and Acceptance Agreement, (x) the assignee thereunder shall be a party to this Agreement, and to the extent that rights and obligations under this Agreement have been assigned to it pursuant to such Assignment and Acceptance Agreement, have the rights and obligations of a Committed Lender hereunder and (y) the assigning Committed Lender shall, to the extent that rights and obligations have been assigned by it pursuant to such Assignment and Acceptance Agreement, relinquish such rights and be released from such obligations under this Agreement (and, in the case of an Assignment and Acceptance Agreement covering all or the remaining portion of an assigning Committed Lender’s rights and obligations under this Agreement, such Committed Lender shall cease to be a party hereto).
96
Error! Unknown document property name.



iii.Register. The Administrative Agent shall, acting solely for this purpose as an agent of the Borrower, maintain at its address referred to on Schedule III of this Agreement (or such other address of the Administrative Agent notified by the Administrative Agent to the other parties hereto) a copy of each Assignment and Acceptance Agreement delivered to and accepted by it and a register for the recordation of the names and addresses of the Committed Lenders and the Conduit Lenders, the Commitment of each Committed Lender and the aggregate outstanding Capital (and stated interest) of the Loans of each Conduit Lender and Committed Lender from time to time (the “Register”). The entries in the Register shall be conclusive and binding for all purposes, absent manifest error, and the Borrower, the Servicer, the Administrative Agent, the Group Agents, and the other Credit Parties may treat each Person whose name is recorded in the Register as a Committed Lender or Conduit Lender, as the case may be, under this Agreement for all purposes of this Agreement. The Register shall be available for inspection by the Borrower, the Servicer, any Group Agent, any Conduit Lender or any Committed Lender at any reasonable time and from time to time upon reasonable prior notice.
iv.Procedure. Upon its receipt of an Assignment and Acceptance Agreement executed and delivered by an assigning Committed Lender and an Eligible Assignee or assignee Committed Lender, the Administrative Agent shall, if such Assignment and Acceptance Agreement has been duly completed, (i) accept such Assignment and Acceptance Agreement, (ii) record the information contained therein in the Register and (iii) give prompt notice thereof to the Borrower and the Servicer.
v.Participations. Each Committed Lender may sell participations to one or more Eligible Assignees (each, a “Participant”) in or to all or a portion of its rights and/or obligations under this Agreement (including, without limitation, all or a portion of its Commitment and the interests in the Loans owned by it); provided, however, that
1.such Committed Lender’s obligations under this Agreement (including, without limitation, its Commitment to the Borrower hereunder) shall remain unchanged, and
2.such Committed Lender shall remain solely responsible to the other parties to this Agreement for the performance of such obligations.
The Administrative Agent, the Group Agents, the Conduit Lenders, the other Committed Lenders, the Borrower and the Servicer shall have the right to continue to deal solely and directly with such Committed Lender in connection with such Committed Lender’s rights and obligations under this Agreement.
vi.Participant Register. Each Committed Lender that sells a participation shall, acting solely for this purpose as an agent of the Borrower, maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant’s interest in the Loans or other obligations under this Agreement (the “Participant Register”); provided that no Committed Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant’s interest in any Commitments, Loans or its other obligations under any this Agreement) to any Person except to the extent that such disclosure is necessary to establish that such Commitment, Loan or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations. The entries in the Participant Register shall be conclusive absent manifest error, and such Committed Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary. For the avoidance of doubt, the Administrative Agent (in its capacity as Administrative Agent) shall have no responsibility for maintaining a Participant Register.
97
Error! Unknown document property name.



vii.Assignments by Agents. This Agreement and the rights and obligations of the Administrative Agent and each Group Agent herein shall be assignable by the Administrative Agent or such Group Agent, as the case may be, and its successors and assigns; provided that in the case of an assignment to a Person that is not an Affiliate of the Administrative Agent or such Group Agent, so long as no Event of Default or Unmatured Event of Default has occurred and is continuing, such assignment shall require the Borrower’s consent (not to be unreasonably withheld, conditioned or delayed).
viii.Assignments by the Borrower or the Servicer. Neither the Borrower nor, except as provided in Section 8.01, the Servicer may assign any of its respective rights or obligations hereunder or any interest herein without the prior written consent of the Administrative Agent and each Group Agent (such consent to be provided or withheld in the sole discretion of such Person).
ix.Addition of Lenders or Groups. The Borrower may, with written consent of the Administrative Agent and the Majority Group Agents, add additional Persons as Lenders (by creating a new Group) or cause an existing Lender to increase its Commitment; provided, however, that the Commitment of any existing Lender may only be increased with the prior written consent of such Lender. Each new Lender (or Group) shall become a party hereto, by executing and delivering to the Administrative Agent and the Borrower, an assumption agreement (each, an “Assumption Agreement”) in the form of Exhibit D hereto (which Assumption Agreement shall, in the case of any new Lender, be executed by each Person in such new Lender’s Group).
x.Removal of Lenders. If (i) any Lender requests compensation under Section 4.01, or if the Borrower is required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 4.03, (iv) any Lender is a Defaulting Lender, or (v) any other circumstance exists hereunder that gives the Borrower the right to replace a Lender as a party hereto, then the Borrower may, at its sole expense and effort, upon notice to such Lender and the Administrative Agent, require such Lender to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in, and consents required by, this Section 13.03), all of its interests, rights (other than its existing rights to payments pursuant to Sections 4.01 and 4.03) and obligations under this Agreement and the related Transaction Documents to an assignee that shall assume such obligations (which assignee may be another Lender, if a Lender accepts such assignment), provided that:
1.such Lender shall have received payment of an amount equal to 100% of the outstanding Capital, accrued interest thereon, accrued fees and all other amounts payable to it hereunder and under the other Transaction Documents from the assignee (to the extent of such outstanding Capital and accrued interest and fees);
2.in the case of any such assignment resulting from a claim for compensation under Section 4.01 or payments required to be made pursuant to Section 4.03, such assignment will result in a reduction in such compensation or payments thereafter; and
3.such assignment does not conflict with Applicable Law.
A Lender shall not be required to make any such assignment or delegation if, prior thereto, as a result of a waiver by such Lender or otherwise, the circumstances entitling the Borrower to require such assignment and delegation cease to apply.
xi.Pledge to a Federal Reserve Bank. Notwithstanding anything to the contrary set forth herein, (i) any Lender, Program Support Provider or any of their respective Affiliates may
98
Error! Unknown document property name.



at any time pledge or grant a security interest in all or any portion of its interest in, to and under this Agreement (including, without limitation, rights to payment of Capital and Interest) and any other Transaction Document to secure its obligations to a Federal Reserve Bank, without notice to or the consent of the Borrower, the Servicer, any Affiliate thereof or any Credit Party; provided, however, that that no such pledge shall relieve such assignor of its obligations under this Agreement.
xii.Pledge to a Security Trustee. Notwithstanding anything to the contrary set forth herein, (i) any Lender, Program Support Provider or any of their respective Affiliates may at any time pledge or grant a security interest in all or any portion of its interest in, to and under this Agreement (including, without limitation, rights to payment of Capital and Interest) and any other Transaction Document to a security trustee in connection with the funding by such Person of Loans, without notice to or the consent of the Borrower, the Servicer, any Affiliate thereof or any Credit Party; provided, however, that that no such pledge shall relieve such assignor of its obligations under this Agreement.
SECTION 1.0d.Costs and Expenses. In addition to the rights of indemnification granted under Section 12.01 hereof, the Borrower agrees to pay on demand all reasonable and documented out-of-pocket costs and expenses in connection with the preparation, negotiation, execution, delivery and administration of this Agreement, any Program Support Agreement (or any supplement or amendment thereof) related to this Agreement and the other Transaction Documents (together with all amendments, restatements, supplements, consents and waivers, if any, from time to time hereto and thereto), including, without limitation, (i) the reasonable Attorney Costs for the Administrative Agent, the Structuring Agent and the other Credit Parties and any of their respective Affiliates with respect thereto and with respect to advising the Administrative Agent, the Structuring Agent and the other Credit Parties and their respective Affiliates as to their rights and remedies under this Agreement and the other Transaction Documents and (ii) reasonable accountants’, auditors’ and consultants’ fees and expenses for the Administrative Agent, the Structuring Agent and the other Credit Parties and any of their respective Affiliates and the fees and charges of any nationally recognized statistical rating agency incurred in connection with the administration and maintenance of this Agreement or advising the Administrative Agent or any other Credit Party as to their rights and remedies under this Agreement or as to any actual or reasonably claimed breach of this Agreement or any other Transaction Document. In addition, the Borrower agrees to pay on demand all reasonable out-of-pocket costs and expenses (including reasonable Attorney Costs), of the Administrative Agent, the Structuring Agent and the other Credit Parties and their respective Affiliates, incurred in connection with the enforcement of any of their respective rights or remedies under the provisions of this Agreement and the other Transaction Documents.
SECTION 1.0e.No Proceedings; Limitation on Payments.
i.Each of the Borrower, the Administrative Agent, the Servicer, each Group Agent, each Lender and each assignee of a Loan or any interest agrees that it will not institute against, or join any other Person in instituting against, any Conduit Lender any Insolvency Proceeding so long as any Notes or other senior indebtedness issued by such Conduit Lender shall be outstanding or there shall not have elapsed one year plus one day since the last day on which any such Notes or other senior indebtedness shall have been outstanding.
ii.Each of the Servicer, each Group Agent, each Lender and each assignee of a Loan or any interest therein, hereby covenants and agrees that it will not institute against, or join any other Person in instituting against, the Borrower any Insolvency Proceeding until one year and one day after the Final Payout Date; provided, that the Administrative Agent may take any such action in its sole discretion following the occurrence of an Event of Default.
99
Error! Unknown document property name.



iii.Notwithstanding any provisions contained in this Agreement to the contrary, a Conduit Lender shall not, and shall be under no obligation to, pay any amount, if any, payable by it pursuant to this Agreement or any other Transaction Document unless (i) such Conduit Lender has received funds which may be used to make such payment and which funds are not required to repay such Conduit Lender’s Notes when due and (ii) after giving effect to such payment, either (x) such Conduit Lender could issue Notes to refinance all of its outstanding Notes (assuming such outstanding Notes matured at such time) in accordance with the program documents governing such Conduit Lender’s securitization program or (y) all of such Conduit Lender’s Notes are paid in full. Any amount which any Conduit Lender does not pay pursuant to the operation of the preceding sentence shall not constitute a claim (as defined in Section 101 of the Bankruptcy Code) against or company obligation of such Conduit Lender for any such insufficiency unless and until such Conduit Lender satisfies the provisions of clauses (i) and (ii) above. The provisions of this Section 13.05 shall survive any termination of this Agreement.
SECTION 1.0f.Confidentiality.
i.Each of the Borrower and the Servicer covenants and agrees to hold in confidence, and not disclose to any Person, the terms of this Agreement or any Fee Letter (including any fees payable in connection with this Agreement, such Fee Letter or any other Transaction Document or the identity of the Administrative Agent or any other Credit Party), except as the Administrative Agent and each Group Agent may have consented to in writing prior to any proposed disclosure; provided, however, that it may disclose such information (i) to its Advisors and Representatives, (ii) to the extent such information has become available to the public other than as a result of a disclosure by or through the Borrower, the Servicer or their Advisors and Representatives or (iii) to the extent it should be (A) required by Applicable Law, or in connection with any legal or regulatory proceeding or (B) requested by any Governmental Authority to disclose such information; provided, that, in the case of clause (iii) above, the Borrower and the Servicer will use reasonable efforts to maintain confidentiality and will (unless otherwise prohibited by Applicable Law) notify the Administrative Agent and the affected Credit Party of its intention to make any such disclosure prior to making such disclosure. Each of the Borrower and the Servicer agrees to be responsible for any breach of this Section 13.06 by its Representatives and Advisors and agrees that its Representatives and Advisors will be advised by it of the confidential nature of such information and shall agree to comply with this Section. Notwithstanding the foregoing, it is expressly agreed that each of the Borrower, the Servicer and their respective Affiliates may publish a press release or otherwise publicly announce the existence and principal amount of the Commitments under this Agreement and the transactions contemplated hereby; provided that the Administrative Agent shall be provided a reasonable opportunity to review such press release or other public announcement prior to its release and provide comment thereon; and provided, further, that no such press release shall name or otherwise identify the Administrative Agent, any other Credit Party or any of their respective Affiliates without such Person’s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed). Notwithstanding the foregoing, the Borrower consents to the publication by the Administrative Agent or any other Credit Party of a tombstone or similar advertising material relating to the financing transactions contemplated by this Agreement.
ii.Each of the Administrative Agent and each other Credit Party, severally and with respect to itself only, agrees to hold in confidence, and not disclose to any Person, any confidential and proprietary information concerning the Borrower, the Servicer and their respective Affiliates and their businesses or the terms of this Agreement (including any fees payable in connection with this Agreement or the other Transaction Documents), except as the Borrower or the Servicer may have consented to in writing prior to any proposed disclosure; provided, however, that it may disclose such information (i) to its Advisors and Representatives and to any related Program Support Provider, (ii) to its assignees and Participants and potential assignees and Participants and their respective counsel if they agree in writing to hold it
100
Error! Unknown document property name.



confidential, (iii) to the extent such information has become available to the public other than as a result of a disclosure by or through it or its Representatives or Advisors or any related Program Support Provider, (iv) to any nationally recognized statistical rating organization in connection with obtaining or maintaining the rating of any Conduit Lender’s Notes or as contemplated by 17 CFR 240.17g-5(a)(3), (v) at the request of a bank examiner or other regulatory authority or in connection with an examination of any of the Administrative Agent, any Group Agent or any Lender or their respective Affiliates or Program Support Providers or (vi) to the extent it should be (A) required by Applicable Law, or in connection with any legal or regulatory proceeding or (B) requested by any Governmental Authority to disclose such information; provided, that, in the case of clause (vi) above, the Administrative Agent, each Group Agent and each Lender will use reasonable efforts to maintain confidentiality and will (unless otherwise prohibited by Applicable Law) notify the Borrower and the Servicer of its making any such disclosure as promptly as reasonably practicable thereafter. Each of the Administrative Agent, each Group Agent and each Lender, severally and with respect to itself only, agrees to be responsible for any breach of this Section 13.06 by its Representatives, Advisors and Program Support Providers and agrees that its Representatives, Advisors and Program Support Providers will be advised by it of the confidential nature of such information and shall agree to comply with this Section.
iii.As used in this Section, (i) “Advisors” means, with respect to any Person, such Person’s accountants, attorneys and other confidential advisors and (ii) “Representatives” means, with respect to any Person, such Person’s Affiliates, and its and their Subsidiaries, directors, managers, officers, employees, members, investors, financing sources, insurers, professional advisors, representatives and agents; provided that such Persons shall not be deemed to Representatives of a Person unless (and solely to the extent that) confidential information is furnished to such Person.
iv.Notwithstanding the foregoing, to the extent not inconsistent with applicable securities laws, each party hereto (and each of its employees, representatives or other agents) may disclose to any and all persons, without limitation of any kind, the tax treatment and tax structure (as defined in Section 1.6011-4 of the Treasury Regulations) of the transactions contemplated by the Transaction Documents and all materials of any kind (including opinions or other tax analyses) that are provided to such Person relating to such tax treatment and tax structure.
SECTION 1.0g.GOVERNING LAW. THIS AGREEMENT, INCLUDING THE RIGHTS AND DUTIES OF THE PARTIES HERETO, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (INCLUDING SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK, BUT WITHOUT REGARD TO ANY OTHER CONFLICTS OF LAW PROVISIONS THEREOF, EXCEPT TO THE EXTENT THAT THE PERFECTION, THE EFFECT OF PERFECTION OR PRIORITY OF THE INTERESTS OF ADMINISTRATIVE AGENT OR ANY LENDER IN THE COLLATERAL IS GOVERNED BY THE LAWS OF A JURISDICTION OTHER THAN THE STATE OF NEW YORK).
SECTION 1.0h.Execution in Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement. Delivery of an executed counterpart hereof by facsimile or other electronic means shall be equally effective as delivery of an originally executed counterpart.
SECTION 1.0i.Integration; Binding Effect; Survival of Termination. This Agreement and the other Transaction Documents contain the final and complete integration of all prior expressions by the parties hereto with respect to the subject matter hereof and shall constitute the entire agreement among the parties hereto with respect to the subject matter hereof
101
Error! Unknown document property name.



superseding all prior oral or written understandings. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Agreement shall create and constitute the continuing obligations of the parties hereto in accordance with its terms and shall remain in full force and effect until the Final Payout Date; provided, however, that the provisions of Sections 4.01, 4.02, 4.03, 10.04, 10.06, 11.04, 12.01, 12.02, 13.04, 13.05, 13.06, 13.09, 13.11 and 13.13 shall survive any termination of this Agreement.
SECTION 1.j.CONSENT TO JURISDICTION.
i.EACH PARTY HERETO HEREBY IRREVOCABLY SUBMITS TO (I) WITH RESPECT TO THE BORROWER AND THE SERVICER, THE EXCLUSIVE JURISDICTION, AND (II) WITH RESPECT TO EACH OF THE OTHER PARTIES HERETO, THE NON-EXCLUSIVE JURISDICTION, IN EACH CASE, OF ANY NEW YORK STATE OR FEDERAL COURT SITTING IN NEW YORK CITY, NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER TRANSACTION DOCUMENT, AND EACH PARTY HERETO HEREBY IRREVOCABLY AGREES THAT ALL CLAIMS IN RESPECT OF SUCH ACTION OR PROCEEDING (I) IF BROUGHT BY THE BORROWER, THE SERVICER OR ANY AFFILIATE THEREOF, SHALL BE HEARD AND DETERMINED, AND (II) IF BROUGHT BY ANY OTHER PARTY TO THIS AGREEMENT OR ANY OTHER TRANSACTION DOCUMENT, MAY BE HEARD AND DETERMINED, IN EACH CASE, IN SUCH NEW YORK STATE COURT OR, TO THE EXTENT PERMITTED BY LAW, IN SUCH FEDERAL COURT. NOTHING IN THIS SECTION 13.10 SHALL AFFECT THE RIGHT OF THE ADMINISTRATIVE AGENT OR ANY OTHER CREDIT PARTY TO BRING ANY ACTION OR PROCEEDING AGAINST THE BORROWER OR THE SERVICER OR ANY OF THEIR RESPECTIVE PROPERTY IN THE COURTS OF OTHER JURISDICTIONS. EACH OF THE BORROWER AND THE SERVICER HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT IT MAY EFFECTIVELY DO SO, THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH ACTION OR PROCEEDING. THE PARTIES HERETO AGREE THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW.
ii.EACH OF THE BORROWER AND THE SERVICER CONSENTS TO THE SERVICE OF ANY AND ALL PROCESS IN ANY SUCH ACTION OR PROCEEDING BY THE MAILING OF COPIES OF SUCH PROCESS TO IT AT ITS ADDRESS SPECIFIED IN SECTION 13.02. NOTHING IN THIS SECTION 13.10 SHALL AFFECT THE RIGHT OF THE ADMINISTRATIVE AGENT OR ANY OTHER CREDIT PARTY TO SERVE LEGAL PROCESS IN ANY OTHER MANNER PERMITTED BY LAW.
SECTION 1.k.WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING, DIRECTLY OR INDIRECTLY, ANY MATTER (WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE) IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS AGREEMENT OR ANY OTHER TRANSACTION DOCUMENT.
SECTION 1.l.Ratable Payments. If any Credit Party, whether by setoff or otherwise, has payment made to it with respect to any Borrower Obligations in a greater proportion than that received by any other Credit Party entitled to receive a ratable share of such Borrower Obligations, such Credit Party agrees, promptly upon demand, to purchase for cash without
102
Error! Unknown document property name.



recourse or warranty a portion of such Borrower Obligations held by the other Credit Parties so that after such purchase each Credit Party will hold its ratable proportion of such Borrower Obligations; provided that if all or any portion of such excess amount is thereafter recovered from such Credit Party, such purchase shall be rescinded and the purchase price restored to the extent of such recovery, but without interest.
SECTION 1.m.Limitation of Liability.
i.No claim may be made by the Borrower or any Affiliate thereof or any other Person against any Credit Party or their respective Affiliates, members, directors, officers, employees, incorporators, attorneys or agents for any special, indirect, consequential or punitive damages in respect of any claim for breach of contract or any other theory of liability arising out of or related to the transactions contemplated by this Agreement or any other Transaction Document, or any act, omission or event occurring in connection herewith or therewith; and each of the Borrower and the Servicer hereby waives, releases, and agrees not to sue upon any claim for any such damages, whether or not accrued and whether or not known or suspected to exist in its favor. None of the Credit Parties and their respective Affiliates shall have any liability to the Borrower or any Affiliate thereof or any other Person asserting claims on behalf of or in right of the Borrower or any Affiliate thereof in connection with or as a result of this Agreement or any other Transaction Document or the transactions contemplated hereby or thereby, except to the extent that any losses, claims, damages, liabilities or expenses incurred by the Borrower or any Affiliate thereof result from the breach of contract, gross negligence or willful misconduct of such Credit Party in performing its duties and obligations hereunder and under the other Transaction Documents to which it is a party.
ii.The obligations of the Administrative Agent and each of the other Credit Parties under this Agreement and each of the Transaction Documents are solely the corporate obligations of such Person. No recourse shall be had for any obligation or claim arising out of or based upon this Agreement or any other Transaction Document against any member, director, officer, employee or incorporator of any such Person.
SECTION 1.n.Intent of the Parties. The Borrower has structured this Agreement with the intention that the Loans and the obligations of the Borrower hereunder will be treated under United States federal, and applicable state, local and foreign tax law as debt (the “Intended Tax Treatment”). The Borrower, the Servicer, the Administrative Agent and the other Credit Parties agree to file no tax return, or take any action, inconsistent with the Intended Tax Treatment unless required by law. Each assignee and each Participant acquiring an interest in a Credit Extension, by its acceptance of such assignment or participation, agrees to comply with the immediately preceding sentence.
SECTION 1.o.USA Patriot Act. Each of the Administrative Agent and each of the other Credit Parties hereby notifies the Borrower and the Servicer that pursuant to the requirements of the USA PATRIOT Act, Title III of Pub. L. 107-56 (signed into law October 26, 2001) (the “PATRIOT Act”), the Administrative Agent and the other Credit Parties may be required to obtain, verify and record information that identifies any Integra Party, which information includes the name, address, tax identification number and other information regarding any Integra Party that will allow the Administrative Agent and the other Credit Parties to identify such Integra Party in accordance with the PATRIOT Act. This notice is given in accordance with the requirements of the PATRIOT Act. Each of the Borrower and the Servicer agrees to provide the Administrative Agent and each other Credit Parties such information and documentation as may reasonably be requested by the Administrative Agent or any Credit Party, from time to time, for purposes of compliance by the Administrative Agent or such Credit Party with Applicable Laws (including without limitation the PATRIOT Act and other “know your
103
Error! Unknown document property name.



customer” and anti-money laundering rules and regulations) and any policy or procedure implemented by the Administrative Agent or such Credit Party to comply therewith.
SECTION 1.p.Right of Setoff. Each Credit Party is hereby authorized (in addition to any other rights it may have), at any time during the continuance of an Event of Default, to setoff, appropriate and apply (without presentment, demand, protest or other notice which are hereby expressly waived) any deposits and any other indebtedness held or owing by such Credit Party (including by any branches or agencies of such Credit Party) to, or for the account of, the Borrower or the Servicer against amounts owing by the Borrower or the Servicer hereunder (even if contingent or unmatured); provided that such Credit Party shall notify the Borrower or the Servicer, as applicable, promptly following such setoff.
SECTION 1.q.Severability. Any provisions of this Agreement which are prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.
SECTION 1.r.Mutual Negotiations. This Agreement and the other Transaction Documents are the product of mutual negotiations by the parties thereto and their counsel, and no party shall be deemed the draftsperson of this Agreement or any other Transaction Document or any provision hereof or thereof or to have provided the same. Accordingly, in the event of any inconsistency or ambiguity of any provision of this Agreement or any other Transaction Document, such inconsistency or ambiguity shall not be interpreted against any party because of such party’s involvement in the drafting thereof.
SECTION 1.s.Captions and Cross References. The various captions (including the table of contents) in this Agreement are provided solely for convenience of reference and shall not affect the meaning or interpretation of any provision of this Agreement. Unless otherwise indicated, references in this Agreement to any Section, Schedule or Exhibit are to such Section Schedule or Exhibit to this Agreement, as the case may be, and references in any Section, subsection, or clause to any subsection, clause or subclause are to such subsection, clause or subclause of such Section, subsection or clause.
[Signature Pages Follow]

104
Error! Unknown document property name.



IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their respective officers thereunto duly authorized, as of the date first above written.
INTEGRA RECEIVABLES LLC,
as the Borrower
By:                         
Name:                     
Title:                         
INTEGRA LIFESCIENCES SALES LLC,
as the Servicer
By:                         
Name:                     
Title:                         



S-1
Receivables Financing Agreement (Integra)
Error! Unknown document property name.



PNC BANK, NATIONAL ASSOCIATION,
as the Administrative Agent
By:                         
Name:                     
Title:                         
PNC BANK, NATIONAL ASSOCIATION,
as the Group Agent for the PNC Group
By:                         
Name:                     
Title:                         
PNC BANK, NATIONAL ASSOCIATION,
as a Committed Lender
By:                         
Name:                     
Title:                         


S-2
Receivables Financing Agreement (Integra)
Error! Unknown document property name.



ACCEPTED AND ACKNOWLEDGED SOLELY WITH RESPECT TO SECTION 10.10 HEREOF:
PNC CAPITAL MARKETS LLC,
as the Structuring Agent
By:                         
Name:
                    
Title:
                        


S-3
Receivables Financing Agreement (Integra)
Error! Unknown document property name.




S-4
Receivables Financing Agreement (Integra)
Error! Unknown document property name.



EXHIBIT A
Form of Loan Request
[Letterhead of Borrower]
[Date]

[Administrative Agent]
[Group Agents]
Re:    Loan Request
Ladies and Gentlemen:
Reference is hereby made to that certain Receivables Financing Agreement, dated as of December 21, 2018, by and among Integra Receivables LLC (the “Borrower”), Integra LifeSciences Sales LLC, as Servicer (the “Servicer”), the Lenders party thereto, the Group Agents party thereto, PNC Bank, National Association, as Administrative Agent (in such capacity, the “Administrative Agent”) and PNC Capital Markets LLC, as Structuring Agent (the “Structuring Agent”) (as amended, supplemented or otherwise modified from time to time, the “Agreement”). Capitalized terms used in this Loan Request and not otherwise defined herein shall have the meanings assigned thereto in the Agreement.
This letter constitutes a Loan Request pursuant to Section 2.02(a) of the Agreement. The Borrower hereby request a Loan in the amount of [$_______] to be made on [_____, 20__] (of which $[___] will be funded by the PNC Group [and $[___] will be funded by the [___] Group]. The proceeds of such Loan should be deposited to [Account number], at [Name, Address and ABA Number of Bank]. After giving effect to such Loan, the Aggregate Capital will be [$_______].
The Borrower hereby represents and warrants as of the date hereof, and after giving effect to such Credit Extension, as follows:
(1)the representations and warranties of the Borrower and the Servicer contained in Sections 6.01 and 6.02 of the Agreement are true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of the date of such Credit Extension as though made on and as of such date unless such representations and warranties by their terms refer to an earlier date, in which case they shall be true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of such earlier date;
(2)no Event of Default or Unmatured Event of Default has occurred and is continuing, and no Event of Default or Unmatured Event of Default would result from such Credit Extension;
(3)no Borrowing Base Deficit exists or would exist after giving effect to such Credit Extension;
(4)the Aggregate Capital will not exceed the Facility Limit;
Exhibit A-1
Error! Unknown document property name.



(5)the sum of (A) the Capital of the applicable Lender, plus (B) the aggregate outstanding Capital of each other Lender in its Group, would not exceed the Group Commitment of such Lender’s Group;
(6)if the applicable Lender is a Committed Lender, the aggregate outstanding Capital of such Committed Lender would not exceed its Commitment;
(7)the Aggregate Capital would not exceed the Borrowing Base at such time; and
(8)the Termination Date has not occurred.

Exhibit A-2
Error! Unknown document property name.



IN WITNESS WHEREOF, the undersigned has executed this letter by its duly authorized officer as of the date first above written.
Very truly yours,
INTEGRA RECEIVABLES LLC
By:     
Name:     
Title:     
Exhibit A-3
Error! Unknown document property name.



EXHIBIT B
Form of Reduction Notice
[Letterhead of Borrower]
[Date]
[Administrative Agent]
[Group Agents]
Re:    Reduction Notice
Ladies and Gentlemen:
Reference is hereby made to that certain Receivables Financing Agreement, dated as of December 21, 2018, by and among Integra Receivables LLC (the “Borrower”), Integra LifeSciences Sales LLC, as Servicer (the “Servicer”), the Lenders party thereto, the Group Agents party thereto, PNC Bank, National Association, as Administrative Agent (in such capacity, the “Administrative Agent”) and PNC Capital Markets LLC, as Structuring Agent (the “Structuring Agent”) (as amended, supplemented or otherwise modified from time to time, the “Agreement”). Capitalized terms used in this Reduction Notice and not otherwise defined herein shall have the meanings assigned thereto in the Agreement.
This letter constitutes a Reduction Notice pursuant to Section 2.02(d) of the Agreement. The Borrower hereby notifies the Administrative Agent and the Lenders that it shall prepay the outstanding Capital of the Lenders in the amount of [$_______] to be made on [_____, 201_]. After giving effect to such prepayment, the Aggregate Capital will be [$_______].
The Borrower hereby represents and warrants as of the date hereof, and after giving effect to such reduction, as follows:
(1)the representations and warranties of the Borrower and the Servicer contained in Sections 6.01 and 6.02 of the Agreement are true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of the date of such prepayment as though made on and as of such date unless such representations and warranties by their terms refer to an earlier date, in which case they shall be true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of such earlier date;
(2)no Event of Default or Unmatured Event of Default has occurred and is continuing, and no Event of Default or Unmatured Event of Default would result from such prepayment;
(3)no Borrowing Base Deficit exists or would exist after giving effect to such prepayment;
    Exhibit B-1
Error! Unknown document property name.



(4)the Aggregate Capital would not equal an amount less than the Minimum Funding Threshold; and
(5)the Termination Date has not occurred.

    Exhibit B-2
Error! Unknown document property name.



In Witness Whereof, the undersigned has executed this letter by its duly authorized officer as of the date first above written.
Very truly yours,
INTEGRA RECEIVABLES LLC
By:     
Name:     
Title:     


    Exhibit B-3
Error! Unknown document property name.



EXHIBIT C
Form of Assignment and Acceptance Agreement
Dated as of ___________, 20__
Section 1.
Commitment assigned:$[_____]
Assignor’s remaining Commitment:$[_____]
Capital allocable to Commitment assigned:$[_____]
Assignor’s remaining Capital:$[_____]
Interest (if any) allocable to Capital assigned:$[_____]
Interest (if any) allocable to Assignor’s remaining Capital:$[_____]

Section 2.
Effective Date of this Assignment and Acceptance Agreement: [__________]
Upon execution and delivery of this Assignment and Acceptance Agreement by the assignee and the assignor and the satisfaction of the other conditions to assignment specified in Section 13.03(b) of the Agreement (as defined below), from and after the effective date specified above, the assignee shall become a party to, and, to the extent of the rights and obligations thereunder being assigned to it pursuant to this Assignment and Acceptance Agreement, shall have the rights and obligations of a Committed Lender under that certain Receivables Financing Agreement, dated as of December 21, 2018, by and among Integra Receivables LLC (the “Borrower”), Integra LifeSciences Sales LLC, as Servicer (the “Servicer”), the Lenders party thereto, the Group Agents party thereto, PNC Bank, National Association, as Administrative Agent (in such capacity, the “Administrative Agent”) and PNC Capital Markets LLC, as Structuring Agent (the “Structuring Agent”) (as amended, supplemented or otherwise modified from time to time, the “Agreement”).
(Signature Pages Follow)

    Exhibit C-1
Error! Unknown document property name.



ASSIGNOR:     [_________]
By:                    
Name:
Title
ASSIGNEE:                         [_________]
By:                    
Name:
Title:
[Address]
Accepted as of date first above
written:
PNC BANK, NATIONAL ASSOCIATION,
as Administrative Agent
By:    
Name:
Title:
INTEGRA RECEIVABLES LLC,
as Borrower
By:    
Name:
Title:


EXHIBIT D
Form of Assumption Agreement
    Exhibit C-2
Error! Unknown document property name.



THIS ASSUMPTION AGREEMENT (this “Agreement”), dated as of [______ __, ____], is among ____________________ (the “Borrower”), [________], as conduit lender (the “[_____] Conduit Lender”), [________], as the Related Committed Lender (the “[______] Committed Lender” and together with the Conduit Lender, the “[_____] Lenders”), and [________], as group agent for the [_____] Lenders (the “[______] Group Agent” and together with the [_____] Lenders, the “[_______] Group”).
BACKGROUND
The Borrower and various others are parties to a certain Receivables Financing Agreement, dated as of December 21, 2018 (as amended through the date hereof and as the same may be amended, amended and restated, supplemented or otherwise modified from time to time, the “Receivables Financing Agreement”). Capitalized terms used and not otherwise defined herein have the respective meaning assigned to such terms in the Receivables Financing Agreement.
NOW, THEREFORE, the parties hereto hereby agree as follows:
SECTION 1.    This letter constitutes an Assumption Agreement pursuant to Section 13.03(i) of the Receivables Financing Agreement. The Borrower desires [the [_____] Lenders] [the [______] Committed Lender] to [become a Group] [increase its existing Commitment] under the Receivables Financing Agreement, and upon the terms and subject to the conditions set forth in the Receivables Financing Agreement, the [the [_____] Lenders] [the [______] Committed Lender] agree[s] to [become Lenders within a Group thereunder] [increase its Commitment to the amount set forth as its “Commitment” under the signature of such [______] Committed Lender hereto].
The Borrower hereby represents and warrants to the [the [_____] Lenders] [the [______] Committed Lender] [and the [_________] Group Agent] as of the date hereof, as follows:
(1)the representations and warranties of the Borrower contained in Section 6.01 of the Receivables Financing Agreement are true and correct on and as of such date as though made on and as of such date;
(2)no Event of Default or Unmatured Event of Default has occurred and is continuing, or would result from the assumption contemplated hereby; and
(3)the Termination Date shall not have occurred.
SECTION 2.    Upon execution and delivery of this Agreement by the Borrower and [each member of the [______] Group] [the [_____] Lenders] [the [______] Committed Lender], satisfaction of the other conditions with respect to the addition of a Group specified in Section 13.03(i) of the Receivables Financing Agreement (including the written consent of the Administrative Agent and the Majority Group Agents) and receipt by the Administrative Agent of counterparts of this Agreement (whether by facsimile or otherwise) executed by each of the parties hereto, [the [_____] Lenders shall become a party to, and have the rights and obligations of Lenders under, the Receivables Financing Agreement and the “Commitment” with respect to the Committed Lenders in such Group as shall be as set forth under the signature of each such Committed Lender hereto] [the [______] Committed Lender shall increase its Commitment to the amount set forth as the “Commitment” under the signature of the [______] Committed Lender hereto].
SECTION 3.    Each party hereto hereby covenants and agrees that it will not institute against, or join any other Person in instituting against, any Conduit Lender, any bankruptcy,
Exhibit D-1
Error! Unknown document property name.



reorganization, arrangement, insolvency or liquidation proceeding, or other proceeding under any federal or state bankruptcy or similar law, for one year and one day after the latest maturing commercial paper notes or other senior indebtedness issued by such Conduit Lender is paid in full. The covenant contained in this paragraph shall survive any termination of the Receivables Financing Agreement.
SECTION 4.    THIS AGREEMENT, INCLUDING THE RIGHTS AND DUTIES OF THE PARTIES HERETO, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (INCLUDING SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK, BUT WITHOUT REGARD TO ANY OTHER CONFLICTS OF LAW PROVISIONS THEREOF). This Agreement may not be amended or supplemented except pursuant to a writing signed be each of the parties hereto and may not be waived except pursuant to a writing signed by the party to be charged. This Agreement may be executed in counterparts, and by the different parties on different counterparts, each of which shall constitute an original, but all together shall constitute one and the same agreement.
(Signature Pages Follow)

Exhibit D-2
Error! Unknown document property name.



IN WITNESS WHEREOF, the parties hereto have executed this Agreement by their duly authorized officers as of the date first above written.
[___________], as a Conduit Lender


By:    

Name Printed:    
Title:
[Address]
[___________], as a Committed Lender

By:    

Name Printed:    
Title:
[Address]
[Commitment]
[_____________], as Group Agent for [_________]

By:    

Name Printed:    
Title:
[Address]

Exhibit D-3
Error! Unknown document property name.



INTEGRA RECEIVABLES LLC,
as Borrower
By:    
Name Printed:    
Title:    
Exhibit D-4
Error! Unknown document property name.



EXHIBIT E
Credit and Collection Procedures
(Attached)


Exhibit E-1
Error! Unknown document property name.



EXHIBIT F
Form of Information Package
(Attached)
    Exhibit F-1
Error! Unknown document property name.



EXHIBIT G
Form of Compliance Certificate
To: PNC Bank, National Association, as Administrative Agent
This Compliance Certificate is furnished pursuant to that certain Receivables Financing Agreement, dated as of December 21, 2018, by and among Integra Receivables LLC (the “Borrower”), Integra LifeSciences Sales LLC, as Servicer (the “Servicer”), the Lenders party thereto, the Group Agents party thereto, PNC Bank, National Association, as Administrative Agent (in such capacity, the “Administrative Agent”) and PNC Capital Markets LLC, as Structuring Agent (the “Structuring Agent”) (as amended, supplemented or otherwise modified from time to time, the “Agreement”). Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to them in the Agreement.
THE UNDERSIGNED HEREBY CERTIFIES THAT:
1.    I am the duly elected ________________of the Servicer.
2.    I have reviewed the terms of the Agreement and each of the other Transaction Documents and I have made, or have caused to be made under my supervision, a detailed review of the transactions and condition of the Borrower during the accounting period covered by the attached financial statements.
3.    The examinations described in paragraph 2 above did not disclose, and I have no knowledge of, the existence of any condition or event which constitutes an Event of Default or an Unmatured Event of Default, as each such term is defined under the Agreement, during or at the end of the accounting period covered by the attached financial statements or as of the date of this Certificate[, except as set forth in paragraph 5 below].
4.    Schedule I attached hereto sets forth financial statements of the Parent and its Subsidiaries for the period referenced on such Schedule I.
[5.    Described below are the exceptions, if any, to paragraph 3 above by listing, in detail, the nature of the condition or event, the period during which it has existed and the action which Borrower has taken, is taking, or proposes to take with respect to each such condition or event:]

    Exhibit G-1
Error! Unknown document property name.



The foregoing certifications are made and delivered this ______ day of ___________________, 20___.
[_________]
By:    
Name:    
Title:    
    Exhibit G-2
Error! Unknown document property name.



SCHEDULE I TO COMPLIANCE CERTIFICATE
1.Schedule of Compliance as of     ___________________, 20__ with Section 7.02(b)(i) of the Agreement. Unless otherwise defined herein, the terms used in this Compliance Certificate have the meanings ascribed thereto in the Agreement.
This schedule relates to the month ended: __________________.
2.The following financial statements of the Parent and its Subsidiaries for the period ending on ______________, 20__, are attached hereto:
3.Consolidated Total Leverage Ratio _____________ for the four consecutive fiscal quarter period ending: _________________.


    Exhibit G-3
Error! Unknown document property name.



EXHIBIT H
Closing Memorandum
(Attached)
    Exhibit H-1
Error! Unknown document property name.



EXHIBIT I
Form of Interim Report
(Attached)


    Exhibit I-1
Error! Unknown document property name.



SCHEDULE I
Commitments
PNC Group
PartyCapacityMaximum Commitment
PNCCommitted Lender$150,000,000
PNCGroup AgentN/A

Schedule I-1
Error! Unknown document property name.



SCHEDULE II
Lock-Boxes, Collection Accounts and Collection Account Banks
Collection Account BankLock-BoxCollection Account
Bank of America, N.A.37563272383756327238


Schedule II-1
Error! Unknown document property name.



SCHEDULE III
Notice Addresses
(A)    in the case of the Borrower, at the following address:
Integra Receivables LLC
1100 Campus Road
Princeton, New Jersey 08540
Attention: Timothy Swiss
Telephone: 609-936-6969
Email: timothy.swiss@integralife.com
(B)    in the case of the Servicer, at the following address:
Integra LifeSciences Sales LLC
1100 Campus Road
Princeton, New Jersey 08540
Attention: Timothy Swiss
Telephone: 609-936-6969
Email: timothy.swiss@integralife.com

(C)    in the case of PNC or the Administrative Agent, at the following address:
PNC Bank, National Association
300 Fifth Avenue
Pittsburgh, PA 15222
Attention: Brian Stanley
Telephone: (412) 768-2001
Facsimile: (412) 803-7142
Email: brian.stanley@pnc.com
(D)    in the case of any other Person, at the address for such Person specified in the other Transaction Documents; in each case, or at such other address as shall be designated by such Person in a written notice to the other parties to this Agreement.
    Schedule III-1
Error! Unknown document property name.



SCHEDULE IV
Excluded Obligors and Originators
Excluded Obligors:
1.None
Excluded Originators (or sub-division or business unit thereof):
1.Integra Pain Management, a business unit or division of Integra LifeSciences Corporation
Schedule IV-1
Error! Unknown document property name.
EX-31.1 3 iart-20230331xexx311.htm EX-31.1 Document

Exhibit 31.1
Certification of Principal Executive Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Jan De Witte, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Integra LifeSciences Holdings Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
Date:April 26, 2023/s/ Jan De Witte
Jan De Witte
President and Chief Executive Officer


EX-31.2 4 iart-20230331xexx312.htm EX-31.2 Document

Exhibit 31.2
Certification of Principal Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Jeffrey A. Mosebrook, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Integra LifeSciences Holdings Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:April 26, 2023/s/ Jeffrey A. Mosebrook
Jeffrey A. Mosebrook
Senior Vice President, Finance


EX-32.1 5 iart-20230331xexx321.htm EX-32.1 Document

Exhibit 32.1
Certification of Principal Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report of Integra LifeSciences Holdings Corporation (the “Company”) on Form 10-Q for the quarter ended March 31, 2023 as filed with the Securities Exchange Commission on the date hereof (the “Report”), I, Jan De Witte, President and Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
1.The Report fully complies with the requirement of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date:April 26, 2023/s/ Jan De Witte
Jan De Witte
President and Chief Executive Officer


EX-32.2 6 iart-20230331xexx322.htm EX-32.2 Document

Exhibit 32.2
Certification of Principal Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report of Integra LifeSciences Holdings Corporation (the “Company”) on Form 10-Q for the quarter ended March 31, 2023 as filed with the Securities Exchange Commission on the date hereof (the “Report”), I, Jeffrey A. Mosebrook, Senior Vice President, Finance of the Company, hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
1.The Report fully complies with the requirement of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date:April 26, 2023/s/ Jeffrey A. Mosebrook
Jeffrey A. Mosebrook
Senior Vice President, Finance


EX-101.SCH 7 iart-20230331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 0000007 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - ACQUISITIONS AND DIVESTITURES link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - DERIVATIVE INSTRUMENTS link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - RETIREMENT PLANS link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - LEASES AND RELATED PARTY LEASES link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - TREASURY STOCK link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - NET INCOME PER SHARE link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - BASIS OF PRESENTATION (Policies) link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - ACQUISITIONS AND DIVESTITURES (Tables) link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables) link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - DERIVATIVE INSTRUMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - NET INCOME PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables) link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - ACQUISITIONS AND DIVESTITURES- Business Combination, Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - INVENTORIES - Schedule of Net Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 0000045 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000047 - Disclosure - DEBT - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000048 - Disclosure - DEBT - Maximum Total Leverage Ratio Table (Details) link:presentationLink link:calculationLink link:definitionLink 0000049 - Disclosure - DEBT - Contractual Maturity Table (Details) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 0000051 - Disclosure - DERIVATIVE INSTRUMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000052 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 0000053 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 0000054 - Disclosure - DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details) link:presentationLink link:calculationLink link:definitionLink 0000055 - Disclosure - DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 0000056 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivatives Not Designated as Hedging Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 0000057 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000058 - Disclosure - RETIREMENT PLANS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000059 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000060 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000061 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000062 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 0000062 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 0000063 - Disclosure - TREASURY STOCK - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000064 - Disclosure - INCOME TAXES - Summary of Effective Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 0000065 - Disclosure - INCOME TAXES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000066 - Disclosure - NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 0000067 - Disclosure - NET INCOME PER SHARE - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000068 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 0000069 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details) link:presentationLink link:calculationLink link:definitionLink 0000070 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000071 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000072 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details) link:presentationLink link:calculationLink link:definitionLink 0000073 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details) link:presentationLink link:calculationLink link:definitionLink 0000074 - Disclosure - COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000075 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 iart-20230331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 iart-20230331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 iart-20230331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Business Acquisition [Axis] Business Acquisition [Axis] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Total minimum lease payments Lessee, Operating Lease, Liability, to be Paid Other non-current liabilities Increase (Decrease) in Other Noncurrent Liabilities Deferred tax assets, net Deferred Income Tax Assets, Net Entity Postal Zip Code Entity Address, Postal Zip Code Contract Liability Change In Contract With Customer, Liability [Roll Forward] Change In Contract With Customer, Liability [Roll Forward] Preferred stock, outstanding shares (in shares) Preferred Stock, Shares Outstanding 2025 Long-Term Debt, Maturity, Year Two Supplemental Balance Sheet Information Assets And Liabilities, Lessee [Table Text Block] Assets And Liabilities, Lessee [Table Text Block] Debt Covenant Period [Axis] Debt Covenant Period [Axis] Debt Covenant Period [Axis] Debt Instrument [Axis] Debt Instrument [Axis] Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Number of renewal options (or more) Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity FDA Approval Of Premarket Approval FDA Approval Of Premarket Approval [Member] FDA Approval Of Premarket Approval Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Fair value Debt Instrument, Fair Value Disclosure Prepaid expenses and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Deferred compensation plan, fair value of assets Deferred Compensation Plan Assets Acquired in-process research and development milestone Payments to Acquire in Process Research and Development Depreciation and amortization Other Depreciation and Amortization Interest rates available Debt Instrument, Basis Spread on Variable Rate Statistical Measurement [Domain] Statistical Measurement [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Tissue Technologies Tissue Technologies [Member] Orthopedics and Tissue Technologies [Member] Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Convertible notes, interest rate Debt Instrument, Interest Rate, Stated Percentage Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations Derivative Instruments, Gain (Loss) [Table Text Block] Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Additional paid-in capital Additional Paid in Capital, Common Stock Period for extended lease Lessee, Operating Lease, Option to Extend Option Indexed to Issuer's Equity [Axis] Option Indexed to Issuer's Equity [Axis] Net periodic benefit costs Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Transfers Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current Employees Employee [Member] Employee [Member] Transferred to trade receivable from contract asset included in beginning of the year contract asset Contract with Customer, Asset, Reclassified to Receivable Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Net income Net income Net income Net Income (Loss) Attributable to Parent Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Securitization program outstanding borrowings, maximum limit Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit Segment Profit Segment Reporting Information, Profit (Loss) [Abstract] Shares excluded from computation as their effect would be antidilutive (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Schedule of Contractual Repayments of Long-Term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Overnight Federal Funds Fed Funds Effective Rate Overnight Index Swap Rate [Member] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Equity Component [Domain] Equity Component [Domain] Interest expense Interest Expense [Member] Secured Debt Secured Debt [Member] Redemption price, percentage Debt Instrument, Redemption Price, Percentage Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] LEASES AND RELATED PARTY LEASES Lessee, Operating Leases [Text Block] Treasury stock Treasury Stock, Common, Value Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Related Party [Domain] Related Party [Domain] Instruments Instruments [Member] Instruments [Member] Contract asset, Beginning of period Contract asset, End of Period Contract with Customer, Asset, after Allowance for Credit Loss Effect of dilutive securities: Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] Standby Letters of Credit Standby Letters of Credit [Member] Hedging Designation [Domain] Hedging Designation [Domain] Estimated fair value of plan assets Defined Benefit Plan, Plan Assets, Amount Rest of World Rest Of World [Member] Revenues from rest of the world. Derivative Instrument [Axis] Derivative, by Nature [Axis] Derivative Instrument [Axis] Lease Contractual Term [Domain] Lease Contractual Term [Domain] Remainder of 2023 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Goodwill [Line Items] Goodwill [Line Items] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Line of credit facility outstanding Long-Term Line of Credit Entity State Entity Address, State or Province Interest payments, year one Interest Payments, Year One Interest Payments, Year One Award Type [Axis] Award Type [Axis] Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Current portion of lease liability - operating leases Current lease liabilities Less: Current lease liabilities Operating Lease, Liability, Current Proceeds from sale of business Proceeds from Divestiture of Businesses Costs and expenses: Costs and Expenses [Abstract] Gain expected to be reclassified to earnings in the next twelve months Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net Terminated notional amount Derivative, Notional Amount, Terminated Derivative, Notional Amount, Terminated Trade accounts receivable, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Liability Class [Axis] Liability Class [Axis] Cross Currency Interest Rate Swap Two Cross Currency Interest Rate Contract Two [Member] Cross Currency Interest Rate Contract Two [Member] Interest Rate Swap Designated October 10, 2018 Tranche 2 Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member] Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member] Total liabilities Liabilities Third Parties Third Parties [Member] Third Parties [Member] Weighted average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Geographical [Axis] Geographical [Axis] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Arkis Arkis BioSciences Inc. [Member] Arkis BioSciences Inc. [Member] SIA Acquisition Working Capital Adjustment Goodwill, Purchase Accounting Adjustments INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] Position [Axis] Position [Axis] Cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Derma Sciences Derma Sciences [Member] Derma Sciences [Member] Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Summary of Accounting Policies on Revenue Recognition and Shipping and Handling Fees Revenue from Contract with Customer [Policy Text Block] Document Type Document Type Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] Revenue Based Performance Milestones Revenue Based Performance Milestones [Member] Revenue Based Performance Milestones Interest payments, year two Interest Payments, Year Two Interest Payments, Year Two Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Segments [Axis] Segments [Axis] Total current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets DEBT Debt Disclosure [Text Block] Cash divested from deconsolidation Cash Divested from Deconsolidation Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Deferred income tax provision Deferred Income Tax Expense (Benefit) 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Gain (loss) recorded in AOCL, change in fair value Amount of Gain (Loss) Recognized in AOCL Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 2026 Long-Term Debt, Maturity, Year Three Leased vehicles Vehicles [Member] Affiliated Entity Affiliated Entity [Member] Interest Rate Swap Designated December 13, 2017 Tranche 3 Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member] Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member] Operating Activities [Domain] Consolidation Items [Domain] Option Indexed to Issuer's Equity, Type [Domain] Option Indexed to Issuer's Equity, Type [Domain] Schedule of Changes in Contract Assets and Contract Liabilities Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Document Period End Date Document Period End Date Current portion of borrowings under senior credit facility Term loan component of senior credit facility Secured Debt, Current Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Schedule of Changes in Accumulated Other Comprehensive Loss by Component Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Total assets Assets Initial strike price (in dollars per share) Option Indexed to Issuer's Equity, Strike Price Debt Disclosure [Abstract] Debt Disclosure [Abstract] Net income per share Earnings Per Share [Abstract] Earnings Per Share [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Performance Stock Performance Shares [Member] Interest rate swap Interest Rate Swap [Member] Balance Beginning of Period, Shares (in shares) Balance End of Period, Shares (in shares) Shares, Issued Accrued expenses and other current liabilities Accrued Liabilities, Current Secured long-term debt, securitization program Secured Long-Term Debt, Securitization Program Secured Long-Term Debt, Securitization Program 2028 Lessee, Operating Lease, Liability, to be Paid, Year Five Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Less: Amounts reclassified from accumulated other comprehensive income, net Gain (loss) reclassified from AOCI Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Product Warranties Extended Product Warranty, Policy [Policy Text Block] Accrued compensation Employee-related Liabilities, Current Gain from sale of businesses Gain (Loss) on Disposition of Business Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Segments [Domain] Segments [Domain] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Interest rate adjustment Debt Instrument, Basis Spread Adjustment On Variable Rate Debt Instrument, Basis Spread Adjustment On Variable Rate NET INCOME PER SHARE Earnings Per Share [Text Block] Product warranty period (up to) Revenue, Product Warranty Period Revenue, Product Warranty Period Other Long-term Liabilities Other Noncurrent Liabilities [Member] Interest Rate Swap Designated March 31, 2023 Interest Rate Swap Designated March 31, 2023 [Member] Interest Rate Swap Designated March 31, 2023 Disposal Group, Disposed of by Sale, Not Discontinued Operations Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Directors and Certain Executive Officers Directors and Certain Executive Officers [Member] Directors and Certain Executive Officers [Member] Gain (loss) recorded, net investment hedge, change in fair value Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Schedule of Fair Value and Presentation of Derivatives Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Award Type [Domain] Award Type [Domain] Weighted-average period for cost recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Payments to acquire businesses, gross Payments to Acquire Businesses, Gross Derivative Contract [Domain] Derivative, Name [Domain] Derivative Contract [Domain] Net Investment Hedges Net Investment Hedging [Member] Entity Registrant Name Entity Registrant Name Inventories, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Foreign currency translation Goodwill, Foreign Currency Translation Gain (Loss) Foreign Currency Items Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Customer relationships Customer Relationships [Member] Entity City Entity Address, City or Town RETIREMENT PLANS Retirement Benefits [Text Block] Gains and Losses on Derivatives Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Leases [Abstract] Leases [Abstract] Number of days from shipment to issue a credit Return Policy, Issue Of Credit, Number Of Days From Shipment Return Policy, Issue of Credit, Number of Days from Shipment TREASURY STOCK Treasury Stock [Text Block] Minimum Minimum [Member] Initial conversion rate Debt Instrument, Convertible, Conversion Ratio Inventory purchase, prepaid expenses and other current assets Discontinued Operation, Continuing Involvement, Prepaid Assets , Current Discontinued Operation, Continuing Involvement, Prepaid Expenses, Current Assets Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Emerging Growth Company Entity Emerging Growth Company Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Proceeds from borrowings of long-term indebtedness Proceeds from Issuance of Secured Debt Debt issuance costs capitalized Debt Issuance Costs, Net Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Trading Symbol Trading Symbol Entity File Number Entity File Number Other liabilities Other Liabilities [Member] Treasury stock, average cost per share (in dollars per share) Treasury Stock Acquired, Average Cost Per Share Treasury stock (in shares) Treasury Stock, Common, Shares Development Milestones Milestone Payment One [Member] Milestone Payment One [Member] Accounts payable, trade Accounts Payable, Trade, Current Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Expected annual amortization expense, in 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Four Long-term portion of contract liability Contract with Customer, Liability, Noncurrent Number of contingent liabilities remaining Business Combination, Contingent Consideration, Number Of Liabilities Business Combination, Contingent Consideration, Number Of Liabilities Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Long-term borrowings under securitization facility Secured Long-Term Debt, Securitization Program, Noncurrent Secured Long-Term Debt, Securitization Program, Noncurrent Title of Individual [Axis] Title of Individual [Axis] Awards granted during the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Reported tax rate Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Total liabilities assumed Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Balance, Beginning of Period Balance, End of Period Fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Accounts payable, accrued expenses and other current liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities INCOME TAXES Income Tax Disclosure [Text Block] Weighted average interest rate on debt Debt, Weighted Average Interest Rate Long-term borrowings under senior credit facility Secured Long-Term Debt, Noncurrent Finished goods Inventory, Finished Goods, Net of Reserves Credit Facility [Domain] Credit Facility [Domain] Intangible asset amortization Amortization Amortization of Intangible Assets Warrant strike price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Interest payments, year three Interest Payments, Year Three Interest Payments, Year Three Schedule of Changes in Carrying Amount of Goodwill Schedule of Goodwill [Table Text Block] Defer payment and taxation, base salary, percentage (up to) Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage Basic (in dollars per share) Basic net income per common share (in dollars per share) Earnings Per Share, Basic Neurosurgery Neurosurgery [Member] Neurosurgery [Member] 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Requisite service periods of awards Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Other assets Other Assets [Member] Corporate and other Corporate, Non-Segment [Member] Defined Benefit Pension Items Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Accounts payable and accrued expenses Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Counterparty Name [Domain] Counterparty Name [Domain] Treasury Stock Treasury Stock [Member] Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Total stockholders’ equity Balance, beginning of period Balance, end of period Stockholders' Equity Attributable to Parent DERIVATIVE INSTRUMENTS Derivative Instruments and Hedging Activities Disclosure [Text Block] Directors Director [Member] Lease Contractual Term [Axis] Lease Contractual Term [Axis] Accelerated share repurchases, additional shares received Accelerated Share Repurchases, Additional Shares Received Accelerated Share Repurchases, Additional Shares Received Current liabilities: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities [Abstract] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Entity Interactive Data Current Entity Interactive Data Current Supplier relationships Supplier Relation Ships [Member] Supplier Relation Ships [Member] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] Expected annual amortization expense, in 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Three Schedule of Contingent Consideration Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Retained Earnings Retained Earnings [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Other income, net Other Nonoperating Income (Expense) [Member] Common Stock Common Stock [Member] Other comprehensive income (loss), net of tax Net current-period other comprehensive gain (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Issuance of common stock for vesting of share based awards, net of shares withheld for taxes Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Other comprehensive gain (loss) OCI, before Reclassifications, Net of Tax, Attributable to Parent Number of reportable segments Number of Reportable Segments Discontinued operation, continuing involvement, prepaid asset Discontinued Operation, Continuing Involvement, Prepaid Asset Discontinued Operation, Continuing Involvement, Prepaid Asset Purchases of treasury stock Payments for Repurchase of Common Stock Contingent consideration, estimated fair value Business Combination, Contingent Consideration, Liability Wound Reconstruction and Care Regenerative Skin And Wound [Member] Regenerative Skin And Wound [Member] Statement [Table] Statement [Table] Option to extend lease, years Lessee, Operating Lease, Renewal Term Document Quarterly Report Document Quarterly Report Gain (loss) reclassified into other income Gain (Loss) on Derivative Instruments, Net, Pretax Current assets: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets [Abstract] Current assets: Assets, Current [Abstract] Lease liability - operating leases Non-current lease liabilities Long-term lease liabilities Operating Lease, Liability, Noncurrent Pension liability adjustment, net of tax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent Accelerated share repurchase program, receipt (payment) Accelerated Share Repurchases, Settlement (Payment) or Receipt Cross Currency Interest Rate Swap One Cross Currency Interest Rate Contract One [Member] Cross Currency Interest Rate Contract One [Member] Statistical Measurement [Axis] Statistical Measurement [Axis] Payment for contingent consideration Payment for Contingent Consideration Liability, Financing Activities Retained earnings Retained Earnings (Accumulated Deficit) Disposal Group Name [Axis] Disposal Group Name [Axis] Trade accounts receivable, net of allowances of $3,544 and $4,304 Accounts Receivable, after Allowance for Credit Loss, Current Equity Components [Axis] Equity Components [Axis] Related Parties Related Parties [Member] Related Parties [Member] Document Fiscal Year Focus Document Fiscal Year Focus OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Sale of business, disposition price Disposal Group, Including Discontinued Operation, Consideration Interest payments, after year three Interest Payments, After Year Three Interest Payments, After Year Three Contingent consideration, current Business Combination, Contingent Consideration, Liability, Current Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Variable Rate [Domain] Variable Rate [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Selling, general and administrative Selling, General and Administrative Expense Loss Contingencies [Table] Loss Contingencies [Table] Change in fair value of contingent consideration and others Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Contract Asset Change In Contract With Customer, Asset [Roll Forward] Change In Contract With Customer, Asset [Roll Forward] Right of use asset - operating leases ROU assets Operating Lease, Right-of-Use Asset Accelerated shares repurchased Stock Repurchased During Period, Value Accumulated Other Comprehensive Loss Total AOCI Attributable to Parent [Member] ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Comprehensive Income (Loss) Note [Text Block] Share repurchases, accrued excise tax Excise Tax Payable On Share Repurchases Excise Tax Payable On Share Repurchases Operating lease expense Operating Lease, Expense Commercial Sales Milestones Milestone Payment Two [Member] Milestone Payment Two [Member] Document Transition Report Document Transition Report Local Phone Number Local Phone Number Operating income Operating income Operating Income (Loss) Inventories Increase (Decrease) in Inventories Contract asset, net of transferred to trade receivables on contracts during the period Contract With Customer, Asset, Net Of Reclassified To Receivable Contract With Customer, Asset, Net Of Reclassified To Receivable Estimated Fair Value Fair Value Asset (Liability) Derivative, Fair Value, Net Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Position [Domain] Position [Domain] Annual rate of lease agreement Annual Rate Of Lease Agreement Annual rate of lease agreement. Goodwill Beginning of Period End of Period Goodwill Other Current Liabilities Other Current Liabilities [Member] Treasury stock, shares (in shares) Balance, beginning of period, treasury stock, shares (in shares) Balance, end of period, treasury stock, shares (in shares) Treasury Stock, Shares Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Accelerated shares repurchased (shares) Stock Repurchased During Period, Shares Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Provision for income taxes Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Deferred tax liabilities Deferred Income Tax Liabilities, Net Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share 2027 Lessee, Operating Lease, Liability, to be Paid, Year Four Income Statement [Abstract] Income Statement [Abstract] Hedging Relationship [Axis] Hedging Relationship [Axis] Additional Paid-In Capital Additional Paid-in Capital [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Document Fiscal Period Focus Document Fiscal Period Focus Basic net income per share: Earnings Per Share, Basic [Abstract] Cost of goods sold Cost of Goods and Services Sold Derivative [Line Items] Derivative [Line Items] Diluted (in shares) Weighted average common shares for diluted earnings per share (in shares) Weighted Average Number of Shares Outstanding, Diluted Schedule of Inventories, Net Schedule of Inventory, Current [Table Text Block] Total derivatives designated as hedges — Liabilities Derivative Liability, Subject to Master Netting Arrangement, before Offset Loss Contingencies [Line Items] Loss Contingencies [Line Items] Long-term convertible securities Convertible Debt, Noncurrent Incremental financing costs capitalized Debt Issuance Costs, Gross Common stock; $0.01 par value; 240,000 authorized shares; 90,813 and 90,477 issued at March 31, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Total current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Interest Rate Swap Designated December 13, 2017 Tranche 2 Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member] Interest Rate Swap Designated December 13, 2017 Tranche 2 Swingline Loans Swingline Loan [Member] Swingline Loan [Member] Other than options, weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Asia Pacific Asia Pacific [Member] Initial conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Operating Segments Operating Segments [Member] Convertible Debt Convertible Debt [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Preferred stock, authorized shares (in shares) Preferred Stock, Shares Authorized 2025 Notes Two Thousand Twenty Five Senior Convertible Notes [Member] Two Thousand Twenty Five Senior Convertible Notes [Member] Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cross Currency Interest Rate Swap Three Cross Currency Interest Rate Contract Three [Member] Cross Currency Interest Rate Contract Three [Member] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Current liabilities: Liabilities, Current [Abstract] Foreign currency forward contracts Foreign Exchange Forward [Member] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Proceeds from exercised stock options Proceeds from Stock Options Exercised Common stock, issued shares (in shares) Common Stock, Shares, Issued Accelerated share repurchases, shares received at inception Accelerated Share Repurchases, Shares Received at Inception Accelerated Share Repurchases, Shares Received at Inception Interest Rate Swap Designated October 10, 2018 Tranche 1 Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member] Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member] Contract liabilities Short-term portion of contract liability Contract with Customer, Liability, Current Income Statement Location [Domain] Income Statement Location [Domain] Cash Flow Hedges Cash Flow Hedging [Member] Amendment Flag Amendment Flag Term Loan Facility Term Loan Facility [Member] Term Loan Facility [Member] Weighted Average Life Finite-Lived Intangible Asset, Useful Life Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Convertible notes, maximum borrowing capacity Debt Instrument, Face Amount Issuance of common stock through employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Comprehensive income (See Note 14) Comprehensive income, net Comprehensive Income (Loss), Net of Tax, Attributable to Parent ACQUISITIONS AND DIVESTITURES Mergers, Acquisitions and Dispositions Disclosures [Text Block] Total liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Schedule of Net Sales and Profit by Segments Schedule of Geographic Revenue by Area Schedule of Segment Reporting Information, by Segment [Table Text Block] Entity Current Reporting Status Entity Current Reporting Status Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Deferred Tax Liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Other assets Other Assets, Noncurrent Recognition of revenue included in beginning of year contract liability Contract With Customer, Liability, Net Of Revenue Recognized Contract With Customer, Liability, Net Of Revenue Recognized Cross-currency swap Cross Currency Interest Rate Contract [Member] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Performance Stock and Restricted Stock Awards Performance Stock And Restricted Stock Awards [Member] Performance Stock And Restricted Stock Awards [Member] Expected annual amortization expense, thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Five Issuance of common stock through employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Counterparty Name [Axis] Counterparty Name [Axis] Schedule of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Derivative [Table] Derivative [Table] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Codman Specialty Surgical Codman Specialty Surgical Codman Specialty Surgical [Member] Codman Specialty Surgical [Member] Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-cash lease expense Noncash Lease Expense Noncash Lease Expense Cost Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill. Contingent consideration Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability Basis Of Presentation Basis of Accounting, Policy [Policy Text Block] Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Property, plant and equipment, net Property, Plant and Equipment, Net Operating cash flows from operating leases Operating Lease, Payments ROU assets obtained in exchange for lease liabilities: Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract] Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract] Change in fair value of contingent consideration liabilities Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Stock Options Share-Based Payment Arrangement, Option [Member] Treasury stock, at cost; 8,918 shares and 6,823 shares at March 31, 2023 and December 31, 2022, respectively Treasury Stock, Value Title of Individual [Domain] Title of Individual [Domain] Contingent consideration, maximum undiscounted payment amount Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Accelerated share repurchases, percentage of expected total repurchased Accelerated Share Repurchases, Percentage Of Expected Total Repurchased Accelerated Share Repurchases, Percentage Of Expected Total Repurchased Trade accounts receivable, allowance Accounts Receivable, Allowance for Credit Loss, Current Principal Repayment Long-Term Debt Other income, net Other Nonoperating Income (Expense) Five Year Option Lease From November 1, 2034 Through October 31, 2039 Five Year Option Lease Period Two [Member] Five-Year Option Lease Period Two Balance Sheet Location [Axis] Balance Sheet Location [Axis] Contingent consideration, noncurrent Business Combination, Contingent Consideration, Liability, Noncurrent Common stock, authorized shares (in shares) Common Stock, Shares Authorized Weighted average interest rate, accounts receivable securitization revolving loan facility Debt, Weighted Average Interest Rate, From Securitization Debt, Weighted Average Interest Rate, From Securitization Derivative instruments not designated as hedging instruments, gain (loss), net Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Maximum Maximum [Member] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Line of credit facility, fair value of amount outstanding Line of Credit Facility, Fair Value of Amount Outstanding Short Short [Member] Minimum settled in cash per principal amount Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Derivatives Not Designated as Hedging Instruments Derivatives Not Designated as Hedging Instruments [Table Text Block] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Total current assets Assets, Current Designated as Hedging Instrument Designated as Hedging Instrument [Member] Contract liability, net of revenue recognized on contracts during the period Contract with Customer, Liability, Revenue Recognized Business Acquisition [Line Items] Business Acquisition [Line Items] Smaller Reporting Company Entity Small Business Number of products offered (more than) Segment Reporting Information, Number Of Products Offered Number of products sold by a segment Change in unrealized loss/(gain) on derivatives, net of tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent ACell ACell [Member] ACell Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to) Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage Sale of business, contingent consideration Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration Performance obligations expected to be satisfied, expected timing Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Total unrecognized compensation costs Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Interest income Interest income Interest Income [Member] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Long Long [Member] Maximum average conversion value of notes Debt Instrument, Maximum Average Conversion Value Of Notes Debt Instrument, Maximum Average Conversion Value Of Notes Accounts receivable Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Trademarks/brand names Trademarks Brand Names [Member] Trademarks Brand Names. Total costs and expenses Costs and Expenses Grants in period, net of forfeitures (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Completed technology Completed Technology [Member] Completed technology. Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] BioD Earnout Payments and Medihoney Earnout Payments BioD Earnout Payments and Medihoney Earnout Payments [Member] BioD Earnout Payments and Medihoney Earnout Payments [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Payment of debt issuance costs Payments of Debt Issuance Costs Total lease liabilities Total lease liabilities Operating Lease, Liability SEGMENT AND GEOGRAPHIC INFORMATION Segment Reporting Disclosure [Text Block] Expected annual amortization expense, in 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Two LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Remainder of 2023 Long-Term Debt, Maturity, Remainder of Fiscal Year Weighted average common shares outstanding (See Note 13): Weighted Average Number of Shares Outstanding, Diluted [Abstract] Loss (gain) on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Other income (expense) Other Expense [Member] Inventories, net Inventories, net Inventory, Net Codman Codman [Member] Codman [Member] ACell, Inc. ACell, Inc. [Member] ACell, Inc. Interest payments, remainder of fiscal year Interest Payments, Reminder Of Fiscal Year Interest Payments, Reminder Of Fiscal Year Other non-current assets Increase (Decrease) in Other Operating Assets Hedging Relationship [Domain] Hedging Relationship [Domain] Hedging Designation [Axis] Hedging Designation [Axis] Write off of debt issuance costs Write off of Deferred Debt Issuance Cost Entity Filer Category Entity Filer Category Basic (in shares) Weighted average common shares outstanding - Basic (in shares) Weighted Average Number of Shares Outstanding, Basic United States UNITED STATES Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Interest Rate Swap Designated October 10, 2018 Tranche 3 Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member] Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member] Security Exchange Name Security Exchange Name Cost of call transactions Payments For Option Index To Issuers Equity Payments For Options Indexed to Issuer's Equity Weighted average life Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Notional Amount Current notional amount Aggregate Notional Amount Derivative, Notional Amount Preferred stock; no par value; 15,000 authorized shares; none outstanding Preferred Stock, Value, Issued Amount of Gain (Loss) Reclassified from AOCL into Earnings Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director Letters of credit outstanding Letters of Credit Outstanding, Amount Restricted Stock Restricted Stock [Member] Total revenue, net Total Revenues Revenue from Contract with Customer, Excluding Assessed Tax Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Supplemental Cash Flow Information Cash Flow, Lessee [Table Text Block] Cash Flow, Lessee [Table Text Block] Service cost component Defined Benefit Plan, Service Cost Securitization facility, outstanding borrowings, fair value Securitization Facility, Fair Value Of Amount Outstanding Securitization Facility, Fair Value Of Amount Outstanding Number of contingent liabilities Business Acquisition, Number Of Contingent Liabilities Business Acquisition, Number Of Contingent Liabilities Cover [Abstract] Cover [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Fair Value, Inputs, Level 3 Fair Value, Inputs, Level 3 [Member] STOCK-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Work in process Inventory, Work in Process, Net of Reserves REVENUES FROM CONTRACTS WITH CUSTOMERS Revenue from Contract with Customer [Text Block] Segment Reporting [Abstract] Segment Reporting [Abstract] Call Option Call Option [Member] Cash taxes paid in net equity settlement Payment, Tax Withholding, Share-Based Payment Arrangement Total liabilities and stockholders’ equity Liabilities and Equity Thereafter Long-Term Debt, Maturity, after Year Three Long-Term Debt, Maturity, after Year Three Related Party [Axis] Related Party [Axis] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Goodwill [Roll Forward] Goodwill [Roll Forward] Traditional Wound Care Traditional Wound Care [Member] Traditional Wound Care Stock options and restricted stock (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Diluted net income per share: Earnings Per Share, Diluted [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Disposal Group Name [Domain] Disposal Group Name [Domain] Derivative Instruments, Gain (Loss) [Roll Forward] Accumulated Other Comprehensive Income (Loss) [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Current Fiscal Year End Date Current Fiscal Year End Date Less: Imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Diluted (in dollars per share) Diluted net income per common share (in dollars per share) Earnings Per Share, Diluted Contingent Consideration Liability Contingent Consideration Liability [Member] Contingent Consideration Liability [Member] Stock options exercisable, vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Share-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Consolidation Items [Axis] Consolidation Items [Axis] Foreign currency translation Contract With Customer, Liability, Increase (Decrease) From Foreign Currency Translation Contract With Customer, Liability, Increase (Decrease) From Foreign Currency Translation Period for revenue based performance milestone Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration, Period Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration, Period Net Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill. Total current liabilities Liabilities, Current Maximum Consolidated Total Leverage Ratio Debt Instrument, Covenant, Maximum Leverage Ratio Debt Instrument, Covenant, Maximum Leverage Ratio Debt Covenant Period [Domain] Debt Covenant Period [Domain] [Domain] for Debt Covenant Period [Axis] 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Maximum selling price of the company's common stock of the conversion price Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period Taxes Collected from Customers Revenue, Transaction Price Measurement, Tax Exclusion [Policy Text Block] Expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Line of credit, commitment fee percentage Line of Credit Facility, Commitment Fee Percentage Schedule of Derivative Instruments Schedule of Derivative Instruments [Table Text Block] Intercompany loan quarterly payments Intercompany Loan, Quarterly Payment Intercompany Loan, Quarterly Payment Total derivatives designated as hedges — Assets Derivative Asset, Subject to Master Netting Arrangement, before Offset Schedule of Operating Lease Maturities Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address Entity Address, Address Line One Contract liability, Beginning of Period Contract liability, End of Period Contract with Customer, Liability Product and Service [Axis] Product and Service [Axis] Europe Europe [Member] March 31, 2023 through December 31, 2024 Debt Covenant Period 1 [Member] Debt Covenant Period 1 Interest expense Interest Expense Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Codman tradename Trade Names [Member] Credit Facility [Axis] Credit Facility [Axis] Disposal group, payable recognized Disposal Group, Including Discontinued Operation, Accounts Payable Five Year Option Lease From November 1, 2029 Through October 31, 2034 Five Year Option Lease Period One [Member] Five-Year Option Lease Period One INVENTORIES Inventory Disclosure [Text Block] Schedule of Long-term Debt Maximum Leverage Ratios Schedule of Long-Term Debt Instruments [Table Text Block] Equity [Abstract] Equity [Abstract] Leased facilities Building [Member] Proceeds from warrant transactions Proceeds from Issuance of Warrants Inventory Disclosure [Abstract] Interest Rate Swap Designated December 15, 2020 Tranche 2 Interest Rate Swap Designated December 15, 2020 Tranche 2 [Member] Interest Rate Swap Designated December 15, 2020 Tranche 2 Entity Tax Identification Number Entity Tax Identification Number Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Mergers, Acquisitions and Dispositions [Abstract] Mergers, Acquisitions and Dispositions Fixed Interest Rate Fixed Rate Derivative, Fixed Interest Rate Surgical Innovation Associates Inc Surgical Innovation Associates Inc [Member] Surgical Innovation Associates Inc Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Expected annual amortization expense, remainder of 2022 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Interest Rate Swap Designated December 18, 2018 Tranche 1 Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member] Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member] Research and development Research and Development Expense (Excluding Acquired in Process Cost) Segment Net Sales Segment Reporting Information, Operating Income (Loss) [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Foreign currency swaps Currency Swap [Member] Schedule of Effective Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] September 30, 2026 and the last day of each fiscal quarter thereafter Debt Covenant Period 3 [Member] Debt Covenant Period 3 [Member] Net decrease in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Private Label Private Label [Member] Private Label [Member] All other All Other [Member] All Other [Member] Accrued expenses and other current liabilities Accrued Expenses And Other Current Liabilities [Member] Accrued expenses and other current liabilities. Expected annual amortization expense, in 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Five Entity Central Index Key Entity Central Index Key Payments on debt Repayments of Secured Debt Interest income Investment Income, Interest Intangible asset acquired, discount rate (percent) Business Combination, Intangible Asset Acquired, Discount Rate Business Combination, Intangible Asset Acquired, Discount Rate Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Raw materials Inventory, Raw Materials and Purchased Parts, Net of Reserves Schedule of Comprehensive Income (Loss) Comprehensive Income (Loss) [Table Text Block] Interest Rate Swap Designated December 15, 2020 Tranche 1 Interest Rate Swap Designated December 15, 2020 Tranche 1 [Member] Interest Rate Swap Designated December 15, 2020 Tranche 1 Interest Rate Swap Designated December 18, 2018 Tranche 2 Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member] Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member] City Area Code City Area Code ASSETS Assets [Abstract] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Expected performance obligation through 2021, percentage Revenue, Remaining Performance Obligation, Percentage FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] 2024 Long-Term Debt, Maturity, Year One Share-based compensation Share-Based Payment Arrangement, Noncash Expense Options, weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Variable Rate [Axis] Variable Rate [Axis] Other liabilities Other Liabilities, Noncurrent March 31, 2025 through June 30, 2026 Debt Covenant Period 2 [Member] Debt Covenant Period 2 Cash paid for amounts included in the measurement of lease liabilities: Cash Flow, Lessee [Abstract] Cash Flow, Lessee [Abstract] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Changes in assets and liabilities: Changes In Assets And Liabilities [Abstract] Changes In Assets And Liabilities [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Expected annual amortization expense, in 2023 Finite-Lived Intangible Asset, Expected Amortization, Year One Basic and Diluted Net Income (Loss) Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Operating leases Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Cost of Sales Cost of Sales [Member] Amortization of debt issuance costs and expenses associated with debt refinancing Amortization Of Debt Issuance Costs And Debt Refinanced Fees Amortization Of Debt Issuance Costs And Debt Refinanced Fees Senior Credit Facility Senior Credit Facility [Member] Senior Credit Facility. EX-101.PRE 11 iart-20230331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - shares
3 Months Ended
Mar. 31, 2023
Apr. 25, 2023
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2023  
Document Transition Report false  
Entity File Number 000-26224  
Entity Registrant Name INTEGRA LIFESCIENCES HOLDINGS CORP  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 51-0317849  
Entity Address 1100 Campus Road  
Entity City Princeton  
Entity State NJ  
Entity Postal Zip Code 08540  
City Area Code 609  
Local Phone Number 275-0500  
Title of 12(b) Security Common Stock, Par Value $.01 Per Share  
Trading Symbol IART  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Smaller Reporting Company false  
Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   81,904,442
Amendment Flag false  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Entity Central Index Key 0000917520  
Current Fiscal Year End Date --12-31  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Total revenue, net $ 380,846 $ 376,638
Costs and expenses:    
Cost of goods sold 147,975 142,569
Research and development 26,724 24,085
Selling, general and administrative 166,657 159,926
Intangible asset amortization 3,108 3,894
Total costs and expenses 344,464 330,474
Operating income 36,382 46,164
Interest income 4,107 1,377
Interest expense (12,100) (11,655)
Other income, net 1,389 3,429
Income before income taxes 29,778 39,315
Provision for income taxes 5,552 6,414
Net income $ 24,226 $ 32,901
Net income per share    
Basic (in dollars per share) $ 0.30 $ 0.39
Diluted (in dollars per share) $ 0.29 $ 0.39
Weighted average common shares outstanding (See Note 13):    
Basic (in shares) 81,871 83,632
Diluted (in shares) 82,323 84,276
Comprehensive income (See Note 14) $ 21,028 $ 57,031
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 307,367 $ 456,661
Trade accounts receivable, net of allowances of $3,544 and $4,304 253,995 263,465
Inventories, net 351,275 324,583
Prepaid expenses and other current assets 116,845 116,789
Total current assets 1,029,482 1,161,498
Property, plant and equipment, net 315,175 311,302
Right of use asset - operating leases 146,514 148,284
Intangible assets, net 1,108,759 1,126,609
Goodwill 1,041,606 1,038,881
Deferred tax assets, net 44,680 45,994
Other assets 56,183 57,190
Total assets 3,742,399 3,889,758
Current liabilities:    
Current portion of borrowings under senior credit facility 0 38,125
Current portion of lease liability - operating leases 14,792 14,624
Accounts payable, trade 112,785 102,100
Contract liabilities 7,743 7,253
Accrued compensation 53,611 78,771
Accrued expenses and other current liabilities 93,362 80,033
Total current liabilities 282,293 320,906
Long-term borrowings under senior credit facility 769,143 733,149
Long-term borrowings under securitization facility 102,500 104,700
Long-term convertible securities 568,069 567,341
Lease liability - operating leases 156,910 157,420
Deferred tax liabilities 61,693 63,338
Other liabilities 126,853 138,501
Total liabilities 2,067,461 2,085,355
Stockholders’ equity:    
Preferred stock; no par value; 15,000 authorized shares; none outstanding 0 0
Common stock; $0.01 par value; 240,000 authorized shares; 90,813 and 90,477 issued at March 31, 2023 and December 31, 2022, respectively 908 905
Additional paid-in capital 1,245,297 1,276,977
Treasury stock, at cost; 8,918 shares and 6,823 shares at March 31, 2023 and December 31, 2022, respectively (481,678) (362,862)
Accumulated other comprehensive loss 7,067 10,265
Retained earnings 903,344 879,118
Total stockholders’ equity 1,674,938 1,804,403
Total liabilities and stockholders’ equity $ 3,742,399 $ 3,889,758
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Trade accounts receivable, allowance $ 3,544 $ 4,304
Preferred stock, par value (in dollars per share) $ 0 $ 0
Preferred stock, authorized shares (in shares) 15,000,000 15,000,000
Preferred stock, outstanding shares (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, authorized shares (in shares) 240,000,000 240,000,000
Common stock, issued shares (in shares) 90,813,000 90,477,000
Treasury stock, shares (in shares) 8,918,000 6,823,000
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
OPERATING ACTIVITIES:    
Net income $ 24,226 $ 32,901
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 31,143 29,724
Deferred income tax provision 1,953 3,544
Share-based compensation 3,620 6,291
Amortization of debt issuance costs and expenses associated with debt refinancing 1,890 1,724
Non-cash lease expense 1,260 (17)
Loss (gain) on disposal of property and equipment (23) 712
Change in fair value of contingent consideration and others 4,699 (765)
Changes in assets and liabilities:    
Accounts receivable 10,041 (3,116)
Inventories (25,423) (11,561)
Prepaid expenses and other current assets (2,164) (5,046)
Other non-current assets (6,009) 2,283
Accounts payable, accrued expenses and other current liabilities (4,984) (9,754)
Other non-current liabilities (14,073) (2,576)
Net cash provided by operating activities 26,156 44,344
INVESTING ACTIVITIES:    
Purchases of property and equipment (13,704) (9,325)
Acquired in-process research and development milestone 0 (4,742)
Net cash used in investing activities (13,704) (14,067)
FINANCING ACTIVITIES:    
Proceeds from borrowings of long-term indebtedness 10,200 11,250
Payments on debt (12,400) (11,750)
Payment of debt issuance costs (7,578) 0
Purchases of treasury stock (150,000) (125,000)
Proceeds from exercised stock options 2,326 1,239
Cash taxes paid in net equity settlement (5,231) (9,204)
Net cash used in financing activities (162,683) (133,465)
Effect of exchange rate changes on cash and cash equivalents 937 (3,168)
Net decrease in cash and cash equivalents (149,294) (106,356)
Cash and cash equivalents at beginning of period 456,661 513,448
Cash and cash equivalents at end of period $ 307,367 $ 407,092
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Balance Beginning of Period, Shares (in shares) at Dec. 31, 2021   89,600,000        
Balance, beginning of period at Dec. 31, 2021 $ 1,684,804 $ 896 $ (234,448) $ 1,264,943 $ (45,155) $ 698,568
Balance, beginning of period, treasury stock, shares (in shares) at Dec. 31, 2021     (4,899,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 32,901         32,901
Other comprehensive income (loss), net of tax 24,130       24,130  
Issuance of common stock through employee stock purchase plan (in shares)   17,000        
Issuance of common stock through employee stock purchase plan 1,078     1,078    
Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (in shares)   339,000 14,000      
Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (9,040) $ 4 $ 714 (9,758)    
Share-based compensation 6,324     6,324    
Accelerated shares repurchased (shares)     (1,938,000)      
Accelerated shares repurchased (125,000)   $ (129,152) 4,152    
Balance End of Period, Shares (in shares) at Mar. 31, 2022   89,956,000        
Balance, end of period at Mar. 31, 2022 1,615,197 $ 900 $ (362,886) 1,266,739 (21,025) 731,469
Balance, end of period, treasury stock, shares (in shares) at Mar. 31, 2022     (6,823,000)      
Balance Beginning of Period, Shares (in shares) at Dec. 31, 2022   90,476,000        
Balance, beginning of period at Dec. 31, 2022 $ 1,804,403 $ 905 $ (362,862) 1,276,977 10,265 879,118
Balance, beginning of period, treasury stock, shares (in shares) at Dec. 31, 2022 (6,823,000)   (6,823,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 24,226         24,226
Other comprehensive income (loss), net of tax (3,198)       (3,198)  
Issuance of common stock through employee stock purchase plan (in shares)   21,000        
Issuance of common stock through employee stock purchase plan 1,107     1,107    
Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (in shares)   316,000 16,000      
Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (4,011) $ 1 $ 846 (4,858)    
Share-based compensation 3,611 $ 2   3,609    
Accelerated shares repurchased (shares)     (2,111,000)      
Accelerated shares repurchased (151,200)   $ (119,662) (31,538)    
Balance End of Period, Shares (in shares) at Mar. 31, 2023   90,813,000        
Balance, end of period at Mar. 31, 2023 $ 1,674,938 $ 908 $ (481,678) $ 1,245,297 $ 7,067 $ 903,344
Balance, end of period, treasury stock, shares (in shares) at Mar. 31, 2023 (8,918,000)   (8,918,000)      
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.1
BASIS OF PRESENTATION
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BASIS OF PRESENTATION BASIS OF PRESENTATION
General
The terms “we,” “our,” “us,” “Company” and “Integra” refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries unless the context suggests otherwise.
In the opinion of management, the March 31, 2023 unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the financial position, statement of changes in shareholders' equity, results of operations and cash flows of the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP") have been condensed or omitted in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements for the year ended December 31, 2022 included in the Company’s Annual Report on Form 10-K. The December 31, 2022 consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. Operating results for the three-month period ended March 31, 2023 are not necessarily indicative of the results to be expected for the entire year.
The preparation of consolidated financial statements is in conformity with GAAP, which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the condensed consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.

Recent Accounting Pronouncements
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848), and subsequent amendment to the initial guidance: ASU 2021-01, Reference Rate Reform (Topic 848): Scope (collectively, “Topic 848”). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied through December 31, 2024. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of the Secured Overnight Financing Rate ("SOFR") as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition. On March 24, 2023, the Company entered into the seventh amendment and restatement (the "March 2023 Amendment") of its Senior Credit Facility (the “Senior Credit Facility”) with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. In connection with the March 2023 Amendment the Company replaced all LIBOR-based contracts with SOFR, which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities (See Note 6). In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of interest rate swaps from LIBOR to SOFR. Integra has elected to adopt the optional expedient under ASC 848, which will allow the interest rate swap hedging relationship to continue, without de-designation, due to the change in the indexed rate from LIBOR to SOFR.
There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.1
ACQUISITIONS AND DIVESTITURES
3 Months Ended
Mar. 31, 2023
Mergers, Acquisitions and Dispositions [Abstract]  
ACQUISITIONS AND DIVESTITURES ACQUISITIONS AND DIVESTITURES
Surgical Innovation Associates, Inc. Acquisition

On December 6, 2022, the Company completed its acquisition of Surgical Innovation Associates, Inc. ("SIA") for an acquisition purchase price of $51.5 million (the "SIA Acquisition"). In addition to the purchase price, the acquisition includes two separate contingent considerations payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $50.0 million in additional payments), as well as 2) the approval by the FDA of the Premarket Approval (“PMA”) Application for DuraSorb for certain uses by certain timing targets (up to $40.0 million in additional payments). SIA's core technology, DuraSorb, is a fully resorbable scaffold of a globally accepted polymer, which is cleared for use in hernia repair, abdominal wall, and other soft tissue reinforcement. DuraSorb sales will be reported within Integra’s Tissue Technologies ("TT") segment as part of its Wound Reconstruction and Care franchise.

Assets Acquired and Liabilities Assumed at Fair Value

The SIA Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired, and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date.



The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:

Dollars in thousandsPreliminary ValuationWeighted Average Life
Current assets:
Cash4,438 
Trade accounts receivable, net 1,551 
Inventories, net2,900 
Prepaid expenses and other current assets1,654 
Total current assets$10,543 
Intangible assets75,000 14 years
Goodwill41,854 
Total assets acquired$127,397 
Current liabilities:
Accounts payable and accrued expenses$2,044 
Total current liabilities$2,044 
Deferred Tax Liability11,799 
Contingent consideration57,607 
Total liabilities assumed71,450 
Net assets acquired$55,947 

Developed Technology

The estimated fair value of the developed technology was determined using the multi-period excess earnings method of the income approach, which estimates value based on the present value of future economic benefits. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&D costs, selling and marketing costs, working capital, and contributory asset charges, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of the asset’s life cycle, and competitive trends impacting the asset and the cash flow stream.

The Company used a discount rate of 18% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.
Goodwill

The Company allocated goodwill related to the SIA Acquisition to the TT segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. A key factor that contributes to the recognition of goodwill, and a driver for the Company’s acquisition of SIA, is the attractive growth opportunities presented by the surgical matrix business in the breast reconstruction market. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.

Contingent Consideration

The Company determines the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resulting most likely payouts are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation will be revalued to estimated fair value and changes in fair value will be reflected as income or expense in the consolidated statement of operations. Changes in the fair value of the contingent considerations may result from changes in discount periods and rates and changes in the timing and amount of revenue estimates. Changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.

As part of the SIA Acquisition, the Company is required to pay to the shareholder of SIA up to $90.0 million for two separate payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $50.0 million in additional payments), as well as 2) the approval by the FDA of the PMA for DuraSorb for certain uses by certain timing targets (up to $40.0 million in additional payments). The Company used iterations of the Monte Carlo simulation to calculate the fair value of the contingent consideration for the revenue-based milestone that considered the possible outcomes of scenarios related to each specific milestone for the revenue based performance milestone. The Company used probabilities of achieving the conditions to calculate the fair value of the contingent consideration for the PMA approval milestone. The Company estimated the fair value of the contingent consideration for the revenue based milestone to be $32.6 million at the acquisition date and $25.0 million for the PMA approval milestone as of December 31, 2022. The company recorded a total of $48.7 million in other liabilities as of March 31, 2023 and $12.5 million in accrued expenses and other current liabilities at March 31, 2023 in the consolidated balance sheet of the company. The change in the fair value of the contingent obligation was primarily as a result of changes in the timing.

Deferred Tax Liabilities

Deferred tax liabilities result from identifiable intangible assets’ fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.

Sale of non-core traditional wound care business
On August 31, 2022, the Company completed its sale of its non-core traditional wound care ("TWC") business to Gentell, LLC ("Gentell") for $28.8 million, which consists of $27.8 million in cash plus $1.0 million in contingent consideration which may be received upon achieving certain revenue-based performance milestones two years after the closing date. The proceeds from the sale of the TWC business of $27.8 million is presented in the consolidated statement of cash flows net of cash transferred of $3.5 million and other transaction fees. The transaction included the sale of the Company's TWC products, such as sponges, gauze and conforming bandages, and certain advanced wound care dressings, such as supportive, calcium alginate, hydrogel, and foam dressings.
The divestiture did not represent a strategic shift that had a major effect on the Company's operations and financial statements. Goodwill was allocated to the assets and liabilities divested using the relative fair value method of the TWC business to the Company's TT reportable business segment. In connection with the sale, the Company recognized $0.6 million as a gain from the sale of the business in the condensed consolidated statement of operations for the year ended December 31, 2022. The transaction is subject to final working capital adjustments.
In addition to the purchase and sale agreement, the Company also entered into a contract manufacturing agreement with Gentell. Under the terms of the agreement, Gentell received inventory, equipment, and tooling to manufacture certain MediHoney® and TCC-EZ® products on behalf of the Company. On the close date of this transaction, the Company transferred all inventory associated with these products to Gentell and recognized an asset of $11.1 million, as a form of a deposit for the inventory transferred, which based on the expected timing of inventory purchases, was primarily included within prepaid expenses and other current assets in the consolidated balance sheet. This deposit will be utilized by the Company on future orders placed to Gentell for such products. As of March 31, 2023, the Company had a deposit remaining of $7.3 million which is included in prepaid assets and recognized a payable due to Gentell of $0.7 million, which is included in the condensed consolidated balance sheet within accrued expenses and other current liabilities.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUES FROM CONTRACTS WITH CUSTOMERS
3 Months Ended
Mar. 31, 2023
Revenue from Contract with Customer [Abstract]  
REVENUES FROM CONTRACTS WITH CUSTOMERS REVENUES FROM CONTRACTS WITH CUSTOMERS
Summary of Accounting Policies on Revenue Recognition
Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services.
Performance Obligations
The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.
Significant Estimates
Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant.
The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract.
The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally 90 days.
The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.
Contract Asset and Liability
Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheets.
Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.
The following table summarized the changes in the contract asset and liability balances for the three months ended March 31, 2023:
Dollars in thousandsTotal
Contract Asset
Contract asset, January 1, 2023
$10,122 
Transferred to trade receivable from contract asset included in beginning of the year contract asset(9,765)
Contract asset, net of transferred to trade receivables on contracts during the period9,713 
Contract asset, March 31, 2023
$10,070 
Contract Liability
Contract liability, January 1, 2023
$16,127 
Recognition of revenue included in beginning of year contract liability$(2,492)
Contract liability, net of revenue recognized on contracts during the period2,921 
Foreign currency translation
Contract liability, March 31, 2023
$16,559 
At March 31, 2023, the short-term portion of the contract liability of $7.7 million and the long-term portion of $8.8 million is included in current liabilities and other liabilities, respectively, in the consolidated balance sheets.
As of March 31, 2023, the Company is expected to recognize revenue of approximately 47% of unsatisfied (or partially unsatisfied) performance obligations as revenue within 12 months, with the remaining balance to be recognized thereafter.
Shipping and Handling Fees
The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.
Product Warranties
Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.
Taxes Collected from Customers
The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.
Disaggregated Revenue
The following table presents revenues disaggregated by the major sources of revenues for the three months ended March 31, 2023 and 2022 (dollar amounts in thousands):
Three Months Ended March 31, 2023Three Months Ended March 31, 2022
Neurosurgery$192,870 $194,675 
Instruments55,266 52,633 
Total Codman Specialty Surgical248,136 247,308 
Wound Reconstruction and Care100,940 94,630 
Private Label31,770 34,700 
Total Tissue Technologies132,710 129,330 
Total revenue$380,846 $376,638 
See Note 15, Segment and Geographical Information, for details of revenues based on the location of the customer.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORIES
3 Months Ended
Mar. 31, 2023
Inventory Disclosure [Abstract]  
INVENTORIES INVENTORIES
Inventories, net consisted of the following:
Dollars in thousandsMarch 31, 2023December 31, 2022
Finished goods$178,626 $172,088 
Work in process80,532 70,598 
Raw materials92,117 81,897 
Total inventories, net$351,275 $324,583 
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND OTHER INTANGIBLE ASSETS
3 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill
Changes in the carrying amount of goodwill for the three-month period ended March 31, 2023 were as follows:
Dollars in thousandsCodman Specialty
Surgical
Tissue TechnologiesTotal
Goodwill at December 31, 2022$656,219 $382,662 $1,038,881 
SIA Acquisition Working Capital Adjustment— 129 129 
Foreign currency translation1,639 957 2,596 
Goodwill at March 31, 2023
$657,858 $383,748 $1,041,606 
Other Intangible Assets
The components of the Company’s identifiable intangible assets were as follows:
 March 31, 2023
Dollars in thousandsWeighted
Average
Life
CostAccumulated
Amortization
Net
Completed technology18 years$1,206,748 $(389,297)$817,451 
Customer relationships12 years$193,297 $(146,098)$47,199 
Trademarks/brand names28 years$97,554 $(35,665)$61,889 
Codman tradenameIndefinite$167,529 $— $167,529 
Supplier relationships30 years$30,211 $(17,415)$12,796 
All other11 years$6,024 $(4,129)$1,895 
$1,701,363 $(592,604)$1,108,759 
 December 31, 2022
Dollars in thousandsWeighted
Average
Life
CostAccumulated
Amortization
Net
Completed technology18 years$1,204,325 $(370,968)$833,357 
Customer relationships12 years193,081 (144,040)49,041 
Trademarks/brand names28 years97,265 (34,674)62,591 
Codman tradenameIndefinite166,693 — 166,693 
Supplier relationships30 years30,211 (17,170)13,041 
All other11 years5,957 (4,071)1,886 
$1,697,532 $(570,923)$1,126,609 
Based on quarter-end exchange rates, amortization expense (including amounts reported in cost of goods sold) is expected to be approximately $61.8 million for the remainder of 2023, $81.8 million in 2024, $81.8 million in 2025, $81.6 million in 2026, $79.7 million in 2027, $78.1 million in 2028 and $474.4 million thereafter.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.23.1
DEBT
3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
DEBT DEBT
Amendment to the Seventh Amended and Restated Senior Credit Agreement
On March 24, 2023, the Company entered into the March 2023 Amendment of the Senior Credit Facility with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The March 2023 Amendment extended the maturity date to March 24, 2028, amended the contractual repayments of Term loan A, and amended the interest rate from LIBOR to SOFR-indexed interest. The Company continues to have the aggregate principal amount of up to approximately $2.1 billion available to it through the following facilities: (i) a $775.0 million term loan facility, and (ii) a $1.3 billion revolving credit facility, which includes a $60 million sublimit for the issuance of standby letters of credit and a $60 million sublimit for swingline loans.
The Company’s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:
Fiscal QuarterMaximum Consolidated Total Leverage Ratio
March 31, 2023 through December 31, 2024
4.50 to 1.00
March 31, 2025 through June 30, 2026
4.25 to 1.00
September 30, 2026 and the last day of each fiscal quarter thereafter
4.00 to 1.00
Borrowings under the Senior Credit Facility bear interest, at the Company’s option, at a rate equal to the following:
i.term SOFR in effect from time to time plus 0.10% plus the applicable rate (ranging from 1.00% to 1.75%), or
ii.the highest of:
1.the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus 0.50%
2.the prime lending rate of Bank of America, N.A. or
3.the one-month Term SOFR plus 1.00%
The applicable rates are based on the Company’s consolidated total leverage ratio (defined as the ratio of (a) consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof to (b) consolidated EBITDA (as defined by the amended Seventh Amended and Restated Credit Agreement (the "Credit Agreement")), for the period of four consecutive fiscal quarters ending on such date).
The Company will pay an annual commitment fee (ranging from 0.15% to 0.30%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility.
The Senior Credit Facility is collateralized by substantially all of the assets of the Company’s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at March 31, 2023, the Company was in compliance with all such covenants. The Company capitalized $7.6 million in deferred financing costs in connection with the modification of the Senior Credit Facility and wrote off $0.2 million of previously capitalized financing costs during the first quarter of 2023.
At March 31, 2023 and December 31, 2022 there was no balance outstanding under the revolving portion of the Senior Credit Facility. At March 31, 2023 and December 31, 2022, there was $775.0 million outstanding under the term loan component of the Senior Credit Facility at a weighted average interest rate of 6.3% and 5.6%, respectively. As of March 31, 2023 there was no portion of the Term Loan component of the Senior Credit Facility classified as current on the condensed consolidated balance sheet. As of December 31, 2022, there was $38.1 million of the Term Loan component of the Senior Credit Facility classified as current on the consolidated balance sheets under the prior terms of the agreement.
The fair value of outstanding borrowings of the Senior Credit Facility's Term Loan component at March 31, 2023 was $750.9 million. This fair value was determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities.
Letters of credit outstanding as of March 31, 2023 and December 31, 2022 totaled $1.6 million. There were no amounts drawn as of March 31, 2023.
Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:
Quarter Ended March 31, 2023
Principal Repayment
Dollars in thousands
Remainder of 2023
$— 
2024
$14,531 
2025
$33,906 
2026
$38,750 
Thereafter687,813 
$775,000 
Future interest payments on the term loan component of the Senior Credit Facility based on current interest rates are expected to approximate $35.9 million for remainder of 2023, $38.1 million in 2024, $32.6 million in 2025, $30.0 million in 2026, and $34.5 million thereafter . Interest is calculated on the term loan portion of the Senior Credit Facility based on SOFR plus the certain amounts set forth in the Credit Agreement. As the revolving credit facility and Securitization Facility can be repaid at any time, no interest has been included in the calculation.
Any outstanding borrowings on the revolving credit component of the Senior Credit Facility is due on March 24, 2028.
Convertible Senior Notes
On February 4, 2020, the Company issued $575.0 million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of 0.5% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the 2025 Notes. In connection with this offering, the Company capitalized $13.2 million of financing fees.
The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of 13.5739 shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $73.67 per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least 130% of the conversion price during the period; (2) if the average trading price per $1,000 principal amount of the 2025 Notes is less than or equal to 98% of the average conversion value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if specified corporate transactions occur. As of March 31, 2023, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.
On December 9, 2020, the Company entered into the First Supplemental Indenture to the original agreement dated as of February 4, 2020 between the Company and Citibank, N.A., as trustee, governing the Company’s outstanding 2025 Notes. The Company irrevocably elected (1) to eliminate the Company’s option to choose physical settlement on any conversion of the 2025 Notes that occurs on or after the date of the First Supplemental Indenture and (2) with respect to any Combination Settlement for a conversion of the 2025 Notes, the Specified Dollar Amount that will be settled in cash per $1,000 principal amount of the 2025 Notes shall be no lower than $1,000.
Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption.
In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the “hedge participants”). The cost of the call transactions was $104.2 million for the 2025 Notes. The Company received $44.5 million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $73.67, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $113.34 for the 2025 Notes, subject to customary anti-dilution adjustments.
At March 31, 2023, the carrying amount of the liability was $575.0 million. The fair value of the 2025 Notes at March 31, 2023 was $561.7 million. Factors that the Company considered when estimating the fair value of the 2025 Notes included recent quoted market prices or dealer quote. The level of the 2025 Notes is considered as Level 1.
Securitization Facility
In 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (“SPE”), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to $150.0 million. The Securitization Facility Agreement ("Securitization Agreement") governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of March 31, 2023, the Company was in compliance with the covenants and none of the termination events had occurred.
On May 28, 2021, the Company entered into an amendment (the "May 2021 Amendment") of the Securitization Facility which extended the maturity date from December 21, 2021 to May 28, 2024. The May 2021 Amendment does not increase the Company’s total indebtedness.
The Securitization Facility is currently indexed to LIBOR. At March 31, 2023 and December 31, 2022, the Company had $102.5 million and $104.7 million, respectively, of outstanding borrowings under its Securitization Facility at a weighted average interest rate of 5.8% and 5.0%, respectively. In April 2023, we amended the facility to replace LIBOR with SOFR-indexed interest. The fair value of the outstanding borrowing of the Securitization Facility at March 31, 2023 was $102.2 million. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable inputs that reflect unadjusted quoted prices for identical assets or liabilities.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.23.1
DERIVATIVE INSTRUMENTS
3 Months Ended
Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS DERIVATIVE INSTRUMENTS
Interest Rate Hedging
The Company’s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected SOFR-indexed borrowings. In connection with the March 2023 Amendment to the Senior Credit Facility, the Company amended its interest rate from LIBOR to SOFR-indexed interest. In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of swaps from LIBOR to SOFR.
The Company held the following interest rate swaps as of March 31, 2023 and December 31, 2022 (dollar amounts in thousands):
March 31, 2023March 31, 2023
Hedged ItemNotional AmountDesignation DateEffective DateTermination DateFixed Interest RateEstimated Fair Value
Asset (Liability)
1-month Term SOFR Loan150,000 December 13, 2017July 1, 2019June 30, 20242.423 %4,022 
1-month Term SOFR Loan200,000 December 13, 2017January 1, 2018December 31, 20242.313 %6,738 
1-month Term SOFR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.220 %1,329 
1-month Term SOFR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.199 %1,539 
1-month Term SOFR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.209 %1,441 
1-month Term SOFR Loan100,000 December 18, 2018December 30, 2022December 31, 20272.885 %2,770 
1-month Term SOFR Loan100,000 December 18, 2018December 30, 2022December 31, 20272.867 %2,708 
1-month Term SOFR Loan575,000 December 15, 2020July 31, 2025December 31, 20271.415 %19,406 
1-month Term SOFR Loan125,000 December 15, 2020July 1, 2025December 31, 20271.404 %4,567 
Basis Swap (1)
March 31, 2023March 24, 2023December 31, 2027N/A(1,842)
$1,475,000 $42,678 
(1) The notional of the basis swap amortizes to match the total notional of the interest rate swap portfolio over time
December 31, 2022December 31, 2022
Hedged ItemNotional AmountDesignation DateEffective DateTermination DateFixed Interest RateEstimated Fair Value
Asset (Liability)
1-month USD LIBOR Loan150,000 December 13, 2017July 1, 2019June 30, 20242.423 %5,012 
1-month USD LIBOR Loan200,000 December 13, 2017January 1, 2018December 31, 20242.313 %8,380 
1-month USD LIBOR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.220 %1,831 
1-month USD LIBOR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.199 %1,905 
1-month USD LIBOR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.209 %1,970 
1-month USD LIBOR Loan100,000 December 18, 2018December 30, 2022December 31, 20272.885 %4,252 
1-month USD LIBOR Loan100,000 December 18, 2018December 30, 2022December 31, 20272.867 %4,153 
1-month USD LIBOR Loan575,000 December 15, 2020July 31, 2025December 31, 20271.415 %23,742 
1-month USD LIBOR Loan125,000 December 15, 2020July 1, 2025December 31, 20271.404 %5,467 
$1,475,000 $56,712 
The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive loss (“AOCL”), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCL to interest expense at that time.
Foreign Currency Hedging
From time to time, the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCL, net of tax. Those amounts are subsequently reclassified to earnings from AOCL as impacted by the hedged item when the hedged item affects earnings. If the hedged forecasted transaction does not occur or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income, net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.
The success of the Company’s hedging anticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows.
Cross-Currency Rate Swaps
On September 26, 2022, the Company amended the CHF-denominated intercompany loan to extend the termination date to September 2023 and as a result, the Company early terminated the cross-currency swap designated as cash flow hedge of an intercompany loan with aggregate notional amount of 50.0 million. Simultaneously, the Company entered into a cross-currency swap agreement to convert a notional amount of CHF 48.5 million equivalent to 49.1 million of this amended intercompany loan into U.S. dollars. The loss recorded by the Company upon the settlement of the swap was not material for the period.
On December 21, 2020, the Company entered into cross-currency swap agreements to convert a notional amount of $471.6 million equivalent to 420.1 million of a CHF-denominated intercompany loan into U.S. dollars. The CHF-denominated intercompany loan was the result of an intra-entity transfer of certain intellectual property rights to a subsidiary in Switzerland completed during the fourth quarter of 2020. The intercompany loan requires quarterly payments of CHF 5.8 million plus accrued interest. As a result, the aggregate notional amount of the related cross-currency swaps will decrease by a corresponding amount.
The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.
The Company held the following cross-currency rate swaps as of March 31, 2023 and December 31, 2022 (dollar amounts in thousands):
March 31, 2023December 31, 2022March 31, 2023December 31, 2022
Effective DateTermination DateFixed RateAggregate Notional AmountFair Value
Asset (Liability)
Pay CHFDecember 21, 2020December 22, 20253.00%CHF373,227 397,137 (3,033)(4,241)
Receive U.S.$3.98%$418,980 445,821 
Pay CHFSeptember 28, 2022September 29, 20231.95%CHF48,533 48,532 (4,011)(3,528)
Receive U.S.$5.32%$49,142 49,142 
Total$(7,044)$(7,769)
The cross-currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCL. For the three months ended March 31, 2023, and 2022, the Company recorded a loss of $4.9 million and a gain $6.5 million, respectively, in other income, net related to change in fair value related to the foreign currency rate translation to offset the losses recognized on the intercompany loans.
For the three months ended March 31, 2023, and 2022, the Company recorded a gain of $7.5 million and $7.9 million in AOCL, respectively, related to change in fair value of the cross-currency swaps.
For the three months ended March 31, 2023, and 2022, the Company recorded a gain of $1.5 million and $1.8 million, respectively, in other income, net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.
The estimated gain that is expected to be reclassified to other income (expense), net from AOCL as of March 31, 2023 within the next twelve months is $0.1 million. As of March 31, 2023, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.
Net Investment Hedges
The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018 and December 16, 2020, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of foreign currency on foreign subsidiaries.
The Company held the following cross-currency rate swaps designated as net investment hedges as of March 31, 2023 and December 31, 2022, respectively (dollar amounts in thousands):
March 31, 2023December 31, 2022
March 31, 2023
December 31, 2022
Effective DateTermination DateFixed RateAggregate Notional AmountFair Value
Asset (Liability)
Pay EUROctober 3, 2018September 30, 2023—%EUR51,760 51,760 3,989 4,713 
Receive U.S.$2.57%$60,000 60,000 
Pay EUROctober 3, 2018September 30, 2025—%EUR38,820 38,820 3,932 4,307 
Receive U.S.$2.19%$45,000 45,000 
Pay CHFMay 26, 2022December 16, 2028—%CHF288,210 288,210 (14,711)(14,663)
Receive U.S.$1.94%$300,000 300,000 
Total$(6,790)$(5,643)
The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were recorded as unrealized gains or losses in AOCL. For the three months ended March 31, 2023 and 2022, the Company recorded a loss of $1.1 million and a gain $1.3 million, respectively, in AOCL related to the change in fair value of the cross-currency swaps.
For the three months ended March 31, 2023, and 2022, the Company recorded gains of $2.1 million and $1.3 million, respectively, in interest income included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.
The estimated gain that is expected to be reclassified to interest income from AOCL as of March 31, 2023 within the next twelve months is $10.9 million.
Foreign Currency Forward Contract
The Company has entered into a hedge for forecasted intercompany purchases denominated in foreign currencies through the use of forward contracts designated as cash flow hedges. To the extent these forward contracts meet hedge accounting criteria, changes in their fair value are not included in accumulated comprehensive loss. These changes in fair value will be recognized into earnings as a component of cost of sales when the forecasted-transaction occurs.
During the first quarter of 2023 the Company entered into Foreign Currency Forward Contracts with a notional amount of $10.8 million to mitigate the risk of foreign currency on intercompany purchases in CHF. During the three months ended March 31, 2023 the Company recorded an immaterial loss in AOCL related to the change in fair value of the Foreign Currency Forward Contracts.
Counterparty Credit Risk
The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company’s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company’s credit ratings from any credit rating agency.
Fair Value of Derivative Instruments
The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk.
The following table summarizes the fair value for derivatives designated as hedging instruments in the condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022:
Fair Value as of
Location on Balance Sheet (1):
March 31, 2023December 31, 2022
Dollars in thousands
Derivatives designated as hedges — Assets:
Prepaid expenses and other current assets
Cash Flow Hedges
Interest rate swap(2)
$15,659 $16,682 
Cross-currency swap4,139 4,497 
Net Investment Hedges
Cross-currency swap10,942 11,653 
Other assets
Cash Flow Hedges
Interest rate swap(2)
28,861 40,030 
Cross-currency swap— — 
Net Investment Hedges
Cross-currency swap2,940 3,311 
Total derivatives designated as hedges — Assets$62,541 $76,173 
Derivatives designated as hedges — Liabilities:
Accrued expenses and other current liabilities
Cash Flow Hedges
Interest rate swap(2)
$762 $— 
Cross-currency swap4,011 3,528 
Foreign currency forward contracts69 
Net Investment Hedges
Cross-currency swap— — 
Other liabilities
Cash Flow Hedges
Interest rate swap(2)
1,080 — 
Cross-currency swap7,172 8,738 
Net Investment Hedges
Cross-currency swap20,672 20,608 
Total derivatives designated as hedges — Liabilities$33,766 $32,874 
(1) The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12 months.
(2) At March 31, 2023 and December 31, 2022, the total notional amounts related to the Company’s interest rate swaps were both $1.5 billion, respectively.
The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying condensed consolidated statement of operations during the three months ended March 31, 2023 and 2022:
Dollars in thousandsBalance in AOCL
Beginning of
Quarter
Amount of
Gain (Loss)
Recognized in
AOCL
Amount of Gain (Loss)
Reclassified from
AOCL into
Earnings
Balance in AOCL
End of Quarter
Location in
Statements of
Operations
Three Months Ended March 31, 2023
Cash Flow Hedges
Interest rate swap$56,712 $(10,534)$3,500 $42,678 Interest expense
Cross-currency swap(20,271)2,191 (3,504)(14,576)Other income, net
Foreign Currency Forward Contract— (69)— (69)Cost of Sales
Net Investment Hedges
Cross-currency swap(6,914)950 2,096 (8,060)Interest income
$29,527 $(7,462)$2,092 $19,973 
Three Months Ended March 31, 2022
Cash Flow Hedges
Interest rate swap$(43,956)$41,675 $(5,213)$2,932 Interest expense
Cross-currency swap(9,688)316 8,331 (17,703)Other income, net
Net Investment Hedges
Cross-currency swap(2,312)1,309 1,320 (2,323)Interest income
$(55,956)$43,300 $4,438 $(17,094)
Derivative Instruments not designated hedges:
During the second quarter of 2021, the Company entered into a foreign currency swap, with a notional amount of $7.3 million to mitigate the risk from fluctuations in foreign currency exchange rates associated with an intercompany loan denominated in JPY. In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another currency at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company subsequently paid down a portion of this swap, bringing the notional amount down to $6.4 million.
The following table summarizes the gains (losses) of derivative instruments not designated as hedges on the condensed consolidated statements of income, which was included in other income:
Dollars in thousandsThree Months Ended March 31,
20232022
Foreign currency swaps55 360 
Total$55 $360 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
As of March 31, 2023, the Company had stock options, restricted stock awards, performance stock awards, contract stock awards and restricted stock unit awards outstanding under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan (the “2003 Plan”). The 2000 and 2001 Equity Incentive Plans were terminated as of February 19, 2021, and no further awards may be issued under the plans.
Stock options issued under the 2003 Plan become exercisable over specified periods, generally within four years from the date of grant for officers and employees, within one year from date of grant for directors which generally expire eight years from the grant date for employees, and from six to ten years for directors and certain executive officers, except in certain instances that result in accelerated vesting due to death, disability, retirement age or change in-control provisions within their grant agreements. The Company values stock option grants using the binomial distribution model. Restricted stock issued under the Plans vests over specified periods, generally three years after the date of grant. The vesting of performance stock issued under the Plans is subject to service and performance conditions.
Stock Options
As of March 31, 2023, there were approximately $5.6 million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately three years. There were 151,293 stock options granted during the three months ended March 31, 2023. For the three months ended March 31, 2023, the weighted average grant date fair value for stock options granted was $21.58 per option.
Awards of Restricted Stock and Performance Stock
Performance stock and restricted stock awards generally have requisite service periods of three years, except in certain instances that result in accelerated vesting due to death, disability, retirement age provision or change in-control provisions in their grant agreements. Performance stock units are subject to graded vesting conditions based on revenue goals of the Company. The Company expenses the fair value of restricted stock awards on a straight-line basis over the requisite service period. As of March 31, 2023, there was approximately $48.6 million of total unrecognized compensation costs related to these unvested awards. The Company expects to recognize these costs over a weighted-average period of approximately two years. The Company granted 346,745 restricted stock awards and 161,218 performance stock awards during the three months ended March 31, 2023. For the three months ended March 31, 2023, the weighted average grant date fair value for restricted stock awards and performance stock units granted was $53.37 and $52.87 per award, respectively.
The Company also maintains an Employee Stock Purchase Plan (the “ESPP”), which provides eligible employees with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan based on its terms.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.23.1
RETIREMENT PLANS
3 Months Ended
Mar. 31, 2023
Retirement Benefits [Abstract]  
RETIREMENT PLANS RETIREMENT PLANS
The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland.
Net periodic benefit costs for the Company’s defined benefit pension plans for the three months ended March 31, 2023 were $0.3 million. The components of the net periodic benefit costs other than the service cost component of $0.5 million for the three months ended March 31, 2023 are included in other income, net in the consolidated statements of operations.
Net periodic benefit costs for the Company’s defined benefit pension plans for the three months ended March 31, 2022 were $0.3 million. The components of the net periodic benefit costs other than the service cost component of $0.7 million for the three months ended March 31, 2022 are included in other income, net in the consolidated statements of operations.
The estimated fair values of plan assets were $36.4 million and $38.1 million as of March 31, 2023 and December 31, 2022, respectively. The net plan assets of the pension plans are invested in common trusts as of March 31, 2023 and December 31, 2022. Common trusts are classified as Level 2 in the fair value hierarchy. The fair value of common trusts is valued at the net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within an appropriate risk profile.
Deferred Compensation Plan
The Company maintains a Deferred Compensation Plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.
This deferred compensation is invested in funds offered under this plan and is valued based on Level 1 measurements in the fair value hierarchy. Assets of the Company's deferred compensation plan are included in other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets were $5.0 million and $4.7 million as of March 31, 2023 and December 31, 2022, respectively. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES AND RELATED PARTY LEASES
3 Months Ended
Mar. 31, 2023
Leases [Abstract]  
LEASES AND RELATED PARTY LEASES LEASES AND RELATED PARTY LEASESThe Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of March 31, 2023. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components.
Most facility leases include one or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the Right of Use ("ROU") assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.
As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments.
Total operating lease expense for the three months ended March 31, 2023 and March 31, 2022 was $6.0 million and $4.9 million respectively, which includes $0.1 million, in related party operating lease expense.
Supplemental balance sheet information related to operating leases were as follows:
Dollars in thousands, except lease term and discount rateMarch 31, 2023
December 31, 2022
ROU assets$146,514 $148,284 
Current lease liabilities14,792 14,624 
Non-current lease liabilities156,910 157,420 
Total lease liabilities$171,702 $172,044 
Weighted average remaining lease term (in years):
Leased facilities17.1 years16.9 years
Leased vehicles2.0 years2.0 years
Weighted average discount rate:
Leased facilities5.4 %5.4 %
Leased vehicles2.8 %2.7 %
Supplemental cash flow information related to leases for the three months ended March 31, 2023 and 2022 were as follows:
Dollars in thousandsMarch 31, 2023
March 31, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$4,319 $4,696 
ROU assets obtained in exchange for lease liabilities:
Operating leases$1,721 $507 
Future minimum lease payments under operating leases at March 31, 2023 were as follows:
Dollars in thousandsRelated PartiesThird PartiesTotal
Remainder of 2023
$222 $15,870 $16,092 
2024296 21,086 21,382 
2025296 19,753 20,049 
2026296 17,148 17,444 
2027296 16,205 16,501 
2028296 13,951 14,247 
Thereafter246 151,206 151,452 
Total minimum lease payments$1,948 $255,219 $257,167 
Less: Imputed interest85,465 
Total lease liabilities171,702 
Less: Current lease liabilities14,792 
Long-term lease liabilities156,910 
There were no future minimum lease payments under finance leases at March 31, 2023.
Related Party Leases
The Company leases its manufacturing facility in Plainsboro, New Jersey, from Plainsboro Associates, a New Jersey general partnership. Ocirne, Inc., a subsidiary of Provco Industries, owns a 50% % interest in Plainsboro Associates. Provco Industries is the corporate general partner of Tru St. Partnership LLP, a principal stockholder of the Company. The term of the current lease agreement is through October 31, 2029 at an annual rate of approximately $0.3 million per year. The current lease agreement also provides (i) a 5-year renewal option for the Company to extend the lease from November 1, 2029 through October 31, 2034 at the fair market rental rate of the premises, and (ii) another 5-year renewal option to extend the lease from November 1, 2034 through October 31, 2039 at the fair market rental rate of the premises.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.23.1
TREASURY STOCK
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
TREASURY STOCK TREASURY STOCK
As of March 31, 2023 and December 31, 2022, there were 8.9 million and 6.8 million shares of treasury stock outstanding with a cost of $481.7 million and $362.9 million, at a weighted average cost per share of $54.01 and $53.18, respectively.
On January 26, 2023, the Company entered into a $150 million accelerated share repurchase ("2023 ASR") and received 2.1 million shares of the Company common stock at inception of the 2023 ASR, which represented approximately 80% of the expected total shares under the 2023 ASR. The remaining repurchase transactions are expected to be completed in the second quarter of 2023.
On August 16, 2022, the Inflation Reduction Act of 2022 (the “Act”) was signed into law. The Act implements a new excise tax of 1% on the net share repurchases made by the company effective for share repurchases performed January 1, 2023, or after. The company accrued $1.2 million regarding the excise tax in Q-1 related to the ASR mentioned above.
On January 12, 2022, the Company entered into a $125 million accelerated share repurchase ("2022 ASR") and received 1.48 million shares of Company common stock at inception of the 2022 ASR, which represented approximately 80% of the expected total shares under the 2022 ASR. On March 24, 2022, the early exercise provision under the 2022 ASR was exercised by 2022 ASR counterparty. Upon settlement on March 24, 2022, the Company received an additional 0.46 million shares determined using the volume-weighted average price of the Company's common stock during the term of the 2022 ASR.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES
3 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
The following table provides a summary of the Company's effective tax rate:
 Three Months Ended March 31,
 20232022
Reported tax rate18.6 %16.3 %
The Company’s effective income tax rates for the three months ended March 31, 2023 and 2022 were 18.6% and 16.3%, respectively. For the three months ended March 31, 2023, the primary driver of the higher tax rate relates to a reduction of excess tax benefits from stock compensation.
Changes to income tax laws and regulations, in any of the tax jurisdictions in which the Company operates, could impact the effective tax rate. Various governments, both U.S. and non-U.S., are increasingly focused on tax reform and revenue-raising legislation. Further, legislation in foreign jurisdictions may be enacted, in response to the base erosion and profit-sharing project begun by the Organization for Economic Cooperation and Development ("OECD"). The OECD recently finalized major reform of the international tax system with respect to a global minimum tax rate. Such changes in U.S. and non-U.S. jurisdictions could have an adverse effect on the Company’s effective tax rate.
As of March 31, 2023, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested unless there is a manner under which to remit the earnings with no material tax cost. Material taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed. The Company will repatriate foreign earnings when there is no need for reinvestment overseas and there is no material cost to bring the earnings back to the United States. Reinvestment considerations would include future acquisitions, transactions, and capital expenditure plans.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.1
NET INCOME PER SHARE
3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
NET INCOME PER SHARE NET INCOME PER SHARE
Basic and diluted net income per share was as follows:
 Three Months Ended March 31,
 Dollars in thousands, except per share amounts20232022
Basic net income per share:
Net income $24,226 $32,901 
Weighted average common shares outstanding81,871 83,632 
Basic net income per common share$0.30 $0.39 
Diluted net income per share:
Net income $24,226 $32,901 
Weighted average common shares outstanding — Basic81,871 83,632 
Effect of dilutive securities:
Stock options and restricted stock452 644 
Weighted average common shares for diluted earnings per share82,323 84,276 
Diluted net income per common share$0.29 $0.39 
Common stock of approximately 0.3 million and 0.2 million shares at March 31, 2023, and 2022, respectively that are issuable through exercise of dilutive securities were not included in the computation of diluted net income per share because their effect would have been anti-dilutive.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.23.1
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Comprehensive income for the three months ended March 31, 2023 and 2022 was as follows:
 Three Months Ended March 31,
Dollars in thousands20232022
Net income $24,226 $32,901 
Foreign currency translation adjustment4,076 (5,683)
Change in unrealized loss/(gain) on derivatives, net of tax(7,377)29,822 
Pension liability adjustment, net of tax103 (9)
Comprehensive income, net$21,028 $57,031 
Changes in accumulated other comprehensive income by component between December 31, 2022 and March 31, 2023 are presented in the table below, net of tax:
Dollars in thousandsGains and Losses on DerivativesDefined Benefit Pension ItemsForeign Currency ItemsTotal
Balance at January 1, 2023
$22,817 $9,322 $(21,874)$10,265 
Other comprehensive gain (loss)(5,754)103 4,076 (1,575)
Less: Amounts reclassified from accumulated other comprehensive income, net1,623 — — 1,623 
Net current-period other comprehensive gain (loss)(7,377)103 4,076 (3,198)
Balance at March 31, 2023
$15,440 $9,425 $(17,798)$7,067 
For the three months ended March 31, 2023, the Company reclassified a gain of $4.3 million and a loss of $2.7 million from accumulated other comprehensive income to other income, net and interest income, respectively.
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENT AND GEOGRAPHIC INFORMATION
3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
SEGMENT AND GEOGRAPHIC INFORMATION SEGMENT AND GEOGRAPHIC INFORMATION
The Company internally manages two global reportable segments and reports the results of its businesses to its chief operating decision maker. The two reportable segments and their activities are described below.
The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.
The TT segment includes such offerings as skin and wound repair, plastics & surgical reconstruction products, bone grafts, and nerve and tendon repair products.
The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.
The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by each reportable segment for the three months ended March 31, 2023 and 2022 are as follows:
Three Months Ended March 31,
Dollars in thousands20232022
Segment Net Sales
Codman Specialty Surgical$248,136 $247,308 
Tissue Technologies
132,710 129,330 
Total revenues$380,846 $376,638 
Segment Profit
Codman Specialty Surgical$110,933 $110,160 
Tissue Technologies
52,281 53,893 
Segment profit163,214 164,053 
Amortization(3,108)(3,894)
Corporate and other(123,724)(113,995)
Operating income$36,382 $46,164 
The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:
 Three Months Ended March 31,
Dollars in thousands20232022
United States$271,002 $263,351 
Europe41,064 43,744 
Asia Pacific50,473 47,717 
Rest of World18,307 21,826 
Total Revenues$380,846 $376,638 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES
3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIESIn consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.
The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.
The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.
Contingent Consideration
The Company determined the fair value of contingent consideration during the three month period ended March 31, 2023 and March 31, 2022 to reflect the change in estimate, additions, payments, transfers and the time value of money during the period.
A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the three months ended March 31, 2023 and March 31, 2022 is as follows (in thousands):
Three Months Ended March 31, 2023Contingent Consideration Liability Related to Acquisition of:
ArkisLocation in Financial StatementsDerma SciencesACellSurgical Innovations Associates, Inc. (FN 2)Location in Financial Statements
Short-termLong-termLong-termLong-termShort-termLong-term
Balance as of January 1, 2023
$2,845 $10,050 $230 $3,700 $— $57,607 
Transfers— — — — 12,500 (12,500)
Change in fair value of contingent consideration liabilities 1,543 1,756 Research and development— (2,200)— 3,600 Selling, general and administrative
Balance as of March 31, 20234,388 11,806 230 1,500 12,500 48,707 
Three Months Ended March 31, 2022Contingent Consideration Liability Related to Acquisition of:
Arkis Location in Financial StatementsDerma SciencesACell Inc.Location in Financial Statements
Short-termLong-termLong-termShort-termLong-term
Balance as of January 1, 2022
$3,691 $11,408 $230 $— $21,800 
Transfers59 (59)— 4,885 (4,885)
Change in fair value of contingent consideration liabilities— (1,065)Research and development— — 300 Selling, general and administrative
Balance as of March 31, 2022
$3,750 $10,284 $230 $4,885 $17,215 
Arkis BioSciences Inc.
As part of the acquisition of Arkis BioSciences Inc. ("Arkis"), the Company is required to pay the former shareholders of Arkis up to $25.5 million based on the timing of certain development milestones of $10.0 million and commercial sales milestones of $15.5 million, respectively. The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $13.1 million at the acquisition date. The estimated fair value as of March 31, 2023 and March 31, 2022 was $16.2 million and $14.0 million, respectively. The Company recorded $11.8 million and $10.3 million in other liabilities at March 31, 2023 and March 31, 2022, respectively, and $4.4 million and $3.8 million in accrued expenses and other current liabilities at March 31, 2023 and March 31, 2022, respectively, in the consolidated balance sheet of the Company.
Derma Sciences
The Company assumed contingent consideration incurred by Derma Sciences, Inc. ("Derma Sciences") related to its acquisitions of BioD and the intellectual property related to Medihoney products. The Company accounted for the contingent liabilities by recording their fair value on the date of the acquisition based on a probability weighted income approach. The Company has already paid $33.3 million related to the aforementioned contingent liabilities. One contingent milestone remains which relates to net sales of Medihoney™ products exceeding certain amounts defined in the agreement between the Company and Derma Sciences. The potential maximum undiscounted payment amounts to $3.0 million. The estimated fair value as of March 31, 2023 and March 31, 2022 was $0.2 million.

ACell Inc.
As part of the ACell Acquisition, the Company is required to make payments to the former shareholders of ACell up to $100 million based on the achievement by the Company of certain revenue-based performance milestones in 2023 and 2025. The Company used iterations of the Monte Carlo simulation to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specific milestone. The Company estimated the fair value of the contingent consideration to be $23.9 million at the acquisition date. The estimated fair value as of March 31, 2023 was $1.5 million. The Company recorded $1.5 million and $17.2 million in other liabilities at March 31, 2023 and March 31, 2022, respectively, and $4.9 million in accrued expenses and other current liabilities at March 31, 2022 in the consolidated balance sheets of the Company. The change in the fair value of the contingent obligation was primarily as a result of changes in the timing and amount of revenue estimates.
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.23.1
BASIS OF PRESENTATION (Policies)
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis Of Presentation BASIS OF PRESENTATION
General
The terms “we,” “our,” “us,” “Company” and “Integra” refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries unless the context suggests otherwise.
In the opinion of management, the March 31, 2023 unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the financial position, statement of changes in shareholders' equity, results of operations and cash flows of the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP") have been condensed or omitted in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements for the year ended December 31, 2022 included in the Company’s Annual Report on Form 10-K. The December 31, 2022 consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. Operating results for the three-month period ended March 31, 2023 are not necessarily indicative of the results to be expected for the entire year.
The preparation of consolidated financial statements is in conformity with GAAP, which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the condensed consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848), and subsequent amendment to the initial guidance: ASU 2021-01, Reference Rate Reform (Topic 848): Scope (collectively, “Topic 848”). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied through December 31, 2024. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of the Secured Overnight Financing Rate ("SOFR") as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition. On March 24, 2023, the Company entered into the seventh amendment and restatement (the "March 2023 Amendment") of its Senior Credit Facility (the “Senior Credit Facility”) with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. In connection with the March 2023 Amendment the Company replaced all LIBOR-based contracts with SOFR, which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities (See Note 6). In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of interest rate swaps from LIBOR to SOFR. Integra has elected to adopt the optional expedient under ASC 848, which will allow the interest rate swap hedging relationship to continue, without de-designation, due to the change in the indexed rate from LIBOR to SOFR.
There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.
Summary of Accounting Policies on Revenue Recognition and Shipping and Handling Fees
Summary of Accounting Policies on Revenue Recognition
Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services.
Performance Obligations
The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.
Significant Estimates
Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant.
The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract.
The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally 90 days.
The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.
Contract Asset and Liability
Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheets.
Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.
Shipping and Handling Fees
The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.
Product Warranties
Product Warranties
Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.
Taxes Collected from Customers
Taxes Collected from Customers
The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.23.1
ACQUISITIONS AND DIVESTITURES (Tables)
3 Months Ended
Mar. 31, 2023
Mergers, Acquisitions and Dispositions [Abstract]  
Schedule of Assets Acquired and Liabilities Assumed
The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:

Dollars in thousandsPreliminary ValuationWeighted Average Life
Current assets:
Cash4,438 
Trade accounts receivable, net 1,551 
Inventories, net2,900 
Prepaid expenses and other current assets1,654 
Total current assets$10,543 
Intangible assets75,000 14 years
Goodwill41,854 
Total assets acquired$127,397 
Current liabilities:
Accounts payable and accrued expenses$2,044 
Total current liabilities$2,044 
Deferred Tax Liability11,799 
Contingent consideration57,607 
Total liabilities assumed71,450 
Net assets acquired$55,947 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)
3 Months Ended
Mar. 31, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Changes in Contract Assets and Contract Liabilities
The following table summarized the changes in the contract asset and liability balances for the three months ended March 31, 2023:
Dollars in thousandsTotal
Contract Asset
Contract asset, January 1, 2023
$10,122 
Transferred to trade receivable from contract asset included in beginning of the year contract asset(9,765)
Contract asset, net of transferred to trade receivables on contracts during the period9,713 
Contract asset, March 31, 2023
$10,070 
Contract Liability
Contract liability, January 1, 2023
$16,127 
Recognition of revenue included in beginning of year contract liability$(2,492)
Contract liability, net of revenue recognized on contracts during the period2,921 
Foreign currency translation
Contract liability, March 31, 2023
$16,559 
Schedule of Disaggregation of Revenue
The following table presents revenues disaggregated by the major sources of revenues for the three months ended March 31, 2023 and 2022 (dollar amounts in thousands):
Three Months Ended March 31, 2023Three Months Ended March 31, 2022
Neurosurgery$192,870 $194,675 
Instruments55,266 52,633 
Total Codman Specialty Surgical248,136 247,308 
Wound Reconstruction and Care100,940 94,630 
Private Label31,770 34,700 
Total Tissue Technologies132,710 129,330 
Total revenue$380,846 $376,638 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORIES (Tables)
3 Months Ended
Mar. 31, 2023
Inventory Disclosure [Abstract]  
Schedule of Inventories, Net
Inventories, net consisted of the following:
Dollars in thousandsMarch 31, 2023December 31, 2022
Finished goods$178,626 $172,088 
Work in process80,532 70,598 
Raw materials92,117 81,897 
Total inventories, net$351,275 $324,583 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
3 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in Carrying Amount of Goodwill
Changes in the carrying amount of goodwill for the three-month period ended March 31, 2023 were as follows:
Dollars in thousandsCodman Specialty
Surgical
Tissue TechnologiesTotal
Goodwill at December 31, 2022$656,219 $382,662 $1,038,881 
SIA Acquisition Working Capital Adjustment— 129 129 
Foreign currency translation1,639 957 2,596 
Goodwill at March 31, 2023
$657,858 $383,748 $1,041,606 
Schedule of Finite-Lived Intangible Assets
The components of the Company’s identifiable intangible assets were as follows:
 March 31, 2023
Dollars in thousandsWeighted
Average
Life
CostAccumulated
Amortization
Net
Completed technology18 years$1,206,748 $(389,297)$817,451 
Customer relationships12 years$193,297 $(146,098)$47,199 
Trademarks/brand names28 years$97,554 $(35,665)$61,889 
Codman tradenameIndefinite$167,529 $— $167,529 
Supplier relationships30 years$30,211 $(17,415)$12,796 
All other11 years$6,024 $(4,129)$1,895 
$1,701,363 $(592,604)$1,108,759 
 December 31, 2022
Dollars in thousandsWeighted
Average
Life
CostAccumulated
Amortization
Net
Completed technology18 years$1,204,325 $(370,968)$833,357 
Customer relationships12 years193,081 (144,040)49,041 
Trademarks/brand names28 years97,265 (34,674)62,591 
Codman tradenameIndefinite166,693 — 166,693 
Supplier relationships30 years30,211 (17,170)13,041 
All other11 years5,957 (4,071)1,886 
$1,697,532 $(570,923)$1,126,609 
Schedule of Indefinite-Lived Intangible Assets
The components of the Company’s identifiable intangible assets were as follows:
 March 31, 2023
Dollars in thousandsWeighted
Average
Life
CostAccumulated
Amortization
Net
Completed technology18 years$1,206,748 $(389,297)$817,451 
Customer relationships12 years$193,297 $(146,098)$47,199 
Trademarks/brand names28 years$97,554 $(35,665)$61,889 
Codman tradenameIndefinite$167,529 $— $167,529 
Supplier relationships30 years$30,211 $(17,415)$12,796 
All other11 years$6,024 $(4,129)$1,895 
$1,701,363 $(592,604)$1,108,759 
 December 31, 2022
Dollars in thousandsWeighted
Average
Life
CostAccumulated
Amortization
Net
Completed technology18 years$1,204,325 $(370,968)$833,357 
Customer relationships12 years193,081 (144,040)49,041 
Trademarks/brand names28 years97,265 (34,674)62,591 
Codman tradenameIndefinite166,693 — 166,693 
Supplier relationships30 years30,211 (17,170)13,041 
All other11 years5,957 (4,071)1,886 
$1,697,532 $(570,923)$1,126,609 
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.1
DEBT (Tables)
3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Schedule of Long-term Debt Maximum Leverage Ratios
The Company’s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:
Fiscal QuarterMaximum Consolidated Total Leverage Ratio
March 31, 2023 through December 31, 2024
4.50 to 1.00
March 31, 2025 through June 30, 2026
4.25 to 1.00
September 30, 2026 and the last day of each fiscal quarter thereafter
4.00 to 1.00
Schedule of Contractual Repayments of Long-Term Debt
Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:
Quarter Ended March 31, 2023
Principal Repayment
Dollars in thousands
Remainder of 2023
$— 
2024
$14,531 
2025
$33,906 
2026
$38,750 
Thereafter687,813 
$775,000 
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.1
DERIVATIVE INSTRUMENTS (Tables)
3 Months Ended
Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments
The Company held the following interest rate swaps as of March 31, 2023 and December 31, 2022 (dollar amounts in thousands):
March 31, 2023March 31, 2023
Hedged ItemNotional AmountDesignation DateEffective DateTermination DateFixed Interest RateEstimated Fair Value
Asset (Liability)
1-month Term SOFR Loan150,000 December 13, 2017July 1, 2019June 30, 20242.423 %4,022 
1-month Term SOFR Loan200,000 December 13, 2017January 1, 2018December 31, 20242.313 %6,738 
1-month Term SOFR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.220 %1,329 
1-month Term SOFR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.199 %1,539 
1-month Term SOFR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.209 %1,441 
1-month Term SOFR Loan100,000 December 18, 2018December 30, 2022December 31, 20272.885 %2,770 
1-month Term SOFR Loan100,000 December 18, 2018December 30, 2022December 31, 20272.867 %2,708 
1-month Term SOFR Loan575,000 December 15, 2020July 31, 2025December 31, 20271.415 %19,406 
1-month Term SOFR Loan125,000 December 15, 2020July 1, 2025December 31, 20271.404 %4,567 
Basis Swap (1)
March 31, 2023March 24, 2023December 31, 2027N/A(1,842)
$1,475,000 $42,678 
(1) The notional of the basis swap amortizes to match the total notional of the interest rate swap portfolio over time
December 31, 2022December 31, 2022
Hedged ItemNotional AmountDesignation DateEffective DateTermination DateFixed Interest RateEstimated Fair Value
Asset (Liability)
1-month USD LIBOR Loan150,000 December 13, 2017July 1, 2019June 30, 20242.423 %5,012 
1-month USD LIBOR Loan200,000 December 13, 2017January 1, 2018December 31, 20242.313 %8,380 
1-month USD LIBOR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.220 %1,831 
1-month USD LIBOR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.199 %1,905 
1-month USD LIBOR Loan75,000 October 10, 2018July 1, 2020June 30, 20253.209 %1,970 
1-month USD LIBOR Loan100,000 December 18, 2018December 30, 2022December 31, 20272.885 %4,252 
1-month USD LIBOR Loan100,000 December 18, 2018December 30, 2022December 31, 20272.867 %4,153 
1-month USD LIBOR Loan575,000 December 15, 2020July 31, 2025December 31, 20271.415 %23,742 
1-month USD LIBOR Loan125,000 December 15, 2020July 1, 2025December 31, 20271.404 %5,467 
$1,475,000 $56,712 
The Company held the following cross-currency rate swaps as of March 31, 2023 and December 31, 2022 (dollar amounts in thousands):
March 31, 2023December 31, 2022March 31, 2023December 31, 2022
Effective DateTermination DateFixed RateAggregate Notional AmountFair Value
Asset (Liability)
Pay CHFDecember 21, 2020December 22, 20253.00%CHF373,227 397,137 (3,033)(4,241)
Receive U.S.$3.98%$418,980 445,821 
Pay CHFSeptember 28, 2022September 29, 20231.95%CHF48,533 48,532 (4,011)(3,528)
Receive U.S.$5.32%$49,142 49,142 
Total$(7,044)$(7,769)
The Company held the following cross-currency rate swaps designated as net investment hedges as of March 31, 2023 and December 31, 2022, respectively (dollar amounts in thousands):
March 31, 2023December 31, 2022
March 31, 2023
December 31, 2022
Effective DateTermination DateFixed RateAggregate Notional AmountFair Value
Asset (Liability)
Pay EUROctober 3, 2018September 30, 2023—%EUR51,760 51,760 3,989 4,713 
Receive U.S.$2.57%$60,000 60,000 
Pay EUROctober 3, 2018September 30, 2025—%EUR38,820 38,820 3,932 4,307 
Receive U.S.$2.19%$45,000 45,000 
Pay CHFMay 26, 2022December 16, 2028—%CHF288,210 288,210 (14,711)(14,663)
Receive U.S.$1.94%$300,000 300,000 
Total$(6,790)$(5,643)
Schedule of Fair Value and Presentation of Derivatives
The following table summarizes the fair value for derivatives designated as hedging instruments in the condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022:
Fair Value as of
Location on Balance Sheet (1):
March 31, 2023December 31, 2022
Dollars in thousands
Derivatives designated as hedges — Assets:
Prepaid expenses and other current assets
Cash Flow Hedges
Interest rate swap(2)
$15,659 $16,682 
Cross-currency swap4,139 4,497 
Net Investment Hedges
Cross-currency swap10,942 11,653 
Other assets
Cash Flow Hedges
Interest rate swap(2)
28,861 40,030 
Cross-currency swap— — 
Net Investment Hedges
Cross-currency swap2,940 3,311 
Total derivatives designated as hedges — Assets$62,541 $76,173 
Derivatives designated as hedges — Liabilities:
Accrued expenses and other current liabilities
Cash Flow Hedges
Interest rate swap(2)
$762 $— 
Cross-currency swap4,011 3,528 
Foreign currency forward contracts69 
Net Investment Hedges
Cross-currency swap— — 
Other liabilities
Cash Flow Hedges
Interest rate swap(2)
1,080 — 
Cross-currency swap7,172 8,738 
Net Investment Hedges
Cross-currency swap20,672 20,608 
Total derivatives designated as hedges — Liabilities$33,766 $32,874 
(1) The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12 months.
(2) At March 31, 2023 and December 31, 2022, the total notional amounts related to the Company’s interest rate swaps were both $1.5 billion, respectively.
Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations
The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying condensed consolidated statement of operations during the three months ended March 31, 2023 and 2022:
Dollars in thousandsBalance in AOCL
Beginning of
Quarter
Amount of
Gain (Loss)
Recognized in
AOCL
Amount of Gain (Loss)
Reclassified from
AOCL into
Earnings
Balance in AOCL
End of Quarter
Location in
Statements of
Operations
Three Months Ended March 31, 2023
Cash Flow Hedges
Interest rate swap$56,712 $(10,534)$3,500 $42,678 Interest expense
Cross-currency swap(20,271)2,191 (3,504)(14,576)Other income, net
Foreign Currency Forward Contract— (69)— (69)Cost of Sales
Net Investment Hedges
Cross-currency swap(6,914)950 2,096 (8,060)Interest income
$29,527 $(7,462)$2,092 $19,973 
Three Months Ended March 31, 2022
Cash Flow Hedges
Interest rate swap$(43,956)$41,675 $(5,213)$2,932 Interest expense
Cross-currency swap(9,688)316 8,331 (17,703)Other income, net
Net Investment Hedges
Cross-currency swap(2,312)1,309 1,320 (2,323)Interest income
$(55,956)$43,300 $4,438 $(17,094)
Derivatives Not Designated as Hedging Instruments
The following table summarizes the gains (losses) of derivative instruments not designated as hedges on the condensed consolidated statements of income, which was included in other income:
Dollars in thousandsThree Months Ended March 31,
20232022
Foreign currency swaps55 360 
Total$55 $360 
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES AND RELATED PARTY LEASES (Tables)
3 Months Ended
Mar. 31, 2023
Leases [Abstract]  
Supplemental Balance Sheet Information
Supplemental balance sheet information related to operating leases were as follows:
Dollars in thousands, except lease term and discount rateMarch 31, 2023
December 31, 2022
ROU assets$146,514 $148,284 
Current lease liabilities14,792 14,624 
Non-current lease liabilities156,910 157,420 
Total lease liabilities$171,702 $172,044 
Weighted average remaining lease term (in years):
Leased facilities17.1 years16.9 years
Leased vehicles2.0 years2.0 years
Weighted average discount rate:
Leased facilities5.4 %5.4 %
Leased vehicles2.8 %2.7 %
Supplemental Cash Flow Information
Supplemental cash flow information related to leases for the three months ended March 31, 2023 and 2022 were as follows:
Dollars in thousandsMarch 31, 2023
March 31, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$4,319 $4,696 
ROU assets obtained in exchange for lease liabilities:
Operating leases$1,721 $507 
Schedule of Operating Lease Maturities
Future minimum lease payments under operating leases at March 31, 2023 were as follows:
Dollars in thousandsRelated PartiesThird PartiesTotal
Remainder of 2023
$222 $15,870 $16,092 
2024296 21,086 21,382 
2025296 19,753 20,049 
2026296 17,148 17,444 
2027296 16,205 16,501 
2028296 13,951 14,247 
Thereafter246 151,206 151,452 
Total minimum lease payments$1,948 $255,219 $257,167 
Less: Imputed interest85,465 
Total lease liabilities171,702 
Less: Current lease liabilities14,792 
Long-term lease liabilities156,910 
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Tables)
3 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Effective Income Tax Rate
The following table provides a summary of the Company's effective tax rate:
 Three Months Ended March 31,
 20232022
Reported tax rate18.6 %16.3 %
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.23.1
NET INCOME PER SHARE (Tables)
3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Basic and Diluted Net Income (Loss) Per Share
Basic and diluted net income per share was as follows:
 Three Months Ended March 31,
 Dollars in thousands, except per share amounts20232022
Basic net income per share:
Net income $24,226 $32,901 
Weighted average common shares outstanding81,871 83,632 
Basic net income per common share$0.30 $0.39 
Diluted net income per share:
Net income $24,226 $32,901 
Weighted average common shares outstanding — Basic81,871 83,632 
Effect of dilutive securities:
Stock options and restricted stock452 644 
Weighted average common shares for diluted earnings per share82,323 84,276 
Diluted net income per common share$0.29 $0.39 
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.23.1
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Schedule of Comprehensive Income (Loss)
Comprehensive income for the three months ended March 31, 2023 and 2022 was as follows:
 Three Months Ended March 31,
Dollars in thousands20232022
Net income $24,226 $32,901 
Foreign currency translation adjustment4,076 (5,683)
Change in unrealized loss/(gain) on derivatives, net of tax(7,377)29,822 
Pension liability adjustment, net of tax103 (9)
Comprehensive income, net$21,028 $57,031 
Schedule of Changes in Accumulated Other Comprehensive Loss by Component
Changes in accumulated other comprehensive income by component between December 31, 2022 and March 31, 2023 are presented in the table below, net of tax:
Dollars in thousandsGains and Losses on DerivativesDefined Benefit Pension ItemsForeign Currency ItemsTotal
Balance at January 1, 2023
$22,817 $9,322 $(21,874)$10,265 
Other comprehensive gain (loss)(5,754)103 4,076 (1,575)
Less: Amounts reclassified from accumulated other comprehensive income, net1,623 — — 1,623 
Net current-period other comprehensive gain (loss)(7,377)103 4,076 (3,198)
Balance at March 31, 2023
$15,440 $9,425 $(17,798)$7,067 
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENT AND GEOGRAPHIC INFORMATION (Tables)
3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Schedule of Net Sales and Profit by Segments Net sales and profit by each reportable segment for the three months ended March 31, 2023 and 2022 are as follows:
Three Months Ended March 31,
Dollars in thousands20232022
Segment Net Sales
Codman Specialty Surgical$248,136 $247,308 
Tissue Technologies
132,710 129,330 
Total revenues$380,846 $376,638 
Segment Profit
Codman Specialty Surgical$110,933 $110,160 
Tissue Technologies
52,281 53,893 
Segment profit163,214 164,053 
Amortization(3,108)(3,894)
Corporate and other(123,724)(113,995)
Operating income$36,382 $46,164 
Total revenue by major geographic area consisted of the following:
 Three Months Ended March 31,
Dollars in thousands20232022
United States$271,002 $263,351 
Europe41,064 43,744 
Asia Pacific50,473 47,717 
Rest of World18,307 21,826 
Total Revenues$380,846 $376,638 
Schedule of Geographic Revenue by Area Net sales and profit by each reportable segment for the three months ended March 31, 2023 and 2022 are as follows:
Three Months Ended March 31,
Dollars in thousands20232022
Segment Net Sales
Codman Specialty Surgical$248,136 $247,308 
Tissue Technologies
132,710 129,330 
Total revenues$380,846 $376,638 
Segment Profit
Codman Specialty Surgical$110,933 $110,160 
Tissue Technologies
52,281 53,893 
Segment profit163,214 164,053 
Amortization(3,108)(3,894)
Corporate and other(123,724)(113,995)
Operating income$36,382 $46,164 
Total revenue by major geographic area consisted of the following:
 Three Months Ended March 31,
Dollars in thousands20232022
United States$271,002 $263,351 
Europe41,064 43,744 
Asia Pacific50,473 47,717 
Rest of World18,307 21,826 
Total Revenues$380,846 $376,638 
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES (Tables)
3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Contingent Consideration
A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the three months ended March 31, 2023 and March 31, 2022 is as follows (in thousands):
Three Months Ended March 31, 2023Contingent Consideration Liability Related to Acquisition of:
ArkisLocation in Financial StatementsDerma SciencesACellSurgical Innovations Associates, Inc. (FN 2)Location in Financial Statements
Short-termLong-termLong-termLong-termShort-termLong-term
Balance as of January 1, 2023
$2,845 $10,050 $230 $3,700 $— $57,607 
Transfers— — — — 12,500 (12,500)
Change in fair value of contingent consideration liabilities 1,543 1,756 Research and development— (2,200)— 3,600 Selling, general and administrative
Balance as of March 31, 20234,388 11,806 230 1,500 12,500 48,707 
Three Months Ended March 31, 2022Contingent Consideration Liability Related to Acquisition of:
Arkis Location in Financial StatementsDerma SciencesACell Inc.Location in Financial Statements
Short-termLong-termLong-termShort-termLong-term
Balance as of January 1, 2022
$3,691 $11,408 $230 $— $21,800 
Transfers59 (59)— 4,885 (4,885)
Change in fair value of contingent consideration liabilities— (1,065)Research and development— — 300 Selling, general and administrative
Balance as of March 31, 2022
$3,750 $10,284 $230 $4,885 $17,215 
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.23.1
ACQUISITIONS AND DIVESTITURES- Business Combination, Narrative (Details) - Surgical Innovation Associates Inc
$ in Millions
Dec. 06, 2022
USD ($)
payment
Mar. 31, 2023
USD ($)
Business Acquisition [Line Items]    
Payments to acquire businesses, gross $ 51.5  
Number of contingent liabilities | payment 2  
Contingent consideration, maximum undiscounted payment amount $ 90.0  
Intangible asset acquired, discount rate (percent) 18.00%  
Contingent consideration, noncurrent   $ 48.7
Contingent consideration, current   $ 12.5
Revenue Based Performance Milestones    
Business Acquisition [Line Items]    
Contingent consideration, maximum undiscounted payment amount $ 50.0  
Contingent consideration, estimated fair value 32.6  
FDA Approval Of Premarket Approval    
Business Acquisition [Line Items]    
Contingent consideration, maximum undiscounted payment amount 40.0  
Contingent consideration, estimated fair value $ 25.0  
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.23.1
ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details) - USD ($)
$ in Thousands
Dec. 06, 2022
Mar. 31, 2023
Dec. 31, 2022
Current assets:      
Goodwill   $ 1,041,606 $ 1,038,881
Surgical Innovation Associates Inc      
Current assets:      
Cash $ 4,438    
Trade accounts receivable, net 1,551    
Inventories, net 2,900    
Prepaid expenses and other current assets 1,654    
Total current assets 10,543    
Intangible assets 75,000    
Goodwill 41,854    
Total assets acquired 127,397    
Current liabilities:      
Accounts payable and accrued expenses 2,044    
Total current liabilities 2,044    
Deferred Tax Liability 11,799    
Contingent consideration 57,607    
Total liabilities assumed 71,450    
Total liabilities assumed $ 55,947    
Weighted average life 14 years    
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.23.1
ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details) - Disposal Group, Disposed of by Sale, Not Discontinued Operations - Traditional Wound Care - USD ($)
$ in Millions
12 Months Ended
Aug. 31, 2022
Dec. 31, 2022
Mar. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Sale of business, disposition price $ 28.8    
Proceeds from sale of business 27.8    
Sale of business, contingent consideration $ 1.0    
Period for revenue based performance milestone 2 years    
Cash divested from deconsolidation $ 3.5    
Gain from sale of businesses   $ 0.6  
Discontinued operation, continuing involvement, prepaid asset $ 11.1    
Inventory purchase, prepaid expenses and other current assets     $ 7.3
Disposal group, payable recognized     $ 0.7
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]    
Number of days from shipment to issue a credit 90 days  
Short-term portion of contract liability $ 7,743 $ 7,253
Long-term portion of contract liability $ 8,800  
Product warranty period (up to) 2 years  
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Mar. 31, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected performance obligation through 2021, percentage 47.00%
Performance obligations expected to be satisfied, expected timing 12 months
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2023
USD ($)
Contract Asset  
Contract asset, Beginning of period $ 10,122
Transferred to trade receivable from contract asset included in beginning of the year contract asset (9,765)
Contract asset, net of transferred to trade receivables on contracts during the period 9,713
Contract asset, End of Period 10,070
Contract Liability  
Contract liability, Beginning of Period 16,127
Recognition of revenue included in beginning of year contract liability (2,492)
Contract liability, net of revenue recognized on contracts during the period 2,921
Foreign currency translation 3
Contract liability, End of Period $ 16,559
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Disaggregation of Revenue [Line Items]    
Total Revenues $ 380,846 $ 376,638
Codman Specialty Surgical    
Disaggregation of Revenue [Line Items]    
Total Revenues 248,136 247,308
Codman Specialty Surgical | Neurosurgery    
Disaggregation of Revenue [Line Items]    
Total Revenues 192,870 194,675
Codman Specialty Surgical | Instruments    
Disaggregation of Revenue [Line Items]    
Total Revenues 55,266 52,633
Tissue Technologies    
Disaggregation of Revenue [Line Items]    
Total Revenues 132,710 129,330
Tissue Technologies | Wound Reconstruction and Care    
Disaggregation of Revenue [Line Items]    
Total Revenues 100,940 94,630
Tissue Technologies | Private Label    
Disaggregation of Revenue [Line Items]    
Total Revenues $ 31,770 $ 34,700
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORIES - Schedule of Net Inventories (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Finished goods $ 178,626 $ 172,088
Work in process 80,532 70,598
Raw materials 92,117 81,897
Inventories, net $ 351,275 $ 324,583
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2023
USD ($)
Goodwill [Roll Forward]  
Beginning of Period $ 1,038,881
Foreign currency translation 2,596
End of Period 1,041,606
Surgical Innovation Associates Inc  
Goodwill [Roll Forward]  
SIA Acquisition Working Capital Adjustment 129
Codman Specialty Surgical  
Goodwill [Roll Forward]  
Beginning of Period 656,219
Foreign currency translation 1,639
End of Period 657,858
Codman Specialty Surgical | Surgical Innovation Associates Inc  
Goodwill [Roll Forward]  
SIA Acquisition Working Capital Adjustment 0
Tissue Technologies  
Goodwill [Roll Forward]  
Beginning of Period 382,662
Foreign currency translation 957
End of Period 383,748
Tissue Technologies | Surgical Innovation Associates Inc  
Goodwill [Roll Forward]  
SIA Acquisition Working Capital Adjustment $ 129
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Acquired Finite-Lived Intangible Assets [Line Items]    
Cost $ 1,701,363 $ 1,697,532
Accumulated Amortization (592,604) (570,923)
Net 1,108,759 1,126,609
Codman tradename    
Acquired Finite-Lived Intangible Assets [Line Items]    
Cost 167,529 166,693
Net $ 167,529 $ 166,693
Completed technology    
Acquired Finite-Lived Intangible Assets [Line Items]    
Weighted Average Life 18 years 18 years
Cost $ 1,206,748 $ 1,204,325
Accumulated Amortization (389,297) (370,968)
Net $ 817,451 $ 833,357
Customer relationships    
Acquired Finite-Lived Intangible Assets [Line Items]    
Weighted Average Life 12 years 12 years
Cost $ 193,297 $ 193,081
Accumulated Amortization (146,098) (144,040)
Net $ 47,199 $ 49,041
Trademarks/brand names    
Acquired Finite-Lived Intangible Assets [Line Items]    
Weighted Average Life 28 years 28 years
Cost $ 97,554 $ 97,265
Accumulated Amortization (35,665) (34,674)
Net $ 61,889 $ 62,591
Supplier relationships    
Acquired Finite-Lived Intangible Assets [Line Items]    
Weighted Average Life 30 years 30 years
Cost $ 30,211 $ 30,211
Accumulated Amortization (17,415) (17,170)
Net $ 12,796 $ 13,041
All other    
Acquired Finite-Lived Intangible Assets [Line Items]    
Weighted Average Life 11 years 11 years
Cost $ 6,024 $ 5,957
Accumulated Amortization (4,129) (4,071)
Net $ 1,895 $ 1,886
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)
$ in Millions
Mar. 31, 2023
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Expected annual amortization expense, remainder of 2022 $ 61.8
Expected annual amortization expense, in 2023 81.8
Expected annual amortization expense, in 2024 81.8
Expected annual amortization expense, in 2025 81.6
Expected annual amortization expense, in 2026 79.7
Expected annual amortization expense, in 2027 78.1
Expected annual amortization expense, thereafter $ 474.4
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.23.1
DEBT - Narrative (Details)
3 Months Ended
Feb. 04, 2020
USD ($)
$ / shares
Mar. 31, 2023
USD ($)
Mar. 24, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 09, 2020
USD ($)
Debt Instrument [Line Items]          
Term loan component of senior credit facility   $ 0   $ 38,125,000  
Interest payments, remainder of fiscal year   35,900,000      
Interest payments, year one   38,100,000      
Interest payments, year two   32,600,000      
Interest payments, year three   30,000,000      
Interest payments, after year three   34,500,000      
Securitization program outstanding borrowings, maximum limit   150,000,000      
Secured long-term debt, securitization program   $ 102,500,000   $ 104,700,000  
Weighted average interest rate, accounts receivable securitization revolving loan facility   5.80%   5.00%  
Fair Value, Inputs, Level 2          
Debt Instrument [Line Items]          
Securitization facility, outstanding borrowings, fair value   $ 102,200,000      
Revolving Credit Facility          
Debt Instrument [Line Items]          
Maximum borrowing capacity     $ 1,300,000,000    
Debt issuance costs capitalized   7,600,000      
Write off of debt issuance costs   200,000      
Line of credit facility outstanding   $ 0   $ 0  
Standby Letters of Credit          
Debt Instrument [Line Items]          
Maximum borrowing capacity     60,000,000    
Swingline Loans          
Debt Instrument [Line Items]          
Maximum borrowing capacity     60,000,000    
Senior Credit Facility          
Debt Instrument [Line Items]          
Maximum borrowing capacity     2,100,000,000    
Senior Credit Facility | Overnight Federal Funds          
Debt Instrument [Line Items]          
Interest rates available   0.50%      
Senior Credit Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate          
Debt Instrument [Line Items]          
Interest rate adjustment   0.10%      
Interest rates available   1.00%      
Senior Credit Facility | Minimum          
Debt Instrument [Line Items]          
Line of credit, commitment fee percentage   0.15%      
Senior Credit Facility | Minimum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate          
Debt Instrument [Line Items]          
Interest rates available   1.00%      
Senior Credit Facility | Maximum          
Debt Instrument [Line Items]          
Line of credit, commitment fee percentage   0.30%      
Senior Credit Facility | Maximum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate          
Debt Instrument [Line Items]          
Interest rates available   1.75%      
Senior Credit Facility | Standby Letters of Credit          
Debt Instrument [Line Items]          
Line of credit facility outstanding   $ 0      
Letters of credit outstanding   1,600,000   1,600,000  
Term Loan Facility | Secured Debt          
Debt Instrument [Line Items]          
Maximum borrowing capacity     $ 775,000,000    
Line of credit facility outstanding   $ 775,000,000   $ 775,000,000  
Weighted average interest rate on debt   6.30%   5.60%  
Term loan component of senior credit facility   $ 0   $ 38,100,000  
Term Loan Facility | Secured Debt | Fair Value, Inputs, Level 2          
Debt Instrument [Line Items]          
Line of credit facility, fair value of amount outstanding   750,900,000      
2025 Notes | Convertible Debt          
Debt Instrument [Line Items]          
Convertible notes, maximum borrowing capacity $ 575,000,000 575,000,000.0      
Convertible notes, interest rate 0.50%        
Incremental financing costs capitalized $ 13,200,000        
Initial conversion rate 0.0135739        
Initial conversion price (in dollars per share) | $ / shares $ 73.67        
Maximum selling price of the company's common stock of the conversion price 130.00%        
Maximum average conversion value of notes 98.00%        
Minimum settled in cash per principal amount         $ 1,000
Redemption price, percentage 100.00%        
Warrant strike price (in dollars per share) | $ / shares $ 113.34        
Fair value   $ 561,700,000      
2025 Notes | Convertible Debt | Call Option          
Debt Instrument [Line Items]          
Cost of call transactions $ 104,200,000        
Proceeds from warrant transactions $ 44,500,000        
Initial strike price (in dollars per share) | $ / shares $ 73.67        
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.23.1
DEBT - Maximum Total Leverage Ratio Table (Details) - Senior Credit Facility
Mar. 24, 2023
March 31, 2023 through December 31, 2024  
Debt Instrument [Line Items]  
Maximum Consolidated Total Leverage Ratio 4.50
March 31, 2025 through June 30, 2026  
Debt Instrument [Line Items]  
Maximum Consolidated Total Leverage Ratio 4.25
September 30, 2026 and the last day of each fiscal quarter thereafter  
Debt Instrument [Line Items]  
Maximum Consolidated Total Leverage Ratio 4.00
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.23.1
DEBT - Contractual Maturity Table (Details)
$ in Thousands
Mar. 31, 2023
USD ($)
Debt Disclosure [Abstract]  
Remainder of 2023 $ 0
2024 14,531
2025 33,906
2026 38,750
Thereafter 687,813
Principal Repayment $ 775,000
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.23.1
DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details) - Cash Flow Hedges - Designated as Hedging Instrument - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Derivative [Line Items]    
Estimated Fair Value $ 42,678 $ 56,712
Interest Rate Swap Designated March 31, 2023    
Derivative [Line Items]    
Notional Amount 0  
Estimated Fair Value (1,842)  
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate    
Derivative [Line Items]    
Notional Amount 1,475,000 1,475,000
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated December 13, 2017 Tranche 2    
Derivative [Line Items]    
Notional Amount $ 150,000 $ 150,000
Fixed Interest Rate 2.423% 2.423%
Estimated Fair Value $ 4,022 $ 5,012
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated December 13, 2017 Tranche 3    
Derivative [Line Items]    
Notional Amount $ 200,000 $ 200,000
Fixed Interest Rate 2.313% 2.313%
Estimated Fair Value $ 6,738 $ 8,380
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated October 10, 2018 Tranche 1    
Derivative [Line Items]    
Notional Amount $ 75,000 $ 75,000
Fixed Interest Rate 3.22% 3.22%
Estimated Fair Value $ 1,329 $ 1,831
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated October 10, 2018 Tranche 2    
Derivative [Line Items]    
Notional Amount $ 75,000 $ 75,000
Fixed Interest Rate 3.199% 3.199%
Estimated Fair Value $ 1,539 $ 1,905
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated October 10, 2018 Tranche 3    
Derivative [Line Items]    
Notional Amount $ 75,000 $ 75,000
Fixed Interest Rate 3.209% 3.209%
Estimated Fair Value $ 1,441 $ 1,970
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated December 18, 2018 Tranche 1    
Derivative [Line Items]    
Notional Amount $ 100,000 $ 100,000
Fixed Interest Rate 2.885% 2.885%
Estimated Fair Value $ 2,770 $ 4,252
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated December 18, 2018 Tranche 2    
Derivative [Line Items]    
Notional Amount $ 100,000 $ 100,000
Fixed Interest Rate 2.867% 2.867%
Estimated Fair Value $ 2,708 $ 4,153
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated December 15, 2020 Tranche 1    
Derivative [Line Items]    
Notional Amount $ 575,000 $ 575,000
Fixed Interest Rate 1.415% 1.415%
Estimated Fair Value $ 19,406 $ 23,742
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated December 15, 2020 Tranche 2    
Derivative [Line Items]    
Notional Amount $ 125,000 $ 125,000
Fixed Interest Rate 1.404% 1.404%
Estimated Fair Value $ 4,567 $ 5,467
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.23.1
DERIVATIVE INSTRUMENTS - Narrative (Details)
SFr in Millions
3 Months Ended
Mar. 31, 2023
USD ($)
Mar. 31, 2023
CHF (SFr)
Mar. 31, 2022
USD ($)
Sep. 26, 2022
USD ($)
Sep. 26, 2022
CHF (SFr)
Sep. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
Dec. 21, 2020
USD ($)
Dec. 21, 2020
CHF (SFr)
Derivative [Line Items]                  
Gain expected to be reclassified to earnings in the next twelve months $ 10,900,000                
Designated as Hedging Instrument                  
Derivative [Line Items]                  
Gain (loss) recorded in AOCL, change in fair value (7,462,000)   $ 43,300,000            
Cross-currency swap                  
Derivative [Line Items]                  
Current notional amount               $ 471,600,000 SFr 420.1
Intercompany loan quarterly payments | SFr   SFr 5.8              
Gain (loss) reclassified into other income 1,500,000   1,800,000            
Gain (loss) recorded in AOCL, change in fair value 7,500,000   7,900,000            
Gain expected to be reclassified to earnings in the next twelve months 100,000                
Cross-currency swap | Cash Flow Hedges | Designated as Hedging Instrument                  
Derivative [Line Items]                  
Gain (loss) reclassified into other income (4,900,000)   6,500,000            
Cross-currency swap | Cash Flow Hedges | Designated as Hedging Instrument | Other income, net                  
Derivative [Line Items]                  
Gain (loss) recorded in AOCL, change in fair value 2,191,000   316,000            
Cross-currency swap | Net Investment Hedges | Designated as Hedging Instrument                  
Derivative [Line Items]                  
Gain (loss) reclassified into other income 2,100,000   1,300,000            
Gain (loss) recorded, net investment hedge, change in fair value 1,100,000   $ (1,300,000)            
Cross-currency swap | Short | Codman                  
Derivative [Line Items]                  
Terminated notional amount       $ 50,000,000          
Current notional amount 49,100,000       SFr 48.5        
Foreign currency swaps | Not Designated as Hedging Instrument                  
Derivative [Line Items]                  
Current notional amount           $ 6,400,000 $ 7,300,000    
Foreign currency forward contracts | Cash Flow Hedges | Designated as Hedging Instrument                  
Derivative [Line Items]                  
Current notional amount 10,800,000                
Gain (loss) recorded in AOCL, change in fair value 0                
Foreign currency forward contracts | Cash Flow Hedges | Designated as Hedging Instrument | Other income, net                  
Derivative [Line Items]                  
Gain (loss) recorded in AOCL, change in fair value $ (69,000)                
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.23.1
DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details)
SFr in Thousands
Mar. 31, 2023
USD ($)
Mar. 31, 2023
CHF (SFr)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
CHF (SFr)
Sep. 26, 2022
CHF (SFr)
Dec. 21, 2020
USD ($)
Dec. 21, 2020
CHF (SFr)
Cross-currency swap              
Derivative [Line Items]              
Aggregate Notional Amount           $ 471,600,000 SFr 420,100
Cross-currency swap | Short | Codman              
Derivative [Line Items]              
Aggregate Notional Amount $ 49,100,000       SFr 48,500    
Cash Flow Hedges | Designated as Hedging Instrument              
Derivative [Line Items]              
Fair Value Asset (Liability) 42,678,000   $ 56,712,000        
Cash Flow Hedges | Designated as Hedging Instrument | Cross-currency swap | Codman              
Derivative [Line Items]              
Fair Value Asset (Liability) (7,044,000)   (7,769,000)        
Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swap One | Codman              
Derivative [Line Items]              
Fair Value Asset (Liability) $ (3,033,000)   (4,241,000)        
Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swap One | Long | Codman              
Derivative [Line Items]              
Fixed Rate 3.00% 3.00%          
Aggregate Notional Amount | SFr   SFr 373,227   SFr 397,137      
Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swap One | Short | Codman              
Derivative [Line Items]              
Fixed Rate 3.98% 3.98%          
Aggregate Notional Amount $ 418,980,000   445,821,000        
Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swap Two | Codman              
Derivative [Line Items]              
Fair Value Asset (Liability) $ (4,011,000)   (3,528,000)        
Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swap Two | Long | Codman              
Derivative [Line Items]              
Fixed Rate 1.95% 1.95%          
Aggregate Notional Amount | SFr   SFr 48,533   SFr 48,532      
Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swap Two | Short | Codman              
Derivative [Line Items]              
Fixed Rate 5.32% 5.32%          
Aggregate Notional Amount $ 49,142,000   $ 49,142,000        
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.23.1
DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details)
€ in Thousands, SFr in Thousands
Mar. 31, 2023
USD ($)
Mar. 31, 2023
CHF (SFr)
Mar. 31, 2023
EUR (€)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
CHF (SFr)
Dec. 31, 2022
EUR (€)
Dec. 21, 2020
USD ($)
Dec. 21, 2020
CHF (SFr)
Cross-currency swap                
Derivative [Line Items]                
Aggregate Notional Amount             $ 471,600,000 SFr 420,100
Designated as Hedging Instrument | Net Investment Hedges | Cross-currency swap                
Derivative [Line Items]                
Fair Value Asset (Liability) $ (6,790,000)     $ (5,643,000)        
Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap One                
Derivative [Line Items]                
Fair Value Asset (Liability) $ 3,989,000     4,713,000        
Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap One | Long                
Derivative [Line Items]                
Fixed Rate 0.00% 0.00% 0.00%          
Aggregate Notional Amount | €     € 51,760     € 51,760    
Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap One | Short                
Derivative [Line Items]                
Fixed Rate 2.57% 2.57% 2.57%          
Aggregate Notional Amount $ 60,000,000     60,000,000        
Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap Two                
Derivative [Line Items]                
Fair Value Asset (Liability) $ 3,932,000     4,307,000        
Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap Two | Long                
Derivative [Line Items]                
Fixed Rate 0.00% 0.00% 0.00%          
Aggregate Notional Amount | €     € 38,820     € 38,820    
Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap Two | Short                
Derivative [Line Items]                
Fixed Rate 2.19% 2.19% 2.19%          
Aggregate Notional Amount $ 45,000,000     45,000,000        
Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap Three                
Derivative [Line Items]                
Fair Value Asset (Liability) $ (14,711,000)     (14,663,000)        
Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap Three | Long                
Derivative [Line Items]                
Fixed Rate 0.00% 0.00% 0.00%          
Aggregate Notional Amount | SFr   SFr 288,210     SFr 288,210      
Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap Three | Short                
Derivative [Line Items]                
Fixed Rate 1.94% 1.94% 1.94%          
Aggregate Notional Amount $ 300,000,000     $ 300,000,000        
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.23.1
DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details)
SFr in Millions
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 21, 2020
USD ($)
Dec. 21, 2020
CHF (SFr)
Designated as Hedging Instrument        
Derivatives, Fair Value [Line Items]        
Total derivatives designated as hedges — Assets $ 62,541,000 $ 76,173,000    
Total derivatives designated as hedges — Liabilities 33,766,000 32,874,000    
Interest rate swap | Cash Flow Hedges | Designated as Hedging Instrument        
Derivatives, Fair Value [Line Items]        
Current notional amount 1,500,000,000 1,500,000,000    
Interest rate swap | Cash Flow Hedges | Designated as Hedging Instrument | Prepaid expenses and other current assets        
Derivatives, Fair Value [Line Items]        
Total derivatives designated as hedges — Assets 15,659,000 16,682,000    
Interest rate swap | Cash Flow Hedges | Designated as Hedging Instrument | Other assets        
Derivatives, Fair Value [Line Items]        
Total derivatives designated as hedges — Assets 28,861,000 40,030,000    
Interest rate swap | Cash Flow Hedges | Designated as Hedging Instrument | Accrued expenses and other current liabilities        
Derivatives, Fair Value [Line Items]        
Total derivatives designated as hedges — Liabilities 762,000 0    
Interest rate swap | Cash Flow Hedges | Designated as Hedging Instrument | Other liabilities        
Derivatives, Fair Value [Line Items]        
Total derivatives designated as hedges — Liabilities 1,080,000 0    
Cross-currency swap        
Derivatives, Fair Value [Line Items]        
Current notional amount     $ 471,600,000 SFr 420.1
Cross-currency swap | Cash Flow Hedges | Designated as Hedging Instrument | Prepaid expenses and other current assets        
Derivatives, Fair Value [Line Items]        
Total derivatives designated as hedges — Assets 4,139,000 4,497,000    
Cross-currency swap | Cash Flow Hedges | Designated as Hedging Instrument | Other assets        
Derivatives, Fair Value [Line Items]        
Total derivatives designated as hedges — Assets 0 0    
Cross-currency swap | Cash Flow Hedges | Designated as Hedging Instrument | Accrued expenses and other current liabilities        
Derivatives, Fair Value [Line Items]        
Total derivatives designated as hedges — Liabilities 4,011,000 3,528,000    
Cross-currency swap | Cash Flow Hedges | Designated as Hedging Instrument | Other liabilities        
Derivatives, Fair Value [Line Items]        
Total derivatives designated as hedges — Liabilities 7,172,000 8,738,000    
Cross-currency swap | Net Investment Hedges | Designated as Hedging Instrument | Prepaid expenses and other current assets        
Derivatives, Fair Value [Line Items]        
Total derivatives designated as hedges — Assets 10,942,000 11,653,000    
Cross-currency swap | Net Investment Hedges | Designated as Hedging Instrument | Other assets        
Derivatives, Fair Value [Line Items]        
Total derivatives designated as hedges — Assets 2,940,000 3,311,000    
Cross-currency swap | Net Investment Hedges | Designated as Hedging Instrument | Accrued expenses and other current liabilities        
Derivatives, Fair Value [Line Items]        
Total derivatives designated as hedges — Liabilities 0 0    
Cross-currency swap | Net Investment Hedges | Designated as Hedging Instrument | Other liabilities        
Derivatives, Fair Value [Line Items]        
Total derivatives designated as hedges — Liabilities 20,672,000 20,608,000    
Foreign currency forward contracts | Cash Flow Hedges | Designated as Hedging Instrument        
Derivatives, Fair Value [Line Items]        
Current notional amount 10,800,000      
Foreign currency forward contracts | Cash Flow Hedges | Designated as Hedging Instrument | Accrued expenses and other current liabilities        
Derivatives, Fair Value [Line Items]        
Total derivatives designated as hedges — Liabilities $ 69,000    
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.23.1
DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Derivative Instruments, Gain (Loss) [Roll Forward]    
Balance, beginning of period $ 1,804,403 $ 1,684,804
Balance, end of period 1,674,938 1,615,197
Accumulated Other Comprehensive Loss    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Balance, beginning of period 10,265 (45,155)
Balance, end of period 7,067 (21,025)
Cross-currency swap    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Amount of Gain (Loss) Recognized in AOCL 7,500 7,900
Designated as Hedging Instrument    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Amount of Gain (Loss) Recognized in AOCL (7,462) 43,300
Amount of Gain (Loss) Reclassified from AOCL into Earnings 2,092 4,438
Designated as Hedging Instrument | Accumulated Other Comprehensive Loss    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Balance, beginning of period 29,527 (55,956)
Balance, end of period 19,973 (17,094)
Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges | Interest expense    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Balance, beginning of period 56,712 (43,956)
Amount of Gain (Loss) Recognized in AOCL (10,534) 41,675
Amount of Gain (Loss) Reclassified from AOCL into Earnings 3,500 (5,213)
Balance, end of period 42,678 2,932
Designated as Hedging Instrument | Cross-currency swap | Cash Flow Hedges | Other income, net    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Balance, beginning of period (20,271) (9,688)
Amount of Gain (Loss) Recognized in AOCL 2,191 316
Amount of Gain (Loss) Reclassified from AOCL into Earnings (3,504) 8,331
Balance, end of period (14,576) (17,703)
Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges | Interest income    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Balance, beginning of period (6,914) (2,312)
Amount of Gain (Loss) Recognized in AOCL 950 1,309
Amount of Gain (Loss) Reclassified from AOCL into Earnings 2,096 1,320
Balance, end of period (8,060) $ (2,323)
Designated as Hedging Instrument | Foreign currency forward contracts | Cash Flow Hedges    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Amount of Gain (Loss) Recognized in AOCL 0  
Designated as Hedging Instrument | Foreign currency forward contracts | Cash Flow Hedges | Other income, net    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Amount of Gain (Loss) Recognized in AOCL (69)  
Designated as Hedging Instrument | Foreign currency forward contracts | Cash Flow Hedges | Cost of Sales    
Derivative Instruments, Gain (Loss) [Roll Forward]    
Balance, beginning of period 0  
Amount of Gain (Loss) Reclassified from AOCL into Earnings 0  
Balance, end of period $ (69)  
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.23.1
DERIVATIVE INSTRUMENTS - Schedule of Derivatives Not Designated as Hedging Instruments (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative instruments not designated as hedging instruments, gain (loss), net $ 55 $ 360
Foreign currency swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative instruments not designated as hedging instruments, gain (loss), net $ 55 $ 360
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION - Narrative (Details)
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grants in period, net of forfeitures (in shares) | shares 151,293
Options, weighted average grant date fair value (in dollars per share) | $ / shares $ 21.58
Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Total unrecognized compensation costs | $ $ 5.6
Weighted-average period for cost recognition 3 years
Stock Options | Directors  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock options exercisable, vesting period 1 year
Stock Options | Employees  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expiration period 8 years
Restricted Stock  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock options exercisable, vesting period 3 years
Total unrecognized compensation costs | $ $ 48.6
Weighted-average period for cost recognition 2 years
Awards granted during the period (in shares) | shares 346,745
Other than options, weighted average grant date fair value (in dollars per share) | $ / shares $ 53.37
Performance Stock and Restricted Stock Awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Requisite service periods of awards 3 years
Performance Stock  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Awards granted during the period (in shares) | shares 161,218
Other than options, weighted average grant date fair value (in dollars per share) | $ / shares $ 52.87
Minimum | Stock Options | Directors and Certain Executive Officers  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expiration period 6 years
Maximum | Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock options exercisable, vesting period 4 years
Maximum | Stock Options | Directors and Certain Executive Officers  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expiration period 10 years
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.23.1
RETIREMENT PLANS - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Retirement Benefits [Abstract]      
Net periodic benefit costs $ 0.3 $ 0.3  
Service cost component 0.5 $ 0.7  
Estimated fair value of plan assets $ 36.4   $ 38.1
Defer payment and taxation, base salary, percentage (up to) 75.00%    
Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to) 100.00%    
Deferred compensation plan, fair value of assets $ 5.0   $ 4.7
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES AND RELATED PARTY LEASES - Narrative (Details)
$ in Millions
3 Months Ended
Mar. 31, 2023
USD ($)
renewal_option
Mar. 31, 2022
USD ($)
Operating Leased Assets [Line Items]    
Number of renewal options (or more) | renewal_option 1  
Operating lease expense $ 6.0 $ 4.9
Affiliated Entity    
Operating Leased Assets [Line Items]    
Operating lease expense $ 0.1 $ 0.1
Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director 50.00%  
Annual rate of lease agreement $ 0.3  
Affiliated Entity | Five Year Option Lease From November 1, 2029 Through October 31, 2034    
Operating Leased Assets [Line Items]    
Option to extend lease, years 5 years  
Period for extended lease November 1, 2029 through October 31, 2034  
Affiliated Entity | Five Year Option Lease From November 1, 2034 Through October 31, 2039    
Operating Leased Assets [Line Items]    
Option to extend lease, years 5 years  
Period for extended lease November 1, 2034 through October 31, 2039  
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Lessee, Lease, Description [Line Items]    
ROU assets $ 146,514 $ 148,284
Current lease liabilities 14,792 14,624
Non-current lease liabilities 156,910 157,420
Total lease liabilities $ 171,702 $ 172,044
Leased facilities    
Lessee, Lease, Description [Line Items]    
Weighted average remaining lease term (in years) 17 years 1 month 6 days 16 years 10 months 24 days
Weighted average discount rate 5.40% 5.40%
Leased vehicles    
Lessee, Lease, Description [Line Items]    
Weighted average remaining lease term (in years) 2 years 2 years
Weighted average discount rate 2.80% 2.70%
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash paid for amounts included in the measurement of lease liabilities:    
Operating cash flows from operating leases $ 4,319 $ 4,696
ROU assets obtained in exchange for lease liabilities:    
Operating leases $ 1,721 $ 507
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Operating Leased Assets [Line Items]    
Remainder of 2023 $ 16,092  
2024 21,382  
2025 20,049  
2026 17,444  
2027 16,501  
2028 14,247  
Thereafter 151,452  
Total minimum lease payments 257,167  
Less: Imputed interest 85,465  
Total lease liabilities 171,702 $ 172,044
Less: Current lease liabilities 14,792 14,624
Long-term lease liabilities 156,910 $ 157,420
Related Parties    
Operating Leased Assets [Line Items]    
Remainder of 2023 222  
2024 296  
2025 296  
2026 296  
2027 296  
2028 296  
Thereafter 246  
Total minimum lease payments 1,948  
Third Parties    
Operating Leased Assets [Line Items]    
Remainder of 2023 15,870  
2024 21,086  
2025 19,753  
2026 17,148  
2027 16,205  
2028 13,951  
Thereafter 151,206  
Total minimum lease payments $ 255,219  
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.23.1
TREASURY STOCK - Narrative (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Jan. 26, 2023
Dec. 31, 2022
Jan. 12, 2022
Mar. 31, 2023
Mar. 24, 2022
Equity [Abstract]            
Treasury stock (in shares) 8,900   6,800   8,900  
Treasury stock $ 481,700   $ 362,900   $ 481,700  
Treasury stock, average cost per share (in dollars per share) $ 54.01   $ 53.18      
Accelerated share repurchase program, receipt (payment)   $ 150,000   $ 125,000    
Accelerated share repurchases, shares received at inception   2,100   1,480    
Accelerated share repurchases, percentage of expected total repurchased   80.00%   80.00%    
Share repurchases, accrued excise tax         $ 1,200  
Accelerated share repurchases, additional shares received           460
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES - Summary of Effective Tax Rate (Details)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Tax Disclosure [Abstract]    
Reported tax rate 18.60% 16.30%
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES - Narrative (Details)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Tax Disclosure [Abstract]    
Effective income tax rate 18.60% 16.30%
XML 77 R66.htm IDEA: XBRL DOCUMENT v3.23.1
NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Basic net income per share:    
Net income $ 24,226 $ 32,901
Weighted average common shares outstanding - Basic (in shares) 81,871 83,632
Basic net income per common share (in dollars per share) $ 0.30 $ 0.39
Diluted net income per share:    
Net income $ 24,226 $ 32,901
Weighted average common shares outstanding - Basic (in shares) 81,871 83,632
Effect of dilutive securities:    
Stock options and restricted stock (in shares) 452 644
Weighted average common shares for diluted earnings per share (in shares) 82,323 84,276
Diluted net income per common share (in dollars per share) $ 0.29 $ 0.39
XML 78 R67.htm IDEA: XBRL DOCUMENT v3.23.1
NET INCOME PER SHARE - Narrative (Details) - shares
shares in Millions
Mar. 31, 2023
Mar. 31, 2022
Earnings Per Share [Abstract]    
Shares excluded from computation as their effect would be antidilutive (in shares) 0.3 0.2
XML 79 R68.htm IDEA: XBRL DOCUMENT v3.23.1
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Equity [Abstract]    
Net income $ 24,226 $ 32,901
Foreign currency translation adjustment 4,076 (5,683)
Change in unrealized loss/(gain) on derivatives, net of tax (7,377) 29,822
Pension liability adjustment, net of tax 103 (9)
Comprehensive income, net $ 21,028 $ 57,031
XML 80 R69.htm IDEA: XBRL DOCUMENT v3.23.1
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Roll Forward]    
Balance, beginning of period $ 1,804,403 $ 1,684,804
Other comprehensive gain (loss) (1,575)  
Less: Amounts reclassified from accumulated other comprehensive income, net 1,623  
Net current-period other comprehensive gain (loss) (3,198) 24,130
Balance, end of period 1,674,938 1,615,197
Total    
Accumulated Other Comprehensive Income (Loss) [Roll Forward]    
Balance, beginning of period 10,265 (45,155)
Net current-period other comprehensive gain (loss) (3,198) 24,130
Balance, end of period 7,067 $ (21,025)
Gains and Losses on Derivatives    
Accumulated Other Comprehensive Income (Loss) [Roll Forward]    
Balance, beginning of period 22,817  
Other comprehensive gain (loss) (5,754)  
Less: Amounts reclassified from accumulated other comprehensive income, net 1,623  
Net current-period other comprehensive gain (loss) (7,377)  
Balance, end of period 15,440  
Defined Benefit Pension Items    
Accumulated Other Comprehensive Income (Loss) [Roll Forward]    
Balance, beginning of period 9,322  
Other comprehensive gain (loss) 103  
Less: Amounts reclassified from accumulated other comprehensive income, net 0  
Net current-period other comprehensive gain (loss) 103  
Balance, end of period 9,425  
Foreign Currency Items    
Accumulated Other Comprehensive Income (Loss) [Roll Forward]    
Balance, beginning of period (21,874)  
Other comprehensive gain (loss) 4,076  
Less: Amounts reclassified from accumulated other comprehensive income, net 0  
Net current-period other comprehensive gain (loss) 4,076  
Balance, end of period $ (17,798)  
XML 81 R70.htm IDEA: XBRL DOCUMENT v3.23.1
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Narrative (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2023
USD ($)
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Gain (loss) reclassified from AOCI $ 1,623
Gains and Losses on Derivatives  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Gain (loss) reclassified from AOCI 1,623
Other income (expense) | Gains and Losses on Derivatives  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Gain (loss) reclassified from AOCI 4,300
Interest income | Gains and Losses on Derivatives  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Gain (loss) reclassified from AOCI $ (2,700)
XML 82 R71.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)
3 Months Ended
Mar. 31, 2023
Segment
product
Segment Reporting Information [Line Items]  
Number of reportable segments | Segment 2
Codman Specialty Surgical  
Segment Reporting Information [Line Items]  
Number of products offered (more than) | product 40,000
XML 83 R72.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Segment Net Sales    
Total Revenues $ 380,846 $ 376,638
Segment Profit    
Operating income 36,382 46,164
Amortization (3,108) (3,894)
Operating Segments    
Segment Profit    
Operating income 163,214 164,053
Corporate and other    
Segment Profit    
Operating income (123,724) (113,995)
Codman Specialty Surgical    
Segment Net Sales    
Total Revenues 248,136 247,308
Codman Specialty Surgical | Operating Segments    
Segment Profit    
Operating income 110,933 110,160
Tissue Technologies    
Segment Net Sales    
Total Revenues 132,710 129,330
Tissue Technologies | Operating Segments    
Segment Profit    
Operating income $ 52,281 $ 53,893
XML 84 R73.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Segment Reporting Information [Line Items]    
Total Revenues $ 380,846 $ 376,638
United States    
Segment Reporting Information [Line Items]    
Total Revenues 271,002 263,351
Europe    
Segment Reporting Information [Line Items]    
Total Revenues 41,064 43,744
Asia Pacific    
Segment Reporting Information [Line Items]    
Total Revenues 50,473 47,717
Rest of World    
Segment Reporting Information [Line Items]    
Total Revenues $ 18,307 $ 21,826
XML 85 R74.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details) - Contingent Consideration Liability - Fair Value, Inputs, Level 3 - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Arkis    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, End of Period $ 16,200 $ 14,000
Arkis | Other Current Liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, Beginning of Period 2,845 3,691
Transfers 0 59
Change in fair value of contingent consideration liabilities 1,543 0
Balance, End of Period 4,388 3,750
Arkis | Other Long-term Liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, Beginning of Period 10,050 11,408
Transfers 0 (59)
Change in fair value of contingent consideration liabilities 1,756 (1,065)
Balance, End of Period 11,806 10,284
Derma Sciences | Other Long-term Liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, Beginning of Period 230 230
Transfers 0 0
Change in fair value of contingent consideration liabilities 0 0
Balance, End of Period 230 230
ACell | Other Current Liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, Beginning of Period   0
Transfers   4,885
Change in fair value of contingent consideration liabilities   0
Balance, End of Period   4,885
ACell | Other Long-term Liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, Beginning of Period 3,700 21,800
Transfers 0 (4,885)
Change in fair value of contingent consideration liabilities (2,200) 300
Balance, End of Period 1,500 $ 17,215
Surgical Innovation Associates Inc | Other Current Liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, Beginning of Period 0  
Transfers 12,500  
Change in fair value of contingent consideration liabilities 0  
Balance, End of Period 12,500  
Surgical Innovation Associates Inc | Other Long-term Liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, Beginning of Period 57,607  
Transfers (12,500)  
Change in fair value of contingent consideration liabilities 3,600  
Balance, End of Period $ 48,707  
XML 86 R75.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES - Narrative (Details)
3 Months Ended
Mar. 31, 2023
USD ($)
liability
Dec. 31, 2022
USD ($)
Mar. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Jan. 20, 2021
USD ($)
Jul. 29, 2019
USD ($)
Arkis            
Loss Contingencies [Line Items]            
Contingent consideration, estimated fair value           $ 25,500,000
Contingent consideration           13,100,000
Arkis | Fair Value, Inputs, Level 3 | Contingent Consideration Liability            
Loss Contingencies [Line Items]            
Fair value $ 16,200,000   $ 14,000,000      
Arkis | Other Long-term Liabilities | Fair Value, Inputs, Level 3 | Contingent Consideration Liability            
Loss Contingencies [Line Items]            
Fair value 11,806,000 $ 10,050,000 10,284,000 $ 11,408,000    
Arkis | Accrued expenses and other current liabilities | Fair Value, Inputs, Level 3 | Contingent Consideration Liability            
Loss Contingencies [Line Items]            
Fair value $ 4,400,000   3,800,000      
Arkis | Development Milestones            
Loss Contingencies [Line Items]            
Contingent consideration, estimated fair value           10,000,000.0
Arkis | Commercial Sales Milestones            
Loss Contingencies [Line Items]            
Contingent consideration, estimated fair value           $ 15,500,000
Derma Sciences            
Loss Contingencies [Line Items]            
Number of contingent liabilities remaining | liability 1          
Contingent consideration, maximum undiscounted payment amount $ 3,000,000          
Derma Sciences | Fair Value, Inputs, Level 3            
Loss Contingencies [Line Items]            
Contingent consideration, estimated fair value 200,000   200,000      
Derma Sciences | Other Long-term Liabilities | Fair Value, Inputs, Level 3 | Contingent Consideration Liability            
Loss Contingencies [Line Items]            
Fair value 230,000 $ 230,000 230,000 $ 230,000    
Derma Sciences | BioD Earnout Payments and Medihoney Earnout Payments            
Loss Contingencies [Line Items]            
Payment for contingent consideration 33,300,000          
ACell, Inc.            
Loss Contingencies [Line Items]            
Contingent consideration, estimated fair value $ 1,500,000   17,200,000      
Contingent consideration         $ 23,900,000  
Contingent consideration, maximum undiscounted payment amount         $ 100,000,000  
Contingent consideration, current     $ 4,900,000      
XML 87 iart-20230331_htm.xml IDEA: XBRL DOCUMENT 0000917520 2023-01-01 2023-03-31 0000917520 2023-04-25 0000917520 2022-01-01 2022-03-31 0000917520 2023-03-31 0000917520 2022-12-31 0000917520 2021-12-31 0000917520 2022-03-31 0000917520 us-gaap:CommonStockMember 2022-12-31 0000917520 us-gaap:TreasuryStockMember 2022-12-31 0000917520 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000917520 us-gaap:RetainedEarningsMember 2022-12-31 0000917520 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000917520 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000917520 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000917520 us-gaap:TreasuryStockMember 2023-01-01 2023-03-31 0000917520 us-gaap:CommonStockMember 2023-03-31 0000917520 us-gaap:TreasuryStockMember 2023-03-31 0000917520 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000917520 us-gaap:RetainedEarningsMember 2023-03-31 0000917520 us-gaap:CommonStockMember 2021-12-31 0000917520 us-gaap:TreasuryStockMember 2021-12-31 0000917520 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000917520 us-gaap:RetainedEarningsMember 2021-12-31 0000917520 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000917520 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000917520 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000917520 us-gaap:TreasuryStockMember 2022-01-01 2022-03-31 0000917520 us-gaap:CommonStockMember 2022-03-31 0000917520 us-gaap:TreasuryStockMember 2022-03-31 0000917520 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000917520 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000917520 us-gaap:RetainedEarningsMember 2022-03-31 0000917520 iart:SurgicalInnovationAssociatesIncMember 2022-12-06 2022-12-06 0000917520 iart:SurgicalInnovationAssociatesIncMember iart:RevenueBasedPerformanceMilestonesMember 2022-12-06 0000917520 iart:SurgicalInnovationAssociatesIncMember iart:FDAApprovalOfPremarketApprovalMember 2022-12-06 0000917520 iart:SurgicalInnovationAssociatesIncMember 2022-12-06 0000917520 iart:SurgicalInnovationAssociatesIncMember 2023-03-31 0000917520 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember iart:TraditionalWoundCareMember 2022-08-31 0000917520 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember iart:TraditionalWoundCareMember 2022-08-31 2022-08-31 0000917520 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember iart:TraditionalWoundCareMember 2022-01-01 2022-12-31 0000917520 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember iart:TraditionalWoundCareMember 2023-03-31 0000917520 2023-04-01 2023-03-31 0000917520 iart:NeurosurgeryMember iart:CodmanSpecialtySurgicalMember 2023-01-01 2023-03-31 0000917520 iart:NeurosurgeryMember iart:CodmanSpecialtySurgicalMember 2022-01-01 2022-03-31 0000917520 iart:InstrumentsMember iart:CodmanSpecialtySurgicalMember 2023-01-01 2023-03-31 0000917520 iart:InstrumentsMember iart:CodmanSpecialtySurgicalMember 2022-01-01 2022-03-31 0000917520 iart:CodmanSpecialtySurgicalMember 2023-01-01 2023-03-31 0000917520 iart:CodmanSpecialtySurgicalMember 2022-01-01 2022-03-31 0000917520 iart:RegenerativeSkinAndWoundMember iart:TissueTechnologiesMember 2023-01-01 2023-03-31 0000917520 iart:RegenerativeSkinAndWoundMember iart:TissueTechnologiesMember 2022-01-01 2022-03-31 0000917520 iart:PrivateLabelMember iart:TissueTechnologiesMember 2023-01-01 2023-03-31 0000917520 iart:PrivateLabelMember iart:TissueTechnologiesMember 2022-01-01 2022-03-31 0000917520 iart:TissueTechnologiesMember 2023-01-01 2023-03-31 0000917520 iart:TissueTechnologiesMember 2022-01-01 2022-03-31 0000917520 iart:CodmanSpecialtySurgicalMember 2022-12-31 0000917520 iart:TissueTechnologiesMember 2022-12-31 0000917520 iart:SurgicalInnovationAssociatesIncMember iart:CodmanSpecialtySurgicalMember 2023-01-01 2023-03-31 0000917520 iart:SurgicalInnovationAssociatesIncMember iart:TissueTechnologiesMember 2023-01-01 2023-03-31 0000917520 iart:SurgicalInnovationAssociatesIncMember 2023-01-01 2023-03-31 0000917520 iart:CodmanSpecialtySurgicalMember 2023-03-31 0000917520 iart:TissueTechnologiesMember 2023-03-31 0000917520 iart:CompletedTechnologyMember 2023-01-01 2023-03-31 0000917520 iart:CompletedTechnologyMember 2023-03-31 0000917520 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-03-31 0000917520 us-gaap:CustomerRelationshipsMember 2023-03-31 0000917520 iart:TrademarksBrandNamesMember 2023-01-01 2023-03-31 0000917520 iart:TrademarksBrandNamesMember 2023-03-31 0000917520 us-gaap:TradeNamesMember 2023-03-31 0000917520 iart:SupplierRelationShipsMember 2023-01-01 2023-03-31 0000917520 iart:SupplierRelationShipsMember 2023-03-31 0000917520 iart:AllOtherMember 2023-01-01 2023-03-31 0000917520 iart:AllOtherMember 2023-03-31 0000917520 iart:CompletedTechnologyMember 2022-01-01 2022-12-31 0000917520 iart:CompletedTechnologyMember 2022-12-31 0000917520 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0000917520 us-gaap:CustomerRelationshipsMember 2022-12-31 0000917520 iart:TrademarksBrandNamesMember 2022-01-01 2022-12-31 0000917520 iart:TrademarksBrandNamesMember 2022-12-31 0000917520 us-gaap:TradeNamesMember 2022-12-31 0000917520 iart:SupplierRelationShipsMember 2022-01-01 2022-12-31 0000917520 iart:SupplierRelationShipsMember 2022-12-31 0000917520 iart:AllOtherMember 2022-01-01 2022-12-31 0000917520 iart:AllOtherMember 2022-12-31 0000917520 iart:SeniorCreditFacilityMember 2023-03-24 0000917520 us-gaap:SecuredDebtMember iart:TermLoanFacilityMember 2023-03-24 0000917520 us-gaap:RevolvingCreditFacilityMember 2023-03-24 0000917520 us-gaap:StandbyLettersOfCreditMember 2023-03-24 0000917520 iart:SwinglineLoanMember 2023-03-24 0000917520 iart:SeniorCreditFacilityMember iart:DebtCovenantPeriod1Member 2023-03-24 0000917520 iart:SeniorCreditFacilityMember iart:DebtCovenantPeriod2Member 2023-03-24 0000917520 iart:SeniorCreditFacilityMember iart:DebtCovenantPeriod3Member 2023-03-24 0000917520 iart:SeniorCreditFacilityMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-01-01 2023-03-31 0000917520 srt:MinimumMember iart:SeniorCreditFacilityMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-01-01 2023-03-31 0000917520 srt:MaximumMember iart:SeniorCreditFacilityMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-01-01 2023-03-31 0000917520 iart:SeniorCreditFacilityMember us-gaap:FederalFundsEffectiveSwapRateMember 2023-01-01 2023-03-31 0000917520 srt:MinimumMember iart:SeniorCreditFacilityMember 2023-01-01 2023-03-31 0000917520 srt:MaximumMember iart:SeniorCreditFacilityMember 2023-01-01 2023-03-31 0000917520 us-gaap:RevolvingCreditFacilityMember 2023-03-31 0000917520 us-gaap:RevolvingCreditFacilityMember 2023-01-01 2023-03-31 0000917520 us-gaap:RevolvingCreditFacilityMember 2022-12-31 0000917520 us-gaap:SecuredDebtMember iart:TermLoanFacilityMember 2022-12-31 0000917520 us-gaap:SecuredDebtMember iart:TermLoanFacilityMember 2023-03-31 0000917520 us-gaap:SecuredDebtMember iart:TermLoanFacilityMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0000917520 us-gaap:StandbyLettersOfCreditMember iart:SeniorCreditFacilityMember 2022-12-31 0000917520 us-gaap:StandbyLettersOfCreditMember iart:SeniorCreditFacilityMember 2023-03-31 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember 2020-02-04 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember 2020-02-04 2020-02-04 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember 2020-12-09 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:CallOptionMember 2020-02-04 2020-02-04 0000917520 iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember us-gaap:ConvertibleDebtMember 2023-03-31 0000917520 us-gaap:FairValueInputsLevel2Member 2023-03-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-03-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche3Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-03-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-03-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-03-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche3Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-03-31 0000917520 iart:InterestRateSwapDesignatedDecember182018Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-03-31 0000917520 iart:InterestRateSwapDesignatedDecember182018Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-03-31 0000917520 iart:InterestRateSwapDesignatedDecember152020Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-03-31 0000917520 iart:InterestRateSwapDesignatedDecember152020Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-03-31 0000917520 iart:InterestRateSwapDesignatedMarch312023Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-03-31 0000917520 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-31 0000917520 iart:InterestRateSwapDesignatedDecember132017Tranche3Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-31 0000917520 iart:InterestRateSwapDesignatedOctober102018Tranche3Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-31 0000917520 iart:InterestRateSwapDesignatedDecember182018Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-31 0000917520 iart:InterestRateSwapDesignatedDecember182018Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-31 0000917520 iart:InterestRateSwapDesignatedDecember152020Tranche1Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-31 0000917520 iart:InterestRateSwapDesignatedDecember152020Tranche2Member us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-31 0000917520 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-31 0000917520 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:ShortMember 2022-09-26 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:ShortMember 2023-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember 2020-12-21 0000917520 us-gaap:CrossCurrencyInterestRateContractMember 2023-01-01 2023-03-31 0000917520 iart:CodmanMember iart:CrossCurrencyInterestRateContractOneMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2023-03-31 0000917520 iart:CodmanMember iart:CrossCurrencyInterestRateContractOneMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2022-12-31 0000917520 iart:CodmanMember iart:CrossCurrencyInterestRateContractOneMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 iart:CodmanMember iart:CrossCurrencyInterestRateContractOneMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 iart:CodmanMember iart:CrossCurrencyInterestRateContractOneMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2023-03-31 0000917520 iart:CodmanMember iart:CrossCurrencyInterestRateContractOneMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2022-12-31 0000917520 iart:CodmanMember iart:CrossCurrencyInterestRateContractTwoMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2023-03-31 0000917520 iart:CodmanMember iart:CrossCurrencyInterestRateContractTwoMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2022-12-31 0000917520 iart:CodmanMember iart:CrossCurrencyInterestRateContractTwoMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 iart:CodmanMember iart:CrossCurrencyInterestRateContractTwoMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 iart:CodmanMember iart:CrossCurrencyInterestRateContractTwoMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2023-03-31 0000917520 iart:CodmanMember iart:CrossCurrencyInterestRateContractTwoMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2022-12-31 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 iart:CodmanMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember 2022-01-01 2022-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember 2023-03-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2023-03-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2022-12-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2023-03-31 0000917520 iart:CrossCurrencyInterestRateContractOneMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2022-12-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2023-03-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2022-12-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2023-03-31 0000917520 iart:CrossCurrencyInterestRateContractTwoMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2022-12-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2023-03-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2022-12-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2023-03-31 0000917520 iart:CrossCurrencyInterestRateContractThreeMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2022-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-03-31 0000917520 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-03-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 us-gaap:OtherAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 us-gaap:OtherAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 us-gaap:OtherLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2022-12-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2023-01-01 2023-03-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2023-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-01-01 2023-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-03-31 0000917520 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2022-12-31 0000917520 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-01-01 2023-03-31 0000917520 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2023-01-01 2023-03-31 0000917520 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2023-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2022-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2023-01-01 2023-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2023-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2021-12-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2022-01-01 2022-03-31 0000917520 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2022-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2021-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-01 2022-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2021-12-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2022-01-01 2022-03-31 0000917520 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2022-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-03-31 0000917520 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000917520 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember 2021-06-30 0000917520 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember 2021-09-30 0000917520 us-gaap:CurrencySwapMember 2023-01-01 2023-03-31 0000917520 us-gaap:CurrencySwapMember 2022-01-01 2022-03-31 0000917520 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0000917520 srt:DirectorMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0000917520 iart:EmployeeMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0000917520 srt:MinimumMember iart:DirectorsandCertainExecutiveOfficersMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0000917520 srt:MaximumMember iart:DirectorsandCertainExecutiveOfficersMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0000917520 us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0000917520 us-gaap:EmployeeStockOptionMember 2023-03-31 0000917520 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0000917520 iart:PerformanceStockAndRestrictedStockAwardsMember 2023-01-01 2023-03-31 0000917520 us-gaap:RestrictedStockMember 2023-03-31 0000917520 us-gaap:PerformanceSharesMember 2023-01-01 2023-03-31 0000917520 srt:AffiliatedEntityMember 2022-01-01 2022-03-31 0000917520 srt:AffiliatedEntityMember 2023-01-01 2023-03-31 0000917520 us-gaap:BuildingMember 2023-03-31 0000917520 us-gaap:BuildingMember 2022-12-31 0000917520 us-gaap:VehiclesMember 2023-03-31 0000917520 us-gaap:VehiclesMember 2022-12-31 0000917520 iart:RelatedPartiesMember 2023-03-31 0000917520 iart:ThirdPartiesMember 2023-03-31 0000917520 iart:FiveYearOptionLeasePeriodOneMember srt:AffiliatedEntityMember 2023-03-31 0000917520 iart:FiveYearOptionLeasePeriodOneMember srt:AffiliatedEntityMember 2023-01-01 2023-03-31 0000917520 iart:FiveYearOptionLeasePeriodTwoMember srt:AffiliatedEntityMember 2023-03-31 0000917520 iart:FiveYearOptionLeasePeriodTwoMember srt:AffiliatedEntityMember 2023-01-01 2023-03-31 0000917520 2023-03-31 2023-03-31 0000917520 2022-12-31 2022-12-31 0000917520 2023-01-26 0000917520 2023-01-26 2023-01-26 0000917520 2022-01-12 0000917520 2022-01-12 2022-01-12 0000917520 2022-03-24 0000917520 2022-03-31 2022-03-31 0000917520 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0000917520 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0000917520 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0000917520 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0000917520 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-03-31 0000917520 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0000917520 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-03-31 0000917520 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-03-31 0000917520 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0000917520 us-gaap:OtherExpenseMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0000917520 us-gaap:InterestIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0000917520 us-gaap:OperatingSegmentsMember iart:CodmanSpecialtySurgicalMember 2023-01-01 2023-03-31 0000917520 us-gaap:OperatingSegmentsMember iart:CodmanSpecialtySurgicalMember 2022-01-01 2022-03-31 0000917520 us-gaap:OperatingSegmentsMember iart:TissueTechnologiesMember 2023-01-01 2023-03-31 0000917520 us-gaap:OperatingSegmentsMember iart:TissueTechnologiesMember 2022-01-01 2022-03-31 0000917520 us-gaap:OperatingSegmentsMember 2023-01-01 2023-03-31 0000917520 us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000917520 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-03-31 0000917520 us-gaap:CorporateNonSegmentMember 2022-01-01 2022-03-31 0000917520 country:US 2023-01-01 2023-03-31 0000917520 country:US 2022-01-01 2022-03-31 0000917520 srt:EuropeMember 2023-01-01 2023-03-31 0000917520 srt:EuropeMember 2022-01-01 2022-03-31 0000917520 srt:AsiaPacificMember 2023-01-01 2023-03-31 0000917520 srt:AsiaPacificMember 2022-01-01 2022-03-31 0000917520 iart:RestOfWorldMember 2023-01-01 2023-03-31 0000917520 iart:RestOfWorldMember 2022-01-01 2022-03-31 0000917520 us-gaap:OtherCurrentLiabilitiesMember iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-12-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-12-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-12-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:ACellMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-12-31 0000917520 us-gaap:OtherCurrentLiabilitiesMember iart:SurgicalInnovationAssociatesIncMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-12-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:SurgicalInnovationAssociatesIncMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-12-31 0000917520 us-gaap:OtherCurrentLiabilitiesMember iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2023-01-01 2023-03-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2023-01-01 2023-03-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2023-01-01 2023-03-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:ACellMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2023-01-01 2023-03-31 0000917520 us-gaap:OtherCurrentLiabilitiesMember iart:SurgicalInnovationAssociatesIncMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2023-01-01 2023-03-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:SurgicalInnovationAssociatesIncMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2023-01-01 2023-03-31 0000917520 us-gaap:OtherCurrentLiabilitiesMember iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2023-03-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2023-03-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2023-03-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:ACellMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2023-03-31 0000917520 us-gaap:OtherCurrentLiabilitiesMember iart:SurgicalInnovationAssociatesIncMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2023-03-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:SurgicalInnovationAssociatesIncMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2023-03-31 0000917520 us-gaap:OtherCurrentLiabilitiesMember iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2021-12-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2021-12-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2021-12-31 0000917520 us-gaap:OtherCurrentLiabilitiesMember iart:ACellMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2021-12-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:ACellMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2021-12-31 0000917520 us-gaap:OtherCurrentLiabilitiesMember iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-01-01 2022-03-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-01-01 2022-03-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-01-01 2022-03-31 0000917520 us-gaap:OtherCurrentLiabilitiesMember iart:ACellMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-01-01 2022-03-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:ACellMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-01-01 2022-03-31 0000917520 us-gaap:OtherCurrentLiabilitiesMember iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-03-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-03-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-03-31 0000917520 us-gaap:OtherCurrentLiabilitiesMember iart:ACellMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-03-31 0000917520 us-gaap:OtherNoncurrentLiabilitiesMember iart:ACellMember us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-03-31 0000917520 iart:ArkisBioSciencesInc.Member 2019-07-29 0000917520 iart:ArkisBioSciencesInc.Member iart:MilestonePaymentOneMember 2019-07-29 0000917520 iart:ArkisBioSciencesInc.Member iart:MilestonePaymentTwoMember 2019-07-29 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2023-03-31 0000917520 iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-03-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2023-03-31 0000917520 iart:AccruedExpensesAndOtherCurrentLiabilitiesMember iart:ArkisBioSciencesInc.Member us-gaap:FairValueInputsLevel3Member iart:ContingentConsiderationLiabilityMember 2022-03-31 0000917520 iart:DermaSciencesMember iart:BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember 2023-01-01 2023-03-31 0000917520 iart:DermaSciencesMember 2023-03-31 0000917520 iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0000917520 iart:DermaSciencesMember us-gaap:FairValueInputsLevel3Member 2022-03-31 0000917520 iart:ACellIncMember 2021-01-20 0000917520 iart:ACellIncMember 2023-03-31 0000917520 iart:ACellIncMember 2022-03-31 shares iso4217:USD iso4217:USD shares iart:payment pure iso4217:CHF iso4217:EUR iart:renewal_option iart:Segment iart:product iart:liability false 2023 Q1 2023-03-31 0000917520 --12-31 0.0135739 P6Y 10-Q true false 000-26224 INTEGRA LIFESCIENCES HOLDINGS CORP DE 51-0317849 1100 Campus Road 08540 Princeton NJ 609 275-0500 Common Stock, Par Value $.01 Per Share IART NASDAQ Yes Yes Large Accelerated Filer false false false 81904442 380846000 376638000 147975000 142569000 26724000 24085000 166657000 159926000 3108000 3894000 344464000 330474000 36382000 46164000 4107000 1377000 12100000 11655000 1389000 3429000 29778000 39315000 5552000 6414000 24226000 32901000 0.30 0.39 0.29 0.39 81871000 83632000 82323000 84276000 21028000 57031000 307367000 456661000 3544000 4304000 253995000 263465000 351275000 324583000 116845000 116789000 1029482000 1161498000 315175000 311302000 146514000 148284000 1108759000 1126609000 1041606000 1038881000 44680000 45994000 56183000 57190000 3742399000 3889758000 0 38125000 14792000 14624000 112785000 102100000 7743000 7253000 53611000 78771000 93362000 80033000 282293000 320906000 769143000 733149000 102500000 104700000 568069000 567341000 156910000 157420000 61693000 63338000 126853000 138501000 2067461000 2085355000 0 0 15000000 15000000 0 0 0 0 0.01 0.01 240000000 240000000 90813000 90477000 908000 905000 1245297000 1276977000 8918000 6823000 481678000 362862000 7067000 10265000 903344000 879118000 1674938000 1804403000 3742399000 3889758000 24226000 32901000 31143000 29724000 1953000 3544000 3620000 6291000 1890000 1724000 1260000 -17000 23000 -712000 4699000 -765000 -10041000 3116000 25423000 11561000 2164000 5046000 6009000 -2283000 -4984000 -9754000 -14073000 -2576000 26156000 44344000 13704000 9325000 0 4742000 -13704000 -14067000 10200000 11250000 12400000 11750000 7578000 0 150000000 125000000 2326000 1239000 5231000 9204000 -162683000 -133465000 937000 -3168000 -149294000 -106356000 456661000 513448000 307367000 407092000 90476000 905000 6823000 -362862000 1276977000 10265000 879118000 1804403000 24226000 24226000 -3198000 -3198000 21000 1107000 1107000 316000 1000 16000 846000 -4858000 -4011000 2000 3609000 3611000 2111000 119662000 31538000 151200000 90813000 908000 8918000 -481678000 1245297000 7067000 903344000 1674938000 89600000 896000 4899000 -234448000 1264943000 -45155000 698568000 1684804000 32901000 32901000 24130000 24130000 17000 1078000 1078000 339000 4000 14000 714000 -9758000 -9040000 6324000 6324000 1938000 129152000 -4152000 125000000 89956000 900000 6823000 -362886000 1266739000 -21025000 731469000 1615197000 BASIS OF PRESENTATION<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms “we,” “our,” “us,” “Company” and “Integra” refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries unless the context suggests otherwise.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the March 31, 2023 unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the financial position, statement of changes in shareholders' equity, results of operations and cash flows of the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP") have been condensed or omitted in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements for the year ended December 31, 2022 included in the Company’s Annual Report on Form 10-K. The December 31, 2022 consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. Operating results for the three-month period ended March 31, 2023 are not necessarily indicative of the results to be expected for the entire year.</span></div>The preparation of consolidated financial statements is in conformity with GAAP, which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the condensed consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. BASIS OF PRESENTATION<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms “we,” “our,” “us,” “Company” and “Integra” refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries unless the context suggests otherwise.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the March 31, 2023 unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the financial position, statement of changes in shareholders' equity, results of operations and cash flows of the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP") have been condensed or omitted in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements for the year ended December 31, 2022 included in the Company’s Annual Report on Form 10-K. The December 31, 2022 consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. Operating results for the three-month period ended March 31, 2023 are not necessarily indicative of the results to be expected for the entire year.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements is in conformity with GAAP, which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the condensed consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Topic 848), and subsequent amendment to the initial guidance: ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (Topic 848): Scope (collectively, “Topic 848”). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied through December 31, 2024. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of the Secured Overnight Financing Rate ("SOFR") as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition. On March 24, 2023, the Company entered into the seventh amendment and restatement (the "March 2023 Amendment") of its Senior Credit Facility (the “Senior Credit Facility”) with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. In connection with the March 2023 Amendment the Company replaced all LIBOR-based contracts with SOFR, which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities (See Note 6). In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of interest rate swaps from LIBOR to SOFR. Integra has elected to adopt the optional expedient under ASC 848, which will allow the interest rate swap hedging relationship to continue, without de-designation, due to the change in the indexed rate from LIBOR to SOFR. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.</span></div> <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Topic 848), and subsequent amendment to the initial guidance: ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (Topic 848): Scope (collectively, “Topic 848”). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied through December 31, 2024. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of the Secured Overnight Financing Rate ("SOFR") as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition. On March 24, 2023, the Company entered into the seventh amendment and restatement (the "March 2023 Amendment") of its Senior Credit Facility (the “Senior Credit Facility”) with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. In connection with the March 2023 Amendment the Company replaced all LIBOR-based contracts with SOFR, which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities (See Note 6). In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of interest rate swaps from LIBOR to SOFR. Integra has elected to adopt the optional expedient under ASC 848, which will allow the interest rate swap hedging relationship to continue, without de-designation, due to the change in the indexed rate from LIBOR to SOFR. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.</span></div> ACQUISITIONS AND DIVESTITURES<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Surgical Innovation Associates, Inc. Acquisition</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On December 6, 2022, the Company completed its acquisition of Surgical Innovation Associates, Inc. ("SIA") for an acquisition purchase price of $51.5 million (the "SIA Acquisition"). In addition to the purchase price, the acquisition includes two separate contingent considerations payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $50.0 million in additional payments), as well as 2) the approval by the FDA of the Premarket Approval (“PMA”) Application for DuraSorb for certain uses by certain timing targets (up to $40.0 million in additional payments). SIA's core technology, DuraSorb, is a fully resorbable scaffold of a globally accepted polymer, which is cleared for use in hernia repair, abdominal wall, and other soft tissue reinforcement. DuraSorb sales will be reported within Integra’s Tissue Technologies ("TT") segment as part of its Wound Reconstruction and Care franchise. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Assets Acquired and Liabilities Assumed at Fair Value</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The SIA Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired, and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Valuation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,438 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,551 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,654 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,543 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,854 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">127,397</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred Tax Liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,799 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,607 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">71,450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">55,947</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Developed Technology</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The estimated fair value of the developed technology was determined using the multi-period excess earnings method of the income approach, which estimates value based on the present value of future economic benefits. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, working capital, and contributory asset charges, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of the asset’s life cycle, and competitive trends impacting the asset and the cash flow stream.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company used a discount rate of 18% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Goodwill</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company allocated goodwill related to the SIA Acquisition to the TT segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. A key factor that contributes to the recognition of goodwill, and a driver for the Company’s acquisition of SIA, is the attractive growth opportunities presented by the surgical matrix business in the breast reconstruction market. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Contingent Consideration</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company determines the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resulting most likely payouts are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation will be revalued to estimated fair value and changes in fair value will be reflected as income or expense in the consolidated statement of operations. Changes in the fair value of the contingent considerations may result from changes in discount periods and rates and changes in the timing and amount of revenue estimates. Changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As part of the SIA Acquisition, the Company is required to pay to the shareholder of SIA up to $90.0 million for two separate payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $50.0 million in additional payments), as well as 2) the approval by the FDA of the PMA for DuraSorb for certain uses by certain timing targets (up to $40.0 million in additional payments). The Company used iterations of the Monte Carlo simulation to calculate the fair value of the contingent consideration for the revenue-based milestone that considered the possible outcomes of scenarios related to each specific milestone for the revenue based performance milestone. The Company used probabilities of achieving the conditions to calculate the fair value of the contingent consideration for the PMA approval milestone. The Company estimated the fair value of the contingent consideration for the revenue based milestone to be $32.6 million at the acquisition date and $25.0 million for the PMA approval milestone as of December 31, 2022. The company recorded a total of $48.7 million in other liabilities as of March 31, 2023 and $12.5 million in accrued expenses and other current liabilities at March 31, 2023 in the consolidated balance sheet of the company. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The change in the fair value of the contingent obligation was primarily as a result of changes in the timing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Deferred Tax Liabilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Deferred tax liabilities result from identifiable intangible assets’ fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Sale of non-core traditional wound care business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2022, the Company completed its sale of its non-core traditional wound care ("TWC") business to Gentell, LLC ("Gentell") for $28.8 million, which consists of $27.8 million in cash plus $1.0 million in contingent consideration which may be received upon achieving certain revenue-based performance milestones two years after the closing date. The proceeds from the sale of the TWC business of $27.8 million is presented in the consolidated statement of cash flows net of cash transferred of $3.5 million and other transaction fees. The transaction included the sale of the Company's TWC products, such as sponges, gauze and conforming bandages, and certain advanced wound care dressings, such as supportive, calcium alginate, hydrogel, and foam dressings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The divestiture did not represent a strategic shift that had a major effect on the Company's operations and financial statements. Goodwill was allocated to the assets and liabilities divested using the relative fair value method of the TWC business to the Company's TT reportable business segment. In connection with the sale, the Company recognized $0.6 million as a gain from the sale of the business in the condensed consolidated statement of operations for the year ended December 31, 2022. The transaction is subject to final working capital adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the purchase and sale agreement, the Company also entered into a contract manufacturing agreement with Gentell. Under the terms of the agreement, Gentell received inventory, equipment, and tooling to manufacture certain MediHoney® and TCC-EZ® products on behalf of the Company. On the close date of this transaction, the Company transferred all inventory associated with these products to Gentell and recognized an asset of $11.1 million, as a form of a deposit for the inventory transferred, which based on the expected timing of inventory purchases, was primarily included within prepaid expenses and other current assets in the consolidated balance sheet. This deposit will be utilized by the Company on future orders placed to Gentell for such products. As of March 31, 2023, the Company had a deposit remaining of $7.3 million which is included in prepaid assets and recognized a payable due to Gentell of $0.7 million, which is included in the condensed consolidated balance sheet within accrued expenses and other current liabilities.</span></div> 51500000 2 50000000 40000000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Valuation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,438 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,551 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,654 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,543 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,854 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">127,397</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred Tax Liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,799 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,607 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">71,450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">55,947</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 4438000 1551000 2900000 1654000 10543000 75000000 P14Y 41854000 127397000 2044000 2044000 11799000 57607000 71450000 55947000 0.18 90000000 2 50000000 40000000 32600000 25000000 48700000 12500000 28800000 27800000 1000000 P2Y 27800000 3500000 600000 11100000 7300000 700000 REVENUES FROM CONTRACTS WITH CUSTOMERS <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Accounting Policies on Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally 90 days.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Asset and Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract asset and liability balances for the three months ended March 31, 2023:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Asset</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset, January 1, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,122 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred to trade receivable from contract asset included in beginning of the year contract asset</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset, net of transferred to trade receivables on contracts during the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,713 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset, March 31, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,070 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability, January 1, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognition of revenue included in beginning of year contract liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,492)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability, net of revenue recognized on contracts during the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,921 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability, March 31, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,559 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023, the short-term portion of the contract liability of $7.7 million and the long-term portion of $8.8 million is included in current liabilities and other liabilities, respectively, in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company is expected to recognize revenue of approximately 47% of unsatisfied (or partially unsatisfied) performance obligations as revenue within 12 months, with the remaining balance to be recognized thereafter.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling Fees</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Warranties</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxes Collected from Customers</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregated Revenue</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenues disaggregated by the major sources of revenues for the three months ended March 31, 2023 and 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Neurosurgery</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192,870 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,675 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,633 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Codman Specialty Surgical</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248,136 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,308 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Wound Reconstruction and Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,940 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private Label</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,700 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,710 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,330 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographical Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of revenues based on the location of the customer.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Accounting Policies on Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally 90 days.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Asset and Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling Fees</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.</span></div> P90D <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract asset and liability balances for the three months ended March 31, 2023:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Asset</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset, January 1, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,122 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred to trade receivable from contract asset included in beginning of the year contract asset</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset, net of transferred to trade receivables on contracts during the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,713 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset, March 31, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,070 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability, January 1, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognition of revenue included in beginning of year contract liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,492)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability, net of revenue recognized on contracts during the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,921 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability, March 31, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,559 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 10122000 9765000 9713000 10070000 16127000 -2492000 -2921000 3000 16559000 7700000 8800000 0.47 P12M <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Warranties</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div> P2Y <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxes Collected from Customers</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.</span></div> <div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenues disaggregated by the major sources of revenues for the three months ended March 31, 2023 and 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Neurosurgery</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192,870 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,675 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,633 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Codman Specialty Surgical</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248,136 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,308 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Wound Reconstruction and Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,940 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private Label</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,700 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,710 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,330 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 192870000 194675000 55266000 52633000 248136000 247308000 100940000 94630000 31770000 34700000 132710000 129330000 380846000 376638000 INVENTORIES<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178,626 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,088 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,532 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,598 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,897 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351,275 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,583 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div> <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178,626 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,088 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,532 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,598 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,897 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351,275 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,583 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div> 178626000 172088000 80532000 70598000 92117000 81897000 351275000 324583000 GOODWILL AND OTHER INTANGIBLE ASSETS<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill for the three-month period ended March 31, 2023 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:55.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.915%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Codman Specialty <br/>Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tissue Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">656,219 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382,662 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,038,881 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SIA Acquisition Working Capital Adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,639 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,596 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill at March 31, 2023</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">657,858 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383,748 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,041,606 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s identifiable intangible assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,206,748 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(389,297)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">817,451 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,297 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,199 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,554 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,665)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,889 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,796 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,024 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,895 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,701,363 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(592,604)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,108,759 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,204,325 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370,968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">833,357 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,081 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(144,040)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,041 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,693 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,693 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,041 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,957 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,886 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,697,532 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(570,923)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,126,609 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on quarter-end exchange rates, amortization expense (including amounts reported in cost of goods sold) is expected to be approximately $61.8 million for the remainder of 2023, $81.8 million in 2024, $81.8 million in 2025, $81.6 million in 2026, $79.7 million in 2027, $78.1 million in 2028 and $474.4 million thereafter.</span></div> <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill for the three-month period ended March 31, 2023 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:55.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.915%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Codman Specialty <br/>Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tissue Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">656,219 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382,662 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,038,881 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SIA Acquisition Working Capital Adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,639 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,596 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill at March 31, 2023</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">657,858 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383,748 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,041,606 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 656219000 382662000 1038881000 0 129000 129000 1639000 957000 2596000 657858000 383748000 1041606000 <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s identifiable intangible assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,206,748 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(389,297)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">817,451 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,297 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,199 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,554 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,665)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,889 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,796 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,024 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,895 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,701,363 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(592,604)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,108,759 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,204,325 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370,968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">833,357 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,081 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(144,040)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,041 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,693 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,693 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,041 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,957 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,886 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,697,532 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(570,923)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,126,609 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div> <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s identifiable intangible assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,206,748 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(389,297)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">817,451 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,297 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,199 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,554 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,665)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,889 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,796 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,024 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,895 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,701,363 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(592,604)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,108,759 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,204,325 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370,968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">833,357 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,081 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(144,040)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,041 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,693 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,693 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,041 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,957 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,886 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,697,532 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(570,923)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,126,609 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div> P18Y 1206748000 389297000 817451000 P12Y 193297000 146098000 47199000 P28Y 97554000 35665000 61889000 167529000 167529000 P30Y 30211000 17415000 12796000 P11Y 6024000 4129000 1895000 1701363000 592604000 1108759000 P18Y 1204325000 370968000 833357000 P12Y 193081000 144040000 49041000 P28Y 97265000 34674000 62591000 166693000 166693000 P30Y 30211000 17170000 13041000 P11Y 5957000 4071000 1886000 1697532000 570923000 1126609000 61800000 81800000 81800000 81600000 79700000 78100000 474400000 DEBT <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amendment to the Seventh Amended and Restated Senior Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 24, 2023, the Company entered into the March 2023 Amendment of the Senior Credit Facility with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The March 2023 Amendment extended the maturity date to March 24, 2028, amended the contractual repayments of Term loan A, and amended the interest rate from LIBOR to SOFR-indexed interest. The Company continues to have the aggregate principal amount of up to approximately $2.1 billion available to it through the following facilities: (i) a $775.0 million term loan facility, and (ii) a $1.3 billion revolving credit facility, which includes a $60 million sublimit for the issuance of standby letters of credit and a $60 million sublimit for swingline loans. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:394.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:111.25pt"/><td style="width:1.0pt"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Consolidated Total Leverage Ratio</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2023 through December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.50 to 1.00</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2025 through June 30, 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.25 to 1.00</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2026 and the last day of each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.00 to 1.00</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Senior Credit Facility bear interest, at the Company’s option, at a rate equal to the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">term SOFR in effect from time to time plus 0.10% plus the applicable rate (ranging from 1.00% to 1.75%), or </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">the highest of: </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus 0.50% </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the prime lending rate of Bank of America, N.A. or</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the one-month Term SOFR plus 1.00% </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable rates are based on the Company’s consolidated total leverage ratio (defined as the ratio of (a) consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof to (b) consolidated EBITDA (as defined by the amended Seventh Amended and Restated Credit Agreement (the "Credit Agreement")), for the period of four consecutive fiscal quarters ending on such date).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will pay an annual commitment fee (ranging from 0.15% to 0.30%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Credit Facility is collateralized by substantially all of the assets of the Company’s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at March 31, 2023, the Company was in compliance with all such covenants. The Company capitalized $7.6 million in deferred financing costs in connection with the modification of the Senior Credit Facility and wrote off $0.2 million of previously capitalized financing costs during the first quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023 and December 31, 2022 there wa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s no balance ou</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tstanding under the revolving portion of the Senior Credit Facility. At March 31, 2023 and December 31, 2022, there was $775.0 million outstanding under the term loan component of the Senior Credit Facility at a weighted average interest rate of 6.3% and 5.6%, respectively. As of March 31, 2023 there was no portion of the Term Loan component of the Senior Credit Facility classified as current on the condensed consolidated balance sheet. As of December 31, 2022, there was $38.1 million of the Term Loan component of the Senior Credit Facility classified as current on the consolidated balance sheets under the prior terms of the agreement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of outstanding borrowings of the Senior Credit Facility's Term Loan component at March 31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $750.9 million. This fair value was determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nputs that reflect unadjusted quoted prices for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit outstanding as of March 31, 2023 and December 31, 2022 to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">taled $1.6 million. There were no amounts drawn as of March 31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quarter Ended March 31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Repayment</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remainder of 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,531 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,906 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687,813 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">775,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future interest payments on the term loan component of the Senior Credit Facility based on current interest rates are expected to approximate $35.9 million for remainder of 2023, $38.1 million in 2024, $32.6 million in 2025, $30.0 million in 2026, and $34.5 million thereafter . Interest is calculated on the term loan portion of the Senior Credit Facility based on SOFR plus the certain amounts set forth in the Credit Agreement. As the revolving credit facility and Securitization Facility can be repaid at any time, no interest has been included in the calculation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any outstanding borrowings on the revolving credit component of the Senior Credit Facility is due on March 24, 2028.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 4, 2020, the Company issued $575.0 million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of 0.5% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the 2025 Notes. In connection with this offering, the Company capitalized $13.2 million of financing fees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of 13.5739 shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $73.67 per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least 130% of the conversion price during the period; (2) if the average trading price per $1,000 principal amount of the 2025 Notes is less than or equal to 98% of the average conversion value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if specified corporate transactions occur. As of March 31, 2023, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Company entered into the First Supplemental Indenture to the original agreement dated as of February 4, 2020 between the Company and Citibank, N.A., as trustee, governing the Company’s outstanding 2025 Notes. The Company irrevocably elected (1) to eliminate the Company’s option to choose physical settlement on any conversion of the 2025 Notes that occurs on or after the date of the First Supplemental Indenture and (2) with respect to any Combination Settlement for a conversion of the 2025 Notes, the Specified Dollar Amount that will be settled in cash per $1,000 principal amount of the 2025 Notes shall be no lower than $1,000.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the “hedge participants”). The cost of the call transactions was $104.2 million for the 2025 Notes. The Company received $44.5 million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $73.67, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $113.34 for the 2025 Notes, subject to customary anti-dilution adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the carrying amount of the liability w</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as $575.0 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million. The fair value of the 2025 Notes at March 31, 2023 was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$561.7</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> million. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors that the Company considered when estimating the fair value of the 2025 Notes included recent quoted market prices or dealer quote. The level of the 2025 Notes is considered as Level 1.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securitization Facility</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (“SPE”), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to $150.0 million. The Securitization Facility Agreement ("Securitization Agreement") governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of March 31, 2023, the Company was in compliance with the covenants and none of the termination events had occurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2021, the Company entered into an amendment (the "May 2021 Amendment") of the Securitization Facility which extended the maturity date from December 21, 2021 to May 28, 2024. The May 2021 Amendment does not increase the Company’s total indebtedness. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securitization Facility is currently indexed to LIBOR. At March 31, 2023 and December 31, 2022, the Company had $102.5 million and $104.7 million, respectively, of outstanding borrowings under its Securitization Facility at a weighted average interest rate of 5.8% and 5.0%, respectively. In April 2023, we amended the facility to replace LIBOR with SOFR-indexed interest. The fair value of the outstanding borrowing of the Securitization Facility at March 31, 2023 was $102.2 million. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nputs that reflect unadjusted quoted prices for identical assets or liabilities.</span></div> 2100000000 775000000 1300000000 60000000 60000000 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:394.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:111.25pt"/><td style="width:1.0pt"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Consolidated Total Leverage Ratio</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2023 through December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.50 to 1.00</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2025 through June 30, 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.25 to 1.00</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2026 and the last day of each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.00 to 1.00</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 4.50 4.25 4.00 0.0010 0.0100 0.0175 0.0050 0.0100 0.0015 0.0030 7600000 200000 0 0 775000000 775000000 0.063 0.056 0 38100000 750900000 1600000 1600000 0 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quarter Ended March 31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Repayment</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remainder of 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,531 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,906 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687,813 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">775,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 14531000 33906000 38750000 687813000 775000000 35900000 38100000 32600000 30000000 34500000 575000000 0.005 0.005 13200000 73.67 1.30 0.98 1000 1 104200000 44500000 73.67 113.34 575000000.0 561700000 150000000 102500000 104700000 0.058 0.050 102200000 DERIVATIVE INSTRUMENTS <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Hedging</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected SOFR-indexed borrowings. In connection with the March 2023 Amendment to the Senior Credit Facility, the Company amended its interest rate from LIBOR to SOFR-indexed interest. In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of swaps from LIBOR to SOFR. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following interest rate swaps as of March 31, 2023 and December 31, 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"/><td style="width:15.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.462%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.423 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,022 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,738 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.220 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.199 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,539 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,441 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,708 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">575,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.415 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,406 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.404 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,567 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis Swap </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 24, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,842)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,475,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,678 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The notional of the basis swap amortizes to match the total notional of the interest rate swap portfolio over time</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:21.122%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.423 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,012 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,380 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.220 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,831 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.199 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,905 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,970 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,252 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,153 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">575,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.415 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,742 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.404 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,475,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,712 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive loss (“AOCL”), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCL to interest expense at that time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Hedging</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCL, net of tax. Those amounts are subsequently reclassified to earnings from AOCL as impacted by the hedged item when the hedged item affects earnings. If the hedged forecasted transaction does not occur or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income, net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of the Company’s hedging anticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-Currency Rate Swaps</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 26, 2022, the Company amended the CHF-denominated intercompany loan to extend the termination date to September 2023 and as a result, the Company early terminated the cross-currency swap designated as cash flow hedge of an intercompany loan with aggregate notional amount of 50.0 million. Simultaneously, the Company entered into a cross-currency swap agreement to convert a notional amount of CHF 48.5 million equivalent to 49.1 million of this amended intercompany loan into U.S. dollars. The loss recorded by the Company upon the settlement of the swap was not material for the period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2020, the Company entered into cross-currency swap agreements to convert a notional amount of $471.6 million equivalent to 420.1 million of a CHF-denominated intercompany loan into U.S. dollars. The CHF-denominated intercompany loan was the result of an intra-entity transfer of certain intellectual property rights to a subsidiary in Switzerland completed during the fourth quarter of 2020. The intercompany loan requires quarterly payments of CHF 5.8 million plus accrued interest. As a result, the aggregate notional amount of the related cross-currency swaps will decrease by a corresponding amount. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of March 31, 2023 and December 31, 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.020%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 22, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">373,227 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">397,137 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,033)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,241)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">418,980 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">445,821 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 28, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 29, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,533 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,532 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,011)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,528)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.32%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,142 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,142 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,044)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,769)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCL. For the three months ended March 31, 2023, and 2022, the Company recorded a loss of $4.9 million and a gain $6.5 million, respectively, in other income, net related to change in fair value related to the foreign currency rate translation to offset the losses recognized on the intercompany loans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, and 2022, the Company recorded a gain of $7.5 million and $7.9 million in AOCL, respectively, related to change in fair value of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, and 2022, the Company recorded a gain of $1.5 million and $1.8 million, respectively, in other income, net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain that is expected to be reclassified to other income (expense), net from AOCL as of March 31, 2023 within the next twelve months is $0.1 million. As of March 31, 2023, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018 and December 16, 2020, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of foreign currency on foreign subsidiaries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of March 31, 2023 and December 31, 2022, respectively (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:14.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.387%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,989 </span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,713 </span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.57%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,932 </span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,307 </span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.19%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 26, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 16, 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288,210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288,210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,711)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,663)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.94%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,790)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,643)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were recorded as unrealized gains or losses in AOCL. For the three months ended March 31, 2023 and 2022, the Company recorded a loss of $1.1 million and a gain $1.3 million, respectively, in AOCL related to the change in fair value of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, and 2022, the Company recorded gains of $2.1 million and $1.3 million, respectively, in interest income included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain that is expected to be reclassified to interest income from AOCL as of March 31, 2023 within the next twelve months is $10.9 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Forward Contract</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into a hedge for forecasted intercompany purchases denominated in foreign currencies through the use of forward contracts designated as cash flow hedges. To the extent these forward contracts meet hedge accounting criteria, changes in their fair value are not included in accumulated comprehensive loss. These changes in fair value will be recognized into earnings as a component of cost of sales when the forecasted-transaction occurs. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023 the Company entered into Foreign Currency Forward Contracts with a notional amount of $10.8 million to mitigate the risk of foreign currency on intercompany purchases in CHF. During the three months ended March 31, 2023 the Company recorded an immaterial loss in AOCL related to the change in fair value of the Foreign Currency Forward Contracts.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Credit Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company’s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company’s credit ratings from any credit rating agency.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Derivative Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value for derivatives designated as hedging instruments in the condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022:</span></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.024%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.174%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location on Balance Sheet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges — Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,659 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,682 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,139 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,497 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,942 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,653 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,861 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,030 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,940 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges — Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,541 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,173 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges — Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">762 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,011 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,528 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,080 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,738 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,672 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,608 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges — Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,766 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,874 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12 months.</span></div><div style="margin-bottom:12pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> At March 31, 2023 and December 31, 2022, the total notional amounts related to the Company’s interest rate swaps were both $1.5 billion, respectively.</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying condensed consolidated statement of operations during the three months ended March 31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance in AOCL<br/>Beginning of<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of<br/>Gain (Loss)<br/>Recognized in<br/>AOCL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Reclassified from<br/>AOCL into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance in AOCL<br/>End of Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in<br/>Statements of<br/>Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,712 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,678 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,191 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,576)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign Currency Forward Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of Sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,914)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,096 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,527 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,462)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,092 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,973 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,956)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,675 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,932 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">316 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,331 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,703)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,309 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,956)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,300 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,438 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,094)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments not designated hedges:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company entered into a foreign currency swap, with a notional amount of $7.3 million to mitigate the risk from fluctuations in foreign currency exchange rates associated with an intercompany loan denominated in JPY. In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another currency at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company subsequently paid down a portion of this swap, bringing the notional amount down to $6.4 million. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gains (losses) of derivative instruments not designated as hedges on the condensed consolidated statements of income, which was included in other income:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:64.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.412%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following interest rate swaps as of March 31, 2023 and December 31, 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"/><td style="width:15.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.462%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.423 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,022 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,738 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.220 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.199 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,539 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,441 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,708 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">575,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.415 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,406 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.404 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,567 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis Swap </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 24, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,842)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,475,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,678 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The notional of the basis swap amortizes to match the total notional of the interest rate swap portfolio over time</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:21.122%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.423 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,012 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,380 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.220 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,831 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.199 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,905 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,970 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,252 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,153 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">575,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.415 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,742 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.404 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,475,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,712 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of March 31, 2023 and December 31, 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.020%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 22, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">373,227 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">397,137 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,033)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,241)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">418,980 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">445,821 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 28, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 29, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,533 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,532 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,011)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,528)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.32%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,142 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,142 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,044)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,769)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of March 31, 2023 and December 31, 2022, respectively (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:14.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.387%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,989 </span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,713 </span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.57%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,932 </span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,307 </span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.19%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 26, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 16, 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288,210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288,210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,711)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,663)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.94%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,790)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,643)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 150000000 0.02423 4022000 200000000 0.02313 6738000 75000000 0.03220 1329000 75000000 0.03199 1539000 75000000 0.03209 1441000 100000000 0.02885 2770000 100000000 0.02867 2708000 575000000 0.01415 19406000 125000000 0.01404 4567000 0 -1842000 1475000000 42678000 150000000 0.02423 5012000 200000000 0.02313 8380000 75000000 0.03220 1831000 75000000 0.03199 1905000 75000000 0.03209 1970000 100000000 0.02885 4252000 100000000 0.02867 4153000 575000000 0.01415 23742000 125000000 0.01404 5467000 1475000000 56712000 50000000 48500000 49100000 471600000 420100000 5800000 0.0300 373227000 397137000 -3033000 -4241000 0.0398 418980000 445821000 0.0195 48533000 48532000 -4011000 -3528000 0.0532 49142000 49142000 -7044000 -7769000 -4900000 6500000 7500000 7900000 1500000 1800000 100000 0 51760000 51760000 3989000 4713000 0.0257 60000000 60000000 0 38820000 38820000 3932000 4307000 0.0219 45000000 45000000 0 288210000 288210000 -14711000 -14663000 0.0194 300000000 300000000 -6790000 -5643000 -1100000 1300000 2100000 1300000 10900000 10800000 0 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value for derivatives designated as hedging instruments in the condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022:</span></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.024%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.174%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location on Balance Sheet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges — Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,659 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,682 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,139 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,497 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,942 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,653 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,861 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,030 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,940 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges — Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,541 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,173 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges — Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">762 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,011 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,528 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,080 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,738 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,672 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,608 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges — Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,766 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,874 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12 months.</span></div><div style="margin-bottom:12pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> At March 31, 2023 and December 31, 2022, the total notional amounts related to the Company’s interest rate swaps were both $1.5 billion, respectively.</span></div> 15659000 16682000 4139000 4497000 10942000 11653000 28861000 40030000 0 0 2940000 3311000 62541000 76173000 762000 0 4011000 3528000 69000 0 0 1080000 0 7172000 8738000 20672000 20608000 33766000 32874000 1500000000 1500000000 <div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying condensed consolidated statement of operations during the three months ended March 31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance in AOCL<br/>Beginning of<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of<br/>Gain (Loss)<br/>Recognized in<br/>AOCL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Reclassified from<br/>AOCL into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance in AOCL<br/>End of Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in<br/>Statements of<br/>Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,712 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,678 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,191 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,576)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign Currency Forward Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of Sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,914)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,096 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,527 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,462)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,092 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,973 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,956)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,675 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,932 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">316 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,331 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,703)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,309 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,956)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,300 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,438 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,094)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 56712000 -10534000 3500000 42678000 -20271000 2191000 -3504000 -14576000 0 -69000 0 -69000 -6914000 950000 2096000 -8060000 29527000 -7462000 2092000 19973000 -43956000 41675000 -5213000 2932000 -9688000 316000 8331000 -17703000 -2312000 1309000 1320000 -2323000 -55956000 43300000 4438000 -17094000 7300000 6400000 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gains (losses) of derivative instruments not designated as hedges on the condensed consolidated statements of income, which was included in other income:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:64.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.412%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 55000 360000 55000 360000 STOCK-BASED COMPENSATION <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company had stock options, restricted stock awards, performance stock awards, contract stock awards and restricted stock unit awards outstanding under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan (the “2003 Plan”). The 2000 and 2001 Equity Incentive Plans were terminated as of February 19, 2021, and no further awards may be issued under the plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options issued under the 2003 Plan become exercisable over specified periods, generally within four years from the date of grant for officers and employees, within one year from date of grant for directors which generally expire eight years from the grant date for employees, and from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfNzIx_2efd93e6-4b81-4ecd-a888-8a73dfd19f51">six</span> to ten years for directors and certain executive officers, except in certain instances that result in accelerated vesting due to death, disability, retirement age or change in-control provisions within their grant agreements. The Company values stock option grants using the binomial distribution model. Restricted stock issued under the Plans vests over specified periods, generally three years after the date of grant. The vesting of performance stock issued under the Plans is subject to service and performance conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, there were approximately $5.6 million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately three years. There were 151,293 stock options granted during the three months ended March 31, 2023. For the three months ended March 31, 2023, the weighted average grant date fair value for stock options granted was $21.58 per option.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Awards of Restricted Stock and Performance Stock</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance stock and restricted stock awards generally have requisite service periods of three years, except in certain instances that result in accelerated vesting due to death, disability, retirement age provision or change in-control provisions in their grant agreements. Performance stock units are subject to graded vesting conditions based on revenue goals of the Company. The Company expenses the fair value of restricted stock awards on a straight-line basis over the requisite service period. As of March 31, 2023, there was approximately $48.6 million of total unrecognized compensation costs related to these unvested awards. The Company expects to recognize these costs over a weighted-average period of approximately two years. The Company granted 346,745 restricted stock awards and 161,218 performance stock awards during the three months ended March 31, 2023. For the three months ended March 31, 2023, the weighted average grant date fair value for restricted stock awards and performance stock units granted was $53.37 and $52.87 per award, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains an Employee Stock Purchase Plan (the “ESPP”), which provides eligible employees with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan based on its terms.</span></div> P4Y P1Y P8Y P10Y P3Y 5600000 P3Y 151293 21.58 P3Y 48600000 P2Y 346745 161218 53.37 52.87 RETIREMENT PLANS<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs for the Company’s defined benefit pension plans for the three months ended March 31, 2023 were $0.3 million. The components of the net periodic benefit costs other than the service cost component of $0.5 million for the three months ended March 31, 2023 are included in other income, net in the consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs for the Company’s defined benefit pension plans for the three months ended March 31, 2022 were $0.3 million. The components of the net periodic benefit costs other than the service cost component of $0.7 million for the three months ended March 31, 2022 are included in other income, net in the consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of plan assets were $36.4 million and $38.1 million as of March 31, 2023 and December 31, 2022, respectively. The net plan assets of the pension plans are invested in common trusts as of March 31, 2023 and December 31, 2022. Common trusts are classified as Level 2 in the fair value hierarchy. The fair value of common trusts is valued at the net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within an appropriate risk profile.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Compensation Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a Deferred Compensation Plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This deferred compensation is invested in funds offered under this plan and is valued based on Level 1 measurements in the fair value hierarchy. Assets of the Company's deferred compensation plan are included in other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets were $5.0 million and $4.7 million as of March 31, 2023 and December 31, 2022, respectively. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.</span></div> 300000 500000 300000 700000 36400000 38100000 0.75 1 5000000.0 4700000 LEASES AND RELATED PARTY LEASESThe Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of March 31, 2023. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components.<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most facility leases include one or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the Right of Use ("ROU") assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease expense for the three months ended March 31, 2023 and March 31, 2022 was $6.0 million and $4.9 million respectively, which includes $0.1 million, in related party operating lease expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands, except lease term and discount rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146,514 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148,284 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,792 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,624 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,910 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,420 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,702 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,044 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the three months ended March 31, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,319 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,721 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">507 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under operating leases at March 31, 2023 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remainder of 2023</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,870 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,092 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,086 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,382 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,753 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,049 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,444 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,951 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,247 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">246 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,206 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,452 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,948 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">255,219 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,167 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,465 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,702 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Current lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,792 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,910 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no future minimum lease payments under finance leases at March 31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Leases</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company leases its manufacturing facility in Plainsboro, New Jersey, from Plainsboro Associates, a New Jersey general partnership. Ocirne, Inc., a subsidiary of Provco Industries, owns a 50% % interest in Plainsboro Associates. Provco Industries is the corporate general partner of Tru St. Partnership LLP, a principal stockholder of the Company. The term of the current lease agreement is through October 31, 2029 at an annual rate of approximately $0.3 million per year. The current lease agreement also provides (i) a 5-year renewal option for the Company to extend the lease from November 1, 2029 through October 31, 2034 at the fair market rental rate of the premises, and (ii) another 5-year renewal option to extend the lease from November 1, 2034 through October 31, 2039 at the fair market rental rate of the premises.</span></div> 1 6000000 4900000 100000 100000 <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands, except lease term and discount rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146,514 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148,284 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,792 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,624 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,910 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,420 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,702 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,044 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 146514000 148284000 14792000 14624000 156910000 157420000 171702000 172044000 P17Y1M6D P16Y10M24D P2Y P2Y 0.054 0.054 0.028 0.027 <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the three months ended March 31, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,319 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,696 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,721 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">507 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 4319000 4696000 1721000 507000 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under operating leases at March 31, 2023 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remainder of 2023</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,870 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,092 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,086 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,382 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,753 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,049 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,444 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,951 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,247 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">246 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,206 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,452 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,948 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">255,219 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,167 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,465 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,702 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Current lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,792 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,910 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 222000 15870000 16092000 296000 21086000 21382000 296000 19753000 20049000 296000 17148000 17444000 296000 16205000 16501000 296000 13951000 14247000 246000 151206000 151452000 1948000 255219000 257167000 85465000 171702000 14792000 156910000 0.50 300000 P5Y November 1, 2029 through October 31, 2034 P5Y November 1, 2034 through October 31, 2039 TREASURY STOCK<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023 and December 31, 2022, there were 8.9 million and 6.8 million shares of treasury stock outstanding with a cost of $481.7 million and $362.9 million, at a weighted average cost per share of $54.01 and $53.18, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January 26, 2023, the Company entered into a $150 million accelerated share repurchase ("2023 ASR") and received 2.1 million shares of the Company common stock at inception of the 2023 ASR, which represented approximately 80% of the expected total shares under the 2023 ASR. The remaining repurchase transactions are expected to be completed in the second quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 16, 2022, the Inflation Reduction Act of 2022 (the “Act”) was signed into law. The Act implements a new excise tax of 1% on the net share repurchases made by the company effective for share repurchases performed January 1, 2023, or after. The company accrued $1.2 million regarding the excise tax in Q-1 related to the ASR mentioned above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2022, the Company entered into a $125 million accelerated share repurchase ("2022 ASR") and received 1.48 million shares of Company common stock at inception of the 2022 ASR, which represented approximately 80% of the expected total shares under the 2022 ASR. On March 24, 2022, the early exercise provision under the 2022 ASR was exercised by 2022 ASR counterparty. Upon settlement on March 24, 2022, the Company received an additional 0.46 million shares determined using the volume-weighted average price of the Company's common stock during the term of the 2022 ASR.</span></div> 8900000 6800000 481700000 362900000 54.01 53.18 150000000 2100000 0.80 1200000 125000000 1480000 0.80 460000 INCOME TAXES<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the Company's effective tax rate:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reported tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company’s effective income tax rates for the three months ended March 31, 2023 and 2022 w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ere 18.6% and 16.3%, respectively. For the three months ended March 31, 2023, the primary driver of the higher tax rate relates to a reduction of excess tax benefits from stock compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Changes to income tax laws and regulations, in any of the tax jurisdictions in which the Company operates, could impact the effective tax rate. Various governments, both U.S. and non-U.S., are increasingly focused on tax reform and revenue-raising legislation. Further, legislation in foreign jurisdictions may be enacted, in response to the base erosion and profit-sharing project begun by the Organization for Economic Cooperation and Development ("OECD"). The OECD recently finalized major reform of the international tax system with respect to a global minimum tax rate. Such changes in U.S. and non-U.S. jurisdictions could have an adverse effect on the Company’s effective tax rate.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of March 31, 2023, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested unless there is a manner under which to remit the earnings with no material tax cost. Material taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed. The Company will repatriate foreign earnings when there is no need for reinvestment overseas and there is no material cost to bring the earnings back to the United States. Reinvestment considerations would include future acquisitions, transactions, and capital expenditure plans.</span></div> <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the Company's effective tax rate:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reported tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 0.186 0.163 0.186 0.163 NET INCOME PER SHARE<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.474%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Dollars in thousands, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Basic net income per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,226 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,901 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,871 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,632 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted net income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,226 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,901 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding — Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,871 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,632 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options and restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">452 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">644 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares for diluted earnings per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,323 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,276 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock of approximately 0.3 million an</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d 0.2 million shares at March 31, 2023, and 2022, res</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pectively that are issuable through exercise of dilutive securities were not included in the computation of diluted net income per share because their effect would have been anti-dilutive.</span></div> <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.474%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Dollars in thousands, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Basic net income per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,226 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,901 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,871 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,632 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted net income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,226 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,901 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding — Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,871 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,632 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options and restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">452 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">644 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares for diluted earnings per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,323 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,276 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 24226000 32901000 81871000 83632000 0.30 0.39 24226000 32901000 81871000 83632000 452000 644000 82323000 84276000 0.29 0.39 300000 200000 ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income for the three months ended March 31, 2023 and 2022 was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,226 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,901 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,683)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized loss/(gain) on derivatives, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,822 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pension liability adjustment, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,028 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,031 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income by component between December 31, 2022 and March 31, 2023 are presented in the table below, net of tax:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,817 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,322 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,874)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,265 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,754)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Amounts reclassified from accumulated other comprehensive income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,623 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,623 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,198)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,440 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,425 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,798)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,067 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, the Company reclassified a gain of $4.3 million and a loss of $2.7 million from accumulated other comprehensive income to other income, net and interest income, respectively.</span></div> <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income for the three months ended March 31, 2023 and 2022 was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,226 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,901 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,683)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized loss/(gain) on derivatives, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,822 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pension liability adjustment, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,028 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,031 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 24226000 32901000 4076000 -5683000 -7377000 29822000 -103000 9000 21028000 57031000 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income by component between December 31, 2022 and March 31, 2023 are presented in the table below, net of tax:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,817 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,322 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,874)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,265 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,754)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Amounts reclassified from accumulated other comprehensive income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,623 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,623 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,198)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,440 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,425 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,798)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,067 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 22817000 9322000 -21874000 10265000 -5754000 103000 4076000 -1575000 1623000 0 0 1623000 -7377000 103000 4076000 -3198000 15440000 9425000 -17798000 7067000 4300000 -2700000 SEGMENT AND GEOGRAPHIC INFORMATION<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company internally manages two global reportable segments and reports the results of its businesses to its chief operating decision maker. The two reportable segments and their activities are described below.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">The TT segment includes such offerings as skin and wound repair, plastics &amp; surgical reconstruction products, bone grafts, and nerve and tendon repair products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by each reportable segment for the three months ended March 31, 2023 and 2022 are as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.129%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248,136 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,308 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tissue Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,710 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,330 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit </span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,933 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tissue Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,893 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163,214 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,053 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,108)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,894)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(123,724)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,995)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,382 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,164 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271,002 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263,351 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,064 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,744 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,473 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,717 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,307 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,826 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 2 2 40000 Net sales and profit by each reportable segment for the three months ended March 31, 2023 and 2022 are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.129%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248,136 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,308 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tissue Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,710 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,330 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit </span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,933 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tissue Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,893 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163,214 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,053 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,108)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,894)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(123,724)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,995)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,382 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,164 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>Total revenue by major geographic area consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271,002 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263,351 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,064 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,744 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,473 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,717 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,307 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,826 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 248136000 247308000 132710000 129330000 380846000 376638000 110933000 110160000 52281000 53893000 163214000 164053000 3108000 3894000 -123724000 -113995000 36382000 46164000 271002000 263351000 41064000 43744000 50473000 47717000 18307000 21826000 380846000 376638000 COMMITMENTS AND CONTINGENCIESIn consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the fair value of contingent consideration during the three month period ended March 31, 2023 and March 31, 2022 to reflect the change in estimate, additions, payments, transfers and the time value of money during the period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the three months ended March 31, 2023 and March 31, 2022 is as follows (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:18.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.024%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.681%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surgical Innovations Associates, Inc. (FN 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,845 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,700 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,607 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,543 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,756 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,388 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,806 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,500 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,707 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:28.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.255%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell Inc.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,691 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,408 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,800 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,065)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,750 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,284 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,885 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,215 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Arkis BioSciences Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the acquisition of Arkis BioSciences Inc. ("Arkis"), the Company is required to pay the former shareholders of Arkis up to $25.5 million based on the timing of certain development milestones of $10.0 million and commercial sales milestones of $15.5 million, respectively. The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $13.1 million at the acquisition date. The estimated fair value as of March 31, 2023 and March 31, 2022 was $16.2 million and $14.0 million, respectively. The Company recorded $11.8 million and $10.3 million in other liabilities at March 31, 2023 and March 31, 2022, respectively, and $4.4 million and $3.8 million in accrued expenses and other current liabilities at March 31, 2023 and March 31, 2022, respectively, in the consolidated balance sheet of the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Derma Sciences</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assumed contingent consideration incurred by Derma Sciences, Inc. ("Derma Sciences") related to its acquisitions of BioD and the intellectual property related to Medihoney products. The Company accounted for the contingent liabilities by recording their fair value on the date of the acquisition based on a probability weighted income approach. The Company has already paid $33.3 million related to the aforementioned contingent liabilities. One contingent milestone remains which relates to net sales of Medihoney™ products exceeding certain amounts defined in the agreement between the Company and Derma Sciences. The potential maximum undiscounted payment amounts to $3.0 million. The estimated fair value as of March 31, 2023 and March 31, 2022 was $0.2 million. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">ACell Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the ACell Acquisition, the Company is required to make payments to the former shareholders of ACell up to $100 million based on the achievement by the Company of certain revenue-based performance milestones in 2023 and 2025. The Company used iterations of the Monte Carlo simulation to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specific milestone. The Company estimated the fair value of the contingent consideration to be $23.9 million at the acquisition date. The estimated fair value as of March 31, 2023 was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.5 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.5 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$17.2 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in other liabilities at March 31, 2023 and March 31, 2022, respectively, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $4.9 million in accrued expenses and other current liabilities at March 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated balance sheets of the Company. The change in the fair value of the contingent obligation was primarily as a result of changes in the timing and amount of revenue estimates.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the three months ended March 31, 2023 and March 31, 2022 is as follows (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:18.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.024%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.681%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surgical Innovations Associates, Inc. (FN 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,845 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,050 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,700 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,607 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,543 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,756 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,388 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,806 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,500 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,707 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:28.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.255%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell Inc.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,691 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,408 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,800 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,065)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,750 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,284 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,885 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,215 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 2845000 10050000 230000 3700000 0 57607000 0 0 0 0 12500000 -12500000 1543000 1756000 0 -2200000 0 3600000 4388000 11806000 230000 1500000 12500000 48707000 3691000 11408000 230000 0 21800000 59000 -59000 0 4885000 -4885000 0 -1065000 0 0 300000 3750000 10284000 230000 4885000 17215000 25500000 10000000.0 15500000 13100000 16200000 14000000 11800000 10300000 4400000 3800000 33300000 1 3000000 200000 200000 100000000 23900000 1500000 1500000 17200000 4900000 EXCEL 88 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end

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

M-8?20$3;8T.P6BP^0"X99K>]9!:G MJOK;8U5](]^+O&RF@^>V?;D>C9KLF1>L^;UZX:4\LJOJ@K5RLWX:-2\U9]OF MF?.VR$?&>.R,"B;*P>W-\5RK>J1N5"W/6E&5W8R/X6_/O\6Z3O(I&/(I< MM._30?\]YP-2B%(4X@??3@?C 6F>J[>'JA8_JK)E>9+559Y/!Y/#@0VO6Y'] MLCOI(%/VV/1[6O88,PDR'3AC><*=J)NV_T5_?B897[G\\6%KWU;W(F]Y/6,M MG]?5_D643]UIY%V,E-OHXW#\/ 3QNOXO8:QV.Y'Q697M"UZVASC6/.\ R^99 MO#0#4K*"3P=^]$/)O0X&T $CK@LVM0=H MI'U)2%.!= !(!Q?RSDN"A$3W9!73A(:2+8C4[N(":"XNFN?_N0Z2H -*B!?. MR"S8T"0-TK5$51 _ 8B?>G"?D2I _$7RN0GP'( MS[B002@ATR@.M*A-QE"V'N,BS:-H]B58+/IFC=('&I- /GOA/+A;4.*IF*!4 MD*TRHW>IR@*Y8X(LCQF-@XWLG1LJ0Y6D\5IJ+=4:%)+&!-D:21KY?PQE,NFS MW7(E\]['3#*!?#%!%D9,TR#N*H&4K*3(M+A!BI@@.V)!9<@.V2VFB]X/*R]. MOY+# 143DL0$V1)I+''6\5?2M[-*!?EA@BR(()2/&B6I]Y<>*4@($V0CA#0E M/[E6,JLE#UY,53;( Q-D$7B^OUZN#T_9(>EV736F#[*WRKRB%LF0' QD.21T MWG?4KE/,:32/O=5#X,NHWD?QTE,3L@')P4 ?D.#$UK88Q.H MGM Q(;F8Z'-:0#VA.="$Y&(BRP54]5";Q(0\8R)[!JXHABHFY!GSDG-<^K,) MF<>\Y#R7-I5I0N8QDC++T T]55>2$#V159FCIAJ9K<]$338J)B0@&UE 9S'I;L#EG(ON@$G/IL.I"%'&0+P9AJ#>= %G*0 M+01CJL,@![*0@VPA?8GVEZ)3Q80LY"!;2)MUE=ER7Q2L?N]&:WU^5S$A"SG( M%OJ ^;& 5S$A"SG(%CHY33PD=ZP1&6&EB@F^8X9LH3.8QZBJF)"%'/3).&@^ M6WMA#[*0@VPA&%-+[Y"%G$N^;:"E=Q>RD'O)MPVT1G;:J2?=Q>,G1LKNWE';[//?EOJA<5&Q[_'_!\;\1M_\ 4$L#!!0 M ( $*#FE9G_%)"3 ( &@L : >&PO7W)E;',O=V]R:V)O;VLN>&UL M+G)E;'/-VDMNHT 4A>&M6"P@N.ZKDE:<44\RC;(!Y)0?BFT0T$JR^[:<@7U0 M#WH2<4:H0%S^"9\0\/A2#LVX;T_#;M\-B\_CX32LJMTX=K_J>ECORK$9[MJN MG,Y'-FU_;,;SLM_67;-^;[:EEN4RZOYV1O7T>#MS\?K5E?^9V&XV^W7YW:[_ M',MI_,?@^J/MWX==*6.U>&WZ;1E75?UYN.X>ZLLFW9TG5XOGMU75/[^EJIX[ M2"!(Y@]2"-+Y@PR";/X@AR"?/R@@*.8/RA"4YP^ZAZ#[^8,>(.AA_J"T1!F7 M!$D3K FT3LAU(O Z(=B)0.R$9"<"LQ.BG0C43LAV(G [(=R)0.Z$="<"NQ/B MG0CT%M1;"/06U%L(]);)PS:!WH)Z"X'>@GH+@=Z">@N!WH)Z"X'>@GH+@=Z" M>@N!WH)Z"X'>BGHK@=Z*>BN!WHIZ*X'>.GE90J"WHMY*H+>BWDJ@MZ+>2J"W MHMY*H+>BWDJ@MZ+>2J"WH=Y&H+>AWD:@MZ'>1J"WH=Y&H+=-7G83Z&VHMQ'H M;:BW$>AMJ+<1Z&VHMQ'H;:BW$>CMJ+<3Z.VHMQ/H[:BW$^CMJ+<3Z.VHMQ/H M[9./E01Z.^KM!'H[ZNT$>COJ[01Z.^KM!'H'ZAT$>@?J'01Z!^H=!'H'ZAT$ M>@?J'01Z!^H=!'K'Y&<3 KT#]0X"O0/U#@*] _4. KTSZIT)],ZH=R;0.Z/> MF4#OC'IG KTSZIT)],ZH=_Y)O8?QZU"&:\_W&J__DU2/YW/+]?*7Y??.R0UU MP;F^K1B>_@)02P,$% @ 0H.:5H:F8T@, @ 82L !, !;0V]N=&5N M=%]4>7!E&ULS=K-;N(P% 7@5T'95L3X-],1L)F9;8=%7\!-+B4BB2W; M;>'MQPEMI58=-!4C]6R(P/8]-[[2MV)Y>_049X>^&^*JV*7DOS,6ZQWU-I;. MTY!7MB[T-N6OX9YY6^_M/3&Q6!A6NR'1D.9IK%&LES]I:Q^Z-/MUR#_'U@VK M(E 7B]F/T\8Q:U58[[NVMBFOL\>A>9Q0X=B^G842S/E_B@1[?=MC4UKG[H\Y$R^D"VB3NB MU'?EJ>C5^>24;YA.G_SB_*G,N<"\&UL4$L! A0#% @ 0H.:5J-\BW3"!0 FAX !@ M ("!#@@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ 0H.:5DI]G_1/ P 8PH !@ ("!-AL 'AL+W=O2 >&PO=V]R:W-H965T&UL4$L! A0#% @ 0H.:5L=H%I:1 @ CP4 !D M ("!RU, 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ 0H.:5FS7&,R5$P X44 !D ("!F&P 'AL+W=O M&PO=V]R:W-H965T& M !X;"]W;W)K&UL4$L! A0#% @ 0H.:5D8) MS,RU!P C!, !D ("!O(L 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 0H.:5J(HEG%V P 0 @ !D M ("!KIT 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ 0H.:5I4T[6#1"0 "QT !D ("! MG:P 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ 0H.:5K: *,=&PO=V]R:W-H965T&UL4$L! A0#% @ 0H.:5@8&&!.& M P " @ !D ("!N=4 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 0H.:5CJD=X)G @ .@4 !D M ("!]N< 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ 0H.:5B0(NGS* P 6 L !D ("!4?( M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M0H.:5AIJUVOE! R!H !D ("!]_X 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 0H.:5JZX<6JG @ [P8 !D M ("!!1&PO=V]R:W-H M965T 0!X;"]W;W)K&UL4$L! M A0#% @ 0H.:5O$&=D;% @ $0@ !D ("!<"0! 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 0H.: M5@C!YO5^ @ 5P8 !D ("!_3&PO=V]R:W-H965T&UL4$L! A0#% @ 0H.:5B88I\6Z!P L5@ M !D ("!+TL! 'AL+W=O&PO=V]R:W-H965T M50@ !=9 9 " @2-< 0!X;"]W;W)K&UL4$L! A0#% @ 0H.:5LI8GMDB!P >2\ !D M ("!KV0! 'AL+W=O8" '"0 &0 @($(; $ >&PO=V]R:W-H965T M&UL4$L! A0# M% @ 0H.:5I"T;AI\ P 00P !D ("!P'0! 'AL+W=O M $ >&PO=V]R:W-H965T&UL4$L! A0#% @ 0H.:5N-; M&MCA @ P@< !D ("!"X$! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 0H.:5BPGEUA9 @ I@4 !D M ("!_HT! 'AL+W=O&PO M=V]R:W-H965T3 0!X;"]W;W)K&UL4$L! A0#% @ 0H.:5CF]#,53 @ 3 4 !D ("! M_98! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ 0H.:5KI"/NH; P .0L !D ("!Y:(! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 0H.:5MY,0X6! P E1@ T M ( !K\ ! 'AL+W-T>6QE&PO=V]R M:V)O;VLN>&UL4$L! A0#% @ 0H.:5F?\4D), @ :"P !H M ( !'LL! 'AL+U]R96QS+W=O XML 89 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 90 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 91 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 352 337 1 false 107 0 false 11 false false R1.htm 0000001 - Document - Cover Sheet http://integralife.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED) Sheet http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED) Statements 2 false false R3.htm 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Sheet http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Statements 3 false false R4.htm 0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Sheet http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 5 false false R6.htm 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) Sheet http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) Statements 6 false false R7.htm 0000007 - Disclosure - BASIS OF PRESENTATION Sheet http://integralife.com/role/BASISOFPRESENTATION BASIS OF PRESENTATION Notes 7 false false R8.htm 0000008 - Disclosure - ACQUISITIONS AND DIVESTITURES Sheet http://integralife.com/role/ACQUISITIONSANDDIVESTITURES ACQUISITIONS AND DIVESTITURES Notes 8 false false R9.htm 0000009 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS Sheet http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS REVENUES FROM CONTRACTS WITH CUSTOMERS Notes 9 false false R10.htm 0000010 - Disclosure - INVENTORIES Sheet http://integralife.com/role/INVENTORIES INVENTORIES Notes 10 false false R11.htm 0000011 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Sheet http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS GOODWILL AND OTHER INTANGIBLE ASSETS Notes 11 false false R12.htm 0000012 - Disclosure - DEBT Sheet http://integralife.com/role/DEBT DEBT Notes 12 false false R13.htm 0000013 - Disclosure - DERIVATIVE INSTRUMENTS Sheet http://integralife.com/role/DERIVATIVEINSTRUMENTS DERIVATIVE INSTRUMENTS Notes 13 false false R14.htm 0000014 - Disclosure - STOCK-BASED COMPENSATION Sheet http://integralife.com/role/STOCKBASEDCOMPENSATION STOCK-BASED COMPENSATION Notes 14 false false R15.htm 0000015 - Disclosure - RETIREMENT PLANS Sheet http://integralife.com/role/RETIREMENTPLANS RETIREMENT PLANS Notes 15 false false R16.htm 0000016 - Disclosure - LEASES AND RELATED PARTY LEASES Sheet http://integralife.com/role/LEASESANDRELATEDPARTYLEASES LEASES AND RELATED PARTY LEASES Notes 16 false false R17.htm 0000017 - Disclosure - TREASURY STOCK Sheet http://integralife.com/role/TREASURYSTOCK TREASURY STOCK Notes 17 false false R18.htm 0000018 - Disclosure - INCOME TAXES Sheet http://integralife.com/role/INCOMETAXES INCOME TAXES Notes 18 false false R19.htm 0000019 - Disclosure - NET INCOME PER SHARE Sheet http://integralife.com/role/NETINCOMEPERSHARE NET INCOME PER SHARE Notes 19 false false R20.htm 0000020 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Sheet http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Notes 20 false false R21.htm 0000021 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION Sheet http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION SEGMENT AND GEOGRAPHIC INFORMATION Notes 21 false false R22.htm 0000022 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://integralife.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 22 false false R23.htm 0000023 - Disclosure - BASIS OF PRESENTATION (Policies) Sheet http://integralife.com/role/BASISOFPRESENTATIONPolicies BASIS OF PRESENTATION (Policies) Policies 23 false false R24.htm 0000024 - Disclosure - ACQUISITIONS AND DIVESTITURES (Tables) Sheet http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables ACQUISITIONS AND DIVESTITURES (Tables) Tables http://integralife.com/role/ACQUISITIONSANDDIVESTITURES 24 false false R25.htm 0000025 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables) Sheet http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables) Tables http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS 25 false false R26.htm 0000026 - Disclosure - INVENTORIES (Tables) Sheet http://integralife.com/role/INVENTORIESTables INVENTORIES (Tables) Tables http://integralife.com/role/INVENTORIES 26 false false R27.htm 0000027 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Sheet http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Tables http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS 27 false false R28.htm 0000028 - Disclosure - DEBT (Tables) Sheet http://integralife.com/role/DEBTTables DEBT (Tables) Tables http://integralife.com/role/DEBT 28 false false R29.htm 0000029 - Disclosure - DERIVATIVE INSTRUMENTS (Tables) Sheet http://integralife.com/role/DERIVATIVEINSTRUMENTSTables DERIVATIVE INSTRUMENTS (Tables) Tables http://integralife.com/role/DERIVATIVEINSTRUMENTS 29 false false R30.htm 0000030 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables) Sheet http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables LEASES AND RELATED PARTY LEASES (Tables) Tables http://integralife.com/role/LEASESANDRELATEDPARTYLEASES 30 false false R31.htm 0000031 - Disclosure - INCOME TAXES (Tables) Sheet http://integralife.com/role/INCOMETAXESTables INCOME TAXES (Tables) Tables http://integralife.com/role/INCOMETAXES 31 false false R32.htm 0000032 - Disclosure - NET INCOME PER SHARE (Tables) Sheet http://integralife.com/role/NETINCOMEPERSHARETables NET INCOME PER SHARE (Tables) Tables http://integralife.com/role/NETINCOMEPERSHARE 32 false false R33.htm 0000033 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables) Sheet http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables) Tables http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS 33 false false R34.htm 0000034 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables) Sheet http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables SEGMENT AND GEOGRAPHIC INFORMATION (Tables) Tables http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION 34 false false R35.htm 0000035 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://integralife.com/role/COMMITMENTSANDCONTINGENCIES 35 false false R36.htm 0000036 - Disclosure - ACQUISITIONS AND DIVESTITURES- Business Combination, Narrative (Details) Sheet http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails ACQUISITIONS AND DIVESTITURES- Business Combination, Narrative (Details) Details 36 false false R37.htm 0000037 - Disclosure - ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details) Sheet http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details) Details 37 false false R38.htm 0000038 - Disclosure - ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details) Sheet http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details) Details 38 false false R39.htm 0000039 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details) Sheet http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details) Details 39 false false R40.htm 0000040 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details) Sheet http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details) Details 40 false false R41.htm 0000041 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details) Sheet http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details) Details 41 false false R42.htm 0000042 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details) Sheet http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details) Details 42 false false R43.htm 0000043 - Disclosure - INVENTORIES - Schedule of Net Inventories (Details) Sheet http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails INVENTORIES - Schedule of Net Inventories (Details) Details 43 false false R44.htm 0000044 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details) Sheet http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details) Details 44 false false R45.htm 0000045 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details) Sheet http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details) Details 45 false false R46.htm 0000046 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) Sheet http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) Details 46 false false R47.htm 0000047 - Disclosure - DEBT - Narrative (Details) Sheet http://integralife.com/role/DEBTNarrativeDetails DEBT - Narrative (Details) Details 47 false false R48.htm 0000048 - Disclosure - DEBT - Maximum Total Leverage Ratio Table (Details) Sheet http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails DEBT - Maximum Total Leverage Ratio Table (Details) Details 48 false false R49.htm 0000049 - Disclosure - DEBT - Contractual Maturity Table (Details) Sheet http://integralife.com/role/DEBTContractualMaturityTableDetails DEBT - Contractual Maturity Table (Details) Details 49 false false R50.htm 0000050 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details) Sheet http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details) Details 50 false false R51.htm 0000051 - Disclosure - DERIVATIVE INSTRUMENTS - Narrative (Details) Sheet http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails DERIVATIVE INSTRUMENTS - Narrative (Details) Details 51 false false R52.htm 0000052 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details) Sheet http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details) Details 52 false false R53.htm 0000053 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details) Sheet http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details) Details 53 false false R54.htm 0000054 - Disclosure - DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details) Sheet http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details) Details 54 false false R55.htm 0000055 - Disclosure - DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details) Sheet http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details) Details 55 false false R56.htm 0000056 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivatives Not Designated as Hedging Instruments (Details) Sheet http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails DERIVATIVE INSTRUMENTS - Schedule of Derivatives Not Designated as Hedging Instruments (Details) Details 56 false false R57.htm 0000057 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) Sheet http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails STOCK-BASED COMPENSATION - Narrative (Details) Details 57 false false R58.htm 0000058 - Disclosure - RETIREMENT PLANS - Narrative (Details) Sheet http://integralife.com/role/RETIREMENTPLANSNarrativeDetails RETIREMENT PLANS - Narrative (Details) Details 58 false false R59.htm 0000059 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details) Sheet http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails LEASES AND RELATED PARTY LEASES - Narrative (Details) Details 59 false false R60.htm 0000060 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details) Sheet http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details) Details 60 false false R61.htm 0000061 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details) Sheet http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details) Details 61 false false R62.htm 0000062 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases (Details) Sheet http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases (Details) Details 62 false false R63.htm 0000063 - Disclosure - TREASURY STOCK - Narrative (Details) Sheet http://integralife.com/role/TREASURYSTOCKNarrativeDetails TREASURY STOCK - Narrative (Details) Details 63 false false R64.htm 0000064 - Disclosure - INCOME TAXES - Summary of Effective Tax Rate (Details) Sheet http://integralife.com/role/INCOMETAXESSummaryofEffectiveTaxRateDetails INCOME TAXES - Summary of Effective Tax Rate (Details) Details 64 false false R65.htm 0000065 - Disclosure - INCOME TAXES - Narrative (Details) Sheet http://integralife.com/role/INCOMETAXESNarrativeDetails INCOME TAXES - Narrative (Details) Details 65 false false R66.htm 0000066 - Disclosure - NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details) Sheet http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details) Details 66 false false R67.htm 0000067 - Disclosure - NET INCOME PER SHARE - Narrative (Details) Sheet http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails NET INCOME PER SHARE - Narrative (Details) Details 67 false false R68.htm 0000068 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details) Sheet http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details) Details http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables 68 false false R69.htm 0000069 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details) Sheet http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details) Details http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables 69 false false R70.htm 0000070 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Narrative (Details) Sheet http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Narrative (Details) Details http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables 70 false false R71.htm 0000071 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details) Sheet http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details) Details 71 false false R72.htm 0000072 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details) Sheet http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details) Details 72 false false R73.htm 0000073 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details) Sheet http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details) Details 73 false false R74.htm 0000074 - Disclosure - COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details) Sheet http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details) Details 74 false false R75.htm 0000075 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details) Sheet http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails COMMITMENTS AND CONTINGENCIES - Narrative (Details) Details 75 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept TreasuryStockShares in us-gaap/2022 used in 6 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. iart-20230331.htm 4 [dq-0542-Deprecated-Concept] Concept TreasuryStockMember in us-gaap/2022 used in 16 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. iart-20230331.htm 4 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: dei:DocumentPeriodEndDate, us-gaap:DebtInstrumentConvertibleConversionRatio1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod - iart-20230331.htm 4 iart-20230331.htm iart-20230331.xsd iart-20230331_cal.xml iart-20230331_def.xml iart-20230331_lab.xml iart-20230331_pre.xml iart-20230331xexx104.htm iart-20230331xexx311.htm iart-20230331xexx312.htm iart-20230331xexx321.htm iart-20230331xexx322.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 94 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "iart-20230331.htm": { "axisCustom": 1, "axisStandard": 32, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 851, "http://xbrl.sec.gov/dei/2022": 29 }, "contextCount": 352, "dts": { "calculationLink": { "local": [ "iart-20230331_cal.xml" ] }, "definitionLink": { "local": [ "iart-20230331_def.xml" ] }, "inline": { "local": [ "iart-20230331.htm" ] }, "labelLink": { "local": [ "iart-20230331_lab.xml" ] }, "presentationLink": { "local": [ "iart-20230331_pre.xml" ] }, "schema": { "local": [ "iart-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 591, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 2, "http://xbrl.sec.gov/dei/2022": 6, "total": 8 }, "keyCustom": 49, "keyStandard": 288, "memberCustom": 52, "memberStandard": 55, "nsprefix": "iart", "nsuri": "http://integralife.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://integralife.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - INVENTORIES", "menuCat": "Notes", "order": "10", "role": "http://integralife.com/role/INVENTORIES", "shortName": "INVENTORIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS", "menuCat": "Notes", "order": "11", "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - DEBT", "menuCat": "Notes", "order": "12", "role": "http://integralife.com/role/DEBT", "shortName": "DEBT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - DERIVATIVE INSTRUMENTS", "menuCat": "Notes", "order": "13", "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTS", "shortName": "DERIVATIVE INSTRUMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - STOCK-BASED COMPENSATION", "menuCat": "Notes", "order": "14", "role": "http://integralife.com/role/STOCKBASEDCOMPENSATION", "shortName": "STOCK-BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - RETIREMENT PLANS", "menuCat": "Notes", "order": "15", "role": "http://integralife.com/role/RETIREMENTPLANS", "shortName": "RETIREMENT PLANS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - LEASES AND RELATED PARTY LEASES", "menuCat": "Notes", "order": "16", "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASES", "shortName": "LEASES AND RELATED PARTY LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - TREASURY STOCK", "menuCat": "Notes", "order": "17", "role": "http://integralife.com/role/TREASURYSTOCK", "shortName": "TREASURY STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "18", "role": "http://integralife.com/role/INCOMETAXES", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - NET INCOME PER SHARE", "menuCat": "Notes", "order": "19", "role": "http://integralife.com/role/NETINCOMEPERSHARE", "shortName": "NET INCOME PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED)", "menuCat": "Statements", "order": "2", "role": "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)", "menuCat": "Notes", "order": "20", "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS", "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION", "menuCat": "Notes", "order": "21", "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION", "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "22", "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - BASIS OF PRESENTATION (Policies)", "menuCat": "Policies", "order": "23", "role": "http://integralife.com/role/BASISOFPRESENTATIONPolicies", "shortName": "BASIS OF PRESENTATION (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - ACQUISITIONS AND DIVESTITURES (Tables)", "menuCat": "Tables", "order": "24", "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables", "shortName": "ACQUISITIONS AND DIVESTITURES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)", "menuCat": "Tables", "order": "25", "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables", "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - INVENTORIES (Tables)", "menuCat": "Tables", "order": "26", "role": "http://integralife.com/role/INVENTORIESTables", "shortName": "INVENTORIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "menuCat": "Tables", "order": "27", "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - DEBT (Tables)", "menuCat": "Tables", "order": "28", "role": "http://integralife.com/role/DEBTTables", "shortName": "DEBT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - DERIVATIVE INSTRUMENTS (Tables)", "menuCat": "Tables", "order": "29", "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables", "shortName": "DERIVATIVE INSTRUMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "menuCat": "Statements", "order": "3", "role": "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "iart:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables)", "menuCat": "Tables", "order": "30", "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables", "shortName": "LEASES AND RELATED PARTY LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "iart:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - INCOME TAXES (Tables)", "menuCat": "Tables", "order": "31", "role": "http://integralife.com/role/INCOMETAXESTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000032 - Disclosure - NET INCOME PER SHARE (Tables)", "menuCat": "Tables", "order": "32", "role": "http://integralife.com/role/NETINCOMEPERSHARETables", "shortName": "NET INCOME PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)", "menuCat": "Tables", "order": "33", "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables", "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)", "menuCat": "Tables", "order": "34", "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables", "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": null }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "menuCat": "Tables", "order": "35", "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i2aee20b22d6c4af1adc9943efb3a200b_D20221206-20221206", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - ACQUISITIONS AND DIVESTITURES- Business Combination, Narrative (Details)", "menuCat": "Details", "order": "36", "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails", "shortName": "ACQUISITIONS AND DIVESTITURES- Business Combination, Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i2aee20b22d6c4af1adc9943efb3a200b_D20221206-20221206", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details)", "menuCat": "Details", "order": "37", "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails", "shortName": "ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i9562f5f76a11487db81f0d5c50e212ba_I20221206", "decimals": "-3", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i945ecb5f56064998992427ac8c2997e7_I20220831", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)", "menuCat": "Details", "order": "38", "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails", "shortName": "ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i945ecb5f56064998992427ac8c2997e7_I20220831", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details)", "menuCat": "Details", "order": "39", "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails", "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "menuCat": "Statements", "order": "4", "role": "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i770b51dde44c4f0f852868d1b571cf9e_I20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details)", "menuCat": "Details", "order": "40", "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails", "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i770b51dde44c4f0f852868d1b571cf9e_I20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i05f0e25f7b574dc197a1e7d75cd2e313_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details)", "menuCat": "Details", "order": "41", "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails", "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i05f0e25f7b574dc197a1e7d75cd2e313_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000042 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details)", "menuCat": "Details", "order": "42", "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails", "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i41cd523bdedf46cc95670faedd457b46_D20230101-20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000043 - Disclosure - INVENTORIES - Schedule of Net Inventories (Details)", "menuCat": "Details", "order": "43", "role": "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails", "shortName": "INVENTORIES - Schedule of Net Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i05f0e25f7b574dc197a1e7d75cd2e313_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000044 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details)", "menuCat": "Details", "order": "44", "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000045 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details)", "menuCat": "Details", "order": "45", "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000046 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)", "menuCat": "Details", "order": "46", "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SecuredDebtCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000047 - Disclosure - DEBT - Narrative (Details)", "menuCat": "Details", "order": "47", "role": "http://integralife.com/role/DEBTNarrativeDetails", "shortName": "DEBT - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-5", "lang": "en-US", "name": "iart:InterestPaymentsReminderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i29c495bb726f416f92c438401600a765_I20230324", "decimals": "INF", "first": true, "lang": "en-US", "name": "iart:DebtInstrumentCovenantMaximumLeverageRatio", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000048 - Disclosure - DEBT - Maximum Total Leverage Ratio Table (Details)", "menuCat": "Details", "order": "48", "role": "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails", "shortName": "DEBT - Maximum Total Leverage Ratio Table (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i29c495bb726f416f92c438401600a765_I20230324", "decimals": "INF", "first": true, "lang": "en-US", "name": "iart:DebtInstrumentCovenantMaximumLeverageRatio", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000049 - Disclosure - DEBT - Contractual Maturity Table (Details)", "menuCat": "Details", "order": "49", "role": "http://integralife.com/role/DEBTContractualMaturityTableDetails", "shortName": "DEBT - Contractual Maturity Table (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "menuCat": "Statements", "order": "5", "role": "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherDepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ibaa12b7418534a0f9c95d84d9ad6b1bb_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000050 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details)", "menuCat": "Details", "order": "50", "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "shortName": "DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "id3e91944e1f34523a944e5c31a1dcfb8_I20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000051 - Disclosure - DERIVATIVE INSTRUMENTS - Narrative (Details)", "menuCat": "Details", "order": "51", "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "shortName": "DERIVATIVE INSTRUMENTS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i0d2cb496f6d34578a914d07e7359d877_I20201221", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000052 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details)", "menuCat": "Details", "order": "52", "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "shortName": "DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "if68feb9648554b258a953ab0b3cf1b44_I20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i0d2cb496f6d34578a914d07e7359d877_I20201221", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000053 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details)", "menuCat": "Details", "order": "53", "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails", "shortName": "DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i58f139fbd41647c48c9057f1580cdac4_I20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i5fcf3db2e33e4516bb7de79733b0c0d0_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000054 - Disclosure - DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details)", "menuCat": "Details", "order": "54", "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails", "shortName": "DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i5fcf3db2e33e4516bb7de79733b0c0d0_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i05f0e25f7b574dc197a1e7d75cd2e313_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000055 - Disclosure - DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details)", "menuCat": "Details", "order": "55", "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "shortName": "DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ie8763013b51645d9b4f267faa1bc585c_D20230101-20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000056 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivatives Not Designated as Hedging Instruments (Details)", "menuCat": "Details", "order": "56", "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails", "shortName": "DERIVATIVE INSTRUMENTS - Schedule of Derivatives Not Designated as Hedging Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000057 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)", "menuCat": "Details", "order": "57", "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "shortName": "STOCK-BASED COMPENSATION - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000058 - Disclosure - RETIREMENT PLANS - Narrative (Details)", "menuCat": "Details", "order": "58", "role": "http://integralife.com/role/RETIREMENTPLANSNarrativeDetails", "shortName": "RETIREMENT PLANS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "iart:LesseeOperatingLeaseNumberOfRenewalOptions", "reportCount": 1, "unique": true, "unitRef": "renewal_option", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000059 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details)", "menuCat": "Details", "order": "59", "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails", "shortName": "LEASES AND RELATED PARTY LEASES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "iart:LesseeOperatingLeaseNumberOfRenewalOptions", "reportCount": 1, "unique": true, "unitRef": "renewal_option", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i5173bceb1ba843f5b9ba6fac4ca9b4ca_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)", "menuCat": "Statements", "order": "6", "role": "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i5173bceb1ba843f5b9ba6fac4ca9b4ca_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "iart:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000060 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)", "menuCat": "Details", "order": "60", "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails", "shortName": "LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "iart:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ief22d29946704881b53879628a3b3a03_I20230331", "decimals": null, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "iart:CashFlowLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000061 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)", "menuCat": "Details", "order": "61", "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails", "shortName": "LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "iart:CashFlowLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000062 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases (Details)", "menuCat": "Details", "order": "62", "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails", "shortName": "LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockCommonShares", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000063 - Disclosure - TREASURY STOCK - Narrative (Details)", "menuCat": "Details", "order": "63", "role": "http://integralife.com/role/TREASURYSTOCKNarrativeDetails", "shortName": "TREASURY STOCK - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i05f0e25f7b574dc197a1e7d75cd2e313_I20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:TreasuryStockCommonShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000064 - Disclosure - INCOME TAXES - Summary of Effective Tax Rate (Details)", "menuCat": "Details", "order": "64", "role": "http://integralife.com/role/INCOMETAXESSummaryofEffectiveTaxRateDetails", "shortName": "INCOME TAXES - Summary of Effective Tax Rate (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000065 - Disclosure - INCOME TAXES - Narrative (Details)", "menuCat": "Details", "order": "65", "role": "http://integralife.com/role/INCOMETAXESNarrativeDetails", "shortName": "INCOME TAXES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000066 - Disclosure - NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details)", "menuCat": "Details", "order": "66", "role": "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails", "shortName": "NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i142beeb645c448e9b1d164dc7254fd2f_D20230331-20230331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000067 - Disclosure - NET INCOME PER SHARE - Narrative (Details)", "menuCat": "Details", "order": "67", "role": "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails", "shortName": "NET INCOME PER SHARE - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i142beeb645c448e9b1d164dc7254fd2f_D20230331-20230331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000068 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details)", "menuCat": "Details", "order": "68", "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails", "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i05f0e25f7b574dc197a1e7d75cd2e313_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000069 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)", "menuCat": "Details", "order": "69", "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails", "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000007 - Disclosure - BASIS OF PRESENTATION", "menuCat": "Notes", "order": "7", "role": "http://integralife.com/role/BASISOFPRESENTATION", "shortName": "BASIS OF PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000070 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Narrative (Details)", "menuCat": "Details", "order": "70", "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails", "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "icf3a5e50a53a4b55a3ef05b821846b94_D20230101-20230331", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000071 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)", "menuCat": "Details", "order": "71", "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails", "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000072 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details)", "menuCat": "Details", "order": "72", "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails", "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ia720faaba52b43d2be21584d13ecec2a_D20230101-20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OperatingIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000073 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details)", "menuCat": "Details", "order": "73", "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails", "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i8ec4e98c494d4152959a7ad4e62f2cdc_D20230101-20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "iaba62da9aab3440ab34c023a05b0b605_I20230331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000074 - Disclosure - COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)", "menuCat": "Details", "order": "74", "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ifcaf924eb8b044b5959cc99978a303a7_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i5d9c6f2f864e40aea1985e58d5f1a41e_I20190729", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000075 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)", "menuCat": "Details", "order": "75", "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "i5d9c6f2f864e40aea1985e58d5f1a41e_I20190729", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000008 - Disclosure - ACQUISITIONS AND DIVESTITURES", "menuCat": "Notes", "order": "8", "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURES", "shortName": "ACQUISITIONS AND DIVESTITURES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS", "menuCat": "Notes", "order": "9", "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS", "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iart-20230331.htm", "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 107, "tag": { "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r660" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r661" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity City" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity State" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r662" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Smaller Reporting Company" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r657" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r659" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://integralife.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "iart_ACellIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ACell, Inc.", "label": "ACell, Inc. [Member]", "terseLabel": "ACell, Inc." } } }, "localname": "ACellIncMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_ACellMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ACell", "label": "ACell [Member]", "terseLabel": "ACell" } } }, "localname": "ACellMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "domainItemType" }, "iart_AcceleratedShareRepurchasesAdditionalSharesReceived": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accelerated Share Repurchases, Additional Shares Received", "label": "Accelerated Share Repurchases, Additional Shares Received", "terseLabel": "Accelerated share repurchases, additional shares received" } } }, "localname": "AcceleratedShareRepurchasesAdditionalSharesReceived", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/TREASURYSTOCKNarrativeDetails" ], "xbrltype": "sharesItemType" }, "iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accelerated Share Repurchases, Percentage Of Expected Total Repurchased", "label": "Accelerated Share Repurchases, Percentage Of Expected Total Repurchased", "terseLabel": "Accelerated share repurchases, percentage of expected total repurchased" } } }, "localname": "AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/TREASURYSTOCKNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_AcceleratedShareRepurchasesSharesReceivedAtInception": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accelerated Share Repurchases, Shares Received at Inception", "label": "Accelerated Share Repurchases, Shares Received at Inception", "terseLabel": "Accelerated share repurchases, shares received at inception" } } }, "localname": "AcceleratedShareRepurchasesSharesReceivedAtInception", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/TREASURYSTOCKNarrativeDetails" ], "xbrltype": "sharesItemType" }, "iart_AccruedExpensesAndOtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued expenses and other current liabilities.", "label": "Accrued Expenses And Other Current Liabilities [Member]", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedExpensesAndOtherCurrentLiabilitiesMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "iart_AllOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All Other [Member]", "label": "All Other [Member]", "terseLabel": "All other" } } }, "localname": "AllOtherMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees": { "auth_ref": [], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization Of Debt Issuance Costs And Debt Refinanced Fees", "label": "Amortization Of Debt Issuance Costs And Debt Refinanced Fees", "terseLabel": "Amortization of debt issuance costs and expenses associated with debt refinancing" } } }, "localname": "AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "iart_AnnualRateOfLeaseAgreement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Annual rate of lease agreement.", "label": "Annual Rate Of Lease Agreement", "terseLabel": "Annual rate of lease agreement" } } }, "localname": "AnnualRateOfLeaseAgreement", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_ArkisBioSciencesInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arkis BioSciences Inc. [Member]", "label": "Arkis BioSciences Inc. [Member]", "terseLabel": "Arkis" } } }, "localname": "ArkisBioSciencesInc.Member", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets And Liabilities, Lessee [Table Text Block]", "label": "Assets And Liabilities, Lessee [Table Text Block]", "terseLabel": "Supplemental Balance Sheet Information" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables" ], "xbrltype": "textBlockItemType" }, "iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "BioD Earnout Payments and Medihoney Earnout Payments [Member]", "label": "BioD Earnout Payments and Medihoney Earnout Payments [Member]", "terseLabel": "BioD Earnout Payments and Medihoney Earnout Payments" } } }, "localname": "BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_BusinessAcquisitionNumberOfContingentLiabilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Acquisition, Number Of Contingent Liabilities", "label": "Business Acquisition, Number Of Contingent Liabilities", "terseLabel": "Number of contingent liabilities" } } }, "localname": "BusinessAcquisitionNumberOfContingentLiabilities", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails" ], "xbrltype": "integerItemType" }, "iart_BusinessCombinationContingentConsiderationNumberOfLiabilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Contingent Consideration, Number Of Liabilities", "label": "Business Combination, Contingent Consideration, Number Of Liabilities", "terseLabel": "Number of contingent liabilities remaining" } } }, "localname": "BusinessCombinationContingentConsiderationNumberOfLiabilities", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "integerItemType" }, "iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Intangible Asset Acquired, Discount Rate", "label": "Business Combination, Intangible Asset Acquired, Discount Rate", "terseLabel": "Intangible asset acquired, discount rate (percent)" } } }, "localname": "BusinessCombinationIntangibleAssetAcquiredDiscountRate", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill": { "auth_ref": [], "calculation": { "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill", "totalLabel": "Total assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "iart_CashFlowLesseeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash Flow, Lessee [Abstract]", "label": "Cash Flow, Lessee [Abstract]", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:" } } }, "localname": "CashFlowLesseeAbstract", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "iart_CashFlowLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash Flow, Lessee [Table Text Block]", "label": "Cash Flow, Lessee [Table Text Block]", "terseLabel": "Supplemental Cash Flow Information" } } }, "localname": "CashFlowLesseeTableTextBlock", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables" ], "xbrltype": "textBlockItemType" }, "iart_ChangeInContractWithCustomerAssetRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Change In Contract With Customer, Asset [Roll Forward]", "label": "Change In Contract With Customer, Asset [Roll Forward]", "terseLabel": "Contract Asset" } } }, "localname": "ChangeInContractWithCustomerAssetRollForward", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "iart_ChangeInContractWithCustomerLiabilityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Change In Contract With Customer, Liability [Roll Forward]", "label": "Change In Contract With Customer, Liability [Roll Forward]", "terseLabel": "Contract Liability" } } }, "localname": "ChangeInContractWithCustomerLiabilityRollForward", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "iart_ChangesInAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Changes In Assets And Liabilities [Abstract]", "label": "Changes In Assets And Liabilities [Abstract]", "terseLabel": "Changes in assets and liabilities:" } } }, "localname": "ChangesInAssetsAndLiabilitiesAbstract", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "iart_CodmanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Codman [Member]", "label": "Codman [Member]", "terseLabel": "Codman" } } }, "localname": "CodmanMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_CodmanSpecialtySurgicalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Codman Specialty Surgical [Member]", "label": "Codman Specialty Surgical [Member]", "terseLabel": "Codman Specialty Surgical", "verboseLabel": "Codman Specialty Surgical" } } }, "localname": "CodmanSpecialtySurgicalMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails", "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails", "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails", "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" ], "xbrltype": "domainItemType" }, "iart_CompletedTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Completed technology.", "label": "Completed Technology [Member]", "terseLabel": "Completed technology" } } }, "localname": "CompletedTechnologyMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "iart_ContingentConsiderationLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingent Consideration Liability [Member]", "label": "Contingent Consideration Liability [Member]", "terseLabel": "Contingent Consideration Liability" } } }, "localname": "ContingentConsiderationLiabilityMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Contract With Customer, Asset, Net Of Reclassified To Receivable", "label": "Contract With Customer, Asset, Net Of Reclassified To Receivable", "terseLabel": "Contract asset, net of transferred to trade receivables on contracts during the period" } } }, "localname": "ContractWithCustomerAssetNetOfReclassifiedToReceivable", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contract With Customer, Liability, Increase (Decrease) From Foreign Currency Translation", "label": "Contract With Customer, Liability, Increase (Decrease) From Foreign Currency Translation", "terseLabel": "Foreign currency translation" } } }, "localname": "ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "iart_ContractWithCustomerLiabilityNetOfRevenueRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contract With Customer, Liability, Net Of Revenue Recognized", "label": "Contract With Customer, Liability, Net Of Revenue Recognized", "terseLabel": "Recognition of revenue included in beginning of year contract liability" } } }, "localname": "ContractWithCustomerLiabilityNetOfRevenueRecognized", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "calculation": { "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails": { "order": 1.0, "parentTag": "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill.", "label": "Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill", "terseLabel": "Cost" } } }, "localname": "CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "iart_CrossCurrencyInterestRateContractOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cross Currency Interest Rate Contract One [Member]", "label": "Cross Currency Interest Rate Contract One [Member]", "terseLabel": "Cross Currency Interest Rate Swap One" } } }, "localname": "CrossCurrencyInterestRateContractOneMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_CrossCurrencyInterestRateContractThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cross Currency Interest Rate Contract Three [Member]", "label": "Cross Currency Interest Rate Contract Three [Member]", "terseLabel": "Cross Currency Interest Rate Swap Three" } } }, "localname": "CrossCurrencyInterestRateContractThreeMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_CrossCurrencyInterestRateContractTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cross Currency Interest Rate Contract Two [Member]", "label": "Cross Currency Interest Rate Contract Two [Member]", "terseLabel": "Cross Currency Interest Rate Swap Two" } } }, "localname": "CrossCurrencyInterestRateContractTwoMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "iart_DebtCovenantPeriod1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Covenant Period 1", "label": "Debt Covenant Period 1 [Member]", "terseLabel": "March 31, 2023 through December 31, 2024" } } }, "localname": "DebtCovenantPeriod1Member", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" ], "xbrltype": "domainItemType" }, "iart_DebtCovenantPeriod2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Covenant Period 2", "label": "Debt Covenant Period 2 [Member]", "terseLabel": "March 31, 2025 through June 30, 2026" } } }, "localname": "DebtCovenantPeriod2Member", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" ], "xbrltype": "domainItemType" }, "iart_DebtCovenantPeriod3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Covenant Period 3 [Member]", "label": "Debt Covenant Period 3 [Member]", "terseLabel": "September 30, 2026 and the last day of each fiscal quarter thereafter" } } }, "localname": "DebtCovenantPeriod3Member", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" ], "xbrltype": "domainItemType" }, "iart_DebtCovenantPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Covenant Period [Axis]", "label": "Debt Covenant Period [Axis]", "terseLabel": "Debt Covenant Period [Axis]" } } }, "localname": "DebtCovenantPeriodAxis", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" ], "xbrltype": "stringItemType" }, "iart_DebtCovenantPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Debt Covenant Period [Axis]", "label": "Debt Covenant Period [Domain]", "terseLabel": "Debt Covenant Period [Domain]" } } }, "localname": "DebtCovenantPeriodDomain", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" ], "xbrltype": "domainItemType" }, "iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Basis Spread Adjustment On Variable Rate", "label": "Debt Instrument, Basis Spread Adjustment On Variable Rate", "terseLabel": "Interest rate adjustment" } } }, "localname": "DebtInstrumentBasisSpreadAdjustmentOnVariableRate", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount", "label": "Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount", "terseLabel": "Minimum settled in cash per principal amount" } } }, "localname": "DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_DebtInstrumentCovenantMaximumLeverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant, Maximum Leverage Ratio", "label": "Debt Instrument, Covenant, Maximum Leverage Ratio", "terseLabel": "Maximum Consolidated Total Leverage Ratio" } } }, "localname": "DebtInstrumentCovenantMaximumLeverageRatio", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" ], "xbrltype": "pureItemType" }, "iart_DebtInstrumentMaximumAverageConversionValueOfNotes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Maximum Average Conversion Value Of Notes", "label": "Debt Instrument, Maximum Average Conversion Value Of Notes", "terseLabel": "Maximum average conversion value of notes" } } }, "localname": "DebtInstrumentMaximumAverageConversionValueOfNotes", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period", "label": "Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period", "terseLabel": "Maximum selling price of the company's common stock of the conversion price" } } }, "localname": "DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_DebtWeightedAverageInterestRateFromSecuritization": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt, Weighted Average Interest Rate, From Securitization", "label": "Debt, Weighted Average Interest Rate, From Securitization", "terseLabel": "Weighted average interest rate, accounts receivable securitization revolving loan facility" } } }, "localname": "DebtWeightedAverageInterestRateFromSecuritization", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage", "label": "Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage", "terseLabel": "Defer payment and taxation, base salary, percentage (up to)" } } }, "localname": "DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/RETIREMENTPLANSNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage", "label": "Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage", "terseLabel": "Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)" } } }, "localname": "DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/RETIREMENTPLANSNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill": { "auth_ref": [], "calculation": { "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill.", "label": "Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill", "totalLabel": "Net" } } }, "localname": "DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "iart_DerivativeNotionalAmountTerminated": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Derivative, Notional Amount, Terminated", "label": "Derivative, Notional Amount, Terminated", "terseLabel": "Terminated notional amount" } } }, "localname": "DerivativeNotionalAmountTerminated", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_DermaSciencesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derma Sciences [Member]", "label": "Derma Sciences [Member]", "terseLabel": "Derma Sciences" } } }, "localname": "DermaSciencesMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_DirectorsandCertainExecutiveOfficersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Directors and Certain Executive Officers [Member]", "label": "Directors and Certain Executive Officers [Member]", "terseLabel": "Directors and Certain Executive Officers" } } }, "localname": "DirectorsandCertainExecutiveOfficersMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Discontinued Operation, Continuing Involvement, Prepaid Asset", "label": "Discontinued Operation, Continuing Involvement, Prepaid Asset", "terseLabel": "Discontinued operation, continuing involvement, prepaid asset" } } }, "localname": "DiscontinuedOperationContinuingInvolvementPrepaidAsset", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Discontinued Operation, Continuing Involvement, Prepaid Expenses, Current Assets", "label": "Discontinued Operation, Continuing Involvement, Prepaid Assets , Current", "terseLabel": "Inventory purchase, prepaid expenses and other current assets" } } }, "localname": "DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration", "label": "Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration", "terseLabel": "Sale of business, contingent consideration" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration, Period", "label": "Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration, Period", "terseLabel": "Period for revenue based performance milestone" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "durationItemType" }, "iart_EmployeeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee [Member]", "label": "Employee [Member]", "terseLabel": "Employees" } } }, "localname": "EmployeeMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_ExciseTaxPayableOnShareRepurchases": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excise Tax Payable On Share Repurchases", "label": "Excise Tax Payable On Share Repurchases", "terseLabel": "Share repurchases, accrued excise tax" } } }, "localname": "ExciseTaxPayableOnShareRepurchases", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/TREASURYSTOCKNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_FDAApprovalOfPremarketApprovalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "FDA Approval Of Premarket Approval", "label": "FDA Approval Of Premarket Approval [Member]", "terseLabel": "FDA Approval Of Premarket Approval" } } }, "localname": "FDAApprovalOfPremarketApprovalMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current", "terseLabel": "Transfers" } } }, "localname": "FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "monetaryItemType" }, "iart_FiveYearOptionLeasePeriodOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Five-Year Option Lease Period One", "label": "Five Year Option Lease Period One [Member]", "terseLabel": "Five Year Option Lease From November 1, 2029 Through October 31, 2034" } } }, "localname": "FiveYearOptionLeasePeriodOneMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_FiveYearOptionLeasePeriodTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Five-Year Option Lease Period Two", "label": "Five Year Option Lease Period Two [Member]", "terseLabel": "Five Year Option Lease From November 1, 2034 Through October 31, 2039" } } }, "localname": "FiveYearOptionLeasePeriodTwoMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_InstrumentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Instruments [Member]", "label": "Instruments [Member]", "terseLabel": "Instruments" } } }, "localname": "InstrumentsMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" ], "xbrltype": "domainItemType" }, "iart_IntercompanyLoanQuarterlyPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intercompany Loan, Quarterly Payment", "label": "Intercompany Loan, Quarterly Payment", "terseLabel": "Intercompany loan quarterly payments" } } }, "localname": "IntercompanyLoanQuarterlyPayment", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_InterestPaymentsAfterYearThree": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest Payments, After Year Three", "label": "Interest Payments, After Year Three", "terseLabel": "Interest payments, after year three" } } }, "localname": "InterestPaymentsAfterYearThree", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_InterestPaymentsReminderOfFiscalYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest Payments, Reminder Of Fiscal Year", "label": "Interest Payments, Reminder Of Fiscal Year", "terseLabel": "Interest payments, remainder of fiscal year" } } }, "localname": "InterestPaymentsReminderOfFiscalYear", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_InterestPaymentsYearOne": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest Payments, Year One", "label": "Interest Payments, Year One", "terseLabel": "Interest payments, year one" } } }, "localname": "InterestPaymentsYearOne", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_InterestPaymentsYearThree": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest Payments, Year Three", "label": "Interest Payments, Year Three", "terseLabel": "Interest payments, year three" } } }, "localname": "InterestPaymentsYearThree", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_InterestPaymentsYearTwo": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest Payments, Year Two", "label": "Interest Payments, Year Two", "terseLabel": "Interest payments, year two" } } }, "localname": "InterestPaymentsYearTwo", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_InterestRateSwapDesignatedDecember132017Tranche2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 2", "label": "Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]", "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 2" } } }, "localname": "InterestRateSwapDesignatedDecember132017Tranche2Member", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedDecember132017Tranche3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]", "label": "Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]", "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 3" } } }, "localname": "InterestRateSwapDesignatedDecember132017Tranche3Member", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedDecember152020Tranche1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap Designated December 15, 2020 Tranche 1", "label": "Interest Rate Swap Designated December 15, 2020 Tranche 1 [Member]", "terseLabel": "Interest Rate Swap Designated December 15, 2020 Tranche 1" } } }, "localname": "InterestRateSwapDesignatedDecember152020Tranche1Member", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedDecember152020Tranche2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap Designated December 15, 2020 Tranche 2", "label": "Interest Rate Swap Designated December 15, 2020 Tranche 2 [Member]", "terseLabel": "Interest Rate Swap Designated December 15, 2020 Tranche 2" } } }, "localname": "InterestRateSwapDesignatedDecember152020Tranche2Member", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedDecember182018Tranche1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]", "label": "Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]", "terseLabel": "Interest Rate Swap Designated December 18, 2018 Tranche 1" } } }, "localname": "InterestRateSwapDesignatedDecember182018Tranche1Member", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedDecember182018Tranche2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]", "label": "Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]", "terseLabel": "Interest Rate Swap Designated December 18, 2018 Tranche 2" } } }, "localname": "InterestRateSwapDesignatedDecember182018Tranche2Member", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedMarch312023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap Designated March 31, 2023", "label": "Interest Rate Swap Designated March 31, 2023 [Member]", "terseLabel": "Interest Rate Swap Designated March 31, 2023" } } }, "localname": "InterestRateSwapDesignatedMarch312023Member", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedOctober102018Tranche1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]", "label": "Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]", "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 1" } } }, "localname": "InterestRateSwapDesignatedOctober102018Tranche1Member", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedOctober102018Tranche2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]", "label": "Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]", "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 2" } } }, "localname": "InterestRateSwapDesignatedOctober102018Tranche2Member", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "iart_InterestRateSwapDesignatedOctober102018Tranche3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]", "label": "Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]", "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 3" } } }, "localname": "InterestRateSwapDesignatedOctober102018Tranche3Member", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "iart_LesseeOperatingLeaseNumberOfRenewalOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Number Of Renewal Options", "label": "Lessee, Operating Lease, Number Of Renewal Options", "terseLabel": "Number of renewal options (or more)" } } }, "localname": "LesseeOperatingLeaseNumberOfRenewalOptions", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" ], "xbrltype": "integerItemType" }, "iart_LongTermDebtMaturityAfterYearThree": { "auth_ref": [], "calculation": { "http://integralife.com/role/DEBTContractualMaturityTableDetails": { "order": 5.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-Term Debt, Maturity, after Year Three", "label": "Long-Term Debt, Maturity, after Year Three", "terseLabel": "Thereafter" } } }, "localname": "LongTermDebtMaturityAfterYearThree", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTContractualMaturityTableDetails" ], "xbrltype": "monetaryItemType" }, "iart_MergersAcquisitionsAndDispositionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mergers, Acquisitions and Dispositions", "label": "Mergers, Acquisitions and Dispositions [Abstract]" } } }, "localname": "MergersAcquisitionsAndDispositionsAbstract", "nsuri": "http://integralife.com/20230331", "xbrltype": "stringItemType" }, "iart_MilestonePaymentOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Milestone Payment One [Member]", "label": "Milestone Payment One [Member]", "terseLabel": "Development Milestones" } } }, "localname": "MilestonePaymentOneMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_MilestonePaymentTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Milestone Payment Two [Member]", "label": "Milestone Payment Two [Member]", "terseLabel": "Commercial Sales Milestones" } } }, "localname": "MilestonePaymentTwoMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_NeurosurgeryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Neurosurgery [Member]", "label": "Neurosurgery [Member]", "terseLabel": "Neurosurgery" } } }, "localname": "NeurosurgeryMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" ], "xbrltype": "domainItemType" }, "iart_NoncashLeaseExpense": { "auth_ref": [], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Noncash Lease Expense", "label": "Noncash Lease Expense", "terseLabel": "Non-cash lease expense" } } }, "localname": "NoncashLeaseExpense", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "iart_PaymentsForOptionIndexToIssuersEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments For Options Indexed to Issuer's Equity", "label": "Payments For Option Index To Issuers Equity", "terseLabel": "Cost of call transactions" } } }, "localname": "PaymentsForOptionIndexToIssuersEquity", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director", "label": "Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director", "terseLabel": "Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director" } } }, "localname": "PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" ], "xbrltype": "percentItemType" }, "iart_PerformanceStockAndRestrictedStockAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Stock And Restricted Stock Awards [Member]", "label": "Performance Stock And Restricted Stock Awards [Member]", "terseLabel": "Performance Stock and Restricted Stock Awards" } } }, "localname": "PerformanceStockAndRestrictedStockAwardsMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_PrivateLabelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Label [Member]", "label": "Private Label [Member]", "terseLabel": "Private Label" } } }, "localname": "PrivateLabelMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" ], "xbrltype": "domainItemType" }, "iart_RegenerativeSkinAndWoundMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Regenerative Skin And Wound [Member]", "label": "Regenerative Skin And Wound [Member]", "terseLabel": "Wound Reconstruction and Care" } } }, "localname": "RegenerativeSkinAndWoundMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" ], "xbrltype": "domainItemType" }, "iart_RelatedPartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Parties [Member]", "label": "Related Parties [Member]", "terseLabel": "Related Parties" } } }, "localname": "RelatedPartiesMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" ], "xbrltype": "domainItemType" }, "iart_RestOfWorldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenues from rest of the world.", "label": "Rest Of World [Member]", "terseLabel": "Rest of World" } } }, "localname": "RestOfWorldMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Return Policy, Issue of Credit, Number of Days from Shipment", "label": "Return Policy, Issue Of Credit, Number Of Days From Shipment", "terseLabel": "Number of days from shipment to issue a credit" } } }, "localname": "ReturnPolicyIssueOfCreditNumberOfDaysFromShipment", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" ], "xbrltype": "durationItemType" }, "iart_RevenueBasedPerformanceMilestonesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue Based Performance Milestones", "label": "Revenue Based Performance Milestones [Member]", "terseLabel": "Revenue Based Performance Milestones" } } }, "localname": "RevenueBasedPerformanceMilestonesMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_RevenueProductWarrantyPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue, Product Warranty Period", "label": "Revenue, Product Warranty Period", "terseLabel": "Product warranty period (up to)" } } }, "localname": "RevenueProductWarrantyPeriod", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" ], "xbrltype": "durationItemType" }, "iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]", "label": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]", "terseLabel": "ROU assets obtained in exchange for lease liabilities:" } } }, "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "iart_SecuredLongTermDebtSecuritizationProgram": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Secured Long-Term Debt, Securitization Program", "label": "Secured Long-Term Debt, Securitization Program", "terseLabel": "Secured long-term debt, securitization program" } } }, "localname": "SecuredLongTermDebtSecuritizationProgram", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_SecuredLongTermDebtSecuritizationProgramNoncurrent": { "auth_ref": [], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Secured Long-Term Debt, Securitization Program, Noncurrent", "label": "Secured Long-Term Debt, Securitization Program, Noncurrent", "terseLabel": "Long-term borrowings under securitization facility" } } }, "localname": "SecuredLongTermDebtSecuritizationProgramNoncurrent", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "iart_SecuritizationFacilityFairValueOfAmountOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Securitization Facility, Fair Value Of Amount Outstanding", "label": "Securitization Facility, Fair Value Of Amount Outstanding", "terseLabel": "Securitization facility, outstanding borrowings, fair value" } } }, "localname": "SecuritizationFacilityFairValueOfAmountOutstanding", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_SegmentReportingInformationNumberOfProductsOffered": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of products sold by a segment", "label": "Segment Reporting Information, Number Of Products Offered", "terseLabel": "Number of products offered (more than)" } } }, "localname": "SegmentReportingInformationNumberOfProductsOffered", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" ], "xbrltype": "integerItemType" }, "iart_SeniorCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Credit Facility.", "label": "Senior Credit Facility [Member]", "terseLabel": "Senior Credit Facility" } } }, "localname": "SeniorCreditFacilityMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails", "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_SupplierRelationShipsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplier Relation Ships [Member]", "label": "Supplier Relation Ships [Member]", "terseLabel": "Supplier relationships" } } }, "localname": "SupplierRelationShipsMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "iart_SurgicalInnovationAssociatesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Surgical Innovation Associates Inc", "label": "Surgical Innovation Associates Inc [Member]", "terseLabel": "Surgical Innovation Associates Inc" } } }, "localname": "SurgicalInnovationAssociatesIncMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails", "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" ], "xbrltype": "domainItemType" }, "iart_SwinglineLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swingline Loan [Member]", "label": "Swingline Loan [Member]", "terseLabel": "Swingline Loans" } } }, "localname": "SwinglineLoanMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_TermLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Loan Facility [Member]", "label": "Term Loan Facility [Member]", "terseLabel": "Term Loan Facility" } } }, "localname": "TermLoanFacilityMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_ThirdPartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third Parties [Member]", "label": "Third Parties [Member]", "verboseLabel": "Third Parties" } } }, "localname": "ThirdPartiesMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" ], "xbrltype": "domainItemType" }, "iart_TissueTechnologiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Orthopedics and Tissue Technologies [Member]", "label": "Tissue Technologies [Member]", "terseLabel": "Tissue Technologies" } } }, "localname": "TissueTechnologiesMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails", "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails", "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" ], "xbrltype": "domainItemType" }, "iart_TrademarksBrandNamesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trademarks Brand Names.", "label": "Trademarks Brand Names [Member]", "terseLabel": "Trademarks/brand names" } } }, "localname": "TrademarksBrandNamesMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "iart_TraditionalWoundCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Traditional Wound Care", "label": "Traditional Wound Care [Member]", "terseLabel": "Traditional Wound Care" } } }, "localname": "TraditionalWoundCareMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "domainItemType" }, "iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit", "label": "Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit", "terseLabel": "Securitization program outstanding borrowings, maximum limit" } } }, "localname": "TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand Twenty Five Senior Convertible Notes [Member]", "label": "Two Thousand Twenty Five Senior Convertible Notes [Member]", "terseLabel": "2025 Notes" } } }, "localname": "TwoThousandTwentyFiveSeniorConvertibleNotesMember", "nsuri": "http://integralife.com/20230331", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r612", "r710", "r725", "r726", "r728" ], "lang": { "en-us": { "role": { "label": "Affiliated Entity [Member]", "terseLabel": "Affiliated Entity" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "Asia Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r252", "r286", "r298", "r299", "r300", "r301", "r302", "r304", "r308", "r354", "r355", "r356", "r357", "r359", "r360", "r362", "r364", "r365", "r702", "r703" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r252", "r286", "r298", "r299", "r300", "r301", "r302", "r304", "r308", "r354", "r355", "r356", "r357", "r359", "r360", "r362", "r364", "r365", "r702", "r703" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Operating Activities [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r250", "r251", "r370", "r396", "r619", "r621" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" ], "xbrltype": "stringItemType" }, "srt_DirectorMember": { "auth_ref": [ "r681" ], "lang": { "en-us": { "role": { "label": "Director [Member]", "terseLabel": "Directors" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Europe [Member]", "terseLabel": "Europe" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r349", "r350", "r351", "r352", "r451", "r561", "r588", "r613", "r614", "r633", "r648", "r656", "r704", "r731", "r732", "r733", "r734", "r735", "r736" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails", "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r349", "r350", "r351", "r352", "r451", "r561", "r588", "r613", "r614", "r633", "r648", "r656", "r704", "r731", "r732", "r733", "r734", "r735", "r736" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails", "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r310", "r562", "r635", "r654", "r699", "r700", "r708", "r737" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r310", "r562", "r635", "r654", "r699", "r700", "r708", "r737" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r349", "r350", "r351", "r352", "r428", "r451", "r480", "r481", "r482", "r560", "r561", "r588", "r613", "r614", "r633", "r648", "r656", "r696", "r704", "r732", "r733", "r734", "r735", "r736" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails", "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r349", "r350", "r351", "r352", "r428", "r451", "r480", "r481", "r482", "r560", "r561", "r588", "r613", "r614", "r633", "r648", "r656", "r696", "r704", "r732", "r733", "r734", "r735", "r736" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails", "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r250", "r251", "r370", "r396", "r620", "r621" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r311", "r312", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r636", "r655", "r708" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r311", "r312", "r601", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r636", "r655", "r708" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r681", "r727" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "Derivative Instruments, Gain (Loss) [Roll Forward]", "verboseLabel": "Accumulated Other Comprehensive Income (Loss) [Roll Forward]" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt": { "auth_ref": [ "r126" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.", "label": "Accelerated Share Repurchases, Settlement (Payment) or Receipt", "terseLabel": "Accelerated share repurchase program, receipt (payment)" } } }, "localname": "AcceleratedShareRepurchasesSettlementPaymentOrReceipt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/TREASURYSTOCKNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r15", "r30" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Accounts payable, trade" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r316", "r317" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Trade accounts receivable, net of allowances of $3,544 and $4,304" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r33" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r45", "r50", "r154", "r666", "r667", "r668" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Defined Benefit Pension Items" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r230", "r238", "r239", "r517", "r622", "r666" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "terseLabel": "Gains and Losses on Derivatives" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails", "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails", "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r48", "r49", "r50", "r223", "r583", "r593", "r594" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r237", "r238", "r535", "r536", "r537", "r538", "r539", "r540" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails", "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r47", "r50", "r154", "r554", "r589", "r590", "r666", "r667", "r668", "r675", "r676", "r677" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Total", "verboseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails", "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED", "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r44", "r50", "r154", "r238", "r239", "r536", "r537", "r538", "r539", "r540", "r666" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Items" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Weighted average life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r22" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r488", "r489", "r490", "r675", "r676", "r677", "r717" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r132", "r133", "r454" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r224", "r318", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Trade accounts receivable, allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r76", "r89", "r95" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "negatedTerseLabel": "Amortization", "terseLabel": "Intangible asset amortization" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED", "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Shares excluded from computation as their effect would be antidilutive (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r193", "r203", "r222", "r247", "r294", "r300", "r306", "r319", "r354", "r355", "r357", "r358", "r359", "r361", "r363", "r365", "r366", "r515", "r519", "r533", "r653", "r702", "r703", "r729" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r216", "r226", "r247", "r319", "r354", "r355", "r357", "r358", "r359", "r361", "r363", "r365", "r366", "r515", "r519", "r533", "r653", "r702", "r703", "r729" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r163", "r167" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis Of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/BASISOFPRESENTATIONPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Leased facilities" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r511", "r646", "r647" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails", "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r138", "r139", "r511", "r646", "r647" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails", "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails", "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r514", "r669" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "verboseLabel": "Change in fair value of contingent consideration and others" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": { "auth_ref": [ "r148" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.", "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High", "terseLabel": "Contingent consideration, maximum undiscounted payment amount" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r145", "r146", "r513" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "verboseLabel": "Contingent consideration, estimated fair value" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": { "auth_ref": [ "r145", "r147" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Current", "terseLabel": "Contingent consideration, current" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "auth_ref": [ "r145", "r147" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "terseLabel": "Contingent consideration, noncurrent" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r141" ], "calculation": { "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "verboseLabel": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability": { "auth_ref": [ "r140", "r141" ], "calculation": { "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability", "terseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "auth_ref": [ "r141" ], "calculation": { "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": { "order": 2.0, "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "totalLabel": "Total current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r141" ], "calculation": { "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r141" ], "calculation": { "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Trade accounts receivable, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "auth_ref": [ "r141" ], "calculation": { "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r141" ], "calculation": { "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r141" ], "calculation": { "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "terseLabel": "Deferred Tax Liability" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r140", "r141" ], "calculation": { "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": { "order": 1.0, "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r140", "r141" ], "calculation": { "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r141" ], "calculation": { "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "totalLabel": "Total liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r141" ], "calculation": { "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Total liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CallOptionMember": { "auth_ref": [ "r595", "r596", "r597", "r598", "r599", "r600" ], "lang": { "en-us": { "role": { "documentation": "Financial contract between two parties, the buyer and the seller of the option, where the buyer has the right but not the obligation to buy an agreed quantity of a particular commodity or financial instrument (the underlying instrument) from the seller of the option for a certain price (the strike price). Seller is obligated to sell the asset to the buyer, if the buyer exercises the option.", "label": "Call Option [Member]", "terseLabel": "Call Option" } } }, "localname": "CallOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r78", "r218", "r615" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r73", "r78", "r79" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r73", "r186" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net decrease in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashDivestedFromDeconsolidation": { "auth_ref": [ "r66" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash.", "label": "Cash Divested from Deconsolidation", "terseLabel": "Cash divested from deconsolidation" } } }, "localname": "CashDivestedFromDeconsolidation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedges" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Warrant strike price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r107", "r346", "r347", "r602", "r701" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r675", "r676", "r717" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, authorized shares (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, issued shares (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r21", "r653" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock; $0.01 par value; 240,000 authorized shares; 90,813 and 90,477 issued at March\u00a031, 2023 and December\u00a031, 2022, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]", "terseLabel": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r51", "r234", "r236", "r242", "r579", "r585" ], "calculation": { "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "terseLabel": "Comprehensive income (See Note 14)", "totalLabel": "Comprehensive income, net" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails", "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r62", "r241", "r578", "r584" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContingentConsiderationByTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of contingent consideration.", "label": "Contingent Consideration by Type [Axis]", "terseLabel": "Contingent Consideration by Type [Axis]" } } }, "localname": "ContingentConsiderationByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ContingentConsiderationTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of contingent payment arrangement.", "label": "Contingent Consideration Type [Domain]", "terseLabel": "Contingent Consideration Type [Domain]" } } }, "localname": "ContingentConsiderationTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r706" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Schedule of Changes in Contract Assets and Contract Liabilities" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNet": { "auth_ref": [ "r400", "r402", "r422" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss", "periodEndLabel": "Contract asset, End of Period", "periodStartLabel": "Contract asset, Beginning of period" } } }, "localname": "ContractWithCustomerAssetNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetReclassifiedToReceivable": { "auth_ref": [ "r634" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.", "label": "Contract with Customer, Asset, Reclassified to Receivable", "negatedTerseLabel": "Transferred to trade receivable from contract asset included in beginning of the year contract asset" } } }, "localname": "ContractWithCustomerAssetReclassifiedToReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r400", "r401", "r422" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "periodEndLabel": "Contract liability, End of Period", "periodStartLabel": "Contract liability, Beginning of Period" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r400", "r401", "r422" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Contract liabilities", "verboseLabel": "Short-term portion of contract liability" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r400", "r401", "r422" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Long-term portion of contract liability" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r423" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "negatedLabel": "Contract liability, net of revenue recognized on contracts during the period" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r114", "r367", "r368", "r379", "r380", "r381", "r385", "r386", "r387", "r388", "r389", "r628", "r629", "r630", "r631", "r632" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtNoncurrent": { "auth_ref": [ "r37" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.", "label": "Convertible Debt, Noncurrent", "terseLabel": "Long-term convertible securities" } } }, "localname": "ConvertibleDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r84", "r299", "r300", "r301", "r302", "r308", "r680" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate and other" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r56", "r562" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of Sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r55" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total costs and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Costs and expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CrossCurrencyInterestRateContractMember": { "auth_ref": [ "r709", "r715" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.", "label": "Cross Currency Interest Rate Contract [Member]", "terseLabel": "Cross-currency swap" } } }, "localname": "CrossCurrencyInterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrencySwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.", "label": "Currency Swap [Member]", "terseLabel": "Foreign currency swaps" } } }, "localname": "CurrencySwapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r144" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "verboseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r116", "r246", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r383", "r390", "r391", "r393" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "DEBT" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBT" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r17", "r18", "r19", "r194", "r195", "r202", "r252", "r367", "r368", "r369", "r370", "r371", "r373", "r379", "r380", "r381", "r382", "r384", "r385", "r386", "r387", "r388", "r389", "r542", "r628", "r629", "r630", "r631", "r632", "r671" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails", "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Interest rates available" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r115", "r369" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Initial conversion price (in dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "auth_ref": [ "r36", "r120", "r121", "r123", "r369" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.", "label": "Debt Instrument, Convertible, Conversion Ratio", "terseLabel": "Initial conversion rate" } } }, "localname": "DebtInstrumentConvertibleConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r188", "r190", "r367", "r542", "r629", "r630" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Convertible notes, maximum borrowing capacity" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r381", "r532", "r629", "r630" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Fair value" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r35", "r368" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Convertible notes, interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails", "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r37", "r252", "r367", "r368", "r369", "r370", "r371", "r373", "r379", "r380", "r381", "r382", "r384", "r385", "r386", "r387", "r388", "r389", "r542", "r628", "r629", "r630", "r631", "r632", "r671" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails", "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Redemption price, percentage" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r37", "r120", "r122", "r123", "r124", "r187", "r188", "r190", "r201", "r252", "r367", "r368", "r369", "r370", "r371", "r373", "r379", "r380", "r381", "r382", "r384", "r385", "r386", "r387", "r388", "r389", "r392", "r542", "r628", "r629", "r630", "r631", "r632", "r671" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails", "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of debt outstanding.", "label": "Debt, Weighted Average Interest Rate", "terseLabel": "Weighted average interest rate on debt" } } }, "localname": "DebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredCompensationPlanAssets": { "auth_ref": [ "r663" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.", "label": "Deferred Compensation Plan Assets", "terseLabel": "Deferred compensation plan, fair value of assets" } } }, "localname": "DeferredCompensationPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/RETIREMENTPLANSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r189" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "terseLabel": "Incremental financing costs capitalized" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r189", "r705" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "terseLabel": "Debt issuance costs capitalized" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r492", "r493" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred tax assets, net" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r76", "r136", "r499", "r504", "r505", "r673" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred income tax provision" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r492", "r493" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": { "auth_ref": [ "r427", "r429", "r431", "r432", "r642", "r643", "r644" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.", "label": "Defined Benefit Plan, Plan Assets, Amount", "terseLabel": "Estimated fair value of plan assets" } } }, "localname": "DefinedBenefitPlanFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/RETIREMENTPLANSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r437", "r446", "r644", "r645" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "terseLabel": "Net periodic benefit costs" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/RETIREMENTPLANSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r426", "r438", "r447", "r644", "r645" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "verboseLabel": "Service cost component" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/RETIREMENTPLANSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]", "verboseLabel": "Derivative, Name [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r42", "r165", "r191", "r227", "r621" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Total derivatives designated as hedges \u2014 Assets" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r42", "r165", "r191", "r227", "r621" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Total derivatives designated as hedges \u2014 Liabilities" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeNet": { "auth_ref": [ "r532" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.", "label": "Derivative, Fair Value, Net", "terseLabel": "Fair Value Asset (Liability)", "verboseLabel": "Estimated Fair Value" } } }, "localname": "DerivativeFairValueOfDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate related to the interest rate derivative.", "label": "Derivative, Fixed Interest Rate", "terseLabel": "Fixed Interest Rate", "verboseLabel": "Fixed Rate" } } }, "localname": "DerivativeFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r164", "r166", "r170", "r172", "r621" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]", "verboseLabel": "Derivative, by Nature [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r182", "r526" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "DERIVATIVE INSTRUMENTS" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r161", "r164", "r170" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r161", "r164", "r170", "r172", "r175", "r176", "r524" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": { "auth_ref": [ "r169", "r714" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.", "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net", "terseLabel": "Derivative instruments not designated as hedging instruments, gain (loss), net" } } }, "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r712", "r713" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "netLabel": "Aggregate Notional Amount", "terseLabel": "Current notional amount", "verboseLabel": "Notional Amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r156", "r157", "r158", "r161", "r162", "r168", "r170", "r173", "r174", "r176", "r526" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DilutiveSecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]", "terseLabel": "Effect of dilutive securities:" } } }, "localname": "DilutiveSecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r421", "r635", "r636", "r637", "r638", "r639", "r640", "r641" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r708" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r457", "r484", "r485", "r487", "r491", "r649" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "STOCK-BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r214" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]", "terseLabel": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]", "terseLabel": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": { "auth_ref": [ "r100", "r105" ], "lang": { "en-us": { "role": { "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.", "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]", "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations" } } }, "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable": { "auth_ref": [ "r0", "r1", "r8", "r104" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accounts Payable", "terseLabel": "Disposal group, payable recognized" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Consideration", "terseLabel": "Sale of business, disposition price" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r646", "r647" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]", "verboseLabel": "Net income per share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r243", "r258", "r259", "r260", "r261", "r262", "r266", "r268", "r273", "r274", "r275", "r279", "r528", "r529", "r580", "r586", "r624" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (in dollars per share)", "verboseLabel": "Basic net income per common share (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED", "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Basic net income per share:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r243", "r258", "r259", "r260", "r261", "r262", "r268", "r273", "r274", "r275", "r279", "r528", "r529", "r580", "r586", "r624" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Diluted net income per common share (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED", "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Diluted net income per share:" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r276", "r277", "r278", "r280" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "NET INCOME PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/NETINCOMEPERSHARE" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r534" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of exchange rate changes on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective income tax rate", "verboseLabel": "Reported tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/INCOMETAXESNarrativeDetails", "http://integralife.com/role/INCOMETAXESSummaryofEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r33" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued compensation" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r486" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Total unrecognized compensation costs" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted-average period for cost recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]", "terseLabel": "Stock Options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r119", "r212", "r237", "r238", "r239", "r253", "r254", "r255", "r257", "r263", "r265", "r281", "r320", "r398", "r488", "r489", "r490", "r500", "r501", "r527", "r535", "r536", "r537", "r538", "r539", "r540", "r554", "r589", "r590", "r591" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails", "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails", "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED", "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ExtendedProductWarrantyPolicy": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability.", "label": "Extended Product Warranty, Policy [Policy Text Block]", "terseLabel": "Product Warranties" } } }, "localname": "ExtendedProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/BASISOFPRESENTATIONPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r381", "r431", "r432", "r433", "r434", "r435", "r436", "r530", "r557", "r558", "r559", "r629", "r630", "r642", "r643", "r644" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r184", "r185" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]", "terseLabel": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r381", "r431", "r436", "r530", "r558", "r629", "r630", "r642", "r643", "r644" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r381", "r431", "r432", "r433", "r434", "r435", "r436", "r530", "r559", "r629", "r630", "r642", "r643", "r644" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Fair Value, Inputs, Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r183", "r185" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r183", "r185" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Contingent Consideration" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r531" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "verboseLabel": "Change in fair value of contingent consideration liabilities" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r183" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Balance, End of Period", "periodStartLabel": "Balance, Beginning of Period", "terseLabel": "Fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r381", "r431", "r432", "r433", "r434", "r435", "r436", "r557", "r558", "r559", "r629", "r630", "r642", "r643", "r644" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r163", "r168", "r175" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FederalFundsEffectiveSwapRateMember": { "auth_ref": [ "r716" ], "lang": { "en-us": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.", "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]", "terseLabel": "Overnight Federal Funds" } } }, "localname": "FederalFundsEffectiveSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Weighted Average Life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r220", "r338" ], "calculation": { "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails": { "order": 2.0, "parentTag": "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "terseLabel": "Expected annual amortization expense, thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r96" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "Expected annual amortization expense, in 2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "terseLabel": "Expected annual amortization expense, remainder of 2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r96" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "Expected annual amortization expense, in 2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r96" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "Expected annual amortization expense, in 2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r96" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "Expected annual amortization expense, in 2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r96" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "Expected annual amortization expense, in 2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r335", "r337", "r338", "r340", "r563", "r564" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r90", "r94" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "terseLabel": "Foreign currency forward contracts" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": { "auth_ref": [ "r164" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.", "label": "Gain (Loss) on Derivative Instruments, Net, Pretax", "terseLabel": "Gain (loss) reclassified into other income" } } }, "localname": "GainLossOnDerivativeInstrumentsNetPretax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnDispositionOfAssets": { "auth_ref": [ "r670", "r694", "r695" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property", "negatedLabel": "Loss (gain) on disposal of property and equipment" } } }, "localname": "GainLossOnDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfBusiness": { "auth_ref": [ "r518", "r670" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.", "label": "Gain (Loss) on Disposition of Business", "terseLabel": "Gain from sale of businesses" } } }, "localname": "GainLossOnSaleOfBusiness", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r219", "r323", "r577", "r627", "r653", "r683", "r690" ], "calculation": { "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": { "order": 3.0, "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill", "weight": 1.0 }, "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "End of Period", "periodStartLabel": "Beginning of Period", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails", "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r329" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign currency translation" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r137", "r689" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Purchase Accounting Adjustments", "terseLabel": "SIA Acquisition Working Capital Adjustment" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r161", "r524" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r53", "r192", "r197", "r210", "r294", "r299", "r305", "r308", "r581", "r626" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r646", "r647" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r1", "r2", "r3", "r4", "r5", "r6", "r7", "r9", "r10", "r11", "r12", "r105", "r106" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]", "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r341", "r343" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r248", "r496", "r497", "r498", "r502", "r506", "r508", "r509", "r510" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/INCOMETAXES" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r249", "r264", "r265", "r292", "r494", "r503", "r507", "r587" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r75" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable, accrued expenses and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r75" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r75" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "terseLabel": "Other non-current liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r75" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other non-current assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r75" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r269", "r270", "r271", "r275", "r456" ], "calculation": { "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Stock options and restricted stock (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r336", "r339" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r92", "r97" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r88", "r93" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r189", "r199", "r240", "r288", "r541" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedTerseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseMember": { "auth_ref": [ "r171" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing interest expense.", "label": "Interest Expense [Member]", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which reported facts about interest income have been included.", "label": "Interest Income [Member]", "terseLabel": "Interest income", "verboseLabel": "Interest income" } } }, "localname": "InterestIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": { "auth_ref": [ "r177" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.", "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net", "terseLabel": "Gain expected to be reclassified to earnings in the next twelve months" } } }, "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "verboseLabel": "Interest rate swap" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "INVENTORIES" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/INVENTORIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r86", "r617" ], "calculation": { "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r225", "r616", "r653" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories, net", "totalLabel": "Inventories, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves": { "auth_ref": [ "r86", "r664" ], "calculation": { "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of items purchased for use as components of a finished product or pieces of machinery and equipment plus any items in their natural and unrefined state. This element may be used when the reporting entity combines raw materials and purchased parts into an aggregate amount.", "label": "Inventory, Raw Materials and Purchased Parts, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsAndPurchasedPartsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r86", "r618" ], "calculation": { "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r59", "r287" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseContractualTermAxis": { "auth_ref": [ "r723" ], "lang": { "en-us": { "role": { "documentation": "Information by contractual term of lease arrangement.", "label": "Lease Contractual Term [Axis]", "terseLabel": "Lease Contractual Term [Axis]" } } }, "localname": "LeaseContractualTermAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseContractualTermDomain": { "auth_ref": [ "r723" ], "lang": { "en-us": { "role": { "documentation": "Contractual term of lease arrangement.", "label": "Lease Contractual Term [Domain]", "terseLabel": "Lease Contractual Term [Domain]" } } }, "localname": "LeaseContractualTermDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r547" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r724" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of Operating Lease Maturities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r552" ], "calculation": { "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r552" ], "calculation": { "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": { "order": 7.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r552" ], "calculation": { "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r552" ], "calculation": { "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2028" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r552" ], "calculation": { "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r552" ], "calculation": { "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r552" ], "calculation": { "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r724" ], "calculation": { "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "terseLabel": "Remainder of 2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r552" ], "calculation": { "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Less: Imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseOptionToExtend": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.", "label": "Lessee, Operating Lease, Option to Extend", "terseLabel": "Period for extended lease" } } }, "localname": "LesseeOperatingLeaseOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r722" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Renewal Term", "terseLabel": "Option to extend lease, years" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r553" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "LEASES AND RELATED PARTY LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASES" ], "xbrltype": "textBlockItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Letters of credit outstanding" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r32", "r247", "r319", "r354", "r355", "r357", "r358", "r359", "r361", "r363", "r365", "r366", "r516", "r519", "r520", "r533", "r625", "r702", "r729", "r730" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r26", "r196", "r207", "r653", "r672", "r682", "r718" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r34", "r217", "r247", "r319", "r354", "r355", "r357", "r358", "r359", "r361", "r363", "r365", "r366", "r516", "r519", "r520", "r533", "r653", "r702", "r729", "r730" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r19", "r195", "r202" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit", "terseLabel": "Line of credit facility outstanding" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Line of credit, commitment fee percentage" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": { "auth_ref": [ "r532" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of the amount outstanding under the credit facility.", "label": "Line of Credit Facility, Fair Value of Amount Outstanding", "terseLabel": "Line of credit facility, fair value of amount outstanding" } } }, "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r31" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicates an ownership position in, or purchase of, a security.", "label": "Long [Member]", "terseLabel": "Long" } } }, "localname": "LongMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r19", "r195", "r205", "r380", "r394", "r629", "r630" ], "calculation": { "http://integralife.com/role/DEBTContractualMaturityTableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "totalLabel": "Principal Repayment" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTContractualMaturityTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r112", "r252", "r385" ], "calculation": { "http://integralife.com/role/DEBTContractualMaturityTableDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTContractualMaturityTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r112", "r252", "r385" ], "calculation": { "http://integralife.com/role/DEBTContractualMaturityTableDetails": { "order": 4.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2026" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTContractualMaturityTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r112", "r252", "r385" ], "calculation": { "http://integralife.com/role/DEBTContractualMaturityTableDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTContractualMaturityTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r674" ], "calculation": { "http://integralife.com/role/DEBTContractualMaturityTableDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "terseLabel": "Remainder of 2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTContractualMaturityTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r37", "r113" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r108", "r109", "r348", "r349", "r350", "r697", "r698" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "auth_ref": [ "r13", "r149" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]", "terseLabel": "ACQUISITIONS AND DIVESTITURES" } } }, "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURES" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r245" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r245" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r73", "r74", "r77" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r54", "r77", "r198", "r209", "r215", "r232", "r235", "r239", "r247", "r256", "r258", "r259", "r260", "r261", "r264", "r265", "r272", "r294", "r299", "r305", "r308", "r319", "r354", "r355", "r357", "r358", "r359", "r361", "r363", "r365", "r366", "r529", "r533", "r626", "r702" ], "calculation": { "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income", "totalLabel": "Net income", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails", "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED", "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED", "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedges" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/BASISOFPRESENTATIONPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Not Designated as Hedging Instrument" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r679" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": { "auth_ref": [ "r50", "r52" ], "calculation": { "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.", "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent", "terseLabel": "Other comprehensive gain (loss)" } } }, "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r294", "r299", "r305", "r308", "r626" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating income", "verboseLabel": "Operating income" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED", "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r721" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r544" ], "calculation": { "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Total lease liabilities", "totalLabel": "Total lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails", "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r544" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "netLabel": "Less: Current lease liabilities", "terseLabel": "Current lease liabilities", "verboseLabel": "Current portion of lease liability - operating leases" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails", "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r544" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "netLabel": "Long-term lease liabilities", "terseLabel": "Non-current lease liabilities", "verboseLabel": "Lease liability - operating leases" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails", "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r545", "r548" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r543" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "ROU assets", "verboseLabel": "Right of use asset - operating leases" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r551", "r652" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r550", "r652" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term (in years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Leased Assets [Line Items]", "terseLabel": "Operating Leased Assets [Line Items]" } } }, "localname": "OperatingLeasedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails", "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r298", "r299", "r300", "r301", "r302", "r308" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OptionIndexedToIssuersEquityEquityAxis": { "auth_ref": [ "r118", "r178", "r179", "r181" ], "lang": { "en-us": { "role": { "documentation": "Information by type of options indexed to an issuer's equity.", "label": "Option Indexed to Issuer's Equity [Axis]", "terseLabel": "Option Indexed to Issuer's Equity [Axis]" } } }, "localname": "OptionIndexedToIssuersEquityEquityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OptionIndexedToIssuersEquityStrikePrice1": { "auth_ref": [ "r117", "r180" ], "lang": { "en-us": { "role": { "documentation": "Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.", "label": "Option Indexed to Issuer's Equity, Strike Price", "terseLabel": "Initial strike price (in dollars per share)" } } }, "localname": "OptionIndexedToIssuersEquityStrikePrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_OptionIndexedToIssuersEquityTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.", "label": "Option Indexed to Issuer's Equity, Type [Domain]", "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]" } } }, "localname": "OptionIndexedToIssuersEquityTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r14", "r155" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "BASIS OF PRESENTATION" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/BASISOFPRESENTATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r163", "r175" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r221" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r46", "r48", "r151", "r153" ], "calculation": { "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": { "order": 4.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent", "negatedTerseLabel": "Pension liability adjustment, net of tax" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r151", "r152", "r153" ], "calculation": { "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "terseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": { "auth_ref": [ "r229" ], "calculation": { "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": { "order": 3.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent", "terseLabel": "Change in unrealized loss/(gain) on derivatives, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r228", "r229", "r521", "r522", "r525" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Gain (loss) recorded in AOCL, change in fair value", "verboseLabel": "Amount\u00a0of Gain (Loss) Recognized\u00a0in AOCL" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "auth_ref": [ "r229", "r231" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "terseLabel": "Amount\u00a0of\u00a0Gain (Loss) Reclassified from AOCL into Earnings" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r523" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "negatedTerseLabel": "Gain (loss) recorded, net investment hedge, change in fair value" } } }, "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r151", "r152", "r153", "r233", "r236" ], "calculation": { "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "terseLabel": "Other comprehensive income (loss), net of tax", "totalLabel": "Net current-period other comprehensive gain (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails", "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current liabilities.", "label": "Other Current Liabilities [Member]", "terseLabel": "Other Current Liabilities" } } }, "localname": "OtherCurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherDepreciationAndAmortization": { "auth_ref": [ "r57", "r76", "r101" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.", "label": "Other Depreciation and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "OtherDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherExpenseMember": { "auth_ref": [ "r171" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other expense.", "label": "Other Expense [Member]", "terseLabel": "Other income (expense)" } } }, "localname": "OtherExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesMember": { "auth_ref": [ "r163", "r175" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other liabilities.", "label": "Other Liabilities [Member]", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r38" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other Long-term Liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails", "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r61" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).", "label": "Other Nonoperating Income (Expense) [Member]", "terseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": { "auth_ref": [ "r72" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.", "label": "Payment for Contingent Consideration Liability, Financing Activities", "terseLabel": "Payment for contingent consideration" } } }, "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r69" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Purchases of treasury stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r71" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Payment of debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r244" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "negatedTerseLabel": "Cash taxes paid in net equity settlement" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r64", "r512" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payments to acquire businesses, gross" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment": { "auth_ref": [ "r64" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.", "label": "Payments to Acquire in Process Research and Development", "negatedLabel": "Acquired in-process research and development milestone" } } }, "localname": "PaymentsToAcquireInProcessResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r65" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r428", "r430", "r436", "r439", "r441", "r442", "r443", "r444", "r445", "r448", "r449", "r450", "r452", "r644" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Retirement Benefits [Text Block]", "terseLabel": "RETIREMENT PLANS" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/RETIREMENTPLANS" ], "xbrltype": "textBlockItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "Performance Stock" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PositionAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by position taken for a security.", "label": "Position [Axis]", "terseLabel": "Position [Axis]" } } }, "localname": "PositionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PositionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicates position taken for a security.", "label": "Position [Domain]", "terseLabel": "Position [Domain]" } } }, "localname": "PositionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r20", "r395" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, authorized shares (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, outstanding shares (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r20", "r653" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock; no par value; 15,000 authorized shares; none outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r665" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.", "label": "Prepaid Expenses and Other Current Assets [Member]", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpensesAndOtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "auth_ref": [ "r63" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.", "label": "Proceeds from Divestiture of Businesses", "terseLabel": "Proceeds from sale of business" } } }, "localname": "ProceedsFromDivestitureOfBusinesses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "auth_ref": [ "r68" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.", "label": "Proceeds from Issuance of Secured Debt", "terseLabel": "Proceeds from borrowings of long-term indebtedness" } } }, "localname": "ProceedsFromIssuanceOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "verboseLabel": "Proceeds from warrant transactions" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r67", "r131" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercised stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r103" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r103", "r208", "r582", "r653" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": { "auth_ref": [ "r50", "r52" ], "calculation": { "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent", "terseLabel": "Less: Amounts reclassified from accumulated other comprehensive income, net", "verboseLabel": "Gain (loss) reclassified from AOCI" } } }, "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails", "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r440", "r555", "r556" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r440", "r555", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r728" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfSecuredDebt": { "auth_ref": [ "r70" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.", "label": "Repayments of Secured Debt", "negatedTerseLabel": "Payments on debt" } } }, "localname": "RepaymentsOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": { "auth_ref": [ "r134" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.", "label": "Research and Development Expense (Excluding Acquired in Process Cost)", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r80" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r23", "r125", "r206", "r592", "r594", "r653" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r212", "r253", "r254", "r255", "r257", "r263", "r265", "r320", "r488", "r489", "r490", "r500", "r501", "r527", "r589", "r591" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r285", "r286", "r298", "r303", "r304", "r310", "r311", "r314", "r420", "r421", "r562" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Total Revenues", "verboseLabel": "Total revenue, net" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED", "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails", "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails", "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r425", "r623" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Summary of Accounting Policies on Revenue Recognition and Shipping and Handling Fees" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/BASISOFPRESENTATIONPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r403", "r404", "r405", "r406", "r407", "r408", "r410", "r411", "r424", "r425" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "REVENUES FROM CONTRACTS WITH CUSTOMERS" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Performance obligations expected to be satisfied, expected timing" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "auth_ref": [ "r707" ], "lang": { "en-us": { "role": { "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Percentage", "terseLabel": "Expected performance obligation through 2021, percentage" } } }, "localname": "RevenueRemainingPerformanceObligationPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for election to exclude from measurement of transaction price tax assessed by governmental authority that are both imposed on and concurrent with specific revenue-producing transaction, and collected from customer. Includes, but is not limited to, sales, use, value-added and excise tax.", "label": "Revenue, Transaction Price Measurement, Tax Exclusion [Policy Text Block]", "terseLabel": "Taxes Collected from Customers" } } }, "localname": "RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/BASISOFPRESENTATIONPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r549", "r652" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Operating leases" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r50", "r719", "r720" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Changes in Accumulated Other Comprehensive Loss by Component" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]", "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r138", "r139", "r511" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails", "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.", "label": "Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r37", "r120", "r122", "r123", "r124", "r187", "r188", "r190", "r201", "r629", "r631", "r674" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-term Debt Maximum Leverage Ratios" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r164", "r170", "r524" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of Fair Value and Presentation of Derivatives" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "auth_ref": [ "r156", "r157", "r158", "r161", "r162", "r168", "r170", "r173", "r174" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Schedule of Derivative Instruments [Table Text Block]", "terseLabel": "Schedule of Derivative Instruments" } } }, "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r678" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Basic and Diluted Net Income (Loss) Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/NETINCOMEPERSHARETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r135" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of Effective Income Tax Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r90", "r94" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r627" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r627", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Changes in Carrying Amount of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r97", "r98" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r16", "r27", "r28", "r29" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventories, Net" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/INVENTORIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "terseLabel": "Schedule of Contractual Repayments of Long-Term Debt" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOperatingLeasedAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Schedule of Operating Leased Assets [Table]", "terseLabel": "Schedule of Operating Leased Assets [Table]" } } }, "localname": "ScheduleOfOperatingLeasedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails", "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r169", "r714" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.", "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]", "terseLabel": "Derivatives Not Designated as Hedging Instruments" } } }, "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r142" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r81", "r82", "r83", "r87" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails", "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails", "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r81", "r82", "r83", "r87" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Geographic Revenue by Area", "verboseLabel": "Schedule of Net Sales and Profit by Segments" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r453", "r455", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SecuredDebtCurrent": { "auth_ref": [ "r17", "r194", "r204" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Secured Debt, Current", "terseLabel": "Current portion of borrowings under senior credit facility", "verboseLabel": "Term loan component of senior credit facility" } } }, "localname": "SecuredDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]", "terseLabel": "Secured Debt" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SecuredLongTermDebt": { "auth_ref": [ "r37" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.", "label": "Secured Long-Term Debt, Noncurrent", "terseLabel": "Long-term borrowings under senior credit facility" } } }, "localname": "SecuredLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "auth_ref": [ "r716" ], "lang": { "en-us": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.", "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate" } } }, "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r282", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r308", "r314", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r344", "r345", "r627", "r737" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails", "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails", "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails", "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r282", "r283", "r284", "r294", "r297", "r302", "r306", "r307", "r308", "r309", "r310", "r313", "r314", "r315" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "SEGMENT AND GEOGRAPHIC INFORMATION" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails", "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails", "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting Information, Operating Income (Loss) [Abstract]", "terseLabel": "Segment Net Sales" } } }, "localname": "SegmentReportingInformationOperatingIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingInformationProfitLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting Information, Profit (Loss) [Abstract]", "terseLabel": "Segment Profit" } } }, "localname": "SegmentReportingInformationProfitLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r58" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r75" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "auth_ref": [ "r649" ], "lang": { "en-us": { "role": { "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period", "terseLabel": "Requisite service periods of awards" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r649" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Stock options exercisable, vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Awards granted during the period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Other than options, weighted average grant date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r711" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures", "terseLabel": "Grants in period, net of forfeitures (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Options, weighted average grant date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r650" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "terseLabel": "Expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r119" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Balance End of Period, Shares (in shares)", "periodStartLabel": "Balance Beginning of Period, Shares (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicates the sale of a borrowed security or written option.", "label": "Short [Member]", "terseLabel": "Short" } } }, "localname": "ShortMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StandbyLettersOfCreditMember": { "auth_ref": [ "r111", "r150", "r211", "r353" ], "lang": { "en-us": { "role": { "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.", "label": "Standby Letters of Credit [Member]", "terseLabel": "Standby Letters of Credit" } } }, "localname": "StandbyLettersOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r213", "r282", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r308", "r314", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r342", "r344", "r345", "r627", "r737" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails", "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails", "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails", "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r40", "r119", "r212", "r237", "r238", "r239", "r253", "r254", "r255", "r257", "r263", "r265", "r281", "r320", "r398", "r488", "r489", "r490", "r500", "r501", "r527", "r535", "r536", "r537", "r538", "r539", "r540", "r554", "r589", "r590", "r591" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails", "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails", "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED", "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r253", "r254", "r255", "r281", "r562" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r20", "r21", "r119", "r125" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Issuance of common stock through employee stock purchase plan (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r20", "r21", "r119", "r125" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r20", "r21", "r119", "r125" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Issuance of common stock through employee stock purchase plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r20", "r21", "r125", "r130" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Issuance of common stock for vesting of share based awards, net of shares withheld for taxes" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r20", "r21", "r119", "r125" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedLabel": "Accelerated shares repurchased (shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r20", "r21", "r119", "r125" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedTerseLabel": "Accelerated shares repurchased" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r21", "r24", "r25", "r85", "r653", "r672", "r682", "r718" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails", "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED", "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Codman tradename" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "auth_ref": [ "r127" ], "lang": { "en-us": { "role": { "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.", "label": "Treasury Stock Acquired, Average Cost Per Share", "terseLabel": "Treasury stock, average cost per share (in dollars per share)" } } }, "localname": "TreasuryStockAcquiredAverageCostPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/TREASURYSTOCKNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r127" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "terseLabel": "Treasury stock (in shares)" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/TREASURYSTOCKNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockCommonValue": { "auth_ref": [ "r41", "r127", "r128" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Value", "terseLabel": "Treasury stock" } } }, "localname": "TreasuryStockCommonValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/TREASURYSTOCKNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r39", "r127" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r39", "r127" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "negatedPeriodEndLabel": "Balance, end of period, treasury stock, shares (in shares)", "negatedPeriodStartLabel": "Balance, beginning of period, treasury stock, shares (in shares)", "terseLabel": "Treasury stock, shares (in shares)" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical", "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockTextBlock": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Treasury Stock [Text Block]", "terseLabel": "TREASURY STOCK" } } }, "localname": "TreasuryStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/TREASURYSTOCK" ], "xbrltype": "textBlockItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r39", "r127", "r128" ], "calculation": { "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost; 8,918 shares and 6,823 shares at March\u00a031, 2023 and December\u00a031, 2022, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails", "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]", "terseLabel": "Leased vehicles" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r267", "r275" ], "calculation": { "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average common shares for diluted earnings per share (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED", "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted average common shares outstanding (See Note 13):" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r266", "r275" ], "calculation": { "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average common shares outstanding - Basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED", "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WriteOffOfDeferredDebtIssuanceCost": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.", "label": "Write off of Deferred Debt Issuance Cost", "terseLabel": "Write off of debt issuance costs" } } }, "localname": "WriteOffOfDeferredDebtIssuanceCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://integralife.com/role/DEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" } }, "unitCount": 11 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907907&loc=d3e12803-110250", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "63", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=126970277&loc=d3e23176-110880", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/subtopic&trid=2208821", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=2122178", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90193-114008", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90198-114008", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "32", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919569&loc=SL82860478-203043", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e526-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "https://asc.fasb.org/topic&trid=2235017", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column E)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column F)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r62": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "https://asc.fasb.org/topic&trid=2134417", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r657": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r658": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r659": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r661": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r662": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r701": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "4CC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(6)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org/topic&trid=2144416", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 95 0000917520-23-000030-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000917520-23-000030-xbrl.zip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